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  Foreword 
 
 
 The present report is being published in the year 2012, which marks the centennial of 
the adoption of the first international drug control treaty, the International Opium 
Convention signed at The Hague on 23 January 1912.1 The 1912 Convention, as it came to be 
known, can be thought of as the cornerstone of international drug control. The present report 
of the International Narcotics Control Board is dedicated to the hundredth anniversary of the 
adoption of that historic convention. 
 Prior to the adoption of the 1912 Convention, the world was experiencing an abysmal 
situation with regard to drugs. In most countries, trade in drugs was not regulated and 
substance abuse was widespread. In the United States of America, for example, about 90 per 
cent of the narcotic drug consumption at that time was for non-medical purposes. In China, 
the amount of opiates consumed each year at the beginning of the twentieth century is 
estimated to have averaged more than 3,000 tons in morphine equivalent — significantly 
more than global consumption (both licit and illicit) 100 years later. The signing of the  
1912 Convention reflected the recognition at that time of the need for international 
cooperation in drug control. 
 At the end of the nineteenth century and the beginning of the twentieth century, non-
governmental organizations worked tirelessly to promote the well-being and welfare of the 
general population in the face of powerful business interests in the then internationally 
legalized drug trade. Those non-governmental organizations succeeded in bringing 
Governments together, first in Shanghai (in 1909) and then in The Hague (in 1912), to agree 
that priority must be given to the protection of individuals and communities against drug 
abuse and addiction, which at the time afflicted a very large proportion of the population. 
 The centennial of the adoption of the 1912 Convention is an appropriate occasion for 
recalling the tremendous efforts by those progressive non-governmental organizations and to 
acknowledge the positive response of Governments at that time. It is important to note that, 
also today, many non-governmental organizations promote the right of people to be free from 
drug abuse. 
 In signing the 1912 Convention, Governments recognized the importance of drugs 
being available for medical and scientific purposes and, at the same time, acknowledged that 
people must be protected against the risk of becoming dependent on dangerous drugs and 
losing their freedom as a result of drug dependence. Subsequent conventions reinforced that 
principle, highlighting the importance of providing for treatment, rehabilitation and social 
reintegration programmes for drug-dependent persons to help them to overcome their 
dependence and regain their freedom, recognizing that being free from drug addiction is a 
human right. 
 Over the past 100 years, significant achievements have been made in international drug 
control, which is now based on the three international drug control conventions: the Single 
Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol;2 the Convention on 
Psychotropic Substances of 1971;3 and the United Nations Convention against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances of 1988.4 Those conventions enjoy almost 
universal adherence, demonstrating the confidence that Governments have in them and in 
the international drug control system. The international drug control system is a great 
example of how multilateralism can succeed in bringing benefits to humanity, preventing the 
abuse of drugs, as well as the harm caused by such abuse, while ensuring adequate availability 
__________________ 
 1  League of Nations, Treaty Series, vol. VIII, No. 222. 
 2  United Nations, Treaty Series, vol. 976, No. 14152. 
 3  Ibid., vol. 1019, No. 14956. 
 4  Ibid., vol. 1582, No. 27627. 
  _ __________ 
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of drugs for medical and scientific purposes, including the treatment of pain and mental 
illness. 
 The diversion of narcotic drugs and psychotropic substances has been almost 
completely eliminated at the international level. Drug traffickers and illicit drug users now 
resort primarily to illicitly manufactured drugs. Implementation of the 1988 Convention has 
led to a well-functioning international system for the control of precursor chemicals, 
preventing their diversion for use in illicit drug manufacture. The control of some precursors 
has been so effective that drug traffickers and illicit drug manufacturers have now resorted to 
using non-scheduled substances as substitutes for the more closely monitored precursor 
chemicals. 
 While much has been achieved in international drug control over the past century, 
significant challenges lie ahead, many of which are highlighted in the present report. 
 Countries throughout the world are faced with the challenge posed by marginalized 
communities, which are vulnerable to drug-related problems. That subject is addressed in the 
present report in chapter I, entitled “Social cohesion, social disorganization and illegal drugs”. 
In that chapter, the Board, while recognizing the importance of personal responsibility, 
describes how, in some communities, drug abuse has become almost endemic, part of a 
vicious cycle involving a wide array of social problems relating to violence, organized crime, 
corruption, unemployment, poor health and poor education. Those communities pose a risk 
not only to the persons living in them, but also to the wider society of which the communities 
are a part. 
 Social cohesion — the ties that bind people together in communities and society — can 
be an indicator of the health of communities, and drug abuse and criminality can be a 
symptom of a “fractured” society — a society suffering from lack of cohesion. Threats to 
social cohesion can include social inequality, migration, political and economic 
transformation, an emerging culture of excess, the growth of individualism and consumerism, 
shifting traditional values, conflict, rapid urbanization, a breakdown in respect for the law, 
and the existence of an illicit drug economy at the local level. While a combination of those 
threats can be seen in many communities throughout the world, their existence does not 
mean that marginalization and drug problems are inevitable. It is important to respond to the 
needs of communities experiencing social disintegration before a tipping point is reached, 
beyond which the capacity for effective counteraction becomes insufficient. 
 Much is being done by Governments to address the causes and meet the needs of 
marginalized communities experiencing drug problems. However, much more can be done to 
address those problems. In this report, the Board provides some examples of efforts under 
way to deal with these problems and makes a number of cross-cutting and multidisciplinary 
recommendations. Key to such efforts is involving local people at every stage of any 
intervention. Addressing the needs of marginalized communities experiencing drug problems 
can be challenging for Governments and local organizations, but the consequences of not 
doing that are much more significant and should be avoided at all cost. 
 Ensuring appropriate access to internationally controlled substances used for medical 
purposes is another challenge. About 80 per cent of the world’s population has limited or no 
access to controlled substances; that means that in most countries many people are suffering 
unnecessarily. In some countries and regions, however, overconsumption of certain controlled 
substances is a growing concern, as it may lead to additional health problems. Recently, the 
international community joined in recognition of the challenge of non-communicable 
diseases at the High-level Meeting of the General Assembly on the Prevention and Control of 
Non-communicable Diseases, held in New York in September 2011. As a participant in that 
meeting, I emphasized the importance of the appropriate availability of internationally 
controlled substances for the relief of pain and treatment of mental illness. I also emphasized 
 v 
that substance use disorders were preventable and treatable, and I stressed the need for 
primary prevention programmes. 
 World drug problems are particularly affected by globalization. Drug control action in 
one country or region can have an impact on individuals or society as a whole in other 
countries or regions. The present report includes an analysis of the world drug control 
situation, considering national drug control action, policy and legislation, regional 
cooperation, illicit drug crop cultivation and illicit drug production, trafficking and abuse, as 
well as treatment and rehabilitation for drug abusers. In many countries, data on the extent of 
drug problems are clearly lacking, which makes it difficult to decide on the appropriate action 
to be taken. 
 One major challenge to the international drug control system is the recent decision by 
the Government of the Plurinational State of Bolivia to denounce the Single Convention on 
Narcotic Drugs of 1961 as amended by the 1972 Protocol. At the same time that it announced 
its decision, the Government made known its intention to reaccede to the Convention with a 
reservation. The Board has noted with regret that unprecedented step taken by the Bolivian 
Government and is concerned that, inter alia, while the denunciation itself may be technically 
permitted under the Convention, it is contrary to the fundamental object and spirit of the 
Convention. If the international community were to adopt an approach whereby States parties 
would use the mechanism of denunciation and reaccession with reservations, the integrity of 
the international drug control system would be undermined and the achievements of the past  
100 years in drug control would be compromised. 
 In its report for 2011, the Board outlines many of today’s challenges in drug control. As 
we celebrate the centennial of the signing of the International Opium Convention at The 
Hague in 1912, let us also celebrate the achievements of the international drug control system 
in the past century and bolster our efforts to make the next century of drug control even more 
successful than the last one. 
 
 
Hamid Ghodse 
President 
International Narcotics Control Board 
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Explanatory notes 
 
 
 Data reported later than 1 November 2011 could not be taken into consideration in preparing 
this report. 
 The designations employed and the presentation of the material in this publication do not 
imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations 
concerning the legal status of any country, territory, city or area or of its authorities, or concerning 
the delimitation of its frontiers or boundaries.  
 Countries and areas are referred to by the names that were in official use at the time the 
relevant data were collected. 
 All references to Kosovo in the present publication should be understood to be in compliance 
with Security Council resolution 1244 (1999). 
 References to dollars ($) are to United States dollars, unless otherwise stated. 
 
 The following abbreviations have been used in this report: 
AIRCOP Airport Communication Project 
ASEAN Association of Southeast Asian Nations 
BZP N-benzylpiperazine 
CARICC Central Asian Regional Information and Coordination Centre 
CARICOM Caribbean Community 
CARPHA Caribbean Public Health Agency 
CICAD Inter-American Drug Abuse Control Commission (Organization 
of American States) 
CICIG International Commission against Impunity in Guatemala 
CONAPRED National Commission for the Study and Prevention of  
Drug-related Crimes (Panama) 
COPOLAD Cooperation Programme on Drug Policies between Latin 
America and the European Union 
mCPP 1-(3-chlorophenyl)piperazine 
DARE Drug Abuse Resistance Education 
DEVIDA National Commission for Development and Life without Drugs 
(Peru) 
DNE National Narcotics Directorate (Colombia) 
ECOWAS Economic Community of West African States 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
Europol European Police Office 
GBL gamma-butyrolactone 
GHB gamma-hydroxybutyric acid 
ha hectare 
INTERPOL International Criminal Police Organization 
ISAF International Security Assistance Force 
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LSD lysergic acid diethylamide 
MDMA methylenedioxymethamphetamine 
3,4-MDP-2-P 3,4-methylenedioxyphenyl-2-propanone 
ONA National Anti-Drug Office (Bolivarian Republic of Venezuela) 
Operation PAAD Operation Phenylacetic Acid and Its Derivatives 
P-2-P 1-phenyl-2-propanone 
PEN Online Pre-Export Notification Online 
SICA Central American Integration System 
THC tetrahydrocannabinol 
UEMOA West African Economic and Monetary Union 
UNODC United Nations Office on Drugs and Crime 
WACI West African Coast Initiative 
WHO World Health Organization 
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 I. Social cohesion, social disorganization and illegal drugs 
 
 
1. The abuse of illegal drugs is one of the greatest 
challenges that the world is facing today. Occurring in all 
countries, from the richest to the poorest, it is a problem 
that involves all groups and, increasingly, all ages, fuelling 
global crime, corruption and terrorism, generating 
unimaginable wealth for the few and limitless harm for the 
many, costing millions of lives and threatening the very 
sustainability of communities the world over.  
2. The scale and impact of the world’s drug problem are 
challenging health, educational, criminal justice, social 
welfare, economic and, in some instances, political systems 
in countries around the globe. It is a problem that has 
gathered enormous momentum and that, with new 
technologies, including the Internet, has found new means 
of increasing its influence and profitability.  
3. The focus of the present chapter, however, is not on 
the general pattern of drug abuse in different societies but 
rather on the development within many countries of 
communities of varying size — some large, some small — 
in which drug abuse has become virtually endemic, driving 
and in turn being driven by a whole host of social 
problems, including violence, organized crime, corruption, 
unemployment, poor health and poor education, in a 
vicious spiral of individual and collective harm. These 
communities present enormous challenges, not only in 
terms of meeting their own needs but also in terms of the 
risk that they may in time come to pose to the wider 
societies of which they are a part.  
4. The problems that these communities are facing and 
the trend towards increasing levels of drug abuse, 
criminality and social disintegration are disheartening. 
There are, however, initiatives already under way within 
many of these communities through which governmental 
and non-governmental agencies are working with 
commitment and determination to bolster the capacity of 
local people and to tackle the multiple social problems that 
have become so endemic in these areas.  
5. The importance of meeting the needs of the residents 
within these communities can hardly be in doubt. The 
Millennium Development Goals of eradicating extreme 
poverty, ensuring the provision of universal primary 
education for all children, promoting gender equality, 
promoting global public health, reducing child mortality, 
improving maternal health, combating HIV/AIDS, 
ensuring environmental sustainability and facilitating 
global partnerships for development provide a political 
consensus for action designed to tackle the needs of these 
high-risk and highly vulnerable communities. 
6. It is important to recognize that, while many of these 
marginal communities pose a major risk to the health and 
welfare of those who live within them, in the course of time 
they could come to pose a major risk to the wider societies 
of which they are a part. These are not communities that 
can or should be ignored, either in terms of their own 
needs or the challenges that they may pose more broadly.  
7. Societies are by their very nature more than the 
accumulation of a large number of discrete individuals. Key 
within the very notions of community and society are the 
ties that bind people together and provide a common sense 
of identity and purpose. When individuals and families 
have a clear sense of being connected to their neighbours, a 
shared investment in the future, a common language, 
mutual respect and a deep sense of trust, there is likely to 
be a strong sense of community.  
8. However, where individuals feel that they have little 
vested interest in the wider society and, crucially, when 
they feel that the wider society has little regard for their 
welfare, there is a real danger that the ties that would 
otherwise bind people together will weaken, creating a 
deeply fractured sense of community and providing an 
enormous impetus to a wide range of social problems. The 
degree of social cohesion within communities and societies 
is very much a barometer of the health of those societies. 
When societies are fractured, with little sense of cohesion, 
there are likely to be multiple problems, of which drug 
abuse and criminality may be only the most visible signs. 
Those problems can give rise to a higher level of social 
disorder and violence, as has been experienced in cities 
throughout the world, and the social disorder and violence 
can spill over into the wider society, well beyond the 
boundaries of those communities. 
 
 
 A. Growth of marginal communities and 
the drug abuse problems in those 
communities 
 
 
9. What is now being seen in countries around the 
globe, in rich nations and in poor nations, is the 
development of marginal communities in which a 
combination of conflict, violence, drug abuse, criminality, 
intimidation, poor health, poor education and limited or 
non-existent opportunities for employment have had a 
devastating effect and become the norm for many of the 
people living within them.  
10. Drug abuse, drug trafficking and organized 
criminality have become everyday occurrences within these 
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communities. These are areas where the ability of the 
national and local governments to regulate activities has 
become increasingly challenged and where heavily armed, 
well-financed criminal gangs have taken on the role of 
providing local governance, shaping the lives of local 
people through a combination of intimidation and short-
term reward. Within these communities, the drug abuse 
problem has acquired extraordinary momentum. Young 
people growing up in these areas are often drawn to the 
enormous wealth and status seemingly enjoyed by those 
involved in drug trafficking and drug dealing.  
11. Although there are well-known and well-publicized 
examples of these marginal communities in countries such 
as Brazil, Mexico, South Africa, the United States of 
America and the United Kingdom of Great Britain and 
Northern Ireland, the problem exists in every region. There 
are communities, some in rural areas and some in the heart 
of the most affluent cities on the planet, where the local 
people no longer feel part of the wider society and where 
the problems of social exclusion and social disintegration 
are all too evident.  
12. Many of these communities are witnessing a 
dangerous downward spiral in which an array of social 
problems, including drug abuse, violence, organized crime, 
poverty, poor health, limited education and widespread 
unemployment, have gathered momentum. These are 
communities in which individuals and families are 
experiencing a profound sense of hopelessness, which leads 
them to believe that the circumstances in which they are 
living will never change and that they will never experience 
the benefits of safety, security and economic stability that 
are enjoyed by other members of their society. Confronted 
by a reality in which they seem to have been cut adrift from 
the wider society, some people may inadvertently feel that 
there is little reason not to engage in a lifestyle involving 
illegal drugs and criminality.  
13. These communities are often seen as “no-go areas”, 
places that one simply does not go to, for fear of 
experiencing violence or intimidation. Those who live 
within these communities may develop a strong sense of 
identity and connection with their community that may be 
both a source of strength and a source of separation from 
the wider society. Equally, those living within the wider 
society may come to see the residents of these areas as 
fundamentally different from themselves, living lives that 
are somehow characterized by danger and criminality.  
14. At the same time, many of the agencies working 
within these communities (police, health services, social 
services and educational services) may come to feel that the 
challenge posed by these areas is simply too great for them 
to address within their finite resources. In the case of the 
police, for example, local criminal gangs can attain a 
position of such power and influence over these 
communities that it is simply beyond the capacity of 
conventional law enforcement agencies to successfully 
investigate criminal acts and prosecute those involved. In 
some instances, criminal gangs have deliberately targeted 
the police, killing significant numbers of law enforcement 
officers and sending a powerful message to local people 
that it is they, the criminal organizations, and not the police 
who are in charge. An additional dimension to the gang 
problem is the gang-versus-gang dynamic, which reinforces 
the individual’s sense of belonging to the gang. 
15. Confronted by a reality in which the capacity of law 
enforcement agencies can seem insufficient to tackle the 
level of organized criminality within these communities, 
those living in these areas may come to feel that they are 
effectively being held hostage within their own homes and 
neighbourhoods. 
16. The message that is often powerfully conveyed to 
local people by these criminal gangs is not to talk to the 
police. It is a message that is often conveyed with both the 
threat of violence and actual violence. Local people may 
become fearful of speaking out against those who are 
engaged in the drug economy within these communities. 
Indeed, even if they may be inclined to report incidents to 
the police, they may fear that corrupt elements within the 
local police may cause their reports to be passed on to 
those who are engaged in such criminality. In turn, this 
may lead to a situation in which little or no information is 
passed to the police, as a result of which the view might 
develop that the entire community is somehow complicit in 
the criminal lifestyle. 
17. When law enforcement agencies do mount 
operations to tackle criminal gangs within these areas, such 
operations may sometimes need to be carried out in a 
manner resembling a military operation. Indeed, on 
occasion the only law enforcement operations deemed safe 
by the authorities are those that combine the police with 
elements of the military, so heavily armed are the criminal 
gangs that are essentially running these areas. No matter 
how well-resourced, well-planned and professionally 
executed these operations are, the impression inevitably 
conveyed is that the authority of the State is under severe 
threat. 
18. Alienation and disintegration within these 
communities are evidenced not only by the extent to which 
drug dealing, drug abuse and drug-related criminality are 
occurring. Very often these communities are characterized 
by poor or non-existent health services, limited social 
services, underfunded educational services, poor or  
non-existent transport systems, poor sanitation and limited 
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access to goods, services and employment, as well as 
elevated levels of morbidity and mortality. 
19. Although meeting the needs of the populations 
within these areas will undoubtedly be challenging, the 
consequences of failure would be far greater and should be 
avoided at all cost. The challenge extends well beyond 
providing effective and efficient law enforcement to socially 
rehabilitating these areas so that their residents can enjoy 
the benefits of full participation within the wider society. 
Moreover, it must be acknowledged that any social 
rehabilitation efforts will face fierce competition from 
entrenched gangs. 
 
 
 B. Threats to social cohesion 
 
 
20. The present section outlines the threats to social 
cohesion that are now being observed within some 
communities. While such threats are numerous and varied, 
it is important to recognize that none of the social 
processes described below should be seen as leading 
individuals inevitably into a lifestyle of drug abuse and 
criminality. Whenever and wherever an individual engages 
in such behaviour, at some level he or she has exercised 
some element of personal choice. This is not to “blame the 
victim” but rather to recognize that, whatever the social 
processes and social pressures at hand, human beings still 
have the capacity to exercise some element of choice in 
what they do and what they refrain from doing. 
Importantly, it is this element of choice that holds out the 
prospect of improvement and rehabilitation, even in the 
most challenging of circumstances, and of individuals 
finding a way out of their current difficulties. 
 
 1. Persistent social inequality 
 
21. It is a feature of many societies that, just as some 
social groups have become increasingly wealthy, the gap 
between the rich and the poor has increased and become 
entrenched. As a consequence of these inequalities, there 
are marked disparities in a range of health and social 
welfare indicators, such as maternal and child health, infant 
mortality, morbidity, life expectancy and literacy.  
22. When societies experience these multiple, persistent 
and long-standing inequalities, some social groups come to 
believe that there is simply no prospect of their ever 
enjoying the benefits of full participation in the wider 
society. Faced with a future with limited opportunities, 
individuals within these communities may increasingly 
become disengaged from the wider society and become 
involved in a range of personally and socially harmful 
behaviours, including drug abuse and drug dealing. 
 
 2. Migration 
 
23. Where individuals and social groups have migrated 
from one area to another, there is an increased risk that 
individuals and communities will face multiple social 
adversities associated with their sense of displacement. 
These may include challenges to their physical and 
psychological health, welfare, employment, education and 
family life. While migration offers many positive benefits to 
the migrant and to society at large, it can create a sense of 
dislocation from the surrounding community and a sense 
of vulnerability on the part of those who are displaced. 
Where migrating social groups have travelled from areas 
associated with illicit drug production and drug abuse, 
there is a greater likelihood of individuals engaging in 
forms of drug misuse as a way of coping with such a sense 
of dislocation. 
 
 3. Political and economic transformation 
 
24. Similarly, societies that are in the midst of political 
and economic transformation may experience a significant 
reduction in the degree of social cohesion. In a situation in 
which past political structures and economic activities are 
no longer supported and new forms of economic activity 
and governance are evolving, some social groups may feel 
isolated and disengaged from the wider society. That sense 
of estrangement from the new structures of governance 
may lead individuals and social groups to engage in a 
variety of socially and personally harmful behaviours.  
 
 4. Emerging cultures of excess 
 
25. Social cohesion can be undermined not only by 
poverty and social exclusion, but also by the emergence of a 
culture of excess. For example, certain individuals who 
enjoy a high standard of living may come to see themselves 
as no longer needing to live in accordance with the norms 
and mores of the wider society and may develop  
self-destructive patterns of behaviour. For some of these 
individuals, their abuse of certain drugs (such as cocaine in 
powder form) can come to symbolize their success and 
status. The abuse of drugs by some celebrities and some 
others working in the arts and in the music and 
entertainment industries may come to be seen as a 
reflection of their creative talent and status. The resulting 
development of a culture of acceptance of illicit drug use on 
the part of some individuals and social groups can 
contribute to a growing normalization of certain forms of 
drug misuse within the wider society and in turn can lead 
to the undermining of social cohesion. 
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 5. Growth of individualism and consumerism 
 
26. There has been an increasing tendency in some 
societies to give meeting the needs of the individual much 
more priority than meeting the needs of the wider 
community. The growing importance accorded to meeting 
the desires of the individual and the increasing emphasis on 
consumerism have weakened social cohesion within some 
societies and led to an increase in some forms of personally 
and socially harmful behaviour such as drug misuse.  
 
 6. Shift in traditional values 
 
27. The level of social cohesion within societies may also 
be severely undermined when there is a shift in traditional 
values as a result of cultural, political, economic and 
spiritual changes, along with a subsequent evolution of new 
sets of values. This situation may result in some social 
groups feeling excluded or disconnected from the new and 
emergent values and more inclined to pursue their own 
interests irrespective of the impact on the wider society. 
 
 7. Conflict and post-conflict societies 
 
28. When societies are experiencing conflict or are in a 
post-conflict state, there are often clear signs of a 
breakdown in social cohesion. In such situations, 
previously close and mutually supportive social ties may 
become strained and weakened, leaving large swathes of the 
population uncertain of the degree to which they are 
members of a shared society. Societies recovering from 
conflict may experience a vacuum of governance, during 
which social services may be lacking and justice and law 
enforcement may not be apparent. This may further 
weaken an already fragile state of social cohesion. 
 
 8. Rapid urbanization 
 
29. Within societies that are undergoing rapid 
urbanization, including those in which populations are 
moving from rural to urban environments, a diminution 
and dissolution of many of the more traditional forms of 
social cohesion may occur. This may include a breakdown 
in family connectedness and family closeness. It may also 
include the development of urban areas as cultural spaces 
in which a greater range of individual behaviours and social 
and personal transgressions are tolerated as a result of the 
increased sense of anonymity within those areas. 
 
 9. Breakdown in respect for the law 
 
30. In situations in which local people feel that their legal 
system is unfair, corrupt or ineffective, there is likely to be a 
predictable loss of faith in those laws and the agencies 
involved in their implementation. At such times, there is a 
real risk that people will simply give up on the expectation 
that the national or local government will ever be able to do 
anything to improve their circumstances. Politicians and 
public officials may be viewed with suspicion and mistrust 
and may be increasingly seen as being motivated by a desire 
to improve their own situation rather than that of the local 
people. Such a situation may lead to criminal gangs 
presenting themselves as the only viable authority in the 
area. 
 
 10. Local drug economy 
 
31. Within these communities, the illicit drug trade may 
become so active as to effectively supplant the legitimate 
economy, with the danger being not only the proliferation 
of the illicit drug trade itself but also the development of a 
culture of drug abuse. In some circumstances, such a 
culture can be self-sustaining in that it provides the people 
who live in these areas with a distinctive identity while 
simultaneously further separating them from the wider 
society. 
32. These are the multiple problems that are being faced 
by “hot-spot” communities in countries and regions 
throughout the world. They are the extreme expression of 
the drug and crime problems that are equally evident 
around the world. These multiple problems often combine 
to such a degree that they shape the lives of the people 
living in such communities. 
 
 
 C. Responding to the problem 
 
 
33. At the present time, governments, community 
agencies and voluntary groups in countries around the 
globe are implementing initiatives aimed at tackling the 
multiple problems posed by these marginal communities. 
For example, community policing, the enhancement of 
social services, the provision of recreational opportunities 
and urban revitalization may be beneficial in improving 
social cohesion in communities experiencing social 
disintegration.  
34. In Brazil, for example, the Government has sought to 
wrest control from armed criminal gangs in the favelas by 
carrying out a series of high-profile raids using a 
combination of police and military personnel to arrest gang 
leaders and institute the rule of law. Such law enforcement 
approaches have been complemented in some areas with a 
commitment to community policing in which “peace 
police” units work to build relationships with local 
residents, sometimes offering classes or supporting groups 
of young people in a way that is more akin to social work. 
Through these combined efforts, an attempt is being made 
to tackle the power base of the organized criminal gangs 
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and to build up a sense of trust between the police and 
residents in such a way as to enhance the safety and 
security of those living in these areas.  
35. Within the Cape Flats area in South Africa, where 
there is a long history of high rates of drug abuse, violence, 
poor health and low employment, national and 
international agencies have implemented initiatives aimed 
at reducing the level of street-related violence through 
urban upgrading. These initiatives, often targeting areas 
with high levels of crime, involve upgrading and developing 
local transport systems, reclaiming neglected urban space, 
improving lighting and closer monitoring as a way of 
enhancing the safety of local residents. Within a number of 
these communities, small community centres called “active 
boxes” have been set up along major pedestrian routes. 
Staffed 24 hours a day by local residents, the centres have 
been used to reduce the risk of violence to local people.  
36. Similar urban upgrading schemes, often funded 
through a variety of national and international 
organizations, have been developed in Colombia and  
El Salvador in an attempt to improve the circumstances of 
marginal communities with high levels of drug abuse and 
crime. 
37. In the United States, the Safe Streets programme, 
developed initially in Chicago and then extended to other 
cities, is aimed at reducing levels of street-related violence 
within marginal communities. In Baltimore, the 
programme has been used to engage a wide range of local 
community groups, spiritual communities and voluntary 
and statutory bodies in an attempt to bolster local 
community efforts to tackle the various problems that have 
become endemic to areas of the city experiencing high 
levels of crime and drug abuse. Outreach work in areas 
where there have been incidents involving firearms is 
aimed at encouraging young people to explore alternative 
ways of resolving disputes and avoiding violence involving 
firearms.  
38. In other United States cities confronted with  
drug-related crime involving the use of firearms, local 
police have been running schemes whereby residents are 
provided with a financial reward in exchange for any 
weapon handed to the police. Although those most likely to 
be involved in street violence will probably not hand in 
their weapons, such schemes produce a feeling that the 
overall level of safety among local people is enhanced as a 
result of fewer weapons being in circulation. 
39. Although technology such as the Internet is 
extensively used by drug traffickers and gangs, it can also 
be used effectively to empower communities to take action 
against drug-related crime and organized crime. For 
example, in India the website “I paid a bribe” enables 
individuals to report instances in which they have been 
requested by an official to provide a bribe to facilitate 
administrative procedures. While such schemes can be 
effective in empowering communities, there is a risk that 
they may also be used by criminals to threaten and 
intimidate others.  
40. In Scotland, where drug abuse and criminality were 
seen to be having a particular impact on a specific area, the 
local police and council developed a child safety initiative 
in which local police were empowered to pick up children 
under the age of 16 who were on the streets and 
unsupervised after 9 p.m. and return them to their parents. 
In Liverpool and some other cities in the United Kingdom, 
similar projects that involve taking vulnerable young 
people off the streets at night have been developed as a way 
of tackling problems involving gang membership and 
street-based criminality.  
41. Police forces in British cities such as Birmingham, 
Liverpool and Manchester, like their colleagues in Brazil, 
have also sought to address the problem of incidents 
involving firearms by combining law enforcement 
responses to the problem with community policing 
initiatives aimed at building trust and mutual support with 
community members. For example, police officers have 
been working closely with the siblings of known gang 
members, who are at particular risk of becoming gang 
members.  
42. In France, a new judicial mechanism has been created 
specifically for deprived areas. Maisons de justice et du droit 
(centres for justice and law) have been established in the 
heart of disadvantaged zones to deal with minor and 
moderate cases of delinquency. Acting, in effect, as 
branches of the courts, the centres essentially operate by 
way of mediation. Managed by a magistrate and supported 
by members of civil society, the centres also receive victims 
and organize legal consultations. There are currently 107 of 
the centres, receiving over 500,000 individuals each year. 
43. Other schemes have involved working with the 
parents of young people known to be at risk of becoming 
gang members, with the aim of supporting the parents’ own 
attempts to limit their children’s exposure to street 
criminality and better enabling the parents to recognize the 
early signs of gang membership among their children. 
Attention has also been given to ensuring that young 
people on the streets in these communities have access to 
alternatives to spending their time with gang members. 
These schemes have entailed providing free or subsidized 
access to facilities for leisure activities, setting up clubs and 
organizing activities for young people in a concerted 
attempt to create alternatives to gang membership, with the 
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added benefit of promoting improved social cohesion 
among young people in the community. 
44. In the Catalonia region of Spain, a unique approach 
to gang membership and gang-related violence has been 
attempted, with a commitment on the part of the provincial 
government to drawing certain gangs into the process of 
local governance. For example, an attempt has been made 
to reconstitute a specific gang as a cultural association 
promoting the interests of young people and facilitating the 
assimilation of Latin American immigrants. Through the 
process of legitimization, the gang has been able to have 
access to a range of public benefits, which has enabled it to 
provide a range of educational and training projects in the 
areas in which it operates. The obligation placed upon gang 
members as part of the process of legitimization is that they 
must cease their involvement in criminal and violent 
activities.  
45. In the Islamic Republic of Iran, there has been a 
determined effort to strengthen the provision of drug abuse 
prevention material in schools, prisons and the workplace 
as a way of reducing the impact of drug abuse and HIV on 
society. Non-governmental organizations working within 
each of these sectors have sought to increase local 
knowledge about risk factors and risk reduction and to 
promote a wide range of leisure and sporting activities in 
an attempt to reduce the number of young people 
becoming involved in drug abuse and drug-related 
activities.  
46. Aside from the various initiatives explicitly focused 
on tackling problems involving drugs and crime in 
marginal communities, there has also been recognition that 
many aspects of the physical and social geography of these 
marginal communities are actually promoting the sense of 
social isolation and disintegration among residents and 
making the task of tackling those problems much more 
difficult. For example, some marginal communities have 
poor or virtually non-existent transport systems, 
hampering the provision of support services while 
furthering their sense of isolation and vulnerability. In an 
attempt to tackle such problems, the Governments of Brazil 
and other countries have made a commitment to 
improving the transport systems as a catalyst for other 
forms of development and support. There has been a 
commitment in some areas to developing for the first time 
an effective system of land registration and land-use 
control in an attempt to reverse the trend towards social 
disintegration. In some countries, such as Côte d’Ivoire, 
Ghana, Malawi, Peru and South Africa, initiatives have 
been developed to improve land registration in order to 
enable local residents to secure loans for development on 
the basis of their land ownership, thereby providing a 
catalyst and a means for development within these 
marginal communities.  
47. As different as these various initiatives are, their 
common element is the importance they place on involving 
local people at every stage of the intervention process.  
48. The International Narcotics Control Board 
emphasizes the importance of responding to the needs of 
communities experiencing social disintegration before they 
reach a point beyond which the regular capacity for 
effective action on the part of governments and local 
organizations becomes insufficient. The early signs of a 
breakdown in social cohesion within communities must be 
recognized and addressed. These signs may include 
changing demographics, changing land-use patterns, 
changing societal dynamics following migration or in  
post-conflict situations, poor levels of educational 
provision, inadequate availability of health services, limited 
retail provision, poor transport systems and escalating rates 
of violence.  
49. The problems posed within these communities have 
the capacity to spread well beyond the borders of the 
communities themselves; left unaddressed over time, the 
problems are indeed likely to do just that. At that point, 
these marginal communities might exert a powerful 
radicalizing effect, threatening the very fabric of the wider 
society. That is a threat that must not be allowed to develop. 
 
 
 D. Recommendations 
 
 
50. Addressing the vicious cycle of social disintegration 
and its associated drug problems requires a 
multidisciplinary approach involving stakeholders at all 
levels, including citizens, families, civil society, various 
levels of government and the private sector. In that regard, 
the Board makes the following recommendations: 
 (a) Governments must ensure the provision of 
drug abuse prevention services, especially in communities 
experiencing social disintegration. All stakeholders — 
schools, community groups, parents and state and 
voluntary agencies — should be involved in the design and 
implementation of interventions aimed at achieving this 
goal. These interventions should be tailored to the specific 
community, and their key message should be that drug 
abuse is not an inevitable feature of growing up within that 
community. Interventions should be implemented as part 
of a package of other activities that provide people, 
especially youth, with a positive sense of their own value 
and achievements and with the life skills required to resist 
engaging in drug-related activity; 
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 (b) Within communities experiencing social 
disintegration, people may be drawn to illicit drug activity 
if they feel that there are no other opportunities available to 
them. Governments should therefore ensure that young 
people and families can have access to educational, 
employment and leisure opportunities similar to those that 
are available in other areas; 
 (c) In communities that are economically 
deprived, the signs of financial success associated with 
involvement in illegal drug activity may draw young people 
into the world of drug abuse, thereby furthering their 
marginalization from the wider society. Governments 
should therefore, as part of their strategies to tackle the 
drug problem in marginalized communities, address the 
visible signs of financial success associated with the illicit 
drug market and aim at promoting alternative role models 
for young people. This is particularly important in areas 
where gang leaders have previously been the only role 
models for young people; 
 (d) In so far as possible, a comprehensive 
programme of community rehabilitation measures should 
be implemented within communities suffering from social 
disintegration and problems related to drug abuse. As a 
first step, where necessary, Governments should support 
the development of an effective system of local governance, 
with the involvement of citizens, families and civil society, 
in order to empower the communities and promote a 
culture of aspiration rather than one of marginalization. In 
some communities, where necessary, Governments should 
invest in the provision of effective and equitable transport, 
health, educational and social support systems, as well as 
employment opportunities, and in the provision of 
adequate retail facilities. The involvement of the private 
sector should be encouraged as an investment opportunity 
rather than as a charitable donation; 
 (e) In planning and development processes, 
Governments should aim to ensure that these marginal 
communities have the capacity and the means to develop 
into thriving communities linked to, rather than cut off 
from, the wider society. The potential of the Internet and 
mobile communication technologies should also be utilized 
to facilitate such a connection; 
 (f) Governments should consider the 
implementation of community policing initiatives to build 
up relationships of trust and mutual respect with local 
people, while at the same time enhancing safety and 
security, so that law enforcement agencies are not seen as a 
threat to local people but rather as an asset for their 
protection and welfare. The active involvement of 
community police in leisure, sporting and cultural activities 
can facilitate the development of trust between residents 
and law enforcement, as well as promote respect for the 
rule of the law; 
 (g) Government agencies should ensure that  
high-quality drug treatment and rehabilitation services are 
easily accessible so that those with a drug abuse disorder 
can receive effective treatment with minimum delay. 
Treatment should be based on enabling individuals to 
become drug-free rather than on simply seeking to reduce 
some of the harm associated with continued levels of drug 
misuse; 
 (h) Law enforcement agencies must be cognizant 
of the importance of social cohesion in addressing social 
disintegration and the drug abuse problem within 
marginalized communities. Governments should ensure 
that law enforcement programmes aimed at wresting 
control from criminal gangs active in these communities 
are complemented by the measures recommended above, 
including community policing, prevention and treatment 
and the provision of services and infrastructure. Such 
efforts should be sustained in order to provide a greater 
sense of safety and security for residents and to challenge 
the apparent power of criminal gangs; 
 (i) A culture of development, empowerment and 
ownership involving all stakeholders should be promoted, 
rather than further marginalizing the affected communities 
by producing a culture of dependency. Microfinance-type 
funding schemes can enable individuals and groups  
in marginal communities to play an active role in 
furthering their own development and independence.  
Land-registration initiatives can provide a further impetus 
to grass-roots initiatives. Restoration processes may need to 
be kick-started by governments to create an example of 
what can be achieved within a community. Nevertheless, 
the necessity of involving members of the community in 
the restoration process and of developing their sense of 
ownership of it cannot be overstated; 
 (j) The Board underlines the importance of 
international cooperation in the building of capacity, the 
provision of technical assistance and the sharing of best 
practice in rehabilitating these marginalized communities 
by investing in social cohesion, services and infrastructure 
with the aim of promoting cohesive, safe and drug-free 
communities. 
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 II. Functioning of the international drug control system 
 
 
 A. Promoting the consistent application 
of the international drug control 
treaties 
 
 
51. In discharging its mandate under the international 
drug control treaties, the Board maintains an ongoing 
dialogue with Governments through various means, such 
as regular consultations and country missions. That 
dialogue has been instrumental to the Board’s efforts to 
assist Governments in complying with the provisions of the 
treaties. 
 
 1. Status of adherence to the international 
drug control treaties 
 
52. After protracted civil unrest that was followed by 
several years of autonomous rule, South Sudan became an 
independent State on 9 July 2011 and a Member State of the 
United Nations on 14 July 2011. The Board welcomes 
South Sudan as a new member of the United Nations 
family and looks forward to cooperating closely with its 
Government in combating drug trafficking and abuse. The 
Board hopes that the Government will give positive 
consideration to becoming a State party to the  
three international drug control treaties in the near future. 
The Board stands ready to assist the Government in 
ensuring that South Sudan’s legal and administrative 
structures are adequate to meet the obligations of those 
treaties. 
53. As at 1 November 2011, the number of States parties 
to the Single Convention on Narcotic Drugs of 19611 or 
that Convention as amended by the 1972 Protocol2 
remained at 186. Of those States, 184 were parties to the 
1961 Convention as amended by the 1972 Protocol. 
Afghanistan and Chad continue to be parties to the  
1961 Convention in its unamended form only. A total of 
nine States have yet to accede to the 1961 Convention or 
that Convention as amended by the 1972 Protocol:  
two States in Africa (Equatorial Guinea and South Sudan), 
one in Asia (Timor-Leste) and six in Oceania (Cook 
Islands, Kiribati, Nauru, Samoa, Tuvalu and Vanuatu). 
54. The number of States parties to the Convention on 
Psychotropic Substances of 19713 stood at 183. A total of  
12 States have yet to become parties to that Convention:  
3 States in Africa (Equatorial Guinea, Liberia and South 
Sudan), 1 in the Americas (Haiti), 1 in Asia (Timor-Leste) 
__________________ 
 1  United Nations, Treaty Series, vol. 520, No. 7515. 
 2  Ibid., vol. 976, No. 14152. 
 3  Ibid., vol. 1019, No. 14956. 
and 7 in Oceania (Cook Islands, Kiribati, Nauru, Samoa, 
Solomon Islands, Tuvalu and Vanuatu). 
55. The number of States parties to the United Nations 
Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 19884 stood at 184. A total of  
11 States have yet to become parties to that Convention:  
3 States in Africa (Equatorial Guinea, Somalia and South 
Sudan), 1 in Asia (Timor-Leste), 1 in Europe (the Holy See) 
and 6 in Oceania (Kiribati, Nauru, Palau, Papua New 
Guinea, Solomon Islands and Tuvalu). 
56. The Board notes that, despite its ongoing efforts to 
promote universal application of the international drug 
control treaties, 16 States, as mentioned above, have not yet 
become parties to all of the international drug control 
treaties. Oceania continues to be the region with the most 
States that have not acceded to all the treaties. The Board is 
concerned that failure to accede to any of the treaties may 
weaken the collective efforts of the international 
community to fight drug trafficking and abuse. The Board 
urges the States concerned to identify any impediments to 
their becoming parties to the international drug control 
treaties and to take the steps necessary to accede to all the 
treaties without further delay. 
 
 2. Evaluation of overall treaty compliance in 
selected countries 
 
57. The Board reviews on a regular basis the drug control 
situation in various countries and Governments’ overall 
compliance with the provisions of the international drug 
control treaties. The review covers various aspects of drug 
control, including the functioning of national drug control 
administrations, the adequacy of national drug control 
legislation and policy, measures taken by Governments to 
combat drug trafficking and abuse, and Governments’ 
fulfilment of their reporting obligations under the treaties. 
58. The findings of the review, as well as the Board’s 
recommendations for remedial action, are conveyed to the 
Governments concerned as part of the ongoing dialogue 
between the Board and Governments to ensure that the 
international drug control treaties are fully implemented. 
59. In 2011, the Board reviewed the drug control 
situation in Albania, Haiti, Mauritania and Papua New 
Guinea, as well as measures taken by the Governments of 
those countries to implement the international drug 
control treaties. In doing so, the Board took into account all 
__________________ 
 4  Ibid., vol. 1582, No. 27627. 
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information available to it, paying particular attention to 
new developments in drug control in those countries. 
 
 (a) Albania 
 
60. The Government of Albania has made some progress 
in drug control in recent years, in particular in the area of 
law enforcement. Drug control legislation is generally 
adequate. The first drug control strategy was concluded in 
2010 and the Government is preparing a new strategy, 
together with an action plan for its implementation, which 
will then be submitted to Parliament for approval. Progress 
has also been noted in providing the required information 
on precursors to the Board.  
61. Resources provided by the Government of Albania 
for drug control efforts remain insufficient. Although 
legislation is in force that provides for the creation of an 
inter-ministerial committee to coordinate drug control 
policy, the committee has not been able to function 
adequately because of a lack of resources. The Board notes 
the continued lack of adequate resources for the regulatory 
control of narcotic drugs, psychotropic substances and 
precursors by the Ministry of Health, which has an adverse 
impact on the effectiveness of such control. No centralized 
data collection mechanism exists and, consequently, there 
are inconsistencies in data on drug seizures and drug abuse.  
62. In Albania, rates of drug abuse are increasing, 
especially among young persons. Lack of coordination in 
the Government has hampered efforts to gather data on the 
drug abuse situation in the country and to establish 
adequate facilities for the treatment of drug addicts. The 
Board wishes to emphasize the importance of conducting a 
national survey on drug abuse in Albania in order to 
address that growing problem in a more effective manner. 
The Board urges the Government to make further efforts 
and to take more effective measures to ensure that progress 
is made in that area.  
63. The Board, as part of its ongoing dialogue with the 
Government of Albania, invited a delegation from the 
Government to attend its session in February 2011. The 
delegates reported on recent measures taken in the field of 
drug control in Albania and assured the Board of the 
Government’s commitment to drug control and to 
cooperating with the Board. The Board notes that 
continued efforts have been made by the Government of 
Albania. The Board looks forward to cooperating more 
closely with the Government with a view to achieving the 
aims of the international drug control treaties.  
 
 (b) Haiti 
 
64. The Board notes that Haiti has made considerable 
progress since the tragic earthquake of 12 January 2010. 
Despite many challenges and difficulties, the progress is 
being made in the reconstruction efforts in the country, 
undertaken with the support of the international 
community. In 2011, the President of the Board held 
meetings with the permanent representatives of Haiti to the 
United Nations in New York and Geneva to discuss issues 
relating to the drug control situation in Haiti and to explore 
the feasibility of conducting a mission of the Board to Haiti 
in due course. 
65. The Board notes with appreciation that the national 
drug control authorities of Haiti have resumed  
their mandatory reporting obligations under the  
three international drug control conventions and have 
regularly furnished statistical data on narcotic drugs, 
psychotropic substances and precursors, as well  
as estimates and assessments on narcotic drugs and 
psychotropic substances. The Board wishes to encourage 
the Government to continue its efforts in those areas.  
The Board trusts that the commitment of the Government 
to international drug control efforts will soon be 
strengthened by the accession of Haiti to the  
1971 Convention.  
66. Haiti continues to be an important transit area for the 
smuggling of cocaine into North America and Europe via 
the West Indies. The smuggling of cannabis from Haiti into 
its neighbouring countries continues to pose challenges to 
drug control efforts in the area. The destruction caused by 
the earthquake in 2010 and the resulting loss of capacity of 
the national drug law enforcement authorities in Haiti have 
given rise to fears that the country may be increasingly 
used by drug traffickers as a trans-shipment area for 
smuggling drugs. If unchecked, the trans-shipment of illicit 
drug consignments through Haiti will undermine efforts by 
the Government and the international community to 
strengthen State institutions and political stability. The 
Board therefore calls on the Government of Haiti to take 
the measures necessary to deter such illicit activity. The 
Board also calls on the international community to assist 
the Government of Haiti in that regard. 
 
 (c) Mauritania 
 
67. Mauritania is a party to all three international drug 
control treaties. In the past, the Board had expressed 
serious concerns regarding the compliance of the 
Government of Mauritania with those treaties. However, 
following intensive dialogue with the Board, the 
Government took steps to improve the national drug 
control mechanism, including through the amendment of 
national legislation on drug control, the adoption of a 
national drug control strategy and the enhancement of the 
country’s inter-ministerial body to improve cooperation. 
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68. The Board welcomes the measures taken by the 
Government of Mauritania to increase its capacity in drug 
control. However, those efforts will need to be further 
reinforced to enable the Government to respond adequately 
to emerging trends in drug abuse in Mauritania and drug 
trafficking in and through the country. The Board remains 
concerned about the increase in the smuggling of drugs 
into Europe through Mauritania and other countries in the 
Sahel area of West Africa.  
69. Like many countries in West Africa, Mauritania lacks 
the resources and capacity to effectively address the 
emerging problems of drug trafficking and drug abuse; the 
Board encourages the Government of Mauritania to step up 
its efforts to reduce illicit drug supply and demand and to 
collaborate with the Governments of neighbouring 
countries in that regard. The Board calls on the United 
Nations Office on Drugs and Crime (UNODC) and other 
international entities to support the capacity-building 
efforts of the Government of Mauritania so that the 
Government may make further progress towards 
compliance with the international drug control treaties. A 
mission of the Board to Mauritania is scheduled to take 
place in the near future. 
 
 (d) Papua New Guinea 
 
70. The Board continues to have concerns regarding the 
situation in Papua New Guinea, including the lack of 
adequate national drug control legislation, the absence of a 
mechanism for Government coordination in the area of 
drug control and the dismal record of the Government in 
cooperating with the Board, in terms of providing data 
required under the international drug control treaties and 
responding to the Board’s requests for information 
regarding the drug control situation in the country.  
71. There is every indication that the illicit cultivation of 
and trafficking in cannabis remain widespread in Papua 
New Guinea. Moreover, national drug control efforts are 
being undermined by a lack of coordination among 
Government agencies. The country also suffers from 
inadequate law enforcement capacity. Papua New Guinea 
remains one of the few countries in the world that have yet 
to become parties to the 1988 Convention. 
72. For many years, the Board has been raising issues of 
concern with the Government of Papua New Guinea. The 
Board will continue its dialogue with the Government with 
a view to promoting the country’s compliance with the 
international drug control treaties. The Board urges the 
Government of Papua New Guinea to give priority to 
taking measures to strengthen drug control and calls on the 
members of the international community, in particular 
UNODC, to provide the assistance necessary to remedy the 
situation as soon as possible. In September 2011, the 
President of the Board met with the Minister for Health of 
Papua New Guinea to discuss issues of concern to the 
Board, as well as a proposed mission of the Board to that 
country. 
 
 3. Country missions 
 
73. In pursuing its mandate under the international drug 
control treaties and as part of its ongoing dialogue with 
Governments, the Board undertakes a number of country 
missions every year to discuss with competent national 
authorities measures taken and progress made in various 
areas of drug control. The missions provide the Board with 
an opportunity to obtain not only first-hand information, 
but also a better understanding of the drug control 
situation in each country it visits, thereby enabling the 
Board to provide Governments with relevant 
recommendations and to promote treaty compliance. 
74. Since the previous report of the Board, the Board  
has sent missions to the following countries: Costa Rica, 
Czech Republic, Denmark, El Salvador, India, Libyan Arab 
Jamahiriya,5 Mexico, Myanmar, Serbia, United States and 
Zimbabwe. 
 
 (a) Costa Rica 
 
75. A mission of the Board visited Costa Rica in  
June 2011. Costa Rica is a party to all three international 
drug control treaties, and the Government is committed to 
the implementation of the provisions of those treaties. The 
Government has initiated legal and institutional reforms  
to increase the country’s capacity to counter drug 
trafficking while ensuring the availability of narcotic drugs 
and psychotropic substances for medical purposes. The  
system for ensuring that narcotic drugs, psychotropic 
substances and precursors are used for legitimate purposes 
only functions well in Costa Rica; there have been few cases 
in which controlled substances have been diverted into 
illicit channels. The Board notes with appreciation that the 
Government is taking measures to improve the availability 
of opioid analgesics for medical purposes.  
76. Because of its strategic location, Costa Rica continues 
to be used by traffickers as a transit country for illicit 
consignments of certain drugs, as well as precursors.  
The Board appreciates that Costa Rican authorities have 
taken steps to ensure that their efforts to counter such 
activities are coordinated with the efforts of national  
law enforcement authorities in other countries. Studies 
indicate that the prevalence of drug abuse in Costa Rica is 
__________________ 
 5  Since 16 September 2011, “Libya” has replaced “Libyan Arab 
Jamahiriya” as the short name used in the United Nations. 
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low but increasing and that the facilities for the treatment  
of drug abusers are having difficulties meeting the  
demand for such treatment. The Board has communicated 
to the Government of Costa Rica comprehensive 
recommendations to further improve the drug control 
system in the country. 
 
 (b) Czech Republic 
 
77. A mission of the Board visited the Czech Republic in 
November 2010. The purpose of the mission was to 
examine developments that had taken place since its 
previous mission to that country, in 2003, in particular 
legislative changes regarding the decriminalization of 
possession of drugs for personal consumption in amounts 
below defined thresholds, and to discuss with the 
competent national authorities measures for countering 
drug abuse and drug trafficking. The Czech Republic is a 
party to all three international drug control treaties. 
78. The Board notes that according to the national drug 
control legislation of the Czech Republic, the possession  
of drugs for personal consumption in amounts below 
defined thresholds is an administrative offence, and the 
cultivation of plants containing narcotic drugs or 
psychotropic substances for personal consumption in 
quantities below defined thresholds is also an 
administrative offence. The Board has entered discussions 
with the Government to examine whether that legislation is 
in conformity with the provisions of article 3, paragraph 2, 
of the 1988 Convention, which requires the establishment 
of such acts as criminal offences.  
79. The Board notes that the Government of the Czech 
Republic is committed to the goals and objectives of  
the international drug control treaties. The National Drug 
Policy Strategy 2010-2018 and the Drug Action  
Plan 2010-2012 reflect a well-balanced national policy on 
drug control. The Board appreciates the measures taken  
by the Government to counter illicit drug manufacture and 
trafficking by improving and strengthening the relevant 
provisions of national drug control legislation. The Board 
commends the Government for having put in place a  
well-organized and comprehensive network of services for 
the in- and outpatient treatment of drug abusers. 
 
 (c) Denmark 
 
80. A mission of the Board visited Denmark in 
September 2011. The aim of the mission was to review the 
Government’s efforts to comply with its obligations under 
the three international drug control conventions, to which 
it is a party, in particular the 1988 Convention, since the 
Board’s last mission to that country in 2004. 
81. In recent years, the estimated annual prevalence of 
illicit drug use among the general population and youth in 
Denmark has not increased, although the illicit use of some 
types of drugs has remained at relatively high levels. 
Programmes for the prevention and treatment of drug 
abuse are carried out by the Government. The Board 
welcomes the involvement of non-governmental 
organizations and community based groups in those 
programmes. The Board notes that comprehensive 
legislative measures and administrative policies related to 
drug control continue to be expanded by the Government. 
Although measures aimed at controlling the movement of 
precursors to, from and through Denmark exist, there is a 
need for Danish authorities to make more consistent use of 
the Pre-Export Notification Online (PEN Online) system, 
developed by the Board, to control all shipments of 
precursors. The Board would also appreciate an 
improvement in reporting on efforts in the country to 
counter the diversion of precursors.  
 
 (d) El Salvador 
 
82. A mission of the Board visited El Salvador in  
June 2011. The Board’s previous mission to that country 
had taken place in 2006. The competent national 
authorities reaffirmed their commitment to complying 
with the provisions of the international drug control 
conventions. The comprehensive national drug control 
strategy foresees, among other things, reforming of the 
legislative basis, enhanced law enforcement activities and 
initiatives to reduce the illicit demand for drugs. 
Administrative mechanisms for the control of narcotic 
drugs, psychotropic substances and precursor chemicals are 
functioning well. The Government has identified some 
factors impeding the availability of opioid analgesics for 
medical purposes, and it is taking steps to remove those 
impediments.  
83. El Salvador continues to be used by traffickers, 
including maras (youth gangs), as a transit country for 
illicit consignments of cocaine and “crack” (a cocaine 
derivative converted from cocaine hydrochloride)  
from South America destined for North America. It is  
also a transit country for precursor chemicals used in the 
illicit manufacture of amphetamine-type stimulants. The 
Board notes the efforts made by the Government  
of El Salvador to prevent drug trafficking through its 
territory. Studies on the prevalence of drug abuse in  
El Salvador appear to be outdated. The Board has made  
comprehensive recommendations to the Government 
aimed at strengthening the drug control situation in  
El Salvador. 
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 (e) India 
 
84. A mission of the Board visited India in  
December 2010. The Board notes with appreciation that 
the Government of India is fully committed to the 
objectives of the international drug control treaties. The 
controls over the licit cultivation of opium poppy and the 
licit production of opium are strictly implemented. The 
extent and patterns of drug abuse in India have changed; 
the Government has taken steps to carry out a new national 
survey on drug abuse; a pilot survey has already been 
conducted.  
85. The mission discussed with the authorities their 
efforts to further expand demand reduction activities and 
strengthen the primary prevention of drug abuse, as well as 
to ensure the sufficient availability of facilities for the 
treatment of drug abusers. Other issues discussed by the 
mission included the measures against the abuse of 
pharmaceutical preparations containing narcotic drugs or 
psychotropic substances, the action to eliminate the illicit 
cultivation of opium poppy and to prevent the illicit 
manufacture of synthetic drugs. The controls applied in 
India to the international trade in narcotic drugs and 
psychotropic substances are functioning well. The mission 
reviewed with the Government steps to improve the quality 
of the reporting by India on domestic licit activities related 
to narcotic drugs and, in particular, psychotropic 
substances. Also discussed were measures to ensure 
rational use of controlled substances, including opioid 
analgesics, and their availability for medical purposes. 
 
 (f) Libyan Arab Jamahiriya 
 
86. A mission of the Board visited the Libyan Arab 
Jamahiriya6 in January 2011. Noting the current situation 
in the country, the Board decided to postpone its 
consideration of recommendations on drug control in that 
country to an appropriate time. 
 
 (g) Mexico 
 
87. The Board sent a mission to Mexico in October 2011. 
The Board notes that the Government of Mexico, a party  
to all three international drug control conventions, is firmly 
committed to the goals and objectives of those treaties. 
Mexico is faced with problems related to the clandestine 
manufacture of methamphetamine on a large scale; most  
of the illicitly manufactured methamphetamine is 
subsequently smuggled into the United States. Mexico is 
also faced with problems related to drug and precursor 
trafficking. The Government of Mexico has implemented a 
__________________ 
 6  Since 16 September 2011, “Libya” has replaced “Libyan 
Arab Jamahiriya” as the short name used in the United 
Nations. 
number of measures since the last mission of the Board,  
in 2005, to address those illicit activities and curb the 
influence of the criminal organizations involved. The 
legislative basis has been strengthened to enable the 
judiciary to better respond to drug and precursor 
trafficking, and further improvements of the legislative 
basis have been planned. Cooperation with law 
enforcement and judicial authorities in other countries in 
the Americas has increased. A number of successes have 
been achieved in the area of law enforcement, and the 
criminal organizations involved in drug and precursor 
trafficking have been weakened.  
88. The Government of Mexico has developed a special 
programme of action to expand its drug abuse prevention, 
outreach and treatment activities. Since 2008, many 
Government facilities have been opened to provide services 
in the area of drug abuse prevention and counselling and 
treatment for drug addicts. The mission discussed with the 
competent national authorities courses of action to reduce 
the illicit demand for controlled substances. The Board 
notes the action taken by the Government to improve the 
availability of opioid analgesics and to address the 
continued problems of the illicit cultivation of cannabis 
plants and the illicit cultivation of opium poppy for  
the purpose of producing opium to be used as a raw 
material for illicit heroin manufacture in the country. The 
Board has provided comprehensive recommendations to 
the Government aimed at reducing the illicit supply of 
controlled substances while strengthening demand 
reduction activities in Mexico. 
 
 (h) Myanmar 
 
89. The Board sent a mission to Myanmar in  
December 2010. The Board notes that the Government of 
Myanmar remains fully committed to the eradication of 
illicit opium poppy cultivation in the country, as evidenced 
by the consistent implementation of the 15-year Drug 
Elimination Plan initiated by the Government in 1999. 
Since the Board’s last mission, in 2006, continued efforts 
have been made in Myanmar to address drug trafficking 
and abuse, and particular progress has been made in drug 
abuse prevention and in the treatment and rehabilitation of 
drug abusers. 
90. The Board notes, however, that significant challenges 
remain. In particular, although the illicit cultivation  
of opium poppy and production of opium declined 
significantly in Myanmar during the period 1999-2006, 
such cultivation has increased every year since 2007  
and, as a result, many of the farmers who used to grow 
opium poppy are likely to return to that activity. The  
Board is also concerned that, despite increased law 
enforcement efforts, Myanmar has emerged as a major 
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illicit manufacturer of amphetamine-type stimulants, in 
particular methamphetamine tablets. In recent years, 
Myanmar has reported the seizure of a considerable 
amount of precursor chemicals. Trafficking in ephedrine 
and pseudoephedrine in the form of pharmaceutical 
preparations has also increased. Furthermore, limited 
progress has been made by the Government in addressing 
the existing problems in ensuring the adequate availability 
of opioids for medical purposes in the country. 
 
 (i) Serbia 
 
91. A mission of the Board visited Serbia in  
October 2011. Serbia is a party to all three international 
drug control conventions and is committed to the 
implementation of the conventions. The Board notes with 
satisfaction the adoption by Serbia of a national drug 
control strategy and action plan, as well as a plan to  
create a national committee to coordinate the concerted 
efforts of all institutional stakeholders to implement 
national drug control initiatives. Serbia continues to be 
used as an important transit country for the smuggling of 
drugs along the Balkan route.  
92. The Board notes that Serbian law enforcement 
authorities have reported successful cooperation with 
regional and international partners, which has led to 
significant seizures of illicit drug consignments and to the 
dismantling of international criminal syndicates. The 
Government has recognized the need for an appropriate 
assessment of Serbia’s requirements for analgesics used for 
the treatment of pain, which remains low, and is 
considering adopting measures to address that issue. In 
recent years, the Government has initiated several 
programmes for the prevention of drug abuse and the 
treatment of drug addiction. However, Serbia does not 
currently have in place any rehabilitation or after-care 
programmes for drug addicts. 
 
 (j) United States of America 
 
93. A mission of the Board visited the United States in 
April 2011. The previous mission to that country had taken 
place in 1998. The mission examined with the authorities 
the “medical” cannabis schemes that exist in some states in 
the United States. The Board requests the Government to 
ensure the implementation of all control measures for 
cannabis plant and cannabis, as required by the  
1961 Convention as amended by the 1972 Protocol, in all 
states and territories falling within its legislative authority, 
as the United States is a party to that convention.  
The Government should send strong and clear messages  
to the public in general and youth in particular regarding 
the adverse health effects of cannabis abuse. The Board  
also encourages the Government to continue to closely 
monitor the situation with regard to the abuse of 
prescription drugs and to strengthen measures to prevent 
and reduce such abuse. 
94. The United States has considerable experience in 
tackling the problem of Internet pharmacies illegally 
distributing narcotic drugs and psychotropic substances. 
The Board encourages the Government to share its 
knowledge and best practices in that area with the 
authorities of other countries facing similar challenges and 
with the Board. The Board appreciates the close 
cooperation of the authorities of the United States in 
precursor control and invites the Government to continue 
its efforts to ensure the high quality of the statistical data 
furnished to the Board on narcotic drugs and psychotropic 
substances. 
 
 (k) Zimbabwe 
 
95. A mission of the Board visited Zimbabwe in  
June 2011. Owing to its central location in Southern Africa, 
Zimbabwe continues to be used as a transit country for 
illicit drug consignments. The abuse of cannabis is 
widespread in the country, and the abuse of some other 
drugs has increased, albeit from low levels. Drug traffickers 
have attempted to divert precursors into illicit channels via 
Zimbabwe. National legislation and administrative 
regulations provide an adequate basis for the 
implementation of the provisions of the international drug 
control treaties. The drug control structures of the 
Government are in place in spite of the political and 
economic upheavals of the past decade; however, the 
capacity of the drug control authorities needs to be 
strengthened.  
96. The mission discussed with the authorities ways to 
enhance demand reduction activities in Zimbabwe, in 
particular among young people, and to ensure that primary 
prevention and treatment are available throughout the 
country for abusers of all drugs. Among the issues 
discussed were measures to increase the capacity of the law 
enforcement authorities to counter drug trafficking and to 
increase the availability of controlled substances, including 
opioid analgesics, for medical purposes. 
 
 4. Evaluation of the implementation by 
Governments of recommendations made by 
the Board following its country missions 
 
97. As part of its ongoing dialogue with Governments, 
the Board also conducts, on a yearly basis, an  
evaluation of Governments’ implementation of the Board’s 
recommendations pursuant to its country missions.  
In 2011, the Board invited the Governments of the 
following five countries, to which it had sent missions  
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in 2008, to provide information on progress made in  
the implementation of its recommendations: Ethiopia, 
Mauritius, Romania, Ukraine and United Arab Emirates.  
98. The Board wishes to express its appreciation to the 
Governments of Mauritius, Romania, Ukraine and United 
Arab Emirates for submitting the information requested. 
Their cooperation facilitated the Board’s assessment of the 
drug control situation in those countries and the 
Governments’ compliance with the international drug 
control treaties. Information from the Government of 
Ethiopia was received too late to be reviewed by the Board 
and the outcome of its review will be included in the annual 
report for 2012. 
99. In addition, the Board reviewed the implementation 
of the Board’s recommendations following its 2007 
missions to Liberia and Viet Nam, which did not provide 
the requested information in time for review in 2010. 
 
 (a) Liberia 
 
100. Little progress has been made by the Government of 
Liberia in the implementation of the Board’s 
recommendations following its mission to that country in 
2007. In view of the many challenges facing the country 
after a protracted civil war, its capacity to effectively deal 
with drug control issues remains limited. The Board notes 
with concern that the country has not yet ratified the  
1971 Convention and that the current national drug 
control legislation has not been updated to meet the 
requirements of the international drug control treaties. 
Control over the licit import of narcotic drugs, 
psychotropic substances and precursor chemicals remains 
weak.  
101. The Board notes that measures need to be taken to 
intensify and streamline the various services of law 
enforcement agencies in Liberia that have a mandate to act 
against drug trafficking, in order to avoid duplicating 
efforts and wasting of resources. The Board calls on the 
Government to establish a system for controlling 
precursors and other chemicals used in the illicit 
manufacture of drugs. That is particularly important as 
Liberia has already been used by traffickers for the 
diversion of those substances.  
102. While drugs are widely abused in Liberia, the extent 
of drug abuse in the country is not known to the 
authorities. There has never been a systematic assessment 
of the nature, extent and patterns of drug abuse. The Board 
calls on the Government to carry out an assessment of drug 
abuse, including the collection and analysis of data on the 
incidence, prevalence and other characteristics of drug 
abuse. Such an objective assessment is indispensable for the 
design of programmes for the prevention of drug abuse and 
the treatment and rehabilitation of drug abusers.  
103. The Board urges the Government of Liberia to make 
further progress in complying with the international drug 
control treaties and to consider requesting UNODC and 
other international bodies to provide the necessary 
technical assistance. 
 
 (b) Mauritius 
 
104. The Government of Mauritius has acted on the 
Board’s recommendations following its mission to that 
country in 2008, and progress has been made in a number 
of areas of drug control. The Board notes with appreciation 
that the national drug control legislation has been 
strengthened and that administrative measures have been 
taken to further improve inter-agency cooperation and the 
coordination of the activities of the institutions, services 
and agencies active in addressing the problems of drug 
trafficking and abuse. Drug demand reduction activities in 
Mauritius are well coordinated by the health authorities, 
and drug abuse prevention campaigns are conducted 
throughout the country, with the support of the drug law 
enforcement authorities.  
105. The Government of Mauritius has strengthened 
national drug control capabilities, including control of sea 
and air boundaries, and has provided increased resources 
for the acquisition of relevant equipment and the training 
of staff. Police and customs authorities regularly carry out 
joint drug control activities at airports and seaports. 
Furthermore, collaboration with international partners at 
the operational level has been intensified to prevent the 
smuggling of drugs, notably preparations from Europe 
containing buprenorphine, into Mauritius.  
106. The Board, while acknowledging the progress made 
in drug control, encourages the Government of Mauritius 
to continue its efforts with regard to the treatment and 
rehabilitation of drug abusers. With regard to the existing 
methadone substitution programmes that are being 
conducted in Mauritius, the Board invites the Government 
to increase the provision of psychosocial support and to 
find ways of guiding drug abusers towards reducing their 
drug intake so that they may eventually stop abusing drugs. 
The Board notes that in Mauritius the availability of 
narcotic drugs and psychotropic substances for medical 
purposes remains limited. 
 
 (c) Romania 
 
107. The Government of Romania has acted on most of 
the recommendations made by the Board following its 
mission to that country in October 2008 and has made 
progress in a number of areas of drug control. The Board 
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notes that the Government has allocated more resources for 
the collection of statistical data to ensure that its reporting 
to the Board, as required under the international drug 
control treaties, is improved. Steps have also been taken to 
improve the availability of narcotic drugs and psychotropic 
substances for medical purposes. 
108. The Board welcomes the measures taken to improve 
customs and border control activities to prevent drug 
trafficking through the territory of Romania, including the 
provision of customs equipment for drug detection, the 
development and application of a drug information system 
within the customs authorities and the establishment of a 
coordinating unit within the police for the effective 
implementation of the National Anti-Drug Strategy for the 
period 2005-2012. Adequate legislation has been adopted 
to bring new substances under national control, and 
internal and international cooperation against drug 
trafficking has also improved. 
109. The Board notes that the Government of Romania is 
taking measures to strengthen its capacity to reduce illicit 
drug demand in the country. The Board encourages the 
Government to continue its efforts to ensure that further 
progress is made in that area, particularly with regard to 
the availability of facilities for the treatment of drug abusers 
and the establishment of reliable data on the drug abuse 
situation in the country. 
 
 (d) Ukraine 
 
110. The Government of Ukraine has acted on the 
recommendations made by the Board following its mission 
to that country in May 2008 and has made progress in a 
number of areas of drug control. The Board notes that the 
Government has taken measures to increase funding for 
the National Narcotics Control Committee. Steps have been 
taken to improve the coordination between national 
bodies, local authorities and law enforcement agencies in 
order to reduce illicit drug supply and demand; the 
information system has also been improved. Measures have 
also been taken to address the abuse of tramadol. 
111. Increased efforts have been made in Ukraine to limit 
the cultivation of opium poppy to an area of land sufficient 
to cover demand for poppy seeds used for culinary 
purposes and to prevent the diversion of poppy straw for 
use in illicit drug manufacture. To that end, the 
Government has carried out annual preventive operations, 
and progress has been made in breeding varieties of opium 
poppy with a low alkaloid content. The Board notes that 
the Government has taken measures to extend the use of 
narcotic drugs and psychotropic substances for medical 
purposes and invites the Government to continue its efforts 
in that regard. 
112. The Government of Ukraine has undertaken 
activities to reduce drug abuse by injection and the spread 
of HIV/AIDS. The Board looks forward to seeing further 
measures taken and progress made by the Government of 
Ukraine in the area of demand reduction. 
 
 (e) United Arab Emirates 
 
113. The Government of the United Arab Emirates has 
acted on the recommendations made by the Board 
following its mission to the country in January 2008 and 
has made progress in a number of areas of drug control. 
The Board notes that the Government has taken measures 
to make all the free trade zones on its territory subject to 
the laws governing the various activities related to the 
import and export of narcotic drugs, psychotropic 
substances and precursor chemicals, in accordance with 
article 18 of the 1988 Convention. The authorities of the 
United Arab Emirates have actively used PEN Online  
since 2009. 
114. Efforts have been made by the Government of the 
United Arab Emirates to strengthen the control of 
containers at seaports and in free trade zones, with 
meetings being held and workshops organized for officials 
responsible for seaports, free trade zones and customs. A 
website is currently being prepared on matters related to 
shipments and companies. The Board welcomes the 
introduction of controls over pharmaceutical preparations 
containing ephedrine or pseudoephedrine through the 
introduction of an authorization requirement for the 
import of such preparations.  
115. The Board notes various activities in the area of 
supply and demand reduction in the United Arab Emirates 
and looks forward to seeing continued progress made by 
the Government, particularly in collecting and 
communicating to the Board data on the extent and nature 
of the drug problem in the country, as well as in 
establishing a system for the detection of suspicious 
consignments in containers in or outside of free trade 
zones. 
 
 (f) Viet Nam 
 
116. The Government of Viet Nam has acted on the 
recommendations made by the Board following its mission 
to the country in October 2007 and has made progress in a 
number of areas of drug control. The Board notes that 
increased efforts have been made to make available drugs 
for medical purposes. Measures have been taken to 
improve the country’s reporting to the Board, as required 
under the international drug control treaties.  
117. The Board welcomes the steps taken in Viet Nam to 
improve the treatment and rehabilitation of drug abusers 
REPORT OF THE INTERNATIONAL NARCOTICS CONTROL BOARD  
 
16 
and the efforts made in participating in different projects 
sponsored by UNODC in that area. The Board encourages 
the Government to reinforce and support existing facilities 
as well as to undertake capacity-building in the field of 
treatment for drug abusers.  
118. The Board notes the measures taken by the 
Government of Viet Nam to cooperate with neighbouring 
countries in strengthening regional law enforcement 
activities in the areas of drug control and crime prevention. 
The Board encourages the Government to strengthen its 
systems for enhancing the detection of drug trafficking. 
119. The Board, while noting the increased efforts to 
provide the national authorities involved in drug control 
with adequate resources, encourages the Government of 
Viet Nam to pursue its efforts in that area in order to 
ensure that progress is made in addressing the drug 
problem in the country. 
 
 5. Evaluation of the implementation by 
Governments of the recommendations made 
by the Board in its annual reports for 2005, 
2006 and 2007 
 
120. In an effort to achieve the aims of the international 
drug control treaties, in 2011 the Board conducted  
an evaluation of implementation of the Board’s 
recommendations published in its annual reports  
for 2005, 2006 and 2007. The evaluation was based on 
information received from 123 countries and territories 
that had responded to the questionnaire developed for  
that purpose, as well as information available to the  
Board regarding treaty adherence and Governments’ 
compliance with control measures. The Board wishes to 
thank the Governments of the respondent countries for 
their contributions. 
121. The outcome of the evaluation suggests that most of 
the Board’s recommendations have been implemented, 
with varying degrees of progress made in the areas of 
concern to the Board, including (a) treaty adherence and 
compliance with control measures; (b) prevention of the 
diversion of controlled substances; (c) reduction of illicit 
crop cultivation and prevention of drug trafficking;  
(d) prevention of drug abuse; (e) availability and rational 
use of narcotic drugs and psychotropic substances for 
medical purposes; and (f) prevention of the illegal 
operation of Internet pharmacies and the misuse of courier 
services.  
122. The Board will continue to monitor the drug control 
situation in various countries, identify weaknesses in drug 
control at the national and international levels and, in 
cooperation with Governments, ensure full implementation 
of the international drug control treaties. The Board looks 
forward to the continued support of Governments in its 
endeavour to achieve the aims of those treaties. 
 
 
 B. Action taken by the Board to ensure 
the implementation of the 
international drug control treaties 
 
 
 1. Action taken by the Board pursuant to  
article 14 of the 1961 Convention and  
article 19 of the 1971 Convention 
 
123. Over the years, the Board has invoked article 14 of 
the 1961 Convention and/or article 19 of the  
1971 Convention with respect to a limited number of 
States. The Board’s objective has been to encourage 
compliance with those Conventions when other means 
have failed. In 2000, the Board invoked article 14 of the 
1961 Convention as amended by the 1972 Protocol with 
respect to Afghanistan, in view of the widespread  
illicit cultivation of opium poppy in that country. 
Afghanistan is currently the only State for which action is 
being taken pursuant to article 14 of the 1961 Convention 
as amended by the 1972 Protocol. 
124. Article 14 of the 1961 Convention (and that 
Convention as amended by the 1972 Protocol) and  
article 19 of the 1971 Convention set out measures that the 
Board may take to ensure the execution of the provisions of 
those Conventions. Such measures, which consist of 
increasingly severe steps, are taken into consideration when 
the Board has reason to believe that the aims of the 
Conventions are being seriously endangered by the failure 
of a State to carry out their provisions. The States 
concerned are not named until the Board decides to bring 
the situation to the attention of the parties, the Economic 
and Social Council and the Commission on Narcotic Drugs 
(as in the case of Afghanistan). Apart from Afghanistan, 
the States concerned have taken sufficient remedial 
measures so that the Board was able to terminate action 
taken under those articles vis-à-vis those States. 
 
 2. Consultation with the Government of 
Afghanistan pursuant to article 14 of the  
1961 Convention 
 
125. Since having invoked article 14 of the  
1961 Convention in 2000, the Board has maintained an 
ongoing dialogue with the Government of Afghanistan. 
Among other measures, the Board has undertaken  
three missions to Afghanistan at the political level,  
and three technical missions to assist the competent 
authorities of the country to comply with their treaty 
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obligations. Furthermore, at the invitation of the Board, 
high-level Government delegations from Afghanistan have 
attended its sessions on a number of occasions, as part of 
the continuing consultations under article 14 of the  
1961 Convention. 
126. Recently, in view of the continuing lack of progress 
made by Afghanistan in the implementation of its 
international obligations and commitments under the 
international drug control treaties, the Board has proposed 
to field a high-level mission to Kabul during 2011. As it was 
not possible to undertake that mission, the Board requested 
the Government of Afghanistan to send a high-level 
delegation to its 102nd session held in November 2011 in 
Vienna, to update the Board on the drug control situation 
in Afghanistan and measures taken and progress made by 
the Government in the implementation of the international 
drug control treaties. However, it was not possible for the 
Government of Afghanistan to comply with that request. 
 
 3. Current drug control situation in Afghanistan 
 
127. In 2011, the total area under illicit opium poppy 
cultivation in Afghanistan increased by 7 per cent, and 
potential illicit opium production increased by 61 per cent, 
amounting to 5,800 tons. Opium poppy cultivation took 
place in half of the country’s 34 provinces, with 95 per cent 
of the cultivation continuing to be concentrated in the 
southern and western regions. Opium poppy cultivation 
increased in most of the provinces of Afghanistan in 2011.  
128. Progress in reducing illicit opium poppy cultivation 
in Afghanistan appears to be slow and fragile. The Board 
urges the Government of Afghanistan to take adequate 
measures to implement its national drug control strategy 
and to ensure that illicit opium poppy cultivation in the 
country is gradually reduced and effectively prevented, 
particularly through the conduct of awareness and 
eradication campaigns and providing alternative 
livelihoods to the farming community in the areas affected. 
129. Afghanistan is a major grower of cannabis and one of 
the world’s largest producers of cannabis resin. The amount 
of land devoted to illicit cannabis cultivation in 2010 was 
estimated to be 9,000-29,000 hectares (ha), compared with 
10,000-24,000 ha in 2009. The number of provinces with 
cannabis cultivation also increased, from 17 in 2009 to  
19 in 2010. Annual production of cannabis resin was 
estimated at between 1,200 and 3,700 tons in 2010, based 
on the country’s high yields of up to 145 kg/ha. 
130. The Board notes with concern that drug abuse 
continues to increase in Afghanistan. Afghanistan has one 
of the highest rates of opiate abuse in the world, with a 
current annual prevalence rate of 2.65 per cent of the 
population aged 15-64 years. This represents a significant 
increase from the rate for 2005 (1.4 per cent). Afghanistan 
is also facing a rapid spread of drug-related HIV/AIDS 
infection.  
131. The Board remains concerned over the continued 
widespread corruption in Afghanistan and its effects on 
counter-narcotics efforts, security, good governance and 
economic development. The Board urges the Government, 
with the assistance of the international community, to 
enhance its efforts to establish a more effective, accountable 
and transparent administration at all levels. 
 
 4. Cooperation by the international community 
 
132. The Board welcomes the ongoing efforts made and 
progress achieved by the international community in 
enhancing security, improving governance and stepping  
up reconstruction and development. Progress in these areas 
is essential in helping Afghanistan to improve the drug 
control situation in the country. The increasing capacity  
of the Afghan National Police in general, and the  
Counter-Narcotics Police in particular, should have a 
significant impact on the Government’s efforts to counter 
illicit drug-related activities.  
133. The Board calls upon the international community to 
continue their efforts to support the implementation  
of the Kabul process following the International 
Conference on Afghanistan held in Kabul in July 2010. The 
Board also calls upon the Government of Afghanistan and 
the international community to take adequate measures 
 to ensure effective implementation of Security Council 
resolution 1817 (2008) on precursor control. The Board 
looks forward to the outcome of the conference  
on Afghanistan to be held in Bonn on 5 December 2011, 
focusing on issues of security, international commitment 
and political process, as well as the third Paris Pact 
ministerial conference, to be held in Vienna on  
16 February 2012. 
 
 5. Conclusions 
 
134. The Board reiterates that it is the Government of 
Afghanistan which has the primary responsibility with 
regard to the implementation of the international drug 
control treaties upon its territory. While the Board is aware 
of the severe obstacles currently facing the Government of 
Afghanistan, the Board believes that a number of 
important normative activities could be undertaken that 
would significantly contribute to improving the country’s 
drug control situation, for instance: improved control over 
the licit movement of internationally controlled substances; 
prevention of diversion and abuse of psychotropic 
substances; and enhanced precursor control.  
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135. The Board urges the Government of Afghanistan to 
step up its efforts in drug control and to improve its 
cooperation with the Board. The Board also urges the 
Government of Afghanistan to take the steps necessary to 
accede to the 1972 Protocol amending the Single 
Convention on Narcotic Drugs of 1961.7 
 
 
 C. Governments’ cooperation with the 
Board 
 
 
 1. Provision of information by Governments to 
the Board 
 
136. Each year, in addition to a report on its work, the 
Board publishes technical publications that provide 
Governments with analyses of statistical information on the 
manufacture, trade, consumption, utilization and stocks of 
internationally controlled substances, as well as analyses of 
estimates and assessments of requirements for 
internationally controlled substances. 
137. The Board’s reports and technical publications are 
based on information that parties to the international drug 
control treaties are obligated to submit. In addition, and 
pursuant to resolutions of the Economic and Social Council 
and the Commission on Narcotic Drugs, Governments 
voluntarily provide information on drug control in order to 
facilitate an accurate and comprehensive evaluation of the 
functioning of the international drug and precursor control 
system. 
138. The analysis of statistical data submitted by 
Governments should enable the Board to monitor licit 
activities involving internationally controlled substances in 
order to prevent the diversion of narcotic drugs and 
psychotropic substances into illicit markets. Their supply to 
licit consumer markets around the world, on time and in 
quantities needed to satisfy the countries’ legitimate needs 
for medical and scientific purposes, can thus be accounted 
for. In addition, data analysis allows the Board to evaluate 
the overall functioning of the international drug control 
system. The observations of the Board, in conjunction with 
explanations on missing or qualitatively questionable data 
furnished by Governments to the Board, are used to 
identify malfunctions and loopholes in national control 
systems. Remedial measures to improve the international 
drug control system can subsequently be identified and 
recommended. 
139. Through its work, the Board highlights best practices 
and significant achievements in drug control and alerts  
the international community to cases involving 
__________________ 
 7   United Nations, Treaty Series, vol. 976, No. 14151. 
Governments’ non-compliance with their treaty 
obligations. (For an account of reporting difficulties 
encountered by some Governments and the causes of those 
difficulties, see paragraphs 157-163 below.) 
 
 2. Submission of statistical reports 
 
140. Governments have an obligation to furnish to the 
Board each year in a timely manner statistical reports 
containing information required by the international drug 
control conventions.  
141. As at 1 November 2011, annual statistical reports on 
narcotic drugs (form C) for 2010 had been furnished by 
161 States and territories, or 76 per cent of the States and 
territories requested to submit such reports. Additional 
Governments are expected to submit their reports for 2010. 
A total of 190 States and territories provided quarterly 
statistics on their imports and exports of narcotic drugs in 
2010, representing 89 per cent of the States and territories 
required to furnish such statistics. The number of 
Governments not submitting their statistics regularly has 
been high in Africa, the Caribbean and Oceania. The rate 
of submission of statistical reports by Governments in 
those regions and that subregion did not improve despite 
repeated requests sent by the Board to the Governments 
concerned. 
142. In 2011, several Governments did not provide the 
requested annual statistical reports on narcotic drugs in a 
timely manner, including the Governments of some 
countries that are major manufacturers, exporters, 
importers and users of narcotic drugs, such as Australia, 
Brazil, Canada, India, Japan and the United Kingdom. The 
late submission of annual statistical reports, particularly by 
major manufacturing and trading countries, delays the 
analysis of global trends by the Board. It also makes it 
difficult for the Board to prepare an annual report and 
technical publications, which it is required to do under 
article 15 of the 1961 Convention. The Board has contacted 
the Governments concerned and requested them to rectify 
the situation.  
143. As at 1 November 2011, annual statistical reports on 
psychotropic substances (form P) for 2010 had been 
submitted to the Board by 158 States and territories, or  
75 per cent of the States and territories required to furnish 
such statistics. In addition, 118 Governments submitted 
voluntarily all four quarterly statistical reports on imports 
and exports of substances listed in Schedule II of the  
1961 Convention, in conformity with Economic and Social 
Council resolution 1981/7. Only six Governments that 
trade in such substances failed to submit any quarterly 
form for 2010, which was the lowest number ever.  
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144. Similar to regional reporting deficiencies for narcotic 
drugs, the number of countries that have not yet submitted 
statistics for psychotropic substances for 2010 has remained 
particularly high in Africa, Central America and the 
Caribbean and Oceania. Some countries, including 
countries that are major manufacturers and exporters of 
psychotropic substances, such as Brazil, Colombia, Ireland 
and Israel, continued to experience difficulties in 
submitting the annual statistical report on psychotropic 
substances by the deadline (30 June).  
145. The Board is pleased to note that in 2011 a total of  
33 Governments have submitted data on consumption of 
psychotropic substances, which has allowed for an 
improved evaluation of their availability. Those data were 
requested for the first time pursuant to Commission on 
Narcotic Drugs resolution 54/6, by which the Commission 
sought to promote adequate availability of internationally 
controlled narcotic drugs and psychotropic substances for 
medical and scientific purposes while preventing their 
diversion and abuse. 
146. As at 1 November 2011, a total of 132 States had 
submitted on form D annual information on substances 
frequently used in the illicit manufacture of narcotic drugs 
and psychotropic substances. For the past five years, an 
average of 137 countries and territories submitted form D. 
However, only 62 countries and territories, on average, 
submitted their reports by the 30 June deadline.  
147. In 2010, according to data provided on form D,  
51 Governments reported having effected seizures of 
substances listed in Tables I and II of the 1988 Convention. 
A majority of those Governments provided the Board only 
with information about the amounts of precursor 
chemicals seized. However, in order to identify any changes 
in drug trafficking trends and modi operandi used by 
traffickers, further information about circumstances 
surrounding the reported seizures is required, pursuant to 
article 12 of the 1988 Convention. The Board urged all 
Governments to furnish information about cases involving 
seizures of internationally controlled substances; seizures of 
chemical substances not scheduled in Table I or II, but 
identified as having been used in illicit manufacture; 
stopped shipments of precursors; and dismantled illicit 
drug laboratories. 
 
 3. Submission of estimates and assessments 
 
148. Pursuant to the 1961 Convention, each year State 
parties are obliged to provide the Board with estimates of 
their requirements for narcotic drugs for the following year. 
As at 1 November 2011, a total of 155 States and territories 
had submitted estimates of their requirements for narcotic 
drugs for 2012; that figure represents 73 per cent of the 
States and territories required to furnish such annual 
estimates for confirmation by the Board. As was the case in 
previous years, in accordance with article 12, paragraph 3, 
of the 1961 Convention, the Board had to establish 
estimates for those States and territories that had not 
submitted their estimates on time. Estimates were also 
established for South Sudan, which became independent  
in 2011.  
149. In addition to estimates of requirements for narcotic 
drugs, pursuant to Economic and Social Council 
resolutions 1981/7 and 1991/44, Governments are 
requested to provide the Board with annual assessments  
of their medical and scientific requirements for 
psychotropic substances in Schedules II, III and IV of the 
1971 Convention.  
150. As at 1 November 2011, the Governments of all 
countries except South Sudan and of all territories had 
submitted assessments of their annual medical and 
scientific requirements for psychotropic substances to the 
Board. The assessments of requirements for psychotropic 
substances for South Sudan were, in accordance with 
Economic and Social Council resolution 1996/30, 
established by the Board in order to enable that country to 
import such substances for medical purposes without 
undue delay.  
151. It is recommended that Governments review and 
update the assessments of their annual medical and 
scientific requirements for psychotropic substances at least 
every three years. Following the Board’s request of  
January 2011, 83 Governments revised fully the 
assessments of their requirements for psychotropic 
substances, and a further 71 Governments submitted 
modifications to assessments for one or more substances. 
The Governments of 15 countries and territories, in 
particular in Africa and Oceania, have not submitted any 
revision of their legitimate requirements for psychotropic 
substances for at least three years.  
152. Failure to submit adequate estimates or assessments 
for narcotic drugs and psychotropic substances may have a 
negative impact on the effectiveness of control. Estimates 
or assessments lower than the actual legitimate 
requirements may hamper or delay the importation or use 
of narcotic drugs or psychotropic substances needed for 
medical or scientific purposes. Estimates or assessments 
significantly higher than the legitimate requirements 
increase the risk of imported narcotic drugs and 
psychotropic substances being diverted into illicit channels. 
The Board calls upon all Governments to ensure the 
adequacy of their estimates and assessments. When 
necessary, Governments should submit to the Board 
supplementary estimates for narcotic drugs or inform the 
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Board of modifications to their assessments for 
psychotropic substances. 
153. In accordance with Economic and Social Council 
resolution 1995/20, Governments provide, on form D, data 
on their licit trade in, uses of and requirements for 
substances in Table I and Table II. As at 1 November 2011, 
more than 100 States and territories had provided 
information on licit trade and uses of precursors. That 
information enabled the Board to monitor patterns in 
international trade in precursor chemicals and to identify 
any new trends or suspicious trade transactions.  
154. The Commission on Narcotic Drugs, in its  
resolution 49/3, requested Member States to provide the 
Board with estimates of their annual legitimate 
requirements of four substances frequently used in the 
manufacture of amphetamine-type stimulants, namely  
3,4-methylenedioxyphenyl-2-propanone (3,4-MDP-2-P),  
1-phenyl-2-propanone (P-2-P), pseudoephedrine and 
ephedrine and, to the extent possible, estimated 
requirements for imports of preparations containing those 
substances. The information on legitimate requirements for 
precursor chemicals for amphetamine-type stimulants 
assists the competent authorities of exporting countries in 
preventing exports of substances in quantities exceeding 
the legitimate requirements of the importing countries, 
which could be liable to diversion to illicit channels. 
155. Both the number of Governments and the number of 
substances in Table I and Table II for which estimates of 
annual legitimate requirements are provided have steadily 
increased. As at 1 November 2011, 137 Governments had 
provided their annual legitimate requirements for at least 
one substance. In 2011, first-time submissions were 
provided by Bhutan, Christmas Island, the Cocos (Keeling) 
Islands, Denmark, the Gambia, the Lao People’s 
Democratic Republic, Namibia, the Netherlands, Senegal, 
Singapore, Trinidad and Tobago, Ukraine and Uzbekistan.  
156. The Board wishes to remind all Governments that 
the totals of estimates of annual medical and scientific 
requirements for narcotic drugs, as well as assessments for 
psychotropic substances, are published in its yearly 
technical publications on narcotic drugs and on 
psychotropic substances and in quarterly publications and 
that their monthly updates are available on its website 
(www.incb.org). The information on annual estimates of 
legitimate requirements for precursors of amphetamine-
type stimulants is also available on the Board’s website, 
where it is updated regularly. 
 
 4. Data examination and identified reporting 
deficiencies 
 
157. The examination of the statistical data provided by 
Governments enables the Board to identify possible 
deficiencies in national control systems. As part of that 
review process, the Board is able to identify discrepancies 
in the data submitted by trading partners, which can 
indicate incorrect methodologies used for data collection 
or processing, overall weaknesses in drug control or 
possible diversion from international trade into illicit 
channels.  
158. A number of countries are providing timely and 
high-quality statistical data to the Board. A common 
characteristic of those countries is that they have  
well-established national drug control agencies that not 
only have the human and technical resources required to 
carry out their responsibilities, but are also operating on 
the basis of appropriate legislation and administrative 
regulations. In particular, they are given the necessary 
authority to fulfil their role under the international drug 
control treaties. Such well-established national drug control 
systems contribute significantly to the good functioning of 
international drug control. By also providing clear  
and sound guidance on the requirements for engaging  
in the manufacture and trade of internationally controlled 
substances, mutually beneficial cooperation can be 
established between national drug control authorities and 
industry representatives. 
159. New technological developments, in particular in the 
area of information technology, have been applied to 
enhance established drug control systems. Many 
Governments now use electronic systems to collect and 
compile data required under the Conventions, as the 
volume of data related to internationally controlled 
substances would otherwise be difficult to handle. The 
Board welcomed such developments, as the use of 
electronic tools assists Governments in meeting reporting 
deadlines and also contributes to the greater accuracy of 
the data provided. The Board, however, notes that such 
systems are sometimes designed or modified in a way that 
simplifies reporting practices. Such modifications, if not 
fully in line with treaty provisions, can result in systematic 
reporting errors. In this regard, in the course of 2011, the 
Board, in cooperation with competent national authorities 
of several interested countries, achieved significant 
progress in the development of an electronic import/export 
authorization system that is expected to facilitate 
mandatory reporting by Governments to the Board (see 
paras. 212-219 below). 
160. In some countries the quality of information 
collected electronically from stakeholders, such as private 
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companies, is low and often contains errors. Regrettably, 
some Governments informed the Board that they could not 
furnish the required information because of the purported 
failure of manufacturers of internationally controlled 
substances to submit the requested data to the national 
competent authorities. 
161. Late submission and the submission of incomplete or 
inaccurate data may significantly obstruct the examination 
and overall analysis of the data by the Board. The Board 
reminds the Governments of countries concerned that it is 
their responsibility to ensure that any electronic system 
they use at the national level for collecting data and 
reporting to the Board is set up and applied in a way that is 
compatible with the provisions of relevant international 
treaties. It is also an obligation of Governments and their 
competent authorities to rectify any entry or conceptual 
errors that may be introduced during any data-gathering or 
-processing stage. 
162. In its resolution 54/6, the Commission on Narcotic 
Drugs encouraged the Board, with the support of Member 
States, to continue to provide assistance to competent 
national authorities, with the aim of improving the national 
reporting of statistical data, the estimation of licit 
requirements for narcotic drugs and the voluntary 
assessment of licit requirements for psychotropic 
substances. The Board will continue to use every 
opportunity within its mandate to provide assistance to 
Governments, as necessary, to strengthen their capacity for 
the control of licit activities involving narcotic drugs, 
psychotropic substances and precursors, including 
reporting. In this regard, the Board will cooperate with 
other international bodies, such as UNODC and the World 
Health Organization (WHO).  
163. The Board is concerned that many parties to the  
1961 Convention and the 1971 Convention, including some 
major producers, manufacturers, importers and exporters 
of internationally controlled substances, have experienced 
difficulties in collecting and reporting information on the 
manufacture of and trade in narcotic drugs and 
psychotropic substances, on their use for the manufacture 
of other substances and/or on stocks held by 
manufacturers. The purported reasons for delayed or 
inaccurate reporting, as communicated to the Board by 
Governments, have included inappropriate legislation, or 
its inadequate implementation, as well as lack of adequate 
resources of the national drug control authorities. The 
Board requests the Governments concerned to review their 
national legislation and administrative regulations 
governing manufacture of and trade in internationally 
controlled substances to identify whether the laws and 
regulations concerned are sufficient and whether they are 
adequately implemented. Where appropriate, Governments 
should take measures to strengthen their national drug 
control authorities in order to increase their capacity to 
collect high-quality data and submit those data to the 
Board in a timely manner. 
 
 
 D. Ensuring the implementation of the 
provisions of the international drug 
control treaties 
 
 
 1. Preventing the diversion of controlled 
substances 
 
164. One of the principal aims of the international drug 
control regime is to prevent the diversion of controlled 
substances into illicit channels for subsequent sale to drug 
abusers or, in the case of precursor chemicals, for use in the 
illicit manufacture of narcotic drugs and psychotropic 
substances. Over the years, loopholes in the 
implementation of the regime were being exploited by 
traffickers to divert controlled substances; once those 
loopholes were identified, the Economic and Social 
Council and the Commission on Narcotic Drugs had to 
adopt additional control measures to close them. In the 
section below, the Board examines action taken by 
Governments to prevent diversion in accordance with the 
treaty provisions and related resolutions of the Council and 
the Commission, describes the problems that continue to 
exist in preventing the diversion of controlled substances 
and provides specific recommendations on how to deal 
with such problems. 
 
 (a) Legislative and administrative basis 
 
165. Governments have to ensure that national legislation 
is in line with the provisions of the international drug 
control treaties. They also have the obligation to amend 
lists of substances controlled at the national level when a 
substance is included in a schedule of an international drug 
control treaty or transferred from one schedule to another. 
Inadequate legislation or implementation mechanisms at 
the national level or delays in bringing lists of substances 
controlled at the national level into line with the schedules 
of the international drug control treaties will result in 
inadequate national controls being applied to substances 
under international control and may lead to the diversion 
of substances into illicit channels. 
166. Some Governments have experienced problems in 
addressing non-compliance by national stakeholders with 
control measures aimed at preventing diversion from 
domestic distribution channels, such as prescription 
requirements for narcotic drugs and psychotropic 
substances and provisions for safe storage of controlled 
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substances to prevent theft. In particular, the penalties 
applicable to individuals or companies found to be 
negligent or unethical have, in some cases, not been 
adequate to prevent persons from cooperating with 
traffickers in cases of diversion. The Board encourages all 
Governments to examine whether the penalties foreseen in 
their national drug control legislation are sufficient to 
prevent such problems and to revise their laws, as 
necessary.  
167. The Board appreciates the fact that Governments 
continue to strengthen their legislation on precursors 
beyond the minimum outlined under the 1988 Convention 
and subsequent resolutions of the Commission on Narcotic 
Drugs, to prevent traffickers from obtaining the precursor 
chemicals needed for illicit drug manufacture. During 
2011, many countries, among them El Salvador, Guatemala 
and Nicaragua, expanded their control measures to include 
phenylacetic acid derivatives that are not under 
international control, in addition to reflecting in their 
national legislation the recent rescheduling of phenylacetic 
acid from Table II to Table I. Canada also broadened  
its legislation to include substances that are not listed  
in the tables of the 1988 Convention yet might be used  
for the illicit manufacture of methamphetamine or 
methylenedioxymethamphetamine (MDMA, commonly 
known as “ecstasy”). 
168. Pursuant to Economic and Social Council  
resolution 1992/29 on measures to prevent the diversion of 
precursor and essential chemicals to the illicit manufacture 
of narcotic drugs and psychotropic substances, the Board 
entered into a partnership with the World Customs 
Organization to establish a discrete tariff code for 
preparations containing ephedrine and pseudoephedrine in 
order to facilitate the monitoring of international trade in 
those substances and the identification of diversion 
attempts. 
 
 (b) Prevention of diversion from international trade 
 
  Estimates and assessments of annual 
requirements for controlled substances 
 
169. The system of estimates of legitimate annual 
requirements is an important control measure that, when 
properly implemented, can prevent the diversion of 
controlled substances from international trade. When 
trading in narcotic drugs, exporting and importing 
countries are bound by the 1961 Convention to observe 
limits based on the estimates of annual requirements 
furnished by Governments and confirmed by the Board. 
The system of assessments of annual requirements for 
psychotropic substances and the system of estimates of 
annual requirements for precursors were adopted by the 
Economic and Social Council and the Commission on 
Narcotic Drugs, respectively, to help Governments to 
identify unusual transactions that might reflect attempts by 
traffickers to divert controlled substances into illicit 
channels.  
170. For the systems to be effective, Governments of 
importing countries should establish a mechanism to 
ensure that their estimates and assessments are in line with 
their actual requirements and that no import of controlled 
substances in quantities exceeding those requirements is 
taking place. If the actual requirements are found to have 
increased beyond the requirements submitted previously to 
the Board, importing countries should inform the Board 
immediately of such changes. For their part, the 
Governments of exporting countries should set up a 
mechanism that will check the estimates and assessments of 
importing countries against all export orders involving 
controlled substances and preclude exports that are not in 
line with legitimate requirements.  
171. The Board regularly investigates cases involving 
possible non-compliance by Governments with the system 
of estimates or assessments, to identify loopholes that could 
lead to diversion. As in previous years, the system of 
estimates for narcotic drugs continues to be respected by 
most countries. For psychotropic substances, in 2010 the 
authorities of 12 countries issued authorizations for 
substances for which they had not established any 
assessments or in quantities that significantly exceeded 
their assessments, whereas most exporting countries paid 
attention to the assessments established in importing 
countries and did not knowingly export psychotropic 
substances in quantities exceeding those assessments. With 
regard to estimates of annual licit requirements for the  
four substances used in the manufacture of amphetamine-
type stimulants,8 some Governments authorized imports of 
those substances in quantities that were far in excess of 
their published legitimate annual requirements. 
172. The Board encourages Governments to review at 
least once every three years their legitimate requirements 
for psychotropic substances, utilizing the guide on 
estimating requirements for substances under international 
control that have been developed by the Board,  
in cooperation with WHO (see paras. 238-242 below), and 
to inform the Board of any changes, as necessary. The 
Board also calls upon Governments, especially those  
with significant trade in (including re-export of) the  
four precursors and their preparations for which estimates 
__________________ 
 8  The four substances are 3,4-MDP-2-P, pseudoephedrine, 
ephedrine and P-2-P. Preparations containing those 
substances are also used in the illicit manufacture of 
amphetamine-type stimulants. 
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were recommended, to exercise vigilance to ensure that the 
estimates of their annual legitimate requirements are 
commensurate with prevailing market conditions. 
 
  Requirement of import and export authorization 
 
173. Another main pillar of the international drug control 
system is the requirement of import and export 
authorizations, as they allow the competent national 
authorities to check the legitimacy of individual 
transactions prior to shipment. Import and export 
authorizations are mandatory for a transaction involving 
any of the substances controlled under the  
1961 Convention or listed in Schedule I or II of the  
1971 Convention. The competent national authorities must 
issue import authorizations for transactions involving the 
importation of such substances into their country. The 
authorities of exporting countries must verify the 
authenticity of the import authorizations before issuing the 
export authorizations required to allow the shipments 
containing the substances to leave their territory.  
174. The 1971 Convention does not require import and 
export authorizations for trade in psychotropic substances 
listed in Schedule III or IV of the Convention. To address 
the problem of widespread diversion of those substances 
from international trade in the 1970s and 1980s, the 
Economic and Social Council, in its resolutions 1985/15, 
1987/30 and 1993/38, requested Governments to extend the 
system of import and export authorizations to cover all 
psychotropic substances. The Board appreciates the fact 
that the Governments of Bulgaria, El Salvador, Iraq, 
Mauritania, Montenegro, Myanmar, Turkey and Ukraine 
have recently amended their national legislation to require 
import authorizations for some or all of the substances in 
Schedules III and IV. The Board again encourages all 
Governments that do not yet require import and export 
authorizations for all psychotropic substances to extend 
such controls to all substances in Schedules III and IV as 
soon as possible and to inform the Board accordingly, 
pursuant to the Council resolutions mentioned above. 
175. Although most countries now require import and 
export authorizations for the majority of the psychotropic 
substances in Schedules III and IV of the 1971 Convention, 
those controls are not yet universally applied to all of those 
substances. To assist Governments and prevent traffickers 
from targeting countries in which controls are less strict, 
the Board has been disseminating to all competent national 
authorities a table showing the import authorization 
requirements for substances in Schedules III and IV 
applied by Governments in accordance with the Economic 
and Social Council resolutions mentioned above. Since 
October 2011, that table has been published on the secure 
area of the Board’s website, which is accessible only to 
specifically authorized Government officials, so that 
competent national authorities of exporting countries may 
be informed as soon as possible of changes in import 
authorization requirements in importing countries. 
 
  Verifying the legitimacy of import authorizations 
 
176. The Board encourages the authorities of exporting 
countries to verify the authenticity of all import 
authorizations that they consider to be suspicious. Such 
action is particularly useful for authorizations using new or 
unknown formats, bearing unknown stamps or signatures, 
or not issued by a recognized competent national authority, 
or for authorizations of consignment consisting of 
substances known to be frequently abused in the region of 
the importing country. The Board notes with appreciation 
that a number of Governments, including those of 
Hungary, India and the United Kingdom, have established 
the practice of verifying, with the competent national 
authorities of importing countries, the legitimacy of import 
authorizations or bringing to their attention documents 
that do not fully comply with the requirements for import 
authorizations set out in the international drug control 
treaties.  
177. Importing countries have also become increasingly 
active in implementing the import authorization system. 
Many Governments of importing countries inform the 
Board regularly of changes in the format of their import 
authorizations and provide the Board with samples of 
revised certificates and authorizations for narcotic drugs, 
psychotropic substances and precursor chemicals so that 
the Board may assist the Governments of exporting 
countries in verifying the authenticity of documents. Some 
importing countries send to the Board a copy of all import 
authorizations they have issued, to expedite verification of 
their legitimacy. The Board continues to receive requests 
from the Governments of exporting countries to assist in 
verifying the legitimacy of import authorizations, 
particularly when their own endeavours to receive feedback 
from the authorities of the importing countries have failed. 
If the Board does not have sufficient information to 
confirm the legitimacy of those authorizations, it contacts 
the importing country to ascertain whether the transaction 
is legitimate.  
178. The Board wishes to remind the Governments of 
importing countries that it is in their interest to respond in 
a timely manner to requests to confirm the legitimacy of 
individual transactions. Failure to quickly respond in such 
cases may hinder the investigation of diversion attempts 
and/or cause delays in legitimate trade in controlled 
substances, thus adversely affecting the availability of those 
substances for legitimate purposes. 
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179. The Board is pleased to note that Governments have 
begun to recognize the importance of the rapid exchange of 
information between exporting and importing countries, 
preferably in an automatic and fully electronic manner, to 
prevent undue delays of legitimate trade in narcotic drugs 
and psychotropic substances while ensuring that the  
system of estimates and the system of assessments of 
controlled substances, as well as the import and export 
authorization requirements envisaged under the 
international drug control regime, are applied. (For action 
taken or planned by the international community to 
develop such an electronic import and export authorization 
system, see paragraphs 212-219 below.) 
 
  Online system of pre-export notifications for 
precursor chemicals 
 
180. For precursor chemicals, the exchange of information 
between exporting and importing countries through the 
pre-export notification system has been an efficient way of 
identifying the legitimacy of individual consignments of 
precursor chemicals. The Board’s PEN Online system is the 
main mode used to exchange such information. The 
number of registered users of PEN Online now stands at 
126, with over 20,000 pre-export notifications sent annually 
to 169 countries and territories. As a cornerstone of efforts 
to monitor international trade in precursor chemicals and 
prevent their diversion, the PEN Online system could have 
an even more positive impact if more countries were to use 
the system on a more regular basis. The Board therefore 
again encourages all Governments that have not yet done 
so to register with and utilize the PEN Online system, 
pursuant to Security Council resolution 1817 (2008). 
 
 (c) Effectiveness of the control measures aimed at 
preventing the diversion of controlled 
substances from international trade 
 
181. The control measures described above are effective. 
No recent cases involving diversion of narcotic drugs and 
psychotropic substances from international trade into illicit 
channels have been identified. Nevertheless, attempts to 
divert narcotic drugs and psychotropic substances from 
international trade continue to be detected by vigilant 
competent national authorities, which often work in close 
cooperation with the Board. 
182. Falsified import authorizations continue to be used 
by traffickers to attempt the diversion of controlled 
substances. In 2011, a diversion attempt was identified 
through the vigilance of the competent national authorities 
of India, who found an import authorization allegedly 
issued by the Government of Malaysia for the import of 
midazolam to be different from the official format known 
to them. Midazolam, a benzodiazepine, is widely abused in 
East Asia. Enquiries with the Government of Malaysia 
confirmed that the authorization in question had been 
falsified and that the transaction constituted a diversion 
attempt. The Board trusts that Governments will 
investigate all such attempts to divert controlled substances 
so that the persons responsible may be identified and 
prosecuted. 
183. From time to time, traffickers, sometimes with the 
help of corrupt individuals, pretend to be acting on behalf 
of Governments that allegedly have weak drug control 
systems. In a recent case, the Board was approached by an 
individual who introduced himself as a Government 
representative of a country in the Americas, referred to the 
low level of availability of narcotic drugs, particularly 
oxycodone, in that country and attempted to obtain from 
the Board information on how to increase estimates for 
that narcotic drug. After the Board enquired about his 
credentials, the individual did not proceed with the request.  
184. With regard to the diversion of precursor chemicals 
from international trade, as a result of stronger controls 
and the rescheduling of substances, traffickers have  
been forced to seek non-scheduled precursor chemicals  
for use in the illicit manufacture of drugs. In order to 
gather more information on such developments, Operation 
Phenylacetic Acid and Its Derivatives (Operation PAAD) 
was launched in March 2011 to monitor global  
trade in phenylacetic acid and its derivatives, used in the 
illicit manufacture of amphetamine-type stimulants.  
That is the first operation to systematically target emerging  
non-scheduled substances. The operation has brought  
very positive results. The active participation of  
63 Governments in the operation enabled 612 tons of 
chemicals to be seized, which otherwise could have been 
used to illicitly manufacture approximately 115 tons of 
methamphetamine hydrochloride.  
185. One key conclusion drawn from Operation PAAD 
was that in Latin America the number of seizures involving 
ephedrine and pseudoephedrine had decreased, as 
traffickers tended to rely on non-scheduled substances such 
as derivatives of phenylacetic acid. Nevertheless, the use of 
ephedrine and pseudoephedrine now appears to be playing 
a greater role in illicit methamphetamine manufacture in 
parts of South-East Asia. Operation PAAD further 
highlighted the flexibility of traffickers in finding sources 
of chemicals to be used for the illicit manufacture of drugs, 
quickly substituting chemicals, source countries and 
trafficking routes. Specifically, during the first few months 
of the operation, shipments seized in Mexico were reported 
as having originated in China. In the second half of the 
operation, shipments were seized en route to Central 
American countries (El Salvador, Guatemala, Honduras 
and Nicaragua), and India emerged as an additional 
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country of origin. Operation PAAD also revealed the 
significant magnitude and sophistication of such illicit 
activity, in terms of both the shipments intercepted and the 
clandestine laboratories dismantled. 
186. Since traffickers do not stop trying to divert 
controlled substances from international trade and they are 
sometimes successful in obtaining precursor chemicals in 
that manner, the Board reiterates its call for Governments 
to remain vigilant and to monitor international trade in the 
substances subject to the control regime laid down in the 
international drug control conventions and the related 
resolutions by using the tools mentioned above. 
 
 (d) Prevention of diversion from domestic 
distribution channels 
 
187. Since it has become more difficult for traffickers to 
obtain narcotic drugs, psychotropic substances and 
precursors from international trade, the diversion of such 
substances from licit domestic distribution channels has 
become a main source for supplying illicit markets. A 
diverted substance may be used for illicit purposes in the 
country in which it was diverted, or it may be smuggled 
into other countries, particularly countries in which there 
is considerable illicit demand for the substance.  
188. For many substances found to have been diverted 
from domestic distribution channels, there is little 
knowledge of the details of diversion such as the methods 
used by traffickers or abusers to obtain the substances in 
question. Frequently, seizure data provide an indication of 
the problems that continue to be experienced with respect 
to such diversion. For narcotic drugs and psychotropic 
substances, data on substance abuse obtained either 
through drug abuse surveys or from treatment and 
counselling centres for drug abusers also confirm the 
widespread availability of narcotic drugs and psychotropic 
substances that have been diverted from licit distribution 
channels. Drug abusers who seek treatment can direct the 
authorities to the sources of the substances in question, 
including pharmacies not adhering to prescription 
requirements, theft or unethical behaviour by patients, 
such as “doctor shopping”. The Board recommends that 
Governments inform it of cases involving the diversion of 
controlled substances from domestic distribution channels 
in their countries so that the lessons learned from such 
diversion cases can be shared with other Governments.  
189. Among narcotic drugs and psychotropic substances, 
the substances most frequently diverted tend to be  
those which are most widely used for legitimate purposes. 
Among narcotic drugs, these include opioid analgesics  
such as fentanyl, hydrocodone, hydromorphone,  
morphine and oxycodone. Among the psychotropic 
substances most frequently diverted are stimulants 
(amphetamines, methylphenidate and anorectics), 
anxiolytics and sedative-hypnotics such as benzodiazepines 
(especially diazepam, alprazolam, lorazepam, clonazepam, 
flunitrazepam and midazolam), barbiturates and  
gamma-hydroxybutyric acid (GHB).  
190. With regard to precursor chemicals, the diversion of 
acetic anhydride from domestic distribution channels, to be 
subsequently smuggled into other countries, has become 
the most common method of obtaining that chemical for 
use in illicit heroin manufacture. In addition, potassium 
permanganate is increasingly being obtained by illicit 
manufacture or being substituted altogether.  
191. The Board wishes to remind all Governments of their 
obligation under the international drug control treaties to 
prevent the diversion of controlled substances into illicit 
channels. To that end, Governments are requested to 
ensure implementation of the control measures foreseen in 
those treaties and the related resolutions of the Economic 
and Social Council and Commission on Narcotic Drugs 
and to apply appropriate sanctions to national stakeholders 
found to be negligent or acting in an unlawful way. 
 
  Diversion of pharmaceutical preparations 
containing controlled substances 
 
192. Prescription drugs (pharmaceutical preparations 
containing controlled substances) are frequently diverted 
from domestic distribution channels. For narcotic drugs 
and psychotropic substances, the quantities diverted in this 
manner can be significant, as prescription drugs have 
become more important as drugs of abuse in many 
countries. The abuse of some pharmaceutical preparations 
(for instance, those containing oxycodone, fentanyl and 
certain benzodiazepines, such as flunitrazepam) has 
become so widespread that, in addition to being diverted, 
they are being illicitly manufactured, in order to respond to 
the growing illicit demand. 
193. International criminal organizations are increasingly 
becoming involved in the diversion of pharmaceutical 
preparations containing controlled substances. To do that, 
they make use of doctors who prescribe such preparations 
without a legitimate medical reason or patients who receive 
such prescriptions by faking some symptoms of diseases 
requiring the preparations as medication. For example,  
in 2010 the national authorities of El Salvador succeeded in 
dismantling a criminal group that had been diverting 
preparations containing oxycodone from domestic 
distribution channels. Twenty-three doctors, two 
pharmacists and two administrative clerks were arrested in 
connection with their role in that case. Similarly, the United 
States has for a number of years identified and investigated 
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medical doctors with unreasonably high prescription levels, 
as well as pharmacies with unreasonably high sales of 
controlled substances, including opioid analgesics and 
benzodiazepines. 
194. Narcotic drugs are also diverted in the form of 
preparations in Schedule III of the 1961 Convention. Those 
preparations are exempt from a number of control 
measures that otherwise have to be applied under that 
Convention, in particular the prescription requirement, the 
requirement for estimates and other control measures for 
international trade, as well as reporting to the Board. 
Among those preparations, cough syrups containing 
codeine, dihydrocodeine, hydrocodone, ethylmorphine and 
pholcodine are reported to be frequently abused, often in 
combination with other drugs and/or alcohol. Preparations 
in Schedule III are often obtained as over-the-counter 
products in pharmacies and other licit distribution outlets 
and then diverted into illicit channels. 
195. The abuse of preparations in Schedule III of the  
1961 Convention has led countries to take 
countermeasures, including the introduction of 
prescription requirements for frequently abused 
preparations in Schedule III and stricter control of  
licit distribution channels, including sales limitations  
and, in some cases, discontinuation of the distribution of 
such preparations or the use of substances other than 
narcotic drugs as the active ingredients. 
 
  Diversion and abuse of drugs used in 
substitution treatment 
 
196. The diversion of substances used in substitution 
treatment, such as buprenorphine, methadone and 
morphine, continues to be a particular problem. The Board 
has examined this issue several times in the past, most 
recently in its annual report for 2010.9 In 2011, the Board 
contacted the major consumer countries of buprenorphine 
to obtain from them information on the current extent of 
the diversion of buprenorphine from domestic distribution 
channels, including from opioid substitution programmes, 
as applicable, as well as on the countermeasures taken by 
those Governments in that regard. The information thus 
received has complemented the information received in 
2010, when the Board asked the countries most affected by 
such diversion and abuse for similar data.  
197. Prior to the finalization of the present report,  
the Board had received responses from 15 countries. 
According to those responses, buprenorphine continues to 
__________________ 
 9  Report of the International Narcotics Control Board for 2010 
(United Nations publication, Sales No. E.11.XI.1), paras. 233 
and 234. 
be frequently diverted from domestic distribution channels. 
Almost all of the responding countries confirmed the abuse 
of preparations containing buprenorphine, particularly 
among opioid addicts entering detoxification and 
substitution treatment programmes. Abuse of a preparation 
containing buprenorphine to which naloxone, an opiate 
antagonist, has been added to make it less liable to be 
abused has also been confirmed. A further concern is the 
finding that preparations containing buprenorphine have 
been dissolved in liquid and then injected intravenously. 
198. Hard data on the extent of diversion and abuse of 
preparations containing buprenorphine are difficult to 
obtain, as are data on the extent of abuse of most 
prescription drugs, yet those problems appear to be 
increasing as a consequence of the expansion of 
substitution programmes in many countries and the 
resulting increased availability of buprenorphine. In 
Finland, buprenorphine abuse was found among one third 
of drug abusers who received treatment in 2009. In the 
United States, the number of emergency room visits related 
to the non-medical use of buprenorphine more than 
tripled, from 4,400 in 2006 to 14,200 in 2009, and law 
enforcement authorities reported a significant increase in 
seizures of buprenorphine.  
199. Smuggling of preparations containing buprenorphine 
has also been reported by a number of countries. For 
instance, Denmark reported the seizure of such 
preparations at its border with Germany; investigation 
revealed that the tablets had been destined for the illicit 
market in Finland and Norway. In Finland, the majority of 
the buprenorphine that is abused has been smuggled out of 
other European countries, including Estonia, France and, 
increasingly, Sweden and the United Kingdom. Smuggling 
of Subutex (a preparation containing buprenorphine) from 
France into Mauritius has also been detected. In their 
responses, some Governments highlighted the role in such 
cases of unethical individuals from the medical profession 
and patients. Doctors were found to be negligent about 
prescribing the quantities needed, and patients had 
successfully requested more doses than required, in order 
to sell them to other drug abusers.  
200. Responses received by the Board also suggest that 
most Governments have taken some measures to address 
problems relating to the diversion and abuse of 
buprenorphine. Such measures include the enactment of 
laws and regulations concerning substitution treatment, the 
monitoring of supply and distribution during such 
treatment, prescription monitoring systems and the 
provision of mandatory training for doctors who are 
qualified to prescribe buprenorphine. In addition, 
Governments have worked closely with the pharmaceutical 
industry to control the production, stockpiling and 
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distribution of preparations containing buprenorphine; 
however, the control measures applied to buprenorphine 
and its preparations vary from country to country, which 
makes concerted action to prevent their diversion and 
abuse more difficult.  
201. In view of the continued abuse and diversion of 
preparations containing buprenorphine from domestic 
distribution channels, the Board urges Governments of all 
countries in which buprenorphine is used for licit purposes 
to remain vigilant and to adopt appropriate control 
measures while making the substance available for medical 
treatment. The Board also encourages Governments of 
those countries into which buprenorphine continues to be 
smuggled to closely monitor the situation and cooperate 
with each other in order to prevent trafficking in 
buprenorphine. 
 
 (e) Other issues regarding the implementation of 
the international drug control treaties or related 
resolutions 
 
  Strengthening international cooperation and 
regulatory and institutional frameworks for the 
control of pharmaceutical preparations 
containing ephedrine and pseudoephedrine 
 
202. As a result of the tightening of control measures for 
precursors in bulk form, over the years the Board has 
repeatedly reported on and expressed its concerns about 
traffickers using pharmaceutical preparations to obtain 
precursors, as such preparations may be beyond the scope 
of existing national control measures in many countries. 
203. Given their widespread use in medicine, 
pharmaceutical preparations containing ephedrine and 
pseudoephedrine (as well as pharmaceutical preparations 
containing other controlled precursors, such as 
ergometrine) enjoy special status under most national drug 
and precursor control systems, which specifically exclude 
medicinal products and pharmaceutical preparations from 
the control measures applicable to the precursors contained 
in the preparations. 
204. However, in the light of extensive evidence  
of diversion and use of pharmaceutical preparations in 
illicit drug manufacturing, a number of Governments  
have recently strengthened, or are in the process of 
strengthening, their mechanisms for the control of  
such products. Malaysia, Thailand and the United Arab 
Emirates have already notified the Board of their requests 
to receive, through PEN Online, pre-export notifications 
for pharmaceutical preparations containing ephedrine  
and pseudoephedrine. Other countries prohibit all 
importation of such preparations, sometimes with the 
exception of specified amounts of liquid preparations for 
injection; those countries include Mexico and several 
Central American countries (Belize, El Salvador, 
Guatemala, Honduras and Nicaragua). Other countries, 
including Bhutan, the Gambia, Guinea-Bissau, Mauritius, 
Monaco, Myanmar, the Netherlands and Singapore,  
have not expressly prohibited imports but have notified  
the Board that they do not have any legitimate 
requirements for such preparations. Information on the 
annual legitimate requirements and prohibitions as 
reported by Governments for the import of such 
preparations is available on the Board’s website 
(www.incb.org/pdf/e/precursors/REQUIREMENTS/INCB_
ALR_WEB.pdf). 
205. The Board is also aware of the strengthening of 
control measures in some countries, including Bangladesh, 
Chile, Malaysia, Panama and Paraguay. Such strengthened 
measures include, for example: 
 (a) Extending import and export licence 
requirements to pharmaceutical preparations containing 
ephedrine and pseudoephedrine; 
 (b) Restricting the import and/or export of 
pharmaceutical preparations containing ephedrine and 
pseudoephedrine to authorized companies; 
 (c) Making such preparations available only with a 
prescription or banning them from being sold in  
non-pharmaceutical outlets. 
206. An important step forward in addressing the 
diversion of pharmaceutical preparations containing 
ephedrine and pseudoephedrine was made by the 
Commission on Narcotic Drugs in March 2011, by 
adopting resolution 54/8. In that resolution, the 
Commission acknowledged that the diversion of 
pharmaceutical preparations containing ephedrine and 
pseudoephedrine was a concern and a significant challenge 
for drug control authorities because such preparations 
might not be subject to a similar level of control as bulk 
ephedrine and pseudoephedrine.  
207. Through its resolution 54/8, the Commission agreed 
to a set of measures that will improve overall control over 
and monitoring of the trade in pharmaceutical 
preparations containing ephedrine and pseudoephedrine, 
thus reducing the risk of diversion. The key measures on 
which the Commission agreed were: 
 (a) To include, to the extent possible and in 
accordance with national legislation, pharmaceutical 
preparations containing ephedrine and pseudoephedrine in 
the pre-export notifications sent through the PEN Online 
system;  
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 (b) To adopt, where appropriate, regulatory 
frameworks to control the production, distribution and 
commercialization of pharmaceutical preparations 
containing ephedrine and pseudoephedrine, to prevent 
diversion, including through the sending of pre-export 
notifications, without impairing the availability of essential 
pharmaceutical preparations for medical use;  
 (c) To apply similar control measures for 
pharmaceutical preparations containing ephedrine and 
pseudoephedrine as those for bulk precursor chemicals. 
208. Importantly, in its resolution 54/8, the Commission 
also encouraged Member States in which different or 
additional regulatory entities were responsible for control 
of preparations, as distinct from the bulk precursor 
chemicals contained in such preparations, to ensure that 
the government entities coordinated and cooperated in 
their control efforts, with the objective of maintaining 
seamless and effective regulatory controls over both 
preparations and bulk precursor chemicals. 
209. The Board welcomes such collective efforts to 
improve a situation that continues to be exploited by 
traffickers. As evidenced in the 2011 report of the Board on 
the implementation of article 12 of the 1988 Convention,10 
the diversion of pharmaceutical preparations containing 
ephedrine and pseudoephedrine appears to have decreased 
in regions previously affected, while it has increased greatly 
in countries in East and South-East Asia. 
210. The Board wishes to remind Governments that the 
PEN Online system has been designed to accommodate 
preparations and that several countries have been using 
that function for some time for the pre-notification of 
exports of substances in the form of pharmaceutical 
preparations. The Board urges all Governments to use the 
PEN Online system for the pre-notification of shipments of 
preparations containing ephedrine and pseudoephedrine. 
211. To further assist efforts to strengthen the monitoring 
of — and to minimize diversions from — international 
trade in pharmaceutical preparations containing ephedrine 
and pseudoephedrine, the Board is liaising with the World 
Customs Organization to establish a discrete tariff code for 
such preparations. 
 
__________________ 
 10  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic Substances: 
Report of the International Narcotics Control Board for 2011 
on the Implementation of Article 12 of the United Nations 
Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988 (United Nations publication, 
Sales No. E.12.XI.4). 
  Developing an international electronic import 
and export authorization system for substances 
under international control 
 
212. Import and export authorizations are an integral part 
of the international drug control mechanism. Article 31 of 
the 1961 Convention as amended by the 1972 Protocol and 
article 12 of the 1971 Convention include detailed 
provisions concerning the requirements of import and 
export authorizations for narcotic drugs and psychotropic 
substances. A well-functioning import and export 
authorization system is therefore essential to enabling drug 
control authorities to monitor international trade in those 
substances and prevent diversion. In recent years, the 
Board has been informed, first by the Government of the 
Republic of Korea, and subsequently by more than 20 other 
Governments, including those of Colombia, Singapore and 
Spain, that they have utilized advancements in information 
and communication technology and undertaken initiatives 
to develop national systems for issuing import and export 
authorizations electronically.  
213. Those national systems are designed to help national 
drug control authorities manage control activities and 
monitor international trade in narcotic drugs and 
psychotropic substances more efficiently. However, none of 
them allow the authorities to directly transmit 
authorizations to, or receive them from, their counterparts 
in other countries. In most cases, the import or export 
authorizations are sent in the form of hard-copy printouts. 
Exchange of paper documents not only raises concerns 
about the risk of forgery, but also increases the workload  
of receiving authorities, which have to verify the 
authenticity of export and import authorizations. In its 
resolution 50/7, the Commission on Narcotic Drugs urged 
all Member States to pay particular attention to security 
measures concerning import and export documents. 
Furthermore, none of the above-mentioned national 
systems provides importing countries with the possibility 
of endorsing the amount actually imported, as required by 
the 1961 Convention and the 1971 Convention.  
214. In view of the above, in March 2009, the Board 
convened an informal meeting with interested 
Governments to identify their needs and requirements with 
regard to a possible international electronic system for 
facilitating the exchange of electronic import and export 
authorizations between the competent national authorities 
of importing and exporting countries. Responses from 
Governments confirmed a strong interest in the initiative. 
At a second informal meeting, organized by the Board in 
March 2010, during the fifty-third session of the 
Commission on Narcotic Drugs, it was decided that the 
system would be developed by UNODC, in consultation 
with the Board and experts from interested Governments.  
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215. To accelerate the development process, in February 
and June 2011, the Board and UNODC jointly organized 
two international expert group meetings. The purpose of 
the meetings was to identify the specific requirements for 
an international electronic import and export authorization 
system for substances under international control. All 
participants agreed that security should be the priority of 
the proposed international system, which would 
complement, but not replace, existing national electronic 
systems. The proposed system would serve as a platform 
for uploading and exchanging import and export 
authorizations between importing and exporting countries. 
For countries without national electronic systems, the 
proposed system would also allow them to generate and 
transmit import and export authorizations electronically 
and to download and print them if necessary.  
216. Another important feature of the proposed 
international system would be automatically checking the 
quantity of a shipment against the latest estimate or 
assessment provided by the importing country for the 
narcotic drug or psychotropic substance in question and 
giving a warning message in cases involving excess imports 
or exports. Furthermore, the international system would 
provide an online endorsement function, which would 
allow the authorities of importing countries to verify the 
quantity of a shipment arriving in their territory. All of 
those important features would be designed to help 
Governments meet their obligations under the 
international drug control treaties and would enhance the 
monitoring of international trade in substances under 
international control and the prevention of their diversion.  
217. As part of the process of developing the proposed 
international system, it is the Board’s responsibility to 
ensure that the business rules of the proposed system fully 
comply with relevant provisions of the 1961 Convention 
and the 1971 Convention regarding import and export 
authorizations. According to the Conventions, any such 
system should be approved by the Commission on Narcotic 
Drugs, and the format and content of the import and 
export authorizations should meet the requirements 
provided for in the Conventions.  
218. Despite the progress that has been achieved so far, 
many challenges still lie ahead. For instance, the 
development of the proposed international system must 
take into consideration the specificities of national 
legislation with regard to import and export authorizations 
for substances under international control. At the same 
time, the system must take into account the needs of 
countries that do not yet have national electronic import 
and export authorization systems. It should also be  
user-friendly and compatible with all national systems, to 
ensure the smooth exchange of data. Moreover, it has been 
recommended that the system have a modular structure.  
In its initial phase, the system should be able to meet the 
most urgent needs of Governments in respect of import 
and export authorizations for narcotic drugs and 
psychotropic substances. More advanced modules may be 
added to the system in the future, for example, to include 
precursor chemicals as well as substances not under 
international control. The Board is convinced that this 
initiative will only succeed through joint international 
efforts. Once it has been put into operation, the system will 
bring long-term benefits to all Governments and the 
international drug control mechanism as a whole. 
219. The Board wishes to express its appreciation to every 
Government that has provided constructive suggestions 
and recommendations on the system. On the basis of their 
input, UNODC has produced a system requirement 
document, which will enable the estimation of 
development and maintenance costs and serve as a 
guideline for the development of the system. The Board 
and UNODC will hold further consultations with 
interested Governments concerning progress in the 
development of the system. 
 
  International cooperation in countering the 
covert administration of psychoactive 
substances related to sexual assault and other 
criminal acts 
 
220. Psychoactive substances have been frequently used 
for the commission of sexual assault or other crimes. In 
2010, the Commission on Narcotic Drugs adopted 
resolution 53/7 to address drug-facilitated sexual assault 
and other crimes. In that resolution, the Commission 
encouraged States to forward any relevant experiences as 
well as research findings to the Board and urged the Board 
to gather relevant information. In July 2010, the Board 
requested all Governments to communicate to it 
information on the extent of the problem, the modi 
operandi of the assailants and the substances used as well as 
the counter measures taken and planned by Governments 
in that regard, pursuant to Commission resolution 53/7. 
The findings from the replies received by 1 November 2010 
were summarized in the report of the Board for 2010.11 
221. By 1 November 2011, five additional Governments 
had provided relevant information on this topic to the 
Board, raising the total number of Governments that 
replied to the Board on this issue to 52. Whereas the replies 
received in 2011 confirm most of the findings summarized 
in the report of the Board for 2010, they also show that the 
evidence on such crime has increased throughout the 
__________________ 
 11  Report of the International Narcotics Control Board for 2010 
..., paras. 276-283. 
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world, particularly in Europe, due to better recognition of 
this problem by the competent authorities.  
222. One worrying feature of such crimes is that the 
victims are often young people who are sexually assaulted 
or forced into prostitution. However, the information 
received so far is indicative rather than comprehensive, 
underlining the need to collect more accurate data on 
drug-facilitated crime. In this connection, it should be 
noted that only one Government informed the Board that 
routine analysis of blood and urine of all rape victims is 
required under the guidelines on how to deal with such 
cases. All Governments are therefore encouraged to take 
measures to ensure that forensic or other legal evidence is 
obtained whenever a drug-facilitated crime is suspected.  
223. Few countries reported having recently undertaken 
scientific research studies on this phenomenon. The 
scientific research that has been undertaken shows that 
drug-facilitated crime is more often committed than 
previously assumed. For example, a recent study confirmed 
the presence of a range of drugs, including substances that 
are internationally controlled, in most cases of suspected 
drug-facilitated sexual assault.  
224. The Board will continue to monitor the situation and 
will share the information it receives with Governments 
and international bodies, as necessary. 
 
  Control over trade in opium poppy seeds 
 
225. Opium poppy seeds originating in areas where the 
cultivation of opium poppy is not permitted continue to be 
sold on the world market. Brokers are reported to be 
involved in such trade. Based on information on the total 
area under illicit opium poppy cultivation worldwide, such 
cultivation could yield tens of thousands of tons of poppy 
seeds each year. The sale of those opium poppy seeds is an 
additional source of income for illicit growers of opium 
poppy, thus indirectly supporting such illicit cultivation. 
226. In March 2010, the Commission on Narcotic Drugs 
adopted resolution 53/12, entitled “Strengthening systems 
for the control of the movement of poppy seeds obtained 
from illicitly grown opium poppy crops”. In that resolution, 
the Commission, recalling the recommendations contained 
in previous resolutions on that issue,12 encouraged all 
Member States to import only opium poppy seeds derived 
from licitly grown opium poppy crops and encouraged the 
Governments of countries that permitted the importation 
__________________ 
 12  Economic and Social Council resolution 1999/32, entitled 
“International regulation and control of trade in poppy 
seeds”, and Commission on Narcotic Drugs  
resolution 51/15, entitled “Control of international 
movement of poppy seeds obtained from illicitly grown 
opium poppy plants”. 
of poppy seeds to obtain from the exporting country an 
appropriate certificate of origin as the basis for 
importation. Exporting countries were also encouraged to 
provide notification of the export of opium poppy seeds to 
the competent authorities of the importing countries. 
Furthermore, countries were urged to inform the Board of 
any suspicious transactions involving poppy seeds and 
seizures of poppy seeds derived from illicitly cultivated 
opium poppy. Governments of countries where opium 
poppy was illicitly cultivated were encouraged to cooperate 
closely with the Governments of neighbouring countries in 
order to prevent the smuggling of poppy seeds. 
227. The Board notes with appreciation that some  
major producers of poppy seeds, including China, the  
Czech Republic, Hungary, Slovakia, Spain and Turkey, have 
identified the authorities responsible for issuing certificates 
of origin of poppy seeds to exporters who request such 
certificates. The Board invites the Governments of the 
other countries where opium poppy is licitly cultivated and 
from which poppy seeds are exported to also identify such 
authorities so that certificates of origin can be issued if such 
certificates are required in the importing country. 
228. At present, only India requires a certificate of origin 
of poppy seeds as a condition for the approval of such 
imports. The Board therefore calls upon the Governments 
of other countries that permit the import of opium poppy 
seeds to implement the provisions of Economic and Social 
Council resolution 1999/32 and Commission on Narcotic 
Drugs resolutions 51/15 and 53/12 and, in particular, to 
require a certificate of the country of origin of the poppy 
seeds as the basis for importation. 
229. The import, export and transit of opium poppy seeds 
are prohibited in many countries adjacent to countries 
where opium poppy is illicitly cultivated. The Board 
requests the Governments of countries where opium poppy 
is illicitly cultivated to cooperate closely with the 
Governments of their neighbouring countries in order to 
prevent the smuggling of opium poppy seeds. The Board 
invites all Governments to inform it of any suspicious 
transactions involving opium poppy seeds. The Board 
would also appreciate being informed by Governments of 
any measures for the control of opium poppy seeds that are 
to be adopted with a view to implementing Economic and 
Social Council resolution 1999/32 and Commission on 
Narcotic Drugs resolutions 51/15 and 53/12. 
 
 2. Ensuring the availability of internationally 
controlled substances for medical and 
scientific purposes 
 
230. Under its mandate to ensure the availability of 
internationally controlled substances for medical and 
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scientific purposes, the Board carries out various activities 
related to the consumption of narcotic drugs and 
psychotropic substances. In addition, with regard to 
narcotic drugs, the Board also has an important role to play 
in the supply of raw materials required for the manufacture 
of all medications containing natural alkaloids, as well as all 
semi-synthetic narcotic drugs. 
 
 (a) Supply of and demand for opiate raw materials 
 
231. The Board, in compliance with the functions 
assigned to it under the 1961 Convention and the relevant 
resolutions of the Economic and Social Council, examines 
on a regular basis developments affecting the supply of and 
demand for opiate raw materials. The Board endeavours, in 
cooperation with Governments, to maintain a lasting 
balance between supply and demand. In order to analyse 
the situation regarding supply of and demand for opiate 
raw materials, the Board uses information from the 
Governments of countries producing opiate raw materials, 
as well as from countries where those materials are utilized 
for the manufacture of opiates or substances not controlled 
under the 1961 Convention. The 2011 technical report of 
the Board on narcotic drugs13 contains a detailed analysis 
of the present situation with regard to the supply of opiate 
raw materials and the demand for those materials 
worldwide. A summary of that analysis is presented below.  
232. The Board recommends that global stocks of opiate 
raw materials be maintained at a level sufficient to cover 
global demand for about one year, in order to ensure the 
availability of opiates for medical needs in case of an 
unexpected shortfall in production. 
233. Production of opiate raw materials rich in morphine, 
as well as of opiate raw materials rich in thebaine, continues 
to be above the levels required to satisfy global demand. 
Therefore, global stocks of opiate raw materials rich in 
morphine and thebaine are expected to reach a level 
covering global demand for a period of more than a year.  
234. In order to prevent the accumulation of excessive 
stocks and the associated risk of diversion of opiate  
raw materials, in May 2011 the Board brought this 
development to the attention of the major producer 
countries and requested them to prevent excessive stock 
levels and to carefully examine estimates and projections of 
requirements for opiate raw materials for 2012.  
235. Global demand for opiate raw materials rich in 
morphine and rich in thebaine is expected to continue to 
rise in the future. In addition, it is anticipated that the 
__________________ 
 13  Narcotic Drugs: Estimated World Requirements for 2012 — 
Statistics for 2010 (United Nations publication, Sales  
No. T.12.XI.2). 
activities of the Board and WHO to ensure the adequate 
availability of opioid analgesics will contribute to the 
continuing rise in global demand for opiates and opiate raw 
materials.  
236. However, producing countries need to carefully 
analyse projected growth rates in global demand for 
opioids when planning future production levels for opiate 
raw materials. The Board requests all producer countries to 
maintain their future production of opiate raw materials at 
a level that conforms to the actual requirements for such 
raw materials worldwide and to avoid keeping excessive 
stocks, since they might be a source of diversion if they are 
not adequately controlled. 
 
 (b) Other initiatives of the International Narcotics 
Control Board 
 
  Consumption of narcotic drugs and psychotropic 
substances 
 
237. Aware of its dual responsibility under the  
1961 Convention and the 1971 Convention to ensure the 
availability of controlled substances for medical and 
scientific needs while preventing their illicit production, 
trafficking and abuse, the Board launched in March 2011 
the Report of the International Narcotics Control Board on 
the Availability of Internationally Controlled Drugs: 
Ensuring Adequate Access for Medical and Scientific 
Purposes14 as a supplement to its annual report for 2010. 
The special report brought to the attention of Governments 
and the general public the stark contrast in consumption 
levels in the different regions of the world. It also contained 
recommendations on the availability and appropriate use of 
controlled drugs, national drug control systems and the 
prevention of diversion and abuse of such drugs. The Board 
appreciates the positive reactions to the special report. The 
Board trusts that Governments will implement those 
recommendations in the report which are relevant to the 
situation in their countries. The Board will in due time 
analyse, in cooperation with Governments, the extent to 
which the recommendations have been implemented.  
 
  Guide on Estimating Requirements for 
Substances under International Control  
 
238. The Board, which is responsible for monitoring the 
compliance of Governments with the international drug 
control treaties, administers the international control 
regime for narcotic drugs and psychotropic substances. An 
essential component of the control regime is a system 
under which countries are requested to estimate their 
annual requirements for internationally controlled 
__________________ 
 14  United Nations publication, Sales No. E.11.XI.7. 
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substances for legitimate purposes and to limit the use of 
such substances to those estimates. If applied correctly, the 
system should promote access to adequate levels of 
controlled substances and at the same time correct 
excessive use of such substances.  
239. A process of estimating requirements for 
internationally controlled substances should use systematic 
procedures for collecting information about the use of and 
the need for such substances; however several factors make 
it difficult for the competent national authorities of many 
countries to develop and apply such procedures. The most 
common difficulties encountered include a lack of 
technical knowledge, a general lack of resources, poorly 
developed health-care infrastructure and the absence of an 
institutional framework that prioritizes access to medicines 
for all segments of the population. As a result, many 
Governments submit inaccurate estimates and assessments 
that exceed or fall short of their actual requirements. 
Several Governments are not able to submit any estimates 
at all and rely on the estimates established by the Board. 
240. The Board is of the opinion that calculating accurate 
estimates and assessments would help Governments to 
identify the levels of pharmaceutical preparations 
containing internationally controlled substances that are 
necessary for their medical services. Realizing that many 
Governments require support in the calculation process, 
the Board, in cooperation with WHO, has developed the 
Guide on Estimating Requirements for Substances under 
International Control. The Guide is to be launched in early 
2012. The intent of the Guide is to assist competent 
national authorities in identifying the most appropriate 
method for calculating the quantities of internationally 
controlled substances required for medical and scientific 
purposes on their territory. To support Governments in 
preparing their estimates and assessments, the guide 
describes the system of estimates and assessments and the 
various methods commonly used to quantify the 
requirements for controlled substances for medical 
purposes.  
241. The Board trusts that the Guide will help 
Governments in the process of determining the quantities 
of internationally controlled substances that are required 
each year to ensure adequate availability of those 
substances. This exercise will also help Governments to 
identify inadequacies in the national system for the supply 
of narcotic drugs and psychotropic substances. If 
Governments carry out this task every year and verify 
whether their consumption data reflect their estimates and 
assessments, they should be in a position to analyse 
deficiencies in their drug control systems that could lead to 
an undersupply or oversupply of narcotic drugs or 
psychotropic substances.  
242. The Board hopes that the Guide will be widely used, 
in particular by all Governments that until now have not 
been in a position to calculate such estimates owing to a 
lack of technical expertise. The Board will provide 
additional information as to the use of the Guide to 
Governments requiring such support. 
 
  Statistical data on the consumption of 
psychotropic substances 
 
243. The 1971 Convention does not foresee the reporting 
of statistical data on the consumption of psychotropic 
substances to the Board. Any evaluation of the adequacy of 
the availability of such substances has therefore been more 
problematic than for narcotic drugs. Consistent and 
reliable statistics on the consumption of narcotic drugs 
have been available for many years, as such statistics had to 
be compiled and furnished to the Board by all countries 
and territories in accordance with the 1961 Convention.  
244. To promote the adequate availability of psychotropic 
substances globally and in specific countries, the Board 
therefore recommended in its report for 2010, and in the 
supplement to that report, that Governments should collect 
reliable statistical data on the consumption of psychotropic 
substances in the same manner as for narcotic drugs and 
provide the Board with those data in a timely fashion.15  
In accordance with that recommendation, the Board 
updated the annual statistical report on substances listed in 
the 1971 Convention (form P) to request the voluntary 
collection and submission of such data by all Governments 
for the first time for 2010. 
245. In March 2011, the Commission on Narcotic Drugs, 
in its resolution 54/6, endorsed the recommendation of the 
Board and encouraged Member States to report to the 
Board data on the consumption of psychotropic substances 
for medical and scientific purposes, in order to enable the 
Board to analyse levels of consumption of psychotropic 
substances in an accurate manner and to promote their 
adequate availability.  
246. The Board notes with appreciation that some 
Governments submitted data for 2010 on the consumption 
of some or all psychotropic substances used on their 
territory for medical and scientific purposes, pursuant to 
the Board’s recommendation and Commission on Narcotic 
Drugs resolution 54/6. Among those Governments are 
Governments of countries that are major manufacturers 
and consumers of psychotropic substances, such as 
Finland, Germany and the United States.  
__________________ 
 15  Report of the International Narcotics Control Board  
for 2010 ..., recommendation 34; and Report of the 
International Narcotics Control Board on the Availability of 
Internationally Controlled Drugs ..., recommendation (h). 
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247. The Board trusts that all other Governments will 
soon follow suit and take measures that would allow them 
to collect reliable data on consumption levels of 
psychotropic substances on their territory and to report 
those data to the Board. That would greatly assist the Board 
in identifying unusual developments in the consumption of 
psychotropic substances in individual countries, with a 
view to recommending remedial action to ensure the 
adequate availability of psychotropic substances, if 
necessary.  
 
  Activities to support scientific analyses and 
research 
 
248. Apart from internationally controlled substances 
required for use in medical treatment, countries also need 
to use such substances for scientific purposes, including 
product development, scientific research and forensic 
analysis. The use of controlled substances for test and 
reference samples is an example of the use of such 
substances for scientific purposes; it was also the subject of 
a publication entitled Guidelines for the Import and Export 
of Drug and Precursor Reference Standards for Use by 
National Drug Testing Laboratories and Competent National 
Authorities,16 the preparation of which was initiated by the 
Board. 
249. Test and reference samples are required by national 
drug testing and forensic laboratories that are engaged in 
the identification and analysis of seized materials suspected 
of being narcotic drugs, psychotropic substances or 
precursors. In March 2011, the Commission on Narcotic 
Drugs adopted resolution 54/3, entitled “Ensuring the 
availability of reference and test samples of controlled 
substances at drug testing laboratories for scientific 
purposes”, in which it invited the Board and UNODC “to 
work closely on feasible mechanisms that will facilitate the 
provision of minimal but sufficient amounts of reference 
and test samples of controlled substances to drug testing 
laboratories, including through the reinforcement of 
existing national programmes, as appropriate, in order to 
support their analytical and quality assurance work”. In 
addition, UNODC brought to the attention of the Board 
cases in which national laboratories continued to encounter 
difficulties in obtaining such samples. 
250. In response to resolution 54/3 and concerns raised by 
UNODC, the Board has undertaken a special study on 
obstacles to obtaining such test and reference samples. The 
Board has recommended a number of measures to be taken 
by national authorities to ensure that national laboratories 
have uninterrupted access to such samples. The outcome of 
the study and the recommendations of the Board are 
__________________ 
 16  United Nations publication, Sales No. M.08.XI.6. 
reflected in the present report in the section entitled 
“Special topics” (see paras. 301-316 below). 
251. The 1961 Convention obliges States parties to submit 
to the Board statistical data on the consumption of narcotic 
drugs. Consumption data are the most important tool for 
evaluating whether adequate quantities of internationally 
controlled substances are available in a country. While 
consumption data with respect to pharmaceutical 
preparations containing narcotic drugs are commercially 
available in some countries, global consumption data on 
narcotic drugs and data on the consumption levels of 
individual countries are available only to the Board. The 
Board recognizes that those data are a unique tool for 
research institutions and organizations active in the areas 
of treatment of pain and palliative care. These statistical 
data are published annually in the Board’s technical 
publication on narcotic drugs. In recent years, the Board 
has frequently been requested to provide those data in 
electronic format. The Board acknowledges that sharing 
consumption data in electronic format would make it easier 
to carry out research projects. That would benefit not only 
the research institutions and organizations working with 
those data but also national health services and medical 
professionals interested in comparing consumption levels 
of narcotic drugs in their country with consumption levels 
in other countries. Ultimately, such research could raise 
awareness among policymakers regarding the adequacy of 
national consumption levels and thereby benefit patients 
who are in need of those medications. 
252. The Board has therefore decided to establish a 
separate secure area on its website where reputable research 
institutions and organizations can register in order to have 
electronic access to the Board’s consumption data. 
Registrants have to fulfil certain conditions and sign an 
agreement with the Board regarding the use of the data. 
The Board hopes that this initiative will support research 
institutions and organizations in their work and ultimately 
benefit national authorities and the general public. 
 
  Response to Commission on Narcotic Drugs  
resolution 54/6  
 
253. In March 2011, the Commission on Narcotic Drugs 
adopted resolution 54/6, entitled “Promoting adequate 
availability of internationally controlled narcotic drugs and 
psychotropic substances for medical and scientific 
purposes while preventing their diversion and abuse”, in 
which the Commission requested the Board to continue its 
efforts in the area of availability of internationally 
controlled drugs and encouraged the Board to take 
additional action. The Board will continue to pay attention 
to the subject of adequate availability of internationally 
controlled substances, as provided for in its mandate under 
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the international drug control treaties. Nevertheless, the 
Board needs to bring to the attention of the international 
community the fact that the budget resources allocated at 
present seriously restrain the activities of the Board. The 
Board wishes to draw attention to the need for additional 
resources to carry out any additional activities and expand 
present activities related to ensuring adequate availability of 
internationally controlled narcotic drugs and psychotropic 
substances.  
 
  Letter to United Nations resident coordinators 
 
254. On 4 February 2011, a joint letter signed by the 
President of the Board, the Director-General of WHO and 
the chair of the United Nations Development Group was 
sent to United Nations resident coordinators. In that letter, 
the issue of the availability of internationally controlled 
substances for medical use was addressed. The letter 
referred to the continuing shortfall in many countries with 
respect to the availability of internationally controlled 
substances required for the treatment of severe pain, 
mental illnesses and psychiatric disorders, opioid 
dependence, epilepsy and birth complications. Resident 
coordinators were urged to integrate the issue of access to 
controlled medicines into health programmes. 
 
  High-level Meeting of the General Assembly on 
the Prevention and Control of Non-
communicable Diseases 
 
255. At the High-level Meeting of the General Assembly 
on the Prevention and Control of Non-communicable 
Diseases, held in New York on 19 and 20 September 2011, 
the President of the Board referred to the importance of the 
appropriate use of internationally controlled drugs, as both 
overconsumption and underconsumption of those drugs 
created problems for public health. With regard to the use 
of controlled substances in the relief of pain and suffering, 
the President highlighted the uneven global distribution of 
analgesics, which left 80 per cent of the world population 
with limited or no access to those medicines. The President 
mentioned the importance of internationally controlled 
substances for the treatment and management of non-
communicable diseases, including cancer and mental 
illness, as well as painful conditions associated with other 
non-communicable diseases, such as diabetes.  
 
 (c) Activities of intergovernmental and  
non-governmental organizations 
 
256. The Board notes that the availability of 
internationally controlled substances, in particular the 
availability of opioid analgesics for pain treatment, has 
become a major area of interest for intergovernmental and 
non-governmental organizations.  
257. In 2011, WHO published new policy guidelines 
entitled Ensuring Balance in National Policies on Controlled 
Substances: Guidance for Availability and Accessibility of 
Controlled Medicines, which replaced the guidelines it had 
published in 2000. The Board welcomes the publication of 
the new guidelines, which were developed with the support 
of the Board. Governments are reminded that the 
guidelines should always be applied with full respect for the 
provisions of the international drug control treaties.  
258. The Board notes the increasing number of  
non-governmental organizations that are actively involved 
in promoting the availability of internationally controlled 
substances for medical purposes and act as advocates  
for the adequate availability of such substances. Their 
activities focus mostly on the availability of analgesics, in 
particular opioids, in the treatment of pain and in palliative 
care. Data collected and processed by the Board and 
published in its technical publications have been used by  
non-governmental organizations and research institutes  
to study the issue of availability globally as well  
as in individual countries. At the same time, the Board 
receives valuable information from non-governmental 
organizations on the situation of patients lacking adequate 
pain treatment and palliative care, as well as on activities 
carried out at the national and international levels to 
improve health services and access to medications for those 
in need of them. 
 
 (d) National activities 
 
259. The latest consumption data on narcotic drugs 
submitted to the Board indicate that consumption levels of 
opioid analgesics for pain treatment remain low in many 
countries. The consumption levels are reflected in the 
tables of the Board’s technical publication on narcotic 
drugs.17 The Board has introduced a new format for the 
tables, which makes it easier for national authorities to 
verify how their country compares in the regional context 
and how their region compares with all other regions. 
Governments are encouraged to examine their national 
consumption levels in those tables. However, national 
consumption levels need to be compared not only with 
regard to low use of internationally controlled drugs but 
also with regard to overconsumption, which has been noted 
in a number of countries. The Board recommends that in 
order to adhere to the principle of appropriate use, 
Governments need also to identify consumption levels  
that may be considered excessively high and therefore 
inappropriate.  
__________________ 
 17   Narcotic Drugs: Estimated World Requirements for 2012 ..., 
tables XIV.1.a-XIV.1.i. 
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260. The Board notes that action has been taken in a 
number of countries to improve the level of consumption 
of internationally controlled substances. In most of those 
countries, the action has related to the consumption of 
narcotic drugs, in particular opioid analgesics.  
261. In Colombia, efforts continue to expand the number 
of pharmacies throughout the country that are open  
24 hours a day, 7 days a week, to dispense opioid analgesics. 
Currently, there are 32 such pharmacies, one in each of the 
country’s 32 departments. In early 2011, the Ministry of 
Social Protection added additional opioids (methadone, 
hydromorphone and morphine solution) to its Obligatory 
Health Plan, which means that patients who present a 
prescription for these medicines will receive them at no 
cost. A new cancer law has been adopted that calls for the 
competent national authority to ensure the adequacy of and 
the opportunity to access opioid drugs for pain 
management.  
262. In France, a first national plan to improve the 
management of pain was introduced in 1998 (for the 
period 1998-2000), followed by a second plan in 2002 (for 
2002-2005) and a third plan, for 2006-2010. At present the 
elaboration of a fourth plan is being discussed. The 
national plan includes as its main pillars the education and 
training of health-care professionals; prescription 
requirements and delivery; and the availability of narcotic 
drugs, including conditions governing the sector of the 
health service institutions (hospitals, specialists, general 
practitioners) from which prescriptions can be obtained 
and the duration for which they can be prescribed. To 
complement those measures, the Government of France 
introduced a surveillance scheme to counter diversion and 
abuse. These measures have led to a significant 
improvement in the availability of opioid analgesics in 
France. 
263. In Georgia, recent Government decrees have 
expanded the number of days for which opioid pain 
medicines can be prescribed, the number of conditions for 
which they can be prescribed, the types of physicians 
(including village doctors) who can prescribe them and the 
number of opioids that can be prescribed on a single 
prescription form. To support the rational use of opioid 
pain medicines, training and education in modern pain 
management is taking place throughout Georgia. The 
procedures for procuring opioid analgesics for patients 
with incurable conditions were revised. Authorities are in 
the process of revising the national drug control law to 
harmonize it with current knowledge and definitions. 
264. In Guatemala, there continues to be a shortage of 
low-cost opioids. Inexpensive morphine is available only in 
injectable form and only for patients who are hospitalized. 
To address the ongoing lack of low-cost oral morphine in 
Guatemala, a national expert team, in cooperation with the 
Pan American Health Organization (which serves as the 
WHO regional office for the Americas), is working to 
revise the requirements for importing oral morphine 
solution. Training efforts are planned to increase the 
number physicians who can lead palliative care efforts at 
public hospitals throughout Guatemala. 
265. In November 2010, the Ministry of Health of Jamaica 
sponsored a national workshop attended by Government 
policymakers, physicians, pharmacists and nurses to 
increase advocacy for improved pain management and 
palliative care throughout the country. Following the 
workshop, the Ministry’s chief medical officer, in an official 
statement, recognized the importance of opioids in pain 
treatment and palliative care and the need to examine the 
policies and legal framework surrounding opioid use. The 
competent national authorities also commenced an 
audit/survey tool to evaluate all hospitals that presently 
stock and dispense opioids to identify the storage and 
handling capabilities of each facility on the island.  
266. In late 2010, Kenya faced a shortage of morphine 
powder owing to problems experienced by the sole supplier 
of morphine in that country. Collaboration among  
the Pharmacy and Poisons Board, the national palliative 
care association (Kenya Hospice and Palliative Care 
Association) and international experts resulted in the 
problem being resolved by increasing the number of 
importers registered to import morphine powder. In recent 
years, the Government of Kenya has been taking a notable 
interest in pain management and palliative care. In  
July 2010, the Ministry of Medical Services issued a 
directive for 10 large hospitals throughout the country to 
establish palliative care services with the assistance and 
collaboration of the Kenya Hospice and Palliative Care 
Association. In August 2011, the Ministry of Public Health 
and Sanitation and the Ministry of Medical Services 
launched the first-ever national cancer control strategy, 
which includes pain management. 
267. In Nepal, with support from international experts, 
health-care practitioners have worked with Government 
and industry to address the availability of opioid analgesics. 
To overcome import delays, coordination of activities was 
established with the Department of Drug Administration 
of the Ministry of Health and Population and with 
importers and exporters. 
268. The Ministry of Health of Viet Nam, in cooperation 
with other governmental and non-governmental 
organizations, conducted from 2006 to 2008 an 
examination of policies and programmes affecting the 
availability of opioids for the treatment of pain in cancer 
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and HIV/AIDS patients, as well as for the medical 
treatment of dependence among persons who abuse drugs 
by injection. An action plan was developed that included 
national guidelines on palliative care; national treatment 
guidelines on methadone substitution therapy for opioid 
dependence; extensive training for clinicians throughout 
the country on those topics; and a radical revision of the 
national opioid prescribing regulations to expand the 
diagnoses eligible for opioid prescriptions, increase from  
5 to 30 the number of days’ supply per prescription, remove 
maximum dosage limits and mandate opioid availability at 
the district level. The Ministry has provided training to 
hospital leaders, provincial and district public health 
officials and health-care providers throughout the country 
on the revised opioid prescribing regulations.  
269. The Board appreciates these national efforts to 
increase the availability of controlled substances for 
medical and scientific purposes. Such cases may serve as 
examples for other national health administrations faced 
with similar problems. The Board wishes to remind 
Governments that all activities carried out to increase the 
availability of internationally controlled substances for 
medical and scientific purposes need to be balanced by 
activities to ensure the prevention of the diversion and 
abuse of such substances. 
 
 
 E. Special topics 
 
 
 1. Plurinational State of Bolivia: national policy 
on coca leaf 
 
270. Over the past several years, the Board has repeatedly 
expressed its concern about certain aspects of drug control 
policy in the Plurinational State of Bolivia that contravene 
the international drug control conventions, notably 
national legislation that allows the cultivation and 
consumption of coca leaf for non-medical purposes, in 
particular coca leaf chewing. The Plurinational State of 
Bolivia has been a party to the 1961 Convention since 1976. 
As the Plurinational State of Bolivia is a major producer of 
coca leaf, the Board is concerned that policy developments 
in that country could have repercussions in other countries.  
271. In the past several years, the Board has expressed its 
concern that the practice of chewing coca leaves and the 
use of other coca products without previous extraction of 
the alkaloids, continues in the Plurinational State of 
Bolivia. The Board reiterated that coca leaf is defined as a 
narcotic drug in the 1961 Convention and listed in 
Schedule I of the Convention, among those narcotic drugs 
to which strict control measures are applicable. Those 
controls include the provisions of article 4, paragraph (c), 
of the Convention, on the general obligation for States 
parties to “limit exclusively to medical and scientific 
purposes the production, manufacture, export, import, 
distribution of, trade in, use and possession of drugs”; 
articles 23 and 26, on the control regimes applicable to 
cultivation and production for parties permitting 
cultivation and production for the extraction of alkaloids; 
and article 27, on the possibility for parties to permit 
cultivation and production “for the preparation of a 
flavouring agent, which shall not contain any alkaloids”. 
272. Article 49 of the 1961 Convention provides parties 
with the right to make a transitional reservation for  
the non-medical use of the substances listed in paragraph 1 
of that article, which include coca leaf chewing (para. 1 (c)). 
Therefore, while a party may, at the time of accession and 
under certain conditions specified in that article, reserve 
the right to permit temporarily on its territory the practice 
of coca leaf chewing, such practice must be abolished 
within 25 years from the coming into force of the 
Convention, pursuant to paragraph 2 (e). No such 
transitional reservation was made by Bolivia at the time of 
its accession to the 1961 Convention, on 23 September 
1976. However, the Board wishes to point out that, within 
25 years following the entry into force of the 1961 
Convention, coca leaf chewing should have been abolished 
in those States which had made a reservation upon 
ratification. Therefore, even if Bolivia would have made 
such a reservation in 1976, as the 1961 Convention came 
into force in 1964, coca leaf chewing should have come to 
an end in 1989 in the territories of all parties to the 1961 
Convention. 
273. Since 2006, the Government of the Plurinational 
State of Bolivia has taken a number of steps towards 
removing coca leaf from international control.  
In September 2006, the President of the Plurinational State 
of Bolivia addressed the General Assembly at its  
sixty-first session, calling on the international community 
to support his position to remove coca leaf from 
international control. On 9 January 2007, the Minister of 
Foreign Affairs of the Plurinational State of Bolivia 
addressed a letter to the Director-General of WHO 
requesting that Organization to take the measures 
necessary to implement a process of validation of the 
medical uses of coca leaf and their contribution to, as part 
of traditional medicine, public health in the Andean 
subregion. On 8 March 2008, in response to the launching 
of the report of the Board for 2007, the Permanent Mission 
of the Plurinational State of Bolivia to the United Nations 
forwarded a note to the Secretary-General on the position 
of the Government on the issue of coca leaf. During  
the high-level segment of the fifty-second session of the 
Commission on Narcotic Drugs, held in Vienna in  
March 2009, the President of the Plurinational State of 
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Bolivia addressed the delegates, arguing for the removal of 
coca leaf from the international drug control regime and 
stating that the agreement to include coca leaf in Schedule I 
of the 1961 Convention had been a historical error and 
claiming that the agreement had been based on a study that 
was “neither serious nor scientific”. 
274. The Board has taken efforts to strengthen its dialogue 
with the Bolivian Government about the issue of coca leaf. 
For many years, the Board has repeatedly stated in its 
annual reports that the use of coca leaf in the Plurinational 
State of Bolivia for chewing and for the manufacture of 
coca tea and other products without extraction of the 
alkaloids goes beyond that which is permitted in the 
relevant provisions of the 1961 Convention, and is 
therefore in contravention of that State’s obligations under 
that Convention, and that the reservation to article 3, 
paragraph 2, of the 1988 Convention that the Bolivian 
Government had made upon acceding to that Convention, 
does not absolve that State from fulfilling its obligations 
under the 1961 Convention. Furthermore, in 2007, the 
Board sent a mission to the country to discuss with the 
competent national authorities the Bolivian Government’s 
policies on coca bush cultivation and coca leaf production. 
In November 2008, at the invitation of the Board, a  
high-level delegation from the Bolivian Government 
attended the ninety-third session of the Board to discuss 
and exchange views with the Board on issues relating to the 
Government’s implementation of the international drug 
control treaties. 
275. On 12 March 2009, the Permanent Mission of the 
Plurinational State of Bolivia to the United Nations 
submitted a proposal to amend article 49 of the  
1961 Convention as amended by the 1972 Protocol, in 
accordance with the procedure established in article 47  
of that Convention. In its note verbale, the Government 
stated that the chewing of the coca leaf was an ancestral 
practice of the Andean indigenous people that should not 
be prohibited. The Government therefore requested the 
deletion, from the 1961 Convention, of article 49, 
paragraph 1 (c), stating that “the socio-cultural practice of 
coca leaf cannot be permitted temporarily …”; and  
article 49, paragraph 2 (e), stating that “it is a serious 
mistake to seek to abolish coca leaf chewing within  
25 years”.  
276. In line with article 47, paragraph 1, of the  
1961 Convention, the Secretary-General communicated the 
Bolivian proposal, on 6 April 2009, to all parties to  
the 1961 Convention and to the Economic and Social 
Council. At its substantive session in July 2009, the Council 
decided to initiate the procedures set out in article 47,  
paragraph 1 (b) of the Convention, which provides that the 
parties shall be asked whether they accept the proposed 
amendment and also to submit to the Council any 
comments on the proposal. Pursuant to article 47, 
paragraph 2, of the Convention, if the proposed 
amendment would not be rejected by any one party within 
18 months after it had been circulated, it should thereupon 
enter into force. If, however, the proposed amendment was 
rejected by any State party, the Council could decide, in the 
light of comments received from States parties, whether a 
conference should be called to consider such amendment. 
By 31 January 2011, formal rejections of the Bolivian 
proposal to amend the 1961 Convention were submitted by 
17 States parties.18 As a consequence of those objections, 
the proposed amendment did not enter into force.  
277. In reaction to that development, the Government  
of the Plurinational State of Bolivia decided to take a 
hitherto unprecedented step: on 29 June 2011, the 
Government formally deposited with the Secretary-General 
an instrument of denunciation of the 1961 Convention  
as amended by the 1972 Protocol. In accordance with  
article 46, paragraph 2, of the Convention, the 
denunciation will take effect on 1 January 2012.  
278. At the same time, the Bolivian Government 
announced its intention to submit a new instrument of 
adherence to the 1961 Convention as amended by the  
1972 Protocol. The Government announced that the new 
instrument of adherence would contain a reservation, in 
conformity with article 50, paragraph 3, of the Convention, 
by means of which the chewing of coca leaf and the 
cultivation of coca bush for that purpose would be legal on 
Bolivian territory.  
279. The Board notes with regret the step taken by the 
Government of the Plurinational State of Bolivia to 
denounce the 1961 Convention as amended by the  
1972 Protocol, to which it had previously acceded. The 
Board is concerned that, while that course of action is 
technically permitted under the Convention, it is contrary 
to the fundamental object and spirit of the Convention. If 
the international community were to adopt an approach 
whereby States parties would use the mechanism of 
denunciation and re-accession with reservations to 
overcome problems in the implementation of certain treaty 
provisions, the integrity of the international drug control 
system would be undermined. The Board feels obliged to 
make Governments of States parties aware of that danger. 
280. The Board will continue its dialogue with the 
Bolivian Government. The Board decided to send a 
mission to the Plurinational State of Bolivia in  
__________________ 
 18  Bulgaria, Canada, Denmark, Estonia, France, Germany, 
Italy, Japan, Latvia, Malaysia, Mexico, Russian 
Federation, Singapore, Slovakia, Sweden, United 
Kingdom and United States. 
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December 2011 in an attempt to assist the Government  
in resolving any existing problems in a manner that is 
respectful of both the letter and the spirit of the  
1961 Convention. 
 
 2. Application of the international drug control 
treaties in countries with federal structures 
 
281. The international drug control treaties must be 
implemented by States parties, including States with federal 
structures, regardless of their internal legislation, on their 
entire territory. While all States have different legal systems 
and legal traditions, the Board wishes to remind the States 
parties of the basic principles of international law 
enshrined in the provisions of articles 27 (on the 
irrelevance of internal law) and 29 (on the application of 
the treaty on the entire territory of the party) of the  
1969 Vienna Convention on the Law of Treaties.19 
282. Over the last few decades, the majority of States 
parties to the international drug control treaties have 
applied adequate control measures, as required under the 
treaties, to ensure that narcotic drugs and psychotropic 
substances are used only for medical and scientific 
purposes. For example, consensus among States parties had 
developed in favour of firm control over cannabis, a 
substance included not only in Schedule I but also in 
Schedule IV of the 1961 Convention as amended by the 
1972 Protocol, which requires the most stringent control 
measures. The Board notes that almost all States parties 
have applied the strict control measures foreseen in the 
international drug control treaties. The almost universal 
application of the treaties has substantially enhanced the 
efforts of the international community to fight drug abuse 
and drug trafficking. 
283. The Board notes, however, some exceptions to those 
developments. A number of States parties are shifting 
towards more lenient national drug policies that are not in 
line with the international drug control treaties. For 
example, some States parties have permitted the use of 
“safer crack kits”, the existence of so-called “coffee shops” 
and the establishment and operation of so-called “drug 
injection rooms”. The Board has warned that such policies 
promote social and legal tolerance of drug abuse and drug 
trafficking and therefore contravene the international drug 
control treaties. 
284. The Board notes that in some countries, such policy 
changes took place at the state and/or provincial level, and 
the federal Government is consequently often confronted 
with challenges in complying with the international drug 
control treaties. In the United States, for example, although 
__________________ 
 19  United Nations, Treaty Series, vol. 1155, No. 18232. 
the use, sale and possession of cannabis remain illegal 
under federal law, an increasing number of states have 
approved laws attempting to decriminalize possession of 
cannabis for personal use and/or created exemptions for 
“medical cannabis”. In Australia, the local authorities in the 
state of New South Wales permitted the establishment of a 
“drug injection room”, despite the fact that, at that time, the 
national policy in Australia did not support the 
establishment of such facilities. In Canada, superior and 
appellate courts in the state of Ontario have repeatedly 
challenged cannabis laws at the federal level, declaring 
Canada’s cannabis laws to be of no force or effect. In 
addition, while the federal Government supports the 
termination of the operation of Insite (a “drug injection 
room”) in Vancouver, the Supreme Court of Canada has 
ruled to uphold Insite’s exemption from the Controlled 
Drugs and Substances Act, allowing the facility to stay open 
indefinitely. In other cases, such as in India, the federal 
Government has had difficulties complying with its 
reporting obligations as required under the international 
drug control treaties because of different laws and 
regulations at the state level. 
285. The situations described above make it difficult for 
the Governments of those countries to fulfil their 
obligations under the international drug control treaties 
and to ensure the implementation of the treaties on their 
entire territory. Some of the Governments concerned have 
stated that their domestic legal systems prevent them from 
fully complying with the treaties, as their state and/or 
provincial legislative and judicial structures and 
competencies are independent and prevail over their 
national or federal legislation and jurisdiction.  
286. The Board underlines the fact that certain state, 
regional and/or provincial powers, jurisdictions and 
delegated competencies are expressly granted and 
guaranteed in the constitutional frameworks of some States 
parties. Acceding to the international drug control treaties 
should result in States parties adopting national strategies 
and measures that ensure their full compliance with the 
treaties. Those treaty obligations are applicable with respect 
to the entire territory of each State party, including its 
federated states and/or provinces.  
287. Moreover, according to international law, as well as 
the international obligations of all parties to the 
international drug control treaties, state and/or provincial 
legislative and/or judicial measures and actions should be 
in compliance with each State’s policies and obligations at 
the international level. If a State, irrespective of its 
constitutional framework and legal system, enters into an 
international agreement by acceding to the international 
drug control treaties, that State must ensure that all state 
and/or provincial policies and measures do not undermine 
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its efforts to combat drug abuse and trafficking in narcotic 
drugs, psychotropic substances and precursor chemicals. 
288. The Board wishes to point out that the changes in 
policy and legislation on cannabis are taking place 
predominantly in developed countries. The growing gap 
between declared Government policy at the international 
level and incomplete implementation at the national level 
remains a matter of concern. It is disturbing that, while 
many developing countries have been devoting their 
limited resources to eradicating cannabis plants and 
fighting trafficking in cannabis, certain developed 
countries have, at the same time, decided to tolerate the 
cultivation of, trade in and use of cannabis for purposes 
other than those provided for by the international drug 
control treaties. The Board wishes to remind States parties 
that when those treaties were adopted, the international 
community emphasized the principle of universality, since 
a breach in the international consensus by one State could 
endanger the implementation of the treaties by other States.  
289. The Board expresses its concern about the decision  
of the Supreme Court of Canada, permitting a “drug 
injection room” to continue to operate in Vancouver. Under 
international law, by virtue of the hierarchy of norms, the 
provisions of internal law cannot be invoked to justify  
non-compliance with provisions of the international drug 
control treaties to which a State has become a party. Those 
treaties do not permit the use of controlled drugs for any 
purposes except medical or scientific purposes. 
290. The Board wishes to reiterate that control measures 
and action against trafficking in and abuse of drugs can be 
effective only if carried out universally in a concerted and 
coordinated manner, in accordance with the international 
drug control treaties. The Board calls upon all States parties 
to take the steps necessary to ensure full compliance with 
the international drug control treaties on their entire 
territory. The structure of all States parties, whether federal, 
state, regional or provincial, should include a 
comprehensive system of intergovernmental coordination 
procedures, so that drug control laws and policies are 
consistent within each country, and that system should be 
continually evaluated. 
 
 3. Illegal Internet pharmacies and seizures of 
licitly manufactured substances ordered via 
the Internet and delivered through the mail 
 
291. Over the past several years, the Board has drawn the 
attention of Governments to the need to work together to 
investigate and close down illegal Internet pharmacies and 
to seize substances which have been illegally ordered on the 
Internet and smuggled through the mail. In order to 
strengthen efforts to tackle this problem, the Board has 
worked with Governments to gain a deeper understanding 
of illegal Internet pharmacies and States’ efforts to combat 
them. In particular, the Board has gathered information on 
the implementation of its 2009 Guidelines for Governments 
on Preventing the Illegal Sale of Internationally Controlled 
Substances through the Internet, seizures of shipments of 
internationally controlled substances sent through the mail 
and important ongoing developments in the illegal trade in 
internationally controlled substances over the Internet. In 
order to gauge the level of implementation of the 
guidelines, the Board sent a questionnaire to all competent 
authorities asking them to provide detailed information on 
the scope of implementation of each specific guideline. The 
majority of the countries whose authorities reported full 
implementation of the Board’s guidelines are those that 
have in place legislation prohibiting Internet pharmacies or 
specifically allowing activities of Internet pharmacies under 
certain conditions. The Board notes that a number of 
countries have prohibited either all operations of Internet 
pharmacies or the sale of internationally controlled 
substances through the Internet. However, while legislation 
may be in place to respond to the guidelines, the level of 
actual implementation and monitoring varies.  
292. According to the responses received, States and 
territories having experience in legislating and regulating 
activities of Internet pharmacies implemented the largest 
number of recommendations. Several countries mentioned 
that they were not in a position to fully implement all of the 
guidelines. The most frequently mentioned difficulties 
encountered were lack of a legislative framework or 
regulations concerning the sale of pharmaceuticals through 
the Internet. Furthermore, the authorities of several 
countries mentioned they lacked the technology, human 
resources and expertise to identify and counter such illegal 
operations. The issues relating to the lack of capacity 
underscore the importance of the guidelines in dealing 
with the sharing of expertise and the provision of technical 
assistance. In addition, lack of international cooperation, 
lack of cooperation with Internet service providers and 
difficulties in coordination and cooperation among various 
national agencies were frequently mentioned. 
 
 (a) Action to be taken 
 
293. One of the principal suggestions made by 
respondents to the questionnaire was that Governments 
that had already implemented the guidelines should share 
their experiences with those that had not, in order to 
identify good practices. A second suggestion was that 
Governments that had implemented the guidelines should 
provide training for those that had not, in order to improve 
the capacity of officials to identify and counteract the 
activities of illegal Internet pharmacies. The responses to 
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the questionnaire show that the vast majority of 
Governments with experience in dealing with illegal 
Internet pharmacies have not, to date, been offering 
technical assistance to those Governments requiring such 
assistance. One example given of the technical assistance 
currently being offered at the international level was 
Project Drug.net of the International Criminal Police 
Organization (INTERPOL). Several Governments 
suggested the use of joint operations to improve procedures 
and controls. That might also help to respond to the 
concern expressed by several Governments that action 
against offending websites could only be taken on their 
territory and that websites based in other countries cannot 
be confronted with restrictive action. 
294. One related problem that has been noted is that 
sometimes illegal Internet pharmacies pretend to be 
located in one specific country but are in fact registered in 
other countries or with registrars outside the country 
concerned, which consequently is in no position to regulate 
them under their national legislation. The Board is of the 
opinion that it would be in the interest of all countries if 
those that have the capability to block websites, filter 
Internet content and monitor website behaviour on a 
regular basis would not concentrate their efforts exclusively 
on identifying web pages that are operating from their own 
territory but would also identify all other offending 
websites and share that information with the authorities 
concerned. In this regard, the Board notes with concern 
that the implementation of its guidelines 24 and 25, aimed 
at ensuring timely responses to requests for cooperation 
from other States, as well as the elaboration of standards for 
the investigation and reporting of such cases, have been 
characterized by a relatively low rate of implementation. 
The Board urges Governments to implement those 
guidelines, as such action may significantly boost 
international efforts to address illegal Internet pharmacies. 
295. A significant portion of illegal Internet pharmacies’ 
activities involve smuggling their products to consumers, 
finding hosting space for their websites and convincing 
consumers that the pharmacies are, in fact, legitimate. In 
response, several Governments suggested that there should 
be increased control of mail and courier services. Some 
Governments suggested introducing sufficient alert and 
control systems at the mail entry and departure points of 
countries and increasing law enforcement authorities’ 
knowledge of control requirements; however, it was 
recognized that the amount of mail entering and leaving a 
country would make this very difficult. Governments also 
recommended systematic identification of and cooperation 
with Internet service providers hosting websites that trade 
illegally, with a view to having the sites withdrawn. Finally, 
several Governments suggested community awareness 
campaigns ahead at providing information on buying 
medicines online. 
296. The Board wishes to remind Governments that the 
recommendations contained in guidelines 7 and 8, relating 
specifically to legislation concerning internationally 
controlled substances, need to be fully implemented by all 
countries, as they reflect obligations of Governments as 
contained in the provisions of the international drug 
control treaties, as well as relevant Economic and Social 
Council resolutions. In particular, the Board notes that in 
the absence of universal implementation of the guidelines, 
illegal Internet pharmacies may be able to continue their 
activities by simply moving them to jurisdictions with 
weaker control measures. The Board wishes to reiterate 
that, in order for global efforts to counter illegal Internet 
pharmacies to be effective, all Governments must ensure 
that comprehensive measures are in place to prevent the 
operation of illegal Internet pharmacies from their 
territory. The Board, therefore, calls on Governments to 
continue to implement the guidelines, to devote efforts for 
improving international cooperation and to provide 
technical assistance to countries requiring it. 
 
 (b) Information on seizures of internationally 
controlled substances sent via the mail 
 
297. In accordance with Commission on Narcotic Drugs 
resolution 50/11, the Board collects information on 
seizures of internationally controlled substances sent via 
the mail, including those ordered via the Internet. To date, 
the Board has received reports of over 12,000 seizures of 
internationally controlled substances sent via the mail. 
Although the Board requested Governments to identify, if 
possible, which of those seizures were ordered via the 
Internet, the vast majority of Governments did not have the 
capacity to do that. 
298. Based on the information provided to the Board, the 
main countries and territories of origin identified for seized 
pharmaceutical preparations were India (accounting for  
58 per cent of seized substances), followed by the United 
States, China and Poland. In addition to national postal 
services, a number of courier or express package delivery 
services were mentioned as being misused for the 
smuggling of drugs, both pharmaceutical preparations and 
illicit drugs. The most frequently seized licit psychotropic 
substances were diazepam and phentermine. The most 
frequently seized licit narcotic drugs were methadone and 
codeine; the most frequently seized precursors were 
ephedrine and pseudoephedrine. The most frequently 
seized drugs of illicit origin included cannabis, khat, 
amphetamine, cocaine, heroin and JWH-122 (a synthetic 
cannabinoid). 
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 (c) Further developments involving illegal Internet 
pharmacies 
 
299. The sale of internationally controlled substances by 
illegal Internet pharmacies continue and the range of media 
used by these Internet pharmacies appears to have 
broadened. After several Internet search engines disallowed 
the use of registered trademarks for prescription drugs in 
their sponsored links, illegal Internet pharmacies 
increasingly publicized their websites through message 
board and social network advertising. Illegal Internet 
pharmacies also have continued to advertise with spam 
sent via e-mail as opposed to via social networking sites; 
nearly 25 per cent of all spam e-mail messages are 
advertisements for medicines. Illegal Internet pharmacies 
use a number of methods to pretend to be legitimate 
pharmacies. The methods include providing quotes and 
images of purported medical doctors; and fraudulently 
displaying a number of logos, including the logos of 
national pharmaceutical regulatory bodies. According to 
information from WHO, over 50 per cent of medicines 
ordered from illegal Internet pharmacies have been found 
to be counterfeit. 
300. Action against activities of illegal Internet pharmacies 
has been carried out by a number of national and 
international organizations and associations. This action 
has included certifying legitimate pharmacies and 
providing a register of approved Internet pharmacies that 
can be consulted by potential consumers. Campaigns 
warning of the risks of purchasing medicines from illegal 
Internet pharmacies have also been initiated. Those efforts 
to educate the general public have been conducted by 
Governments and the private sector. In some countries, 
companies in the private sector, including Internet 
registrars, providers of hosting space, credit companies and 
search engine providers, have decided to share information 
relating to activities of illegal Internet pharmacies to enable 
companies to take steps to prevent misuse of their services 
by such Internet pharmacies. The Board welcomes those 
initiatives and recommends that Governments encourage 
companies to deny illegal Internet pharmacies access to the 
legitimate business services required to carry out those 
activities. 
 
 4. Obstacles to the availability of 
internationally controlled substances for 
scientific purposes 
 
301. The Board has made repeated efforts to raise 
awareness within the international community of the 
important role played by drug-testing laboratories and of 
the need to ensure that they are granted adequate access to 
the test samples they require. In the pursuit of its mandate, 
the Board has encouraged States to consider the adoption 
of measures aimed at facilitating the availability of test and 
reference samples, while reminding them of the need for 
such measures to comply with the provisions of the 
international drug control treaties. 
302. That issue was discussed by the Board in its annual 
report for 2005.20 In 2007, the Board issued the Guidelines 
for the Import and Export of Drug and Precursor Reference 
Standards for Use by National Drug-Testing Laboratories 
and Competent National Authorities,21 in which it 
recognized the importance of forensic laboratories, as well 
as the need to ensure that such laboratories had access to 
the facilities and tools they need to carry out their work, 
including high-quality reference standards. In the 
guidelines, the Board identified some of the obstacles to 
obtaining reference samples in a timely manner that were 
encountered most frequently by laboratories, and guidance 
was provided on possible ways to remove those obstacles.  
303. Since the publication of the guidelines, some progress 
has been made. There has been almost universal 
recognition on the part of States of the importance of 
ensuring the availability of test and reference samples, and 
many measures have been adopted to that end at the 
national and regional levels. In spite of that progress, many 
laboratories continue to experience difficulties and/or 
delays in obtaining all the test and reference samples they 
require. 
304. Concerned by those continuing difficulties, the 
Commission on Narcotic Drugs adopted resolution 54/3, 
on ensuring the availability of reference and test samples of 
controlled substances at drug-testing laboratories for 
scientific purposes. In the resolution, the Commission 
requested Member States to review, in consultation with the 
Board and UNODC, national procedures, in order to 
facilitate access to internationally controlled substances for 
use as test and reference samples by drug-testing 
laboratories.  
305. In its resolution 54/3, the Commission encouraged 
the Board to continue its efforts to ensure the adequate 
availability of internationally controlled substances for 
scientific purposes and stressed the importance of the 
UNODC quality assurance programme for drug analysis 
laboratories. In addition, the Commission invited the 
Board and UNODC to work together to establish feasible 
mechanisms for facilitating the provision of minimal but 
__________________ 
 20  Report of the International Narcotics Control Board for 2005 
(United Nations publication, Sales No. E.06.XI.2),  
paras. 216-218. 
 21  United Nations publication, Sales No. M.08.XI.6 (available at 
www.incb.org/documents/Reference_ 
standard_guidelines/reference-standards_en.pdf). 
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sufficient amounts of reference and test samples of 
controlled substances to drug-testing laboratories.  
306. The Board and UNODC prepared two questionnaires 
to solicit information from competent national authorities 
and drug-testing laboratories on persistent obstacles to the 
availability of test and reference samples of internationally 
controlled substances with a view to identifying ways to 
remove those obstacles.  
307. Responses provided by drug-testing laboratories 
confirm that many of them continue to encounter 
difficulties in obtaining the test and reference samples they 
require, especially if those samples are not available from 
domestic sources and need to be imported. The four most 
common difficulties reported by laboratories are related to 
the following: shipping, approval of imports by competent 
national authorities, customs clearance and costs.  
308. Responses provided by competent national 
authorities indicate that where the procedures for applying 
for import authorizations are not known or not fully 
complied with by drug-testing laboratories, authorizations 
may be delayed or even denied. Common difficulties cited 
by competent national authorities were related to a lack of 
knowledge of import authorization procedures on the part 
of laboratories, incomplete or erroneous information 
provided in import authorization requests, and inadequate 
supporting documentation. One of the most common 
grounds given for the refusal of the import or export of test 
and reference sample material was that drug-testing 
laboratories do not follow established procedures and/or do 
not complete the forms and provide the documentation 
required. The Board invites competent national authorities 
to consider working with drug-testing laboratories to 
improve knowledge of import and export authorization 
application procedures and to establish contact points 
within their administrations to assist drug-testing 
laboratories with their applications. 
309. Drug-testing laboratories indicated in the survey that 
the formalities associated with the approval of the import 
and export of test and reference samples of internationally 
controlled substances were a significant hindrance to the 
availability of the samples needed by the laboratories to 
complete their work. When seeking to import multiple 
substances from the same provider, drug-testing 
laboratories are often required to submit, and pay for, 
multiple import authorization requests, which causes 
delays and additional financial burdens. In some cases, 
import and export authorizations are valid for a limited 
period, and delays in approval lead to the documents 
expiring before the acquisition by the drug-testing 
laboratories is completed. In order to expedite the approval 
process and reduce costs, the Board invites competent 
national authorities to consider giving priority to 
processing import authorization applications that are filed 
by drug-testing laboratories and waiving applicable fees. 
Competent national authorities may also wish to provide 
the possibility for laboratories to request the import of 
several substances on the same form so that less supporting 
documentation is required, to ensure that import and 
export authorization documents are valid for a period of  
six months or longer, and to instruct their customs 
authorities to give priority to requests for shipments of test 
and reference samples for drug-testing laboratories.  
310. Respondents to the survey addressed to drug-testing 
laboratories included laboratories participating in the 
international collaborative exercise, a component of the 
UNODC international quality assurance programme. 
Participants in this initiative reported significantly fewer 
difficulties and delays in obtaining test and reference 
samples of internationally controlled substances compared 
with non-participants. Drug-testing laboratories, 
particularly those in countries where access to test and 
reference samples is limited, may wish to consider 
participating in the international collaborative exercise 
programme or similar quality-assurance programmes. The 
Board encourages Governments that have the resources to 
do so to provide support and adequate resources for those 
initiatives.  
311. The Board has noted that, if competent national 
authorities are unaware of the importance of test and 
reference samples for drug-testing laboratories or of the 
work done by those laboratories, they may unnecessarily 
delay or deny imports, thus hindering availability. The 
Board reminds all States that all parties involved in  
the acquisition of test and reference samples of 
internationally controlled substances should be made aware 
of their critical importance to the work of drug-testing 
laboratories and should cooperate in facilitating access to 
such samples. Possible awareness-raising measures may 
include the designation of a national coordinator for the 
procurement and distribution of reference samples; the 
institutionalization of cooperation between Government 
agencies, such as the formation of an inter-agency working 
group; and the establishment of a coordinating body for 
classifying new drugs that are seized and distributing 
samples of them to laboratories throughout the country. 
312. Several competent national authorities reported that 
they refused imports of test and reference samples if they 
exceeded the estimates provided to the Board for the 
substances in question. Others reported that although such 
imports were not refused, they were delayed until a 
supplementary estimate for the substances in question 
could be sent to the Board. In order to avoid the refusal of 
imports on the basis of estimates that do not take into 
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account the needs of drug-testing laboratories, the Board 
invites all States parties to the international drug control 
conventions to consult those laboratories when establishing 
their estimated annual requirements of internationally 
controlled substances. The Board also reminds States 
parties that they may, at any time, submit supplementary 
estimates should their initial estimates need to be increased 
to meet unforeseen needs, including those of drug-testing 
laboratories.  
313. The answers provided by drug-testing laboratories 
have confirmed that shipping difficulties continue to be a 
major obstacle to the availability of test and reference 
samples of internationally controlled substances. The vast 
majority of the competent national authorities that 
responded to the survey indicated that they did not  
have any procedural requirements in place for postal 
services and shipping companies with regard to the import 
and export of test and reference samples of internationally 
controlled substances. The Board encourages States parties 
to consider establishing clear requirements on the transport 
of test and reference samples of internationally controlled 
substances in order to avoid unnecessary refusals  
of shipments caused by vague guidelines, and to apply 
discretion in approval procedures. Any revised 
requirements should also seek to prevent the diversion of 
the samples by establishing safeguards, such as the use of 
couriers. 
314. The Board notes that in suggesting possible 
mechanisms to facilitate access to test and reference 
samples, several European Union member States pointed to 
Council of the European Union decision 2001/419/JHA on 
the transmission of samples of controlled substances as a 
possible model from which solutions could be drawn. The 
decision establishes a system for the transmission of 
samples of controlled substances between European Union 
member States, subject to certain formal requirements such 
as that the samples be intended for use in the detection, 
investigation and prosecution of criminal offences or for 
the forensic analysis of samples. Moreover, the quantity of 
the sample should not exceed the quantity deemed 
necessary for law enforcement and judicial purposes. In its 
decision, the Council provided for the designation of 
national contact points, which could act as the sole 
competent bodies for authorizing the transmission of 
samples. The transmission of samples is agreed upon 
between the national contact points of the sending and the 
receiving States using a standardized form, and the national 
contact points of any transit States are also duly informed 
ahead of time. The decision states that samples must be 
transported in a secure way and it provides guidelines on 
which means of transport are considered secure. In seeking 
to identify solutions to the problem of the availability of 
test and reference samples at the international level, the 
Board invites all States to share best practices that have 
been adopted at the national and regional levels and that 
have proved effective in fostering greater availability of test 
and reference samples of internationally controlled 
substances. 
315. The Board reiterates that the key to removing 
obstacles to the availability of test and reference samples of 
internationally controlled substances is awareness-raising 
and inter-agency cooperation and invites all States to renew 
their efforts to ensure that drug-testing laboratories are 
given the tools they need to carry out their indispensable 
work. 
316. In summary, the survey undertaken by the Board 
revealed that there are a number of possible courses of 
action that can be taken to improve access to test and 
reference samples of internationally controlled substances 
for use by drug-testing laboratories. The guidelines 
prepared by the Board include recommendations for 
overcoming obstacles to shipping, approval of imports by 
competent national authorities, customs clearance and 
costs. The Board strongly encourages Governments to 
implement the guidelines in order to ensure the availability 
of test and reference samples of internationally controlled 
substances for use by drug-testing laboratories. The survey 
has also enabled the Board to identify a number of 
additional courses of action that can be followed to help to 
improve access to such test and reference samples. These 
can be found on the Board’s website (www.incb.org), 
together with the guidelines. 
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 III. Analysis of the world situation 
 
 
 A. Africa 
 
 
 1. Major developments 
 
317. In 2011, a number of countries in North Africa 
underwent social and political change. For example, 
Egypt, the Libyan Arab Jamahiriya22 and Tunisia 
experienced political revolutions aimed at establishing 
democratic societies. During such revolutions, there is a 
risk of drug traffickers exploiting periods in which drug 
law enforcement is weakened. 
318. While cannabis remains the most widely cultivated, 
trafficked and abused drug in Africa, the smuggling of 
cocaine from South America through Africa and into 
Europe has emerged as a major threat. The amount of 
cocaine trafficked via Africa seemed to decrease in 2008 
and 2009; however, there are indications that traffickers 
have simply modified their modus operandi, finding new 
methods for smuggling cocaine through West Africa that 
entail concealing the drug in maritime cargo containers. 
The increasing number of large seizures of cocaine 
hidden in such containers in or en route to West African 
countries in 2010 and 2011 is evidence of that 
development. Reports indicate increasing levels of abuse 
of cocaine in some countries affected by such trafficking. 
319. The Security Council has recognized the threat 
posed by drug trafficking, which is undermining 
development, stability and security in West Africa. A 
number of special sessions of the General Assembly have 
been convened to address the issue of drug trafficking. In 
December 2010, the Secretary-General reiterated his 
appeal to the international community to step up its 
support for regional endeavours on combating the threats 
to peace and security as a result of trafficking in drugs 
and cross-border crimes.23 
320. Heroin enters Africa through airports and seaports 
in East Africa. From there, it is smuggled, either directly 
or via West Africa, into Europe and other regions. In 
2011, record seizures of heroin were effected in Kenya 
and the United Republic of Tanzania. Heroin is also 
smuggled via Mozambique into South Africa, where it is 
abused by the local population or smuggled into other 
countries in Southern Africa and elsewhere. The 
increasing flow of heroin entering Africa has led to 
__________________ 
 22 Since 16 September 2011, “Libya” has replaced “Libyan Arab 
Jamahiriya” as the short name used in the United Nations. 
 23 “Report of the Secretary-General on the activities of the 
United Nations Office for West Africa” (S/2010/614),  
para. 74. 
increased drug abuse throughout the region, particularly 
in East Africa and Southern Africa. 
321. Concerns that the illicit manufacture of 
amphetamine-type stimulants might take hold in  
West Africa were confirmed by the seizure of a  
large methamphetamine laboratory in Lagos in  
June 2011. Nigeria is at risk of becoming a hub for the 
smuggling of amphetamine-type stimulants, notably 
methamphetamine. In 2010, Nigerian authorities seized 
two shipments of amphetamine and methamphetamine 
totalling 63 kg. One shipment was being sent via  
South Africa to the United States of America, and the 
other was en route to Japan. 
322. The countries in the Horn of Africa are enduring 
the worst drought in more than half a century and are at 
risk of experiencing massive famine. The food crisis in 
countries such as Ethiopia, Kenya and Somalia will leave 
millions of people in need of humanitarian aid and 
medical care. The Board requests all Governments to 
cooperate in facilitating the supply of medicines 
containing controlled substances to the affected countries 
in East Africa. 
 
 2. Regional cooperation 
 
323. The African Union is implementing its Plan of 
Action on Drug Control and Crime Prevention  
(2007-2012). The Commission of the African Union is 
working on the main components for the Plan of Action 
on Drug Control and Crime Prevention  
(2013-2018), to be submitted to the African Union 
Conference of Ministers for Drug Control and Crime 
Prevention at its fifth session, to be held in Addis Ababa 
in 2012. 
324. At the fourth session of the African Union 
Conference of Ministers for Drug Control and Crime 
Prevention, held in Addis Ababa from 28 September to  
2 October 2010, ministers agreed to give priority to the 
following activities: strengthening cooperation and 
coordination in the fight against drugs and crime; 
harmonizing drug control legislation of member States by 
2012; improving control over precursor chemicals; 
exploring the need for an African training facility for the 
treatment of drug dependence; and strengthening the 
African Union’s Continental Early Warning System. In a 
statement presented to the Conference of Ministers, the 
President of the International Narcotics Control Board 
emphasized the need for regulatory aspects of drug 
control to be addressed by African States. 
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325. While participating in the World Health Assembly 
in Geneva in May 2011, the President of  
the Board presented to a meeting of ministers of health 
from the WHO African Region a statement on the 
availability of internationally controlled drugs for medical 
and scientific purposes. 
326. The efforts of member States of the Economic 
Community of West African States (ECOWAS) to prevent 
drug trafficking and abuse are coordinated within the 
framework of the ECOWAS action plan against drug 
trafficking, organized crime and drug abuse. At a meeting 
of the West African Police Chiefs Committee, a 
specialized institution of ECOWAS, held in Abuja in  
May 2011, ECOWAS member States agreed to combine 
their efforts to step up the fight against crime, at the 
national and international levels, and to encourage their 
police forces to cooperate with INTERPOL. 
327. The West African Coast Initiative (WACI), 
launched in 2009 to support the implementation of the 
operational component of the ECOWAS action plan in 
Côte d’Ivoire, Guinea-Bissau, Liberia and Sierra Leone, 
held a high-level policy meeting in Dakar in June 2011. At 
the meeting, all four WACI member States were 
represented at the ministerial level. The ECOWAS 
Commission, United Nations agencies and INTERPOL 
were also represented at the meeting. Plans are being 
made to expand the membership of WACI to include 
Guinea. 
328. Important international initiatives were undertaken 
in 2011 to counter the smuggling of cocaine across the 
Atlantic. The Group of Eight held a ministerial meeting in 
Paris in May 2011. The meeting was attended by 
representatives of 22 countries, including several West 
African countries (Ghana, Nigeria and Senegal), and 
ECOWAS. The participants adopted a political 
declaration and action plan for strengthening 
international cooperation, including in the areas of 
information-sharing, intercepting shipments at sea and 
coordinating technical assistance. Furthermore, the 
Trans-Atlantic Symposium on Dismantling Transnational 
Illicit Networks was organized by the United States and 
the European Union in Lisbon in May 2011 to strengthen 
international and interregional cooperation between West 
Africa, Europe and the Americas. 
329. The 21st African Regional Conference of 
INTERPOL was held in Gaborone in February 2011. The 
Conference was attended by senior law enforcement 
officials from countries throughout Africa. The 
participants expressed support for more concerted 
regional action against cross-border crime in Africa, 
including trafficking in cannabis, cocaine, heroin and 
psychotropic substances, and improved sharing of 
information between law enforcement agencies. 
330. The Twenty-first Meeting of Heads of National 
Drug Law Enforcement Agencies, Africa, was held in 
Addis Ababa in September 2011. The Meeting agreed on 
action to counter drug trafficking, including by using 
controlled delivery operations, and the diversion of 
precursor chemicals in Africa, particularly substances 
used in the illicit manufacture of amphetamine-type 
stimulants. 
331. Cooperation between police drug law enforcement 
units of East African Community member States 
(Burundi, Kenya, Rwanda, Uganda and the United 
Republic of Tanzania) is well established. As follow-up to 
a conference of the Eastern African Police Chiefs 
Organization held in December 2010, a workshop was 
held in Nairobi in June 2011 on the concept of units for 
fighting transnational organized crime. Representatives of 
Djibouti, Ethiopia, Kenya, Mauritius, Uganda and the 
United Republic of Tanzania participated in the 
workshop. The participants agreed to work towards the 
establishment of such units in their countries. 
332. INTERPOL organized a workshop on international 
and regional cross-border operations, in cooperation with 
the Southern African Regional Police Chiefs Cooperation 
Organization in Harare in June 2011. Participants in the 
workshop analysed current and emerging crime trends in 
Southern Africa and discussed drug law enforcement 
operational techniques, in particular controlled delivery. 
333. UNODC addresses problems related to drug 
trafficking and abuse and organized crime in Africa 
through integrated subregional programmes. Such 
programmes were put in place for the countries of North 
Africa, West Africa and East Africa in 2009 and 2010. A 
similar programme is currently being developed, in 
cooperation with the Southern African Development 
Community (SADC), for the countries of Southern 
Africa. 
334. The second phase of the UNODC Airport 
Communication Project (AIRCOP) was launched in 
January 2011. AIRCOP, which is conducted in 
cooperation with INTERPOL and the World Customs 
Organization, is aimed at establishing an international 
communication network among specialized units along 
trafficking routes leading from South America and the 
Caribbean through Africa to destination countries in 
Europe. In June 2011, a meeting of the AIRCOP Steering 
Committee was held in Cape Verde, with the 
participation of Brazil and all the African beneficiary 
countries (Benin, Cameroon, Cape Verde, Côte d’Ivoire, 
Ghana, Guinea, Kenya, Mali, Nigeria, Senegal and Togo) 
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and associated member States (Ethiopia and South 
Africa). 
335. The Container Control Programme, which is 
implemented jointly by UNODC and the World Customs 
Organization, used to provide assistance to Governments 
of countries in Africa, Central America, South America 
and Central Asia in establishing effective container 
controls to prevent the smuggling of drugs and other 
contraband. In Africa, the programme has been in 
operation in Cape Verde, Ghana and Senegal. In  
March 2011, the programme became fully operational in 
Benin and Togo. Assessments were undertaken in 2011 to 
expand the programme to include Mali and Nigeria. 
 
 3. National legislation, policy and action 
 
336. In 2010, the Government of Ethiopia established an 
inter-ministerial coordination committee, composed of 
15 ministries and Government agencies, to step up action 
against drug trafficking at Bole International Airport, 
near Addis Ababa. Already in 2009, an inter-agency 
coordination team had been established to improve 
operational cooperation at the airport among the relevant 
drug law enforcement entities. An international 
conference on drug trafficking is to be held in Addis 
Ababa in January 2012 to establish contacts and facilitate 
cooperation between the key airports with direct flight 
connections to Bole International Airport, including 
airports in Ghana, India, Kenya, Nigeria, Pakistan, 
Uganda, the United Arab Emirates and the United 
Republic of Tanzania. 
337. In Ghana, a national integrated programme against 
drug trafficking and organized crime was endorsed by the 
national authorities in 2011. Activities under the 
programme have already started, including the delivery of 
training to staff attached to the Economic and Organized 
Crime Office of the Ministry of the Interior of Ghana, 
which was recently established to combat organized 
crime, drug trafficking and other forms of serious crime.  
338. In view of the threats posed by the smuggling of 
cocaine through West Africa, the Government of Guinea 
has made the fight against drug trafficking one of its 
priorities. In January 2011, it created a general secretariat 
attached to the Presidency with responsibility for special 
services and the fight against drug trafficking and 
organized crime.  
339. In June 2011, the Government of Guinea-Bissau 
adopted a political declaration and an action plan on 
combating and preventing drug trafficking and organized 
crime. While in the declaration, the Government 
reaffirmed the commitment of Guinea-Bissau to 
promoting an environment free of problems related to 
drugs and crime, the action plan set forth the operational 
objectives and the activities needed to reach those 
objectives. The action plan complements the ECOWAS 
action plan against drug trafficking, organized crime and 
drug abuse covering the period 2008-2011. Drug 
trafficking remains a major threat to the development of 
Guinea-Bissau and has led to an increase in drug abuse in 
that country.  
340. Comprehensive national drug and crime control 
plans were drawn up and approved by the Government of 
Ghana and the Government of Sao Tome and Principe in 
2011. The Government of Nigeria, in consultation with 
civil society, international development partners and 
United Nations agencies, is in the process of preparing an 
integrated national drug and crime control programme 
for the period 2012-2014. 
341. The Government of Mauritius is finalizing  
a national drug control master plan for the  
period 2012-2016. 
342. The Board notes the commitment of the 
Government of Morocco to addressing drug abuse and 
developing options for the treatment of drug abusers. 
Under a nationwide programme set up in 1999, the 
Government has established four centres for the 
treatment of young people with addictive behaviour; in 
2011, construction work began on two additional centres. 
The Government has also established a programme for 
training staff of psychiatric hospitals in the treatment of 
drug addiction, launched a campaign to raise the 
awareness of schoolchildren about the dangers of drug 
abuse and created drug-free school zones. Since 2010, a 
programme that uses methadone for substitution 
treatment has been in place in the country. Morocco is 
the first country in North Africa, as well as in the Arab 
world, to allow the use of methadone in the treatment of 
drug dependence. 
343. Since the completion of the national drug control 
master plan for the period 2006-2011, the Central Drug 
Authority of South Africa has been working on a national 
drug control master plan for the period 2012-2017, which 
will address the problem of substance abuse and give 
priority to addressing the needs of the rural areas in the 
country by using community-based approaches. 
344. The Government of South Africa hosted a 
substance abuse summit in Durban in March 2011. The 
summit was attended by several hundred representatives 
of Government entities and civil society, including the 
President of South Africa and other high-level 
Government officials. The participants adopted a number 
of resolutions to improve efforts to address the problem 
of substance abuse in South Africa. 
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345. A number of African States have taken further 
action to counter money-laundering. In December 2010, 
Mali became the fourth State (after Senegal, Togo and 
Côte d’Ivoire) to incorporate into its national legislation 
the West African Economic and Monetary Union 
(UEMOA) uniform law in the fight against the financing 
of terrorism. Angola, which enacted a law against money-
laundering in June 2010, approved regulations for 
implementing that law in January 2011. The regulations 
provide for the establishment of a financial intelligence 
unit within the Central Bank. 
 
 4. Cultivation, production, manufacture and 
trafficking 
 
 (a) Narcotic drugs 
 
346. Cannabis, which grows widely throughout Africa 
and is also illicitly cultivated in some countries in the 
region, remains the most commonly abused drug on the 
African continent. While cannabis resin is illicitly 
produced mainly in Morocco, cannabis herb is illicitly 
produced in countries throughout the region.  
347. Most of the cannabis resin illicitly produced in 
Morocco is destined for Europe or North Africa. The 
Government of Morocco has reported having continued 
to make efforts to combat the illicit cultivation and 
production of and trafficking in cannabis. According  
 to data provided by the Government, 9,400 ha of illicitly 
cultivated cannabis plants were eradicated during 2010. 
Thus, the total area under illicit cannabis cultivation 
decreased from 134,000 ha in 2003 to 47,500 ha  
in 2010. The Moroccan drug law enforcement policy is 
supported by a comprehensive alternative development 
approach and a crop substitution programme valued at 
$116 million, under which socio-economic and 
environmental development projects have been initiated 
in 74 rural communities. Despite those efforts, Morocco 
remains a major source of the cannabis resin in Western 
Europe, as corroborated by data on seizures of cannabis 
resin reported by Governments. Data on seizures and 
prices in Europe suggest that the flow of cannabis resin 
from Morocco into the region has remained the same or 
has slightly decreased. The Board reiterates its call for the 
Government of Morocco to conduct, as soon as possible, 
the survey on cannabis plant cultivation and cannabis 
production that was to be carried out by the Government, 
in cooperation with UNODC, in 2010. 
348. While an increased amount of cannabis resin was 
reported to have been seized in a number of countries in 
North Africa in 2009, that development did not continue 
into 2010. For instance, the total amount of cannabis 
resin seized in Morocco rose from 114 tons in 2008 to  
188 tons in 2009 — the highest level on record — but fell 
back to 118 tons in 2010. In Algeria, the amount of seized 
cannabis resin also increased, to 74.6 tons in 2009 
(compared with 1.7 tons in 2005) but fell to 23 tons  
in 2010. In contrast, the amount of seized cannabis resin 
increased in Egypt — from 12.8 tons in 2009 to 15.4 tons 
in 2010 — and in the Libyan Arab Jamahiriya — from 
14.8 tons in 2006 to 23 tons in 2010. 
349. Cannabis herb is illicitly produced in all subregions 
of Africa. In North Africa, significant production of 
cannabis herb is taking place in Egypt and Morocco. 
Cannabis plants continue to be illicitly cultivated in Egypt 
in the northern part of the Sinai peninsula. In Egypt, a 
total of 510 ha of illicit cannabis cultivation were 
eradicated in 2010, compared with 313 ha in 2008. 
Cannabis herb production is also taking place in 
countries in West Africa and Central Africa (notably in 
Ghana, Nigeria, Senegal and Togo) and in East Africa (in 
Ethiopia, Kenya, Madagascar, Uganda and the United 
Republic of Tanzania). Cannabis plants are illicitly 
cultivated throughout Southern Africa. The cannabis 
produced in South Africa is abused by the local 
population or smuggled into other countries. Significant 
quantities of cannabis herb are also illicitly produced in 
Lesotho, Malawi and Swaziland. 
350. In 2009, 640 tons of cannabis herb were seized in 
Africa, or 11 per cent of the amount seized worldwide. In 
Africa, seizures of cannabis resin remained concentrated 
in a small number of countries: Egypt, Kenya, Malawi, 
Morocco, Nigeria, South Africa and the United Republic 
of Tanzania accounted for at least 90 per cent of the total 
amount of cannabis resin seized in Africa. In Nigeria,  
175 tons of cannabis herb were seized in 2010, and in 
Morocco 144 tons were seized in the first 11 months of 
that year. South Africa is used by traffickers as a source, 
consumer and transit country for cannabis herb. In 2009, 
126 tons of cannabis herb were seized in South Africa. 
According to South African authorities, an estimated  
30 per cent of the cannabis herb seized in South Africa 
was destined for Europe. 
351. While there is no evidence of illicit coca bush 
cultivation or illicit manufacture of cocaine in the region, 
parts of Africa, particularly West Africa, continue to be 
used for smuggling cocaine from South America into 
Europe. Cocaine trafficking routes leading through Africa 
gained strongly in importance between 2004 and 2007 but 
have lost some of their importance since 2008. According 
to estimates, the amount of cocaine trafficked via West 
Africa increased from 3 tons in 2004 to about 47 tons in 
2007, before falling to about 21 tons in 2009. 
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352. In 2008, a significant shift was observed in the 
methods used by drug traffickers in West Africa. Most of 
the drugs smuggled into West Africa used to be 
transported by large mother ships, which unloaded the 
drugs onto smaller, locally owned vessels off the West 
African coast. Today, however, drug traffickers seem to 
have changed their tactics, utilizing containerized 
shipping to smuggle cocaine into West Africa. For most of 
the recent cocaine shipments detected in containers en 
route from South America to West Africa, the country of 
destination was Ghana or Nigeria. In July 2010, Nigerian 
authorities seized 450 kg of cocaine in the port of Lagos 
on a vessel originating in Chile. Two additional seizures 
of cocaine, totalling 275 kg, were effected in January 2011. 
In Ghana, 125 kg of cocaine were seized in October 2010 
in a container that had originated in the United States and 
passed through Panama. In October 2011, a record 
seizure of 1.5 tons of cocaine was made in Cape Verde. In 
addition, in a series of seven seizures effected in Africa 
and the Americas in 2011, a total of over 1.4 tons of 
cocaine was seized; the cocaine had been concealed in 
consignments destined for Benin. Furthermore, 480 kg of 
cocaine destined for Nigeria were seized in Brazil in 
October 2011. 
353. Traffickers also use commercial aircraft to transport 
cocaine to West Africa. In 2010, an increasing number of 
modified aircraft departed from the Bolivarian Republic 
of Venezuela for countries in West Africa, including Cape 
Verde, Guinea-Bissau, Mali, Mauritania and Sierra Leone. 
From West Africa, most of the cocaine that is destined for 
Europe is transported by air, usually by couriers on 
commercial air flights but also by air freight. Some 
cocaine from West Africa is smuggled across the Sahara 
into North Africa before it reaches Europe. 
354. Cocaine is increasingly entering East Africa and 
Southern Africa. Investigations by the South African 
police indicate significant movement of cocaine between 
South American countries and Namibia, South Africa 
and Zimbabwe. That finding is corroborated by a number 
of significant seizures of cocaine effected in South Africa 
in 2010 and 2011. South Africa reported having seized in 
December 2010 1.7 tons of cocaine found in a ship 
coming from Paraguay and 165 kg of cocaine found in a 
container from Paraguay in August 2010. In July 2011, the 
Portuguese navy intercepted a fishing boat from Namibia 
carrying nearly 1.7 tons of cocaine destined for Europe. 
In May 2011, 875 kg of cocaine were seized in Paraguay; 
the drug had been concealed in a sea container destined 
for Mozambique. According to estimates of the 
authorities of South Africa, about 40 per cent of the 
cocaine trafficked in South Africa is destined for Europe, 
and the remaining 60 per cent is abused by the local 
population or smuggled into other countries in Southern 
Africa. 
355. Illicit cultivation of opium poppy continues to take 
place on a small scale in Upper Egypt and on the Sinai 
peninsula. In Egypt, 222 ha of illicitly cultivated opium 
poppy were eradicated and 51 kg of opium were seized in 
2010. According to the Egyptian authorities, there was no 
recorded instance of heroin manufacture in the country. 
356. African countries are increasingly being used by 
traffickers to smuggle heroin into other regions. It is 
estimated that between 40 and 45 tons of Afghan heroin 
were smuggled into Africa in 2009. East Africa continues 
to be used as the main transit area for West Asian heroin 
destined for illicit markets in Europe, North America and 
some parts of Asia. Other countries in Africa that are 
major hubs for heroin trafficking include Nigeria and 
South Africa. The increasing flow of heroin into Africa 
has led to increased drug abuse throughout the region, 
particularly in East Africa and Southern Africa. 
357. In East Africa, the United Republic of Tanzania has 
reported the seizure of large consignments of heroin that 
had been transported by sea to its coast. For instance, in 
December 2010, 50 kg of heroin were seized in that 
country; the heroin was to be smuggled into the Sudan 
via Nairobi. Two seizures of heroin totalling 178 kg were 
effected in Dar es Salaam in March and September 2011. 
The largest single seizure of heroin in East Africa —  
179 kg — was made in the United Republic of Tanzania in 
February 2011. In Kenya, 102 kg of heroin were 
intercepted in March 2011; the heroin had been brought 
to that country’s coastal area on a mother ship and was 
then collected by small speedboats. Ethiopia has become 
a transit area for heroin and cocaine consignments 
destined for illicit markets in Europe, North America and 
West Africa and Southern Africa. The main trafficking 
hub is Bole International Airport, near Addis Ababa, 
which connects Ethiopia to other countries in Africa and 
other regions. Drug trafficking routes leading from Brazil 
through Ethiopia to the United Republic of Tanzania were 
identified in 2010, and routes leading from Mali to the 
Philippines were identified in early 2011. 
358. South Africa is an important country of destination 
for heroin shipments; it is also an important area for 
heroin consignments destined for countries in Southern 
Africa (notably Mauritius), countries in Europe and 
Australia. The international airport at Johannesburg is an 
important hub for illicit consignments destined for the 
United Kingdom of Great Britain and Northern Ireland. 
Heroin is smuggled through Mozambique into South 
Africa; once it arrives in South Africa, it is transported via 
Durban to the Eastern Cape, where it is abused by the 
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local population. Heroin is also smuggled by air courier 
and in air cargo via Nairobi and Addis Ababa in the 
direction of West Africa. 
359. Nigeria has emerged as a significant heroin 
distribution hub in West Africa. According to estimates of 
Nigerian authorities, in 2009, about one half of the heroin 
trafficked in Nigeria was intended for the United States, 
40 per cent was intended for Europe and 10 per cent was 
intended for China. Heroin is also transported overland 
from Nigeria to other West African countries before it is 
shipped further along air routes. For 2010, Nigeria 
reported having seized a total of 202 kg of heroin. Major 
heroin consignments recently uncovered in sea containers 
in West African countries include a consignment of  
193 kg of heroin arriving from the Islamic Republic of 
Iran and seized in Nigeria in November 2010 and a 
consignment of 200 kg of heroin arriving from Pakistan 
and seized in Benin in April 2011. 
360. In recent years, there has been a significant increase 
in the amount of heroin seized in Egypt. In 2008, Egypt 
seized a total of 211 kg of heroin, or two thirds of the total 
amount of heroin seized in Africa. That figure fell to  
159 kg in 2009 but rose again in 2010, to over 222 kg. 
 
 (b) Psychotropic substances 
 
361. The smuggling of amphetamine-type stimulants 
from Africa into other regions has emerged as a new 
threat. West Africa, in particular, is now one of the 
sources of the methamphetamine found on illicit markets 
in countries in East Asia, above all Japan and the Republic 
of Korea, but also Malaysia and Thailand. Since 2009, 
reports on the smuggling of methamphetamine from 
countries in West Africa, including Benin, Cameroon, 
Côte d’Ivoire, Ghana, Nigeria and Senegal, have increased 
markedly. That smuggling activity, which mainly involves 
the use of air couriers, and the seizure in Guinea in 2009 
of equipment and chemicals used in illicit drug 
manufacture were considered to be indications that 
amphetamine-type stimulants might be illicitly 
manufactured in that subregion. In June 2010, the 
Government of the United States indicted members of a 
drug trafficking network for attempting to establish a 
clandestine methamphetamine laboratory in Liberia. 
Those indications were further corroborated in  
June 2011, when a large clandestine methamphetamine 
laboratory was seized in Lagos, together with crystalline 
methamphetamine and precursor chemicals such as 
toluene, acetone, sulphuric acid, sodium hydroxide, 
sodium iodide and phosphorus acid. The laboratory 
reportedly had a production capacity of 20-50 kg per 
cycle. 
362. In North Africa, limited clandestine manufacture  
of amphetamine-type stimulants has been reported  
by Egyptian authorities for a number of years. The  
illicitly manufactured drugs are mainly abused by the 
local population. In April 2010, a clandestine 
methamphetamine laboratory was seized in Egypt. 
363. In South Africa, significant quantities of synthetic 
drugs, notably methaqualone (Mandrax), methcathinone 
and methamphetamine, continue to be illicitly 
manufactured and are primarily abused by the local 
population. In addition, large amounts of methaqualone 
from East and South-East Asia are smuggled into South 
Africa. In April 2011, South African police seized a 
clandestine laboratory in Cape Town and nearly 1 ton of 
methaqualone powder, which would have been sufficient 
to manufacture about 1.6 million Mandrax tablets. 
Precursor chemicals were seized at the site, in amounts 
that would have been sufficient to manufacture an 
additional 2 million Mandrax tablets. MDMA (“ecstasy”) 
is smuggled into South Africa mainly from Europe by air 
freight and parcel post. Illicit consignments of 
amphetamine-type stimulants have also been intercepted 
on their way from South Africa to countries in the Gulf 
area and East Asia; those consignments were smuggled 
mainly using air couriers. Illicit consignments of 
amphetamine-type stimulants have been seized while en 
route from Mozambique to South Africa; one of those 
consignments contained 10 kg of methamphetamine and 
was seized on South Africa’s border with Mozambique in 
May 2011. 
364. One serious problem in many African countries 
continues to be the availability of prescription drugs on 
unregulated markets outside the control of the health 
authorities. Often those drugs have been diverted or 
counterfeited, and they contain controlled substances, 
possibly amphetamine-type stimulants, as well as 
sedatives and tranquillizers. In some African countries, 
there was an increase in the total amount of such 
substances reported to have been seized: for instance, 
2,556 kg of non-specified psychotropic substances were 
seized in Nigeria in 2010, compared with 712 kg in 2009; 
and 105,940 units of psychotropic substances were seized 
in Morocco in 2010, compared with 61,254 units in 2009. 
 
 (c) Precursors  
 
365. Africa continues to be used by traffickers as an area 
for the diversion of precursor chemicals and as a possible 
destination for smuggled precursors. However, precursor 
trafficking patterns in Africa contrast sharply with the 
low number of precursor seizures made by the authorities 
in African countries. Few diversions or attempted 
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diversions of precursor chemicals were reported in Africa 
in 2011. 
366. East Africa and West Africa, which have recently 
been identified as sources of illicit methamphetamine 
consignments bound for East Asia, continue to be 
vulnerable to trafficking in precursors, notably ephedrine 
and pseudoephedrine, used in the illicit manufacture of 
amphetamine-type stimulants. For instance, a series of 
cases involving the theft of shipments containing 
ephedrine and pseudoephedrine were reported at Jomo 
Kenyatta International Airport, at Nairobi, including a 
shipment of 500 kg of ephedrine destined for Nigeria that 
had been stolen in November 2010. Furthermore, a 
number of suspicious shipments of ephedrine, as well as 
one shipment of 500 kg of P-2-P, intended for companies 
in East Africa, were suspended by the exporting country 
pending the confirmation of the legitimacy of the 
transactions. 
367. South Africa regularly reports the dismantling of 
clandestine drug laboratories, and some of the dismantled 
laboratories are very large. While South Africa operates a 
precursor control programme, most other countries in 
Africa lack such programmes. In South Africa, large 
quantities of legally imported ephedrine and 
pseudoephedrine are diverted to be used for the illicit 
manufacture of methamphetamine. 
 
 (d) Substances not under international control 
 
368. Khat (Catha edulis), a substance not under 
international control, is cultivated in several East African 
countries, mainly Ethiopia and Kenya. In a number of 
countries — including countries in Africa — the 
cultivation of and trade in khat are prohibited by law.  
In Ethiopia, where khat is legal, one major concern  
of drug law enforcement authorities is the use of the  
khat distribution channels for the distribution of illegal 
drugs.  
 
 5. Abuse and treatment  
 
369. Most countries in Africa continue to lack proper 
systems for monitoring drug abuse and are therefore 
unable to gather sufficient data on the extent and patterns 
of drug abuse or to carry out accurate assessments of 
prevalence rates. The only systematic monitoring of drug 
abuse in the region is taking place in South Africa, 
through the South African Community Epidemiology 
Network on Drug Use, a drug abuse monitoring system 
based on demand for treatment. Consequently, the need 
for the treatment and rehabilitation of drug abusers 
cannot be properly assessed. Most national estimates of 
the prevalence of drug abuse are based on rapid 
assessments of drug abuse among specific groups within 
the drug-abusing population and a limited number of 
school surveys. 
370. Available information suggests that cannabis 
remains the most widely abused drug in Africa. The 
estimated annual prevalence rate for cannabis abuse in 
Africa is the second highest of all the regions: it is 
estimated that between 3.8 and 10.4 per cent of the 
African population aged 15-64, or between 21.6 million 
and 59.1 million people, abuse cannabis. The estimated 
prevalence of cannabis abuse is higher in West Africa, 
North Africa and Central Africa than in the other African 
subregions. According to available data, in Africa 
cannabis abuse accounts for 64 per cent of all treatments 
for drug-related problems — a higher proportion than in 
any other region. 
371. Cocaine abuse in Africa seems to be on the increase. 
The annual prevalence of cocaine abuse in Africa is 
estimated to be about 0.2 per cent of the population aged 
15-64; in other words, about 1 million people in Africa 
are estimated to have abused cocaine in the past year. In 
North Africa, where the prevalence of cocaine abuse is 
considered to be low, cocaine abuse was reported to have 
increased in Algeria and Morocco. Southern Africa is the 
African subregion with the second largest market for 
cocaine: in 2009, illicit demand for cocaine was estimated 
at 4 tons (adjusted for purity). In West Africa and Central 
Africa, subregions affected by significant transit 
trafficking in cocaine from South America (consignments 
mainly destined for Europe), illicit demand for cocaine is 
estimated to be as high as 13 tons per year. In Africa, 
persons admitted for treatment for cocaine-related 
problems reportedly account for about 5 per cent of all 
persons admitted for treatment for drug abuse. According 
to the South African Community Epidemiology Network 
on Drug Use, demand for treatment for cocaine abuse has 
declined in South Africa over the past few years. 
372. The abuse of heroin in Africa appears to have 
increased: 60 per cent of the countries that provided 
relevant information for 2009 reported an increase in the 
abuse of opioids. In 2009, the annual prevalence of opiate 
abuse in Africa was estimated at 0.2-0.6 per cent of the 
population aged 15-64. The prevalence of heroin abuse is 
higher in East Africa (particularly in Mauritius and 
Kenya) than in other subregions of Africa. Abuse of 
heroin by injection is reportedly common among drug 
abusers in Kenya, where nearly 43 per cent of persons 
who abuse heroin by injection are infected with 
HIV/AIDS. Increasing abuse of heroin by injection has 
been reported in the United Republic of Tanzania, 
especially in the coastal areas of that country. In the 
United Republic of Tanzania, it is estimated that there are 
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currently 25,000 persons who abuse drugs by injection,  
40 per cent of whom are infected with HIV/AIDS. In 
Nigeria, the prevalence rate for the abuse of opiates 
(mainly heroin) was estimated to have increased from 
0.57 to 0.70 per cent in 2009, meaning that there were 
between 500,000 and 600,000 heroin abusers in the 
country. In North Africa, the prevalence of abuse of 
heroin by injection is particularly high among drug 
abusers in Egypt. In Cairo, it is estimated that 6.8 per cent 
of persons who abuse drugs by injection are infected with 
HIV/AIDS. 
373. For most parts of Africa there are limited or no 
reliable data available on the abuse of psychotropic 
substances. In South Africa, methaqualone, 
methamphetamine and methcathinone are the most 
commonly abused psychotropic substances. The annual 
prevalence of abuse of amphetamines is estimated by 
UNODC at 0.7-1.4 per cent of the adult population 
(persons aged 15-64) in South Africa. Methamphetamine 
(locally known as “tik”) continues to be the primary 
substance of abuse for which people seek treatment in 
Cape Town. 
374. In many African countries, the non-medical use of 
prescription drugs, notably buprenorphine, pentazocine 
and benzodiazepines, continues to cause considerable 
problems. In East Africa, West Africa and Central Africa, 
the prescription stimulants are frequently abused. In 
Mauritius, buprenorphine (Subutex) is abused more 
frequently than heroin. It is estimated that in Mauritius 
there are about 12,000 persons who abuse heroin or 
buprenorphine. Mauritius has in recent years introduced 
methadone maintenance treatment and a needle 
exchange programme. In South Africa, about 7 per cent 
of patients in treatment for drug abuse reported 
prescription opioids or tranquillizers to be their primary 
or secondary drug of abuse. 
375. In many countries in Africa, the national  
health-care systems are not able to adequately meet 
demand for the treatment and rehabilitation of  
drug-dependent persons. Frequently, only a small 
number of drug-dependent persons can be 
accommodated in the psychiatric wards of general 
hospitals. In Africa, the treatment and rehabilitation of 
drug-dependent persons often depend on assistance 
provided by international and non-governmental 
organizations. 
376. In some countries in North Africa, including Egypt 
and Morocco, capacity-building initiatives have been 
conducted on drug abuse prevention and the treatment of 
drug abusers, as well as on HIV prevention among 
persons who abuse drugs by injection, in communities 
(through community outreach programmes) and in 
prison settings. 
377. In Kenya, a major programme on HIV prevention 
among persons who abuse drugs by injection has been 
implemented. Over 38,800 contacts with drug abusers 
were made in communities in Nairobi and in Coast 
province, and 8,500 persons have received treatment for 
drug dependence, on an inpatient or outpatient basis, 
from government hospitals or civil society organizations. 
378. In January 2011, in response to an upsurge in 
treatment demand in Mombasa, Kenya, caused by a 
sudden decrease in the availability of heroin on the illicit 
markets in Coast province, the Government of Kenya 
decentralized treatment for drug dependence, so that 
such treatment became available in 12 health-care centres 
in Mombasa, and provided free access to HIV prevention 
and treatment services. Also in January 2011, the 
Government announced that it would introduce measures 
such as opiate substitution therapy and needle and 
syringe exchange programmes to further reduce HIV 
infection among persons who abuse drugs by injection. In 
February 2011, the United Republic of Tanzania initiated 
in Dar es Salaam a methadone maintenance programme 
for persons who abuse drugs by injection.  
379. In South Africa, the provincial government of the 
Western Cape is currently implementing a project for 
reducing illicit drug demand that includes HIV 
prevention among youth. A large study is being 
conducted to examine the patterns and extent of drug 
abuse among youth in schools, as well as mental health 
issues and risky behaviour. 
 
 
 B. Americas 
 
 
  Central America and the Caribbean 
 
 
 1. Major developments 
 
380. The region of Central America and the Caribbean, 
because of its strategic geographical location, continues to 
be used as a major transit area for smuggling drugs from 
South America into North America. Some Mexican drug 
cartels, under pressure from Mexican law enforcement 
authorities, have moved their drug trafficking operations 
to Central America, which has resulted in increased levels 
of violence, kidnapping, bribery, torture and homicide in 
that subregion. Drug trafficking organizations have 
increased their operations in Central America and the 
Caribbean, posing a serious threat to human security, 
affecting everyday life, in the region. Guatemala has 
recently been used as a transit area for smuggling cocaine  
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into Mexico. Central American countries have gained in 
importance as trans-shipment areas in recent years. 
Despite efforts to counter drug trafficking in Costa Rica, 
Honduras and Nicaragua, in 2010, those countries were, 
for the first time, identified as major transit countries 
used for smuggling drugs primarily destined for the 
United States. At the same time, the Caribbean has 
become less important as a trans-shipment area for 
smuggling drugs into North America; that appears to be 
attributable to increased maritime control in Central 
America and the Caribbean. In 2009 and 2010, Caribbean 
countries began playing an increasing role as secondary 
distribution points for cocaine shipments destined for 
Europe.  
381. In Central America, the escalating drug-related 
violence involving drug trafficking organizations, 
transnational and local gangs and other criminal groups 
has reached alarming and unprecedented levels, 
significantly worsening security and making the 
subregion one of the most violent areas in the world. 
Crime and drug-related violence continue to be key issues 
of concern in Central American countries. Drug 
trafficking (including fighting between and within drug 
trafficking and criminal organizations operating out of 
Colombia and Mexico), youth-related violence and street 
gangs, along with the widespread availability of firearms, 
have contributed to increasingly high crime rates in the 
subregion. There are more than 900 maras (local gangs) 
active in Central America today, with over  
70,000 members. According to a recent report by the 
World Bank, drug trafficking is both an important driver 
of homicide rates in Central America and the main single 
factor behind the rising levels of violence in the 
subregion. The countries of the so-called “Northern 
Triangle” (El Salvador, Guatemala and Honduras), 
together with Jamaica, now have the world’s highest 
homicide rates. 
382. The drug problem has also led to drug-related 
corruption, which has increasingly weakened the criminal 
justice systems in Central America and the Caribbean. 
Corruption, including among police and other law 
enforcement officials, has interfered with the ability of 
States in the region to promote development, blocking the 
delivery of services and distorting public spending. Drug 
funds and corruption in the security services have 
become entrenched in Central America, paving the way 
for other forms of organized crime, including trafficking 
in firearms. Corruption and limited law enforcement 
capacity in Central America and the Caribbean have 
facilitated the use of smuggling channels and drug 
trafficking activities. The Board encourages the 
Governments of countries in Central America and the 
Caribbean to consider regional strategies for countering 
the drug problem that call for concerted action in the area 
of crime prevention and criminal justice reform, together 
with regional approaches to reducing drug trafficking and 
controlling firearms.  
383. Factors in Central America and the Caribbean 
region that have permitted illicit drug trafficking to grow 
are poverty, social inequality and lack of economic 
opportunities for youth, as well as emigration. Central 
American countries and Mexico have some of the most 
complex migration dynamics in the world, involving 
hundreds of thousands of migrants. Jamaica’s vulnerable 
borders have been increasingly subject to infiltration by 
various criminal networks, which use Jamaica as a transit 
country and a country of destination for smuggling 
drugs, firearms, ammunition and migrants.  
 
 2. Regional cooperation 
 
384. The Inter-American Drug Abuse Control 
Commission (CICAD) Group of Experts on Chemical 
Substances and Pharmaceutical Products held a meeting, 
in San José in August 2010 that was chaired and hosted by 
the Government of Costa Rica. Attending the meeting 
were more than 40 participants from 15 CICAD member 
States and observer States, including Costa Rica, the 
Dominican Republic, El Salvador, Guatemala and 
Panama. The participants acknowledged that the 
diversion of precursor chemicals remained an ongoing 
challenge and that countries in Central America faced an 
increasing problem involving the diversion of 
psychoactive pharmaceutical products. Key elements for a 
permit scheme were defined and permit holders were 
recommended to notify competent authorities of plans 
for export, transit or trans-shipment and, if possible, to 
make use of a common system, such as the PEN Online 
system, developed by the Board.  
385. The Twentieth Meeting of Heads of National Drug 
Law Enforcement Agencies, Latin America and the 
Caribbean, was held in Lima in October 2010. 
Participants discussed issues such as targeting drug 
trafficking by air, drug trafficking and corruption, 
trafficking in synthetic drugs and control of precursors. 
The participants noted that the region of Central America 
and the Caribbean had once more grown in terms of its 
strategic importance as a staging point for private aircraft 
used to transport illicit drug consignments to North 
America and Europe. The meeting concluded that there 
needed to be more international cooperation with regard 
to the exchange of information on the ownership and 
movement of private aircraft in the region. Participants 
also noted that pharmaceutical preparations containing 
ephedrine and pseudoephedrine were becoming an 
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increasingly significant challenge for drug control 
authorities.  
386. Within the framework of the Santo Domingo Pact, 
UNODC organized for all countries of the Central 
American Integration System (SICA) a regional workshop 
on drug trafficking and urban violence, which was held in 
San Salvador in November 2010. The objective was to 
improve the participants’ knowledge of the threats related 
to drug trafficking in Central America, as well as the 
main characteristics, actors and consequences of drug 
trafficking, with a special focus on the connections 
between drug trafficking and youth gangs and urban 
violence. 
387. The Government of Trinidad and Tobago, the 
Caribbean Community (CARICOM) Implementation 
Agency for Crime and Security, UNODC and SICA held a 
meeting in Port of Spain in December 2010 to discuss 
new responses in the fight against organized crime and 
drug trafficking for the Caribbean, interconnections with 
Central America and issues related to the coordination of 
technical assistance. 
388. A joint CICAD-CARICOM Regional Meeting  
with Caribbean Universities on the Drug Phenomenon 
was held in Kingston in March 2011. Leaders of  
eight Caribbean universities and representatives from 
governments and international organizations discussed 
how to prepare graduates to tackle the social, economic 
and criminal consequences of drug-related problems in 
the Caribbean, in particular in the area of demand 
reduction. The discussion focused on how to introduce 
drug-related content in under- and postgraduate 
curricula, to engage in community outreach activities for 
the promotion of healthy and sustainable lifestyles and 
drug abuse prevention and to carry out research on  
drug-related problems.  
389. UNODC continued to support the development of a 
regional research network on drug addiction for Central 
America and the Caribbean, in cooperation with 
universities, treatment centres and ministries of health. It 
also supported the launching of a centre of excellence on 
drug demand reduction and treatment in the Dominican 
Republic in June 2011, which will examine problems 
related to drug demand reduction in communities and 
prison settings so as to adjust strategies and activities for 
drug abuse prevention, and the treatment and care of 
drug abusers in the region. 
390. The 32nd Annual Meeting of the Conference of 
Heads of Government of CARICOM was organized in 
Saint Kitts and Nevis in July 2011. With regard to health 
and drug-related issues, it was announced at the meeting 
that the new regional Caribbean Public Health Agency 
(CARPHA) had recently been established to improve the 
delivery of health care in the subregion by merging the 
core functions of the five subregional health institutions: 
the Caribbean Epidemiology Centre, the Caribbean 
Health Research Council, the Caribbean Food and 
Nutrition Institute, the Caribbean Environmental Health 
Institute and the Caribbean Regional Drug Testing 
Laboratory. One of the main functions of CARPHA 
would be surveillance and health analysis, contributing to 
collecting national, regional and international 
information on diseases and behavioural change by 
publication of data from the Caribbean on behaviour 
relating to drug abuse. CARPHA will facilitate a 
coordinated approach regarding public health issues and 
the risk of outbreaks of disease in the Caribbean. 
391. The Secretary-General of INTERPOL conducted a 
series of meetings with senior police and government 
officials in Central America in 2011. Visits to Belize, 
Guatemala and Honduras provided INTERPOL with an 
opportunity for direct consultations with senior officials 
of the national police forces and the broader law 
enforcement community to discuss issues concerning 
drug law enforcement, trafficking in persons and 
transnational organized crime. 
392. The Workshop on Training for Timely Screening 
and Referral by Primary Health Care for Problems with 
Alcohol and Other Drug Use was organized, in Antigua, 
Guatemala, in September 2011 by the Organization of 
American States, the Pan American Health Organization 
and Spain. Participants included representatives of the 
ministries of health and national drug commissions of 
several Central American countries, including Costa 
Rica, the Dominican Republic and Guatemala. One of the 
objectives of the meeting was to generate favourable 
conditions in national drug control commissions and 
ministries of health for the development of integrated 
programmes for the timely detection and treatment of 
persons affected by drug abuse problems, with focus on 
primary care. 
 
 3. National legislation, policy and action 
 
393. Costa Rica continued to implement its national 
drug control plan for the period 2008-2012, whose main 
strategic objective is to respond in a coordinated manner 
to drug-related problems by preventing drug-related 
crime and minimizing the negative effects of drug abuse 
and drug trafficking. In the area of arresting drug 
traffickers and dealers, the country adopted specific 
programmes in 2010 through the Drug Control Police of 
the Ministry of Public Security and the Narcotics 
Division of the Judicial Investigative Body. Costa Rica had 
adopted legislation against organized delinquency in 2009 
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that established legal provisions for judges to authorize 
the interception of communications to clarify crimes 
involving narcotic drugs or psychotropic substances.  
394. In 2011, Cuba created the Technical Investigation 
Police, a new law enforcement and drug control body 
responsible for preventing, and reducing the impact of, 
international drug trafficking and its manifestations at 
the national level. Based on multilateral treaties to which 
Cuba is a party, the country continued to cooperate with 
intelligence services from other countries and with 
INTERPOL.  
395. According to the World Customs Organization, in 
2010 a significant fall in the number of illegal drug flights 
was noted in the Dominican Republic following the 
country’s purchase of eight surveillance aircraft. In 
addition, the Government of the Dominican Republic 
created the new Passenger Risk Analysis Division at the 
Directorate General of Customs and reinforced its 
National Directorate of Drug Control as legal actions in 
an attempt to reduce drug trafficking in the country.  
396. In 2010, the Higher Council for Public Health of the 
Government of El Salvador issued a prohibition on 
ephedrine, its salts, optical isomers and salts of its optical 
isomers, as well as pharmaceutical products containing 
such substances, with the exception of the injectable 
pharmaceutical form used for humans. The Council also 
adopted legal modifications in November 2010 
concerning the listing of substances subject to control, 
extending the control of phenylacetic acid and its 
derivative salts in order to prevent the smuggling of the 
substance in El Salvador and its export to other countries.  
397. In 2010, El Salvador adopted national legislation to 
ban maras (local gangs). The Special Law on 
Telecommunications Intervention was also adopted in 
2010 by the Government of El Salvador. The Special Law 
contains measures to combat illicit activities relating to 
trafficking in narcotic drugs and psychotropic substances. 
In March 2011, the national drug control strategy, for the 
period 2011-2015 was drawn up by the National Anti-
Drug Commission of El Salvador and adopted by 
presidential decree with a view to addressing demand 
reduction and drug control and drug-related offences. 
The strategy’s principal aim is to reduce drug abuse and 
to combat drug trafficking and drug-related crime. The 
strategy includes a plan of action and was based on 
national and international drug control tools, such as the 
Hemispheric Drug Strategy of CICAD.  
398. The Ministry of Public Health and Social Welfare of 
Guatemala issued a new ministerial agreement to modify 
the country’s lists of precursors and chemical substances, 
which entered into force in January 2011. Phenylacetic 
acid and its derivatives, including its salts and esters, 
potassium permanganate and acetic anhydride were 
transferred from List Two to List One in order to 
strengthen the control and regulation of those substances.  
399. In 2011, the Government of Panama tightened its 
system of control and monitoring of substances through 
the Chemical Control Unit of its National Commission 
for the Study and Prevention of Drug-Related Crimes 
(CONAPRED), transferring certain substances from 
being monitored to being controlled, such as acetic acid, 
methylamine and phenylacetic acid, in addition to 
putting under the same control monoethylamine, 
triethanolamine and ethanolamine.  
400. In 2010, the global Container Control Programme, 
a joint initiative of Panama, UNODC and the World 
Customs Organization continued to operate at seaports in 
11 countries of Central America, including Costa Rica, 
Guatemala and Panama, and West Africa, Central Asia 
and West Asia. The Programme has assisted port 
authorities in using modern control techniques to detect 
illegal goods, including illicit drugs, hidden in containers 
without disrupting trade in legal goods. 
401. Existing evidence suggests that corruption is 
increased by drug trafficking and has a negative influence 
on the criminal justice systems of certain countries in 
Central America. According to the World Bank, 
corruption, together with crime, has been identified as 
one of the top five constraints to productivity and growth 
in Costa Rica, El Salvador, Guatemala, Honduras, 
Nicaragua and Panama, despite the efforts of the 
Governments concerned. The International Commission 
against Impunity in Guatemala (CICIG) has provided a 
suitable channel to bring international investigative 
expertise to Guatemala to resolve high-profile cases and 
address drug-related corruption and impunity. Despite 
progress by the justice sectors of Central American 
countries since the end of the civil conflicts of the 1980s, 
corruption remains a significant problem in the police 
and criminal justice systems of El Salvador, Guatemala 
and Honduras, and has restricted the ability of law 
enforcement authorities in those countries to adequately 
address drug-related violence. According to the World 
Bank, in a survey conducted on public insecurity in 
Central America in 2009, the perception that local police 
were involved in crime (close to 50 per cent of 
respondents believed that they were) appeared as one of 
the most important contributors to feelings of insecurity; 
it was followed by drug trafficking and the presence of 
gangs. 
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 4. Cultivation, production, manufacture and 
trafficking 
 
 (a) Narcotic drugs  
 
402. Most of the countries in Central America and the 
Caribbean have significant levels of production of 
cannabis herb. Jamaica has been the largest illicit 
producer and exporter of cannabis in the region. Recent 
reports suggest that cannabis production is destined 
primarily for domestic abuse in most countries. 
According to a recent report by CICAD, of the  
12 Caribbean countries included in a study, only Jamaica 
and Saint Vincent and the Grenadines produced cannabis 
for export to other countries. The Dominican Republic 
was the main country of destination for cannabis. 
403. Cuban authorities seized a total of 2,894 kg of 
cannabis and eradicated 9,451 cannabis plants in 2010. In 
the first six months of 2011, Cuban authorities seized 
5,256 kg of cannabis and eradicated 5,822 cannabis 
plants. A decline in cannabis eradication was observed in 
the Dominican Republic in 2010, when less than 5 ha of 
cannabis plants were eradicated. The Dominican 
Republic reported having seized a total of 658 kg of 
cannabis herb in 2010. In Guatemala, approximately  
870 tons of cannabis plants were eradicated in 2010, 
compared with about 430 tons in 2009. According to the 
World Customs Organization, in 2010 a large 
consignment (442 kg) of cannabis was found hidden in 
sea freight from Jamaica en route to Costa Rica. Jamaican 
authorities seized a total of 35.5 tons of cannabis herb in 
2008, accounting for 70 per cent of all the cannabis seized 
in the Caribbean, while no data on cannabis seizures have 
been provided by Jamaica for 2009 or 2010. In 2010, a 
vessel carrying 541 kg of cannabis, with three individuals 
from the Bahamas on board, was intercepted by the 
maritime authorities of Cuba as it departed from Jamaica; 
the consignment had been destined for the Bahamas. Law 
enforcement authorities from the Bahamas, working 
together with their Cuban counterparts, intercepted two 
vessels used for drug trafficking and arrested five drug 
traffickers in 2011.  
404. It is estimated that approximately 90 per cent of the 
cocaine in the United States arrived in that country via 
Mexico. A growing share of the cocaine arriving in 
Mexico first passes through countries in Central America. 
The value added of the cocaine flowing through the 
Central American corridor could be close to 5 per cent of 
the gross domestic product of that subregion. Drugs 
continue to be smuggled into the subregion primarily by 
sea, with drug traffickers making use of go-fast boats and 
submersible and semi-submersible vessels. Land 
transport vehicles and light aircraft have also been 
increasingly used by criminal groups, which take 
advantage of insufficient border control, including poor 
seaport security, and inadequately equipped law 
enforcement officers. The use of containers and cargo 
ships to smuggle drugs has become an increasing concern 
in the subregion. 
405. Several countries in Central America and the 
Caribbean reported seizures of “crack” cocaine, cocaine 
base or cocaine salts. The largest number of such seizures 
worldwide — 4,173 cases — occurred in the Dominican 
Republic. Panama ranked fourth in the world in terms of 
the quantity of cocaine seized in 2009, when 
approximately 53,000 kg of the substance were seized. 
Costa Rica (20,896 kg), Nicaragua (9,800 kg) and 
Guatemala (6,493 kg) also reported very significant 
seizures of cocaine during the same year.  
406. During 2010, Costa Rica significantly reduced 
cocaine trans-shipments along its coastal borders. The 
Dominican Republic continued to be used as a transit 
area for cocaine and heroin consignments destined for 
countries in other regions, including Canada, the United 
States and several countries in the European Union. In 
2010, six cases involving cocaine trafficking were 
reported by the Government of the Dominican Republic; 
Colombia was the country of origin in all of those cases 
and the United States was the main country of 
destination. The Dominican Republic reported having 
seized a total of 4,526 kg of cocaine hydrochloride and  
30 kg of heroin in 2010. Jamaica’s importance as a country 
of departure for cocaine consignments also increased in 
2010: 1,217 kg of cocaine were seized in that country in 
2010, compared with only 44 kg in 2009. Grenada 
reported for 2010 that cannabis herb ranked first and 
cocaine second in order of prevalence of abuse in the 
country, with some decrease in the prevalence of abuse of 
cocaine powder, salt and “crack”. 
407. Over 11 million containers transit annually through 
the Panama Canal. The global Container Control 
Programme has helped local authorities in Panama to 
seize nearly 1,200 kg of cocaine since September 2009. 
With its regional headquarters in Panama, the 
Programme has 27 container control units operating 
throughout the world.  
408. Diversion of pharmaceutical products containing 
narcotic drugs has been uncovered in Central America. In 
2010, the police of El Salvador identified 23 doctors and  
2 pharmacists involved in the diversion of oxycodone, 
which had been prescribed to fictitious patients. 
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 (b) Psychotropic substances 
 
409. The illicit manufacture of amphetamine-type 
stimulants is increasingly being reported by authorities  
in Central America and has recently emerged in  
Belize, Guatemala and Nicaragua, countries with little or 
no previous history of such illicit manufacture.  
In Guatemala, three clandestine laboratories  
for manufacturing both amphetamine and MDMA 
(“ecstasy”) were dismantled in 2009, and  
five methamphetamine laboratories discovered near that 
country’s border with Mexico were dismantled in 2011. In 
2010, authorities in Nicaragua dismantled a large 
clandestine methamphetamine laboratory. In  
August 2011, the Anti-Narcotics Police of El Salvador 
seized 12 containers of precursor chemicals frequently 
used for the manufacture of synthetic drugs; an 
investigation revealed that the substances, which had 
entered the country by sea, had been intended for use in 
the illicit manufacture of methamphetamine or 
amphetamine. 
410. The region of Central America and the Caribbean 
accounted for less than 1 per cent of global seizures of 
amphetamine-type stimulants in 2009 (56 kg were seized 
in Central America and 102 kg were seized in the 
Caribbean). Most of the seizures of amphetamine-type 
stimulants in the region in the past two years involved 
amphetamine. A significant change in the methods used 
for smuggling MDMA (“ecstasy”) was observed in the 
Dominican Republic: in 2009 most seizures of the drug 
were made at airports; in 2010, however, all “ecstasy” 
seizures were made on roads and highways within the 
country. In 2009, small quantities of amphetamine-type 
stimulants were seized in the Bahamas (“ecstasy”), Costa 
Rica (methamphetamine and “ecstasy”), Cuba 
(methamphetamine and unspecified amphetamine-type 
stimulants) and El Salvador (amphetamine). Jamaica was 
one of the countries of destination for shipments of 
“ecstasy” seized in or en route from Canada. 
411. The non-medical use of pharmaceutical 
preparations containing stimulants is widespread in 
Central America and the Caribbean. The abuse of 
sedatives in the form of prescription medicaments is a 
problem in Costa Rica and El Salvador. The substances in 
question often are obtained from pharmacies without 
prescription or through the Internet. There are 
indications that there may be smuggling of such 
pharmaceutical preparations among the countries in the 
region. 
 
 (c) Precursors 
 
412. Countries in Central America have previously 
reported significant seizures of ephedrine and 
pseudoephedrine, but a decreasing trend has been noted 
since the peak in 2007/2008. In 2011, several countries in 
the subregion reported seizures of esters of phenylacetic 
acid, which can be used as substitutes for 
pseudoephedrine and ephedrine in methamphetamine 
manufacture. Those esters are currently not under 
international control.  
413. Controls over precursors of amphetamine-type 
stimulants continued to be strengthened throughout 
Central America. In 2011, El Salvador, Guatemala and 
Nicaragua strengthened their existing controls over 
phenylacetic acid by prohibiting the import, export, 
production, manufacture, possession, distribution and 
transport of the substance. In many cases, the controls 
were also extended to include esters and other derivatives 
of phenylacetic acid.  
414. Governments of countries in Central America and 
the Caribbean should continue to implement measures to 
control non-scheduled substances and substitute 
chemicals used in the manufacture of traditional 
precursors.  
 
 5. Abuse and treatment 
 
415. Surveys suggest that about 1 per cent of all cannabis 
abusers worldwide are found in Central America and the 
Caribbean. Cannabis abuse patterns and trends in  
the region remain fairly unchanged. Nevertheless, Central 
America has experienced some increases in cannabis 
abuse in the past few years. It is estimated that 
approximately 610,000 persons in Central America  
and some 2.1 million persons in the Caribbean were 
cannabis abusers in 2009. According to a 2010 report by 
CICAD, there were large variations in the prevalence rates 
for cannabis abuse in the past year in the Caribbean:  
the rate ranged from approximately 1.1 per cent in Haiti 
to 17.5 per cent in Dominica. Among students in  
12 Caribbean countries, the average age of first-time 
abusers of cannabis was 13 years. 
416. Approximately 50 per cent of all demand for 
treatment for drug abuse in the region is reportedly 
related to cocaine abuse, while cocaine is also ranked  
as the main substance causing drug-induced or  
drug-related deaths. It is estimated that 140,000 persons 
in Central America and 330,000 persons in the Caribbean 
aged 15-64 were cocaine abusers in 2009. The prevalence 
of cocaine abuse in Central America and the Caribbean is 
above the global average: about 0.5-0.6 per cent of  
 CHAPTER III. ANALYSIS OF THE WORLD SITUATION
 
57 
the population aged 15-64 abuse cocaine in Central 
America and 0.4-1.2 per cent in the Caribbean. 
417. According to the latest data available, the Central 
American countries with the highest annual prevalence 
rates for the abuse of amphetamine-type stimulants 
among the general population (aged 12-70) are  
El Salvador (3.3 per cent in 2005), Belize (1.4 per cent in 
2005) and Costa Rica (1.3 per cent in 2006). In Central 
America, the prevalence of abuse of MDMA (“ecstasy”) 
continues to be low among the general population, 
though it is higher among youth. Both El Salvador and 
Trinidad and Tobago reported an increase in “ecstasy” 
abuse in 2009. 
418. According to a survey carried out from 2010 to 
2011, in El Salvador, 12.6 per cent of the students 
questioned said that they had abused cannabis at least 
once in their lives, and the average age of first-time 
abusers was 19. The percentage of university students in 
El Salvador who said that they had abused cocaine for the 
first time in their lives during that period was 3.7 per 
cent. The tendency to abuse cocaine in El Salvador was 
much higher among males than among females. Some 
increase was reported in the number of patients treated 
for the abuse of cocaine and opioids, as well as for the 
abuse of amphetamine-type stimulants in 2010. The 
number of cannabis patients remained stable in 2010. 
419. Grenada has a register for compiling national data 
on treatment for drug abuse, and every three-five years a 
rapid situation assessment and a school population 
survey are carried out nationwide. Treatment for 
problems associated with cannabis and cocaine abuse was 
offered in Grenada in 2010. Of the persons treated for 
drug abuse, some 48 per cent were treated for polydrug 
abuse. There was some decline in the number of patients 
receiving treatment for cannabis abuse. The average age 
of people receiving treatment was 25. According to the 
Government, no abuse of drugs by injection was detected 
in the country in 2010. 
420. In Guatemala, authorities estimated that some  
300 people required treatment for drug abuse in 2010 and 
that 33 per cent of the slots in the treatment facilities were 
for outpatients. Policies on drug abuse prevention cover 
drug abuse in the workplace.  
421. In Central America and the Caribbean,  
most programmes for the treatment of drug abusers 
established in accordance with public policy aim to halt 
drug abuse. Heroin abuse is rather rare, and consequently 
so is substitution treatment using methadone or 
buprenorphine, except in Puerto Rico.  
422. In Panama, the number of cases treated in officially 
licensed specialized treatment facilities for problems 
associated with drug abuse reached 1,033 in 2009, but no 
treatment facilities offered aftercare programmes. The 
Board encourages the Governments of countries in 
Central America and the Caribbean to consider allocating 
additional resources to drug abuse prevention and to 
implement public health and drug abuse prevention 
programmes with a focus on campaigns for educating 
youth about the dangers of drug abuse and providing 
appropriate treatment for drug abusers, and invites 
Governments to cooperate in that regard. 
 
 
  North America 
 
 
 1. Major developments 
 
423. North America continued to have the world’s largest 
illicit drug market in 2010. All three countries in the 
region continued to be characterized by high levels of 
illicit drug production, manufacture, trade and 
consumption. The scope of the drug problem in the 
region, as well as the vigilance of law enforcement 
authorities, is illustrated by the fact that in 2009, 70 per 
cent of all global seizures of cannabis, 70 per cent of all 
seizures of MDMA (“ecstasy”) and 44 per cent of seizures 
of methamphetamine occurred in North America. The 
region also accounted for 99 per cent of all 
methamphetamine laboratories dismantled worldwide. 
424. The human, social and economic costs of drug 
abuse in North America have been high. According to the 
most recent estimates, over 45,000 people in the region 
die of drug-related causes every year, the highest annual 
drug-related mortality rate in the world. 
425. According to a report released in April 2011 by the 
National Drug Intelligence Center of the United States 
Department of Justice aimed at measuring the economic 
impact of illicit drug use in the United States, the 
estimated economic impact of illicit drug use on United 
States society in 2007 exceeded $193 billion. That figure 
takes into account expenditure related to criminal justice, 
health-care costs, loss of economic competitiveness, 
military readiness, educational outcomes and workforce 
productivity. The Canadian Centre on Substance Abuse 
has estimated the costs of illicit drug use to the Canadian 
economy to be over $8 billion per year. 
426. In Mexico, the Government has budgeted  
security-related expenditures of approximately  
$10.7 billion for the fiscal year 2012. Mexico continues  
to be used by drug trafficking organizations as a major 
source of and transit country for illicit drugs. The 
Government has continued to take vigorous action to 
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disrupt drug trafficking activities, to dismantle drug 
trafficking syndicates and to prevent and repress drug-
related acts of violence. In 2011, Mexican law 
enforcement officials reported significant seizures of 
internationally controlled substances. Faced with  
the Government’s resolve, drug trafficking organizations 
have resorted to unprecedented levels of violence. 
According to figures released by the Government, over 
35,000 people were killed in drug-related violence in the  
period 2006-2010, with more than 11,500 deaths in 2010 
alone. In addition, drug syndicates have sought to 
undermine the state apparatus, including federal and state 
police, the criminal justice system and the media through 
the use of corruption, as well as threats and intimidation. 
The Board acknowledges the strong commitment shown 
by the Government of Mexico through the decisive 
measures it has taken to address the country’s drug-
related problems and encourages the Government to 
ensure that appropriate attention is given to prevention 
measures.  
427. Prescription drug abuse in the United States has 
become the country’s fastest growing drug problem. 
Alarming data contained in the National Survey on Drug 
Use and Health show that over a quarter of the 
population aged 12 years or older who used drugs for the 
first time in 2010 did so by using prescription drugs for 
non-medical purposes. The most recent figures available 
suggest that prescription pharmaceuticals were second 
only to cannabis as the substances abused by the largest 
number of new drug abusers aged 12 or older having 
initiated their drug abuse over the past year. Moreover, 
among United States youth, prescription drugs are now 
the second most abused type of drug, after cannabis. In 
addition, there has been a twofold increase in  
drug-induced deaths in the last 10 years, driven by 
prescription drugs. The abuse of prescription drugs has 
also been a significant problem in Canada and Mexico.  
428. In seeking to implement their international drug 
control obligations, the Governments of Canada and the 
United States have faced particular challenges owing to 
the division of powers within their respective federal 
structures. In Canada, the Government lodged an appeal 
with the Supreme Court against a decision by the Court 
of Appeal of British Columbia allowing so-called “drug 
injection rooms” to continue to be exempted from federal 
drug control legislation; the appeal was rejected. In the 
United States, a similar issue has been the adoption of 
laws introducing “medical” cannabis schemes in a 
number of states, despite the existence of federal 
legislation explicitly subjecting the manufacture, sale and 
distribution of cannabis to criminal prosecution. The 
Board continues to emphasize to the Governments of all 
States that, in order to respect their international 
obligations under the drug control treaties, States must 
ensure the consistent implementation of those norms 
over the entire national territory, irrespective of their 
internal legal orders. 
429. In the United States, 16 states and the District of 
Columbia have, to date, enacted legislation allowing  
the sale and use of cannabis for medical purposes; similar 
legislation is pending in an additional 10 states.  
The enactment of that legislation at the state level has 
occurred despite the existence of the Controlled 
Substances Act, a federal statute explicitly prohibiting  
the possession, manufacture and distribution of  
cannabis except for limited legitimate uses. The Attorney-
General was asked by several United States attorneys to 
clarify the United States Administration’s position on 
medical cannabis laws. In June 2011, the Deputy  
Attorney-General issued a memorandum reaffirming the 
Department of Justice’s commitment to the enforcement 
of the Controlled Substances Act and clearly stating that 
individuals who cultivate, sell or distribute cannabis and 
those who knowingly facilitate such activities are in 
violation of the Act and are subject to federal 
enforcement, including criminal prosecution. The Board 
notes that the control requirements that have been 
adopted in the 16 states in question and in the District of 
Columbia under the “medical” cannabis schemes fall 
short of the requirements set forth in the  
1961 Convention as amended by the 1972 Protocol and 
requests that the Government of the United States ensure 
the implementation of all control measures for cannabis 
plants and cannabis as required under that Convention in 
all states and territories falling within its legislative 
authority. 
 
 2. Regional cooperation 
 
430. In February 2011, the President of the United States 
and the Prime Minister of Canada issued the declaration 
entitled “Beyond the border: shared vision for perimeter 
security and economic competitiveness”, aimed at 
strengthening cooperation between the two countries on 
a number of trade and security issues, including the 
adoption of joint measures to combat drug trafficking. 
Building upon that initiative, the Governments of Canada 
and the United States released in March 2011 the United 
States-Canada Joint Border Threat and Risk Assessment, 
which was prepared by the border protection agencies of 
both countries, as well as the Royal Canadian Mounted 
Police. The assessment is aimed at providing United 
States and Canadian policymakers, law enforcement 
officials and other stakeholders with specific information 
regarding established threats along the border, including 
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those affecting national security and those linked to 
criminal enterprises. 
431. The third meeting of the United States-Mexico 
Merida High-Level Consultative Group on Bilateral 
Cooperation against Transnational Criminal 
Organizations was held in April 2011. The Group, 
composed of cabinet secretaries from the United States 
and Mexico, aims to increase bilateral cooperation and 
coordinate action against transnational organized crime 
by building upon the implementation framework 
developed under the Merida Initiative. The four 
objectives agreed upon by the parties, called “pillars”, are 
the disruption of organized criminal groups, the 
institutionalization of the rule of law, the building of a 
twenty-first century border and the building of strong 
and resilient communities. Specific actions to be 
undertaken in the pursuit of those objectives include 
optimizing the use and sharing of intelligence; 
broadening support for state-level justice system reforms; 
modernizing border infrastructure; and the initiation of a 
binational demand reduction study. The Board welcomes 
these and any other initiatives aimed at improving 
regional cooperation and border security in the region. 
432. In their capacity as member States of the 
Organization of American States, the three countries in 
North America have continued to participate in the joint 
drug control initiatives under the aegis of CICAD. In  
May 2011, CICAD released its Hemispheric Plan of 
Action on Drugs, 2011-2015. The Plan of Action is aimed 
at supporting the implementation of the Hemispheric 
Drug Strategy by establishing benchmarks and priorities 
for the period 2011-2015, related to the following: 
institutional strengthening, demand reduction, supply 
reduction, control measures and international 
cooperation. In addition to coordinating joint action 
among CICAD members, the identification of the 
priorities set forth in the Plan of Action is intended to 
guide the adoption of drug control measures at the 
national level. The Plan of Action also underscores the 
importance of financing and training as cross-cutting 
issues that must be addressed to enable successful 
implementation of the Plan of Action. 
433. The twenty-eighth International Drug Enforcement 
Conference was held in Cancún, Mexico, in April 2011. 
The Conference was attended by representatives of  
75 member and 20 observer States and territories and was 
presided over by the Secretary of Public Security of 
Mexico and the Administrator of the United States Drug 
Enforcement Administration. During the Conference, 
concurrent sessions were held in order to provide 
delegates with topic-specific information. Deliberations 
also took place within regional working groups on issues 
related to drug trafficking organizations, money-flow 
strategies and chemical controls. 
434. In July 2011 in Montreal, Canada, the Canadian 
Centre on Substance Abuse, in partnership with the 
Office of National Drug Control Policy of the United 
States, the European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) and the United States 
National Institute on Drug Abuse, hosted the 
International Drugs and Driving Symposium. The 
purpose of the Symposium was to build upon 
Commission on Narcotic Drugs resolution 54/2, in which 
the Commission underscored the importance of 
elaborating collective responses to drugged driving 
through evidence-based research. 
 
 3. National legislation, policy and action 
 
435. As noted in the report of the Board for 2010,24 the 
Penalties for Organized Drug Crime Act was introduced 
in the Canadian Senate in May 2010. The bill provided for 
mandatory minimum sentences for a variety of  
drug-related offences, including illicit drug production, 
trafficking, possession for the purpose of trafficking, 
importing, exporting and possession for the purpose of 
exporting. According to the bill, mandatory minimum 
sentences would apply in the presence of an aggravating 
factor, including that the crime was committed for the 
benefit of organized crime, in a prison, in relation to a 
youth or involving a youth. The Act was voted on in  
May 2011, but was not adopted. Since then, the newly 
elected Government has expressed its intention to 
reintroduce various legislative measures drawn from 
legislation that was not adopted in the previous session of 
Parliament, including the Penalties for Organized Drug 
Crime Act. 
436. Also in Canada, the Act to Amend the Controlled 
Drugs and Substances Act (Methamphetamine and 
Ecstasy) entered into force in June 2011, aimed at 
prohibiting the possession, production, sale or 
importation of anything with the knowledge that it will be 
used to manufacture or traffic in methamphetamine or 
MDMA (“ecstasy”). The Act provides for penalties of 
imprisonment of up to 10 years less a day. 
437. In September 2011, the Supreme Court of Canada 
handed down its judgement with respect to the 
applicability of the Controlled Drugs and Substances Act 
to a supervised drug injection facility in Vancouver. The 
facility had been allowed to operate due to an exemption 
to the application of the law for “medical or scientific 
__________________ 
 24 Report of the International Narcotics Control Board for 2010 
..., para. 410. 
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purposes” that had been granted by a previous 
Government. The Court ruled against the Government’s 
decision to refuse to extend the injection facility’s legal 
exemption, thereby allowing the facility to continue to 
operate. The Board reiterates that under international law, 
provisions of national law cannot be invoked to justify 
non-compliance with the international drug control 
treaties to which a State has become a party. The Board 
further reiterates its position that drug injection and 
consumption outlets that allow illicit drug possession and 
use are not in line with the international drug control 
conventions, to which Canada is a party. 
438. The Drugs and Organized Crime Awareness Service 
of the Royal Canadian Mounted Police has continued its 
efforts under the Drug Abuse Resistance Education 
(DARE) programme aimed at helping schoolchildren to 
recognize and resist social pressure to experiment with 
drugs, alcohol and tobacco. In the period 2010-2011, the 
programme, using Royal Canadian Mounted Police 
officers to teach a formal curriculum to students in a 
classroom setting, reached nearly 81,000 students in  
1,895 schools.  
439. In July 2011, the President of Mexico inaugurated a 
state-of-the-art laboratory of forensic sciences of the 
Attorney-General’s Office, the Laboratorio Central de 
Servicios Periciales, commissioned to support law 
enforcement and judicial authorities. The President 
underscored the importance of ensuring that justice for 
victims of crime and their families be done and 
emphasized the fundamental importance of forensic 
science in solving crime and securing convictions. 
440. According to the National Commission on Human 
Rights of Mexico, 71 journalists have been murdered in 
the country since 2000, while many others have been 
subjected to threats and intimidation, forcing some to flee 
the country. In seeking to address persistent violence 
committed by drug trafficking groups against journalists 
in Mexico, UNODC has partnered with the United 
Nations Educational, Scientific and Cultural 
Organization, the Office of the United Nations High 
Commissioner for Human Rights, governments at the 
federal and state levels, media representatives and 
universities to hold media consultation workshops 
throughout 2011. The workshops were held in the nine 
Mexican states most affected by drug-related violence 
against the media. The project, developed as part of the 
UNODC country strategy for Mexico for 2008-2011, was 
aimed at forging working relationships between 
stakeholders and at leading to the formulation of 
recommendations intended to increase the security of 
members of the media and protect freedom of the press. 
The Board notes with concern the targeting of journalists 
in Mexico by drug trafficking syndicates and welcomes 
this joint initiative aimed at improving the security of 
journalists and at safeguarding freedom of the press.  
441. In 2011, the United States Administration released 
an update of its National Drug Control Strategy issued in 
2010. The 2011 update acknowledges important 
developments that occurred in 2010, including the 
passage of the Fair Sentencing Act and the Secure and 
Responsible Drug Disposal Act. The 2011 update also 
identifies “key populations” requiring special support in 
their efforts to deal with drug abuse: military personnel 
on active duty, veterans and their families; women and 
their families; college and university students; and 
individuals in the criminal justice system. 
442. In April 2011, in response to the challenges posed 
by widespread prescription drug abuse, the United States 
Administration issued the Prescription Drug Abuse 
Prevention Plan, aimed at complementing its National 
Drug Control Strategy. The Prevention Plan sets out 
courses of action in four major areas: education, 
including through awareness-raising among youth, 
parents and health-care providers; the institution of 
prescription monitoring programmes; the establishment 
of proper disposal mechanisms; and the enforcement of 
laws and regulations governing the prescription of drugs. 
The strategy reiterates the objectives of reducing the 
annual prevalence of non-medical abuse of prescription 
drugs among people 12 years or older by 15 per cent and 
sets forth concrete measures aimed at reaching that 
objective, including the formulation and dissemination of 
model legislation; increasing funding for treatment 
programmes; encouraging States to adopt prescription 
drug monitoring programmes; and establishing 
programmes facilitating safe disposal. At the state level, 
48 states in the United States have now enacted legislation 
enabling some form of prescription drug monitoring 
programme to assist physicians and pharmacists in 
monitoring the issuance of prescriptions for controlled 
substances, as well as to keep track of the identity of the 
individuals for whom they are prescribed. In the  
two remaining states, Missouri and New Hampshire, 
similar legislation is pending. The Board welcomes the 
adoption by the United States of a comprehensive set of 
measures aimed at addressing the continued widespread 
abuse of prescription drugs in the country and will 
continue to follow the progress made. 
443. Also in April 2011, the second National 
Prescription Drug Take-Back Day was held in the United 
States, allowing individuals to dispose of unwanted or 
unused medications at thousands of collection sites across 
the country. The event resulted in the collection of 
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approximately 188 tons of unwanted or expired 
medications. 
444. In July 2011, the United States Administration 
launched its Strategy to Combat Transnational Organized 
Crime, drawn up following a comprehensive assessment 
of the issue concluded in 2010. The Strategy reflects many 
of the findings of the assessment, including proliferation 
of transnational organized criminal networks; their use of 
corruption to co-opt or weaken governance in many 
states; and the growing links between terrorist networks 
and drug trafficking organizations. Reflecting the 
increasingly symbiotic relationship between drug 
syndicates and other criminal activities, the Strategy sets 
forth 56 priority actions under five distinct chapters, 
including one entitled “Disrupt drug trafficking and its 
facilitation of other transnational threats”. 
445. In February 2011, the Director of National Drug 
Control Policy in the United States issued a statement 
expressing his deep concern over the growing abuse of 
synthetic stimulants, in particular those marketed as legal 
substances, including designer cathinones commonly 
referred to as “bath salts”. In response to this emerging 
threat, the National Conference of State Legislatures has 
reported that 30 states have already adopted laws banning 
synthetic cathinones, and 9 more have similar legislation 
pending. 
446. In March 2011, the United States Drug Enforcement 
Administration took emergency administrative measures 
leading to the temporary placement of five synthetic 
cannabinoids into Schedule I of the Controlled 
Substances Act. That action was based on the decision of 
the Administrator that the placement of those substances 
into Schedule I was necessary to avoid an imminent 
threat to public safety. Pursuant to that decision, the 
manufacture, distribution, possession, import and export 
of the five substances in question will be governed by the 
extensive inventory of criminal, civil, administrative and 
regulatory provisions for substances in Schedule I as set 
forth in the Controlled Substances Act. At the state level, 
38 states now have legislation banning synthetic 
cannabinoids, as recommended by the Board. 
447. In August 2011, the United States Department of 
Justice issued a statement announcing an agreement 
reached with a leading Internet search engine for the 
forfeiture by the company of $500 million for allowing 
Canadian Internet pharmacies to place advertisements 
targeting consumers in the United States and, as a result, 
to export prescription drugs to the United States in 
violation of United States law. The forfeiture, one of the 
largest in United States history, represents the total of the 
gross advertising revenues collected by the company and 
of the estimated gross revenues made by the Canadian 
online pharmacies as a result of their sales to United 
States consumers. In addition to moneys forfeited, the 
company acknowledged its responsibility for the conduct 
in question and agreed to subject itself to various 
compliance measures in order to prevent recurrence.  
448. In June 2011, at the 79th Annual Meeting of the 
United States Conference of Mayors, held in Baltimore, 
the Children, Health and Human Services Committee 
adopted a resolution in support of the United States 
Administration’s 2011 Prescription Drug Abuse 
Prevention Plan. The resolution endorses the approaches 
outlined in the Prevention Plan and reiterates the 
importance of education and awareness initiatives, 
prescription drug monitoring programmes, prescription 
drug disposal programmes and ending improper 
prescription practices. 
 
 4. Cultivation, production, manufacture and 
trafficking 
 
 (a) Narcotic drugs 
 
449. Cannabis remains the most widely produced drug 
in the region, with vast amounts produced in all three 
countries. Trafficking in cannabis in North America is a 
regional phenomenon: a substantial proportion of 
cannabis produced in Mexico and some produced in 
Canada is destined for the United States market, though 
most of the cannabis produced in Canada is consumed 
within the country. Cannabis seizures in Canada 
increased significantly, from 1.3 tons in 2009 to nearly 
105.3 tons in 2010. 
450. In Canada and the United States, indoor cultivation 
persists, while in Mexico law enforcement raids have 
continued to reveal outdoor growth operations of an 
unprecedented scale and sophistication. Reflecting the 
sustained efforts of Mexican customs and law 
enforcement agencies, cannabis seizures in Mexico 
increased from 2,109 tons in 2009 to more than  
2,248 tons in 2010. In July 2011, the National Defense 
Secretariat announced that the army had discovered the 
largest cannabis plantation ever detected in Mexico. The 
plantation covered almost 120 ha and could have yielded 
an estimated 120 tons of cannabis with a street value of 
approximately $160 million. 
451. According to the Domestic Cannabis 
Eradication/Suppression Program Statistical Report of 
the Drug Enforcement Administration, 10.3 million 
cannabis plants were eradicated in the United States in 
2010. In all, 92 per cent of all plants eradicated were 
found in the top seven cannabis-producing states 
(California, Kentucky, Oregon, Tennessee, Utah, 
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Washington and West Virginia). The total amount of 
cannabis seized in the United States in 2010 was 
approximately 1,900 tons. 
452. Cocaine seizures in North America declined by 
approximately 43 per cent from 2005 to 2009, reflecting 
the decreased prevalence of the drug in the region. Of the 
three countries in the region, Mexico has seen by far the 
steepest decline in cocaine seizures, with seizures 
dropping from a high of over 48 tons in 2007 to 9.4 tons 
in 2010, the latter figure representing a decrease of over 
12 tons from the 2009 level. With the exception of a spike 
in 2007, cocaine seizures in Canada from 2005 to 2010 
declined sharply, from approximately 2,352 kg in 2005 to 
1,131 kg in 2010. However, in the same period, the annual 
amount of cocaine seized entering Canada from the 
United States more than doubled, making the United 
States the primary transit area for cocaine smuggled into 
Canada. According to the Canadian Border Services 
Agency, the other primary countries of origin/transit for 
cocaine intercepted at points of entry into Canada in 2010 
were Argentina, Chile, the Dominican Republic and 
Mexico. Canadian law enforcement sources have 
identified a variety of organized criminal groups involved 
in the smuggling of cocaine into Canada, including 
motorcycle gangs, Asian drug gangs, and “Italian based” 
organizations. In addition, there is mounting evidence to 
suggest that Mexican organized criminal groups, already 
established in Canada, are expanding their activities in 
the country. Reflecting decreased demand, cocaine 
seizures in the United States have also seen a sharp 
decline, from a peak of over 382 tons in 2007 to 66 tons in 
2010, a 25 per cent reduction from 2009 figures.  
453. The illicit cultivation of opium poppy has continued 
in Mexico. On the basis of available data on opium  
poppy cultivation, the potential manufacture of heroin in 
Mexico could be estimated at 9 per cent of the global 
total. Eradication efforts by the Government of Mexico 
have continued, with approximately 14 ha reported 
eradicated in 2009. The three primary source countries 
for heroin abused in North America in 2009 continued to 
be Afghanistan, Colombia and Mexico. According to the 
United States Drug Enforcement Administration, 58 per 
cent of the heroin seized in the United States was of 
Colombian origin and 39 per cent originated in Mexico. 
The United States-Mexico border continues to be the 
main entry point for heroin smuggled into the United 
States from Mexico by drug traffickers. The drugs are 
most commonly hidden in motor vehicles and are often 
transported by the human couriers known as “mules”. In 
contrast, the primary source country for heroin abused in 
Canada continues to be Afghanistan, thought to account 
for approximately 78 per cent of heroin abused in the 
country. Afghan heroin bound for Canada is typically 
smuggled by Indo-Canadian, Iranian and Pakistani 
criminal organizations, and is transited through India, 
Pakistan, Turkey and, increasingly, the Islamic Republic 
of Iran. The amount of heroin seized in the United States 
from 2005 to 2010 almost doubled, from approximately 
1.3 tons in 2005 to 2.42 tons in 2010. Over the same 
period in Canada, seizures of heroin declined from 83 kg 
to no seizures reported. In Mexico, seizures have dropped 
from just under 459 kg in 2005 to 369 kg in 2010. 
454. Prescription drug abuse in North America 
continues to be a major problem. The most common 
classes of prescription drugs abused are opioids, central 
nervous system depressants and stimulants. Law 
enforcement officials have indicated that street gangs 
involved in trafficking in illicit drugs are increasingly 
involved in trafficking in prescription medications. The 
diversion of prescription drugs in the region has been 
facilitated by the fact that the substances are legal as such 
and has been compounded by their widespread 
availability. According to the 2010 National Survey on 
Drug Use and Health, over 71 per cent of individuals over 
12 years of age having consumed prescription drugs for 
non-medical purposes in the previous year got the drugs 
from a friend or family member. In contrast, only 4.4 per 
cent reported getting the drugs from a drug dealer and a 
mere 0.4 per cent ordering them on the Internet. Given 
the multiple legitimate uses for prescription drugs 
requiring their widespread availability, policymakers in 
North America have tried to focus on abuse prevention. 
In Canada, the Controlled Drugs and Substances Act 
already bans the selling or giving away of prescription 
opioid medications, as well as procuring the same 
medication from more than one doctor over a short 
period of time without the knowledge of the medical 
practitioners involved. In the United States, one of the 
cornerstones of the Prescription Drug Abuse Prevention 
Plan is the establishment of disposal programmes for 
prescription drugs that are no longer needed. 
 
 (b) Psychotropic substances 
 
455. According to UNODC, North America accounted 
for 99 per cent of all methamphetamine laboratories 
dismantled worldwide in 2009. Seizures of 
methamphetamine in the region for the same year 
accounted for 44 per cent of the global total.  
456. There was an increase of approximately 92 per  
cent in the number of seizures of methamphetamine 
laboratories in the United States between 2007 and 2009. 
Over the last decade, Mexico has also become an 
important manufacturer of methamphetamine, as 
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reflected by an increase in laboratories dismantled  
from 21 in 2008 to 191 in 2009. 
457. Although the number of methamphetamine 
laboratories in the United States far exceeds that in 
Mexico, a Mexican laboratory typically produces far 
greater quantities of the drug than one in the United 
States. 
458. In 2009, seizures of MDMA (“ecstasy”) in North 
America accounted for more than half of the global total. 
Canada remains a significant manufacturer of “ecstasy”, 
which, although primarily intended for domestic use,  
is increasingly being trafficked to the United States, as 
well as expanding markets such as Australia, Japan and  
New Zealand.  
459. Canada remains a significant source for “ecstasy” 
trafficked into the United States, with a resurgence of the 
abuse of the substance in the United States being 
attributed by officials to its smuggling into the country 
from Canada. The resurgence of the smuggling of 
“ecstasy” from Canada into the United States has also 
been illustrated by the fact that seizures of “ecstasy” 
consignments en route from Canada to the United States 
doubled between 2007 and 2008. “Ecstasy” traffickers in 
Canada have also reportedly expanded to new markets in 
Asia, the Caribbean and Mexico.  
460. The Board remains concerned about unusually high 
consumption levels of licitly manufactured amphetamine-
type stimulants and methylphenidate in the United States. 
These substances are used for medical purposes for the 
treatment of attention deficit disorder and narcolepsy.  
As previously noted by the Board, the diversion and abuse 
of pharmaceutical preparations containing such 
substances are often linked to high consumption levels of 
those preparations. The Board requests Governments to 
ensure that the control measures set forth in the  
1971 Convention are fully implemented. As the Board has 
stated on numerous occasions, the education of doctors 
and other health-care professionals on the rational use of 
psychoactive drugs is of paramount importance to the 
prevention of drug abuse, including of prescription drugs. 
 
 (c) Precursors 
 
461. Owing to the more stringent controls placed on 
precursors of amphetamine-type stimulants by the 
Government of Mexico over the past few years, there is 
evidence to suggest that some of the illicit manufacturing 
of drugs using precursors has been displaced to countries 
in Central America. However, precursor chemicals have 
continued to be smuggled into the country for use in the 
illicit manufacture of drugs. Efforts to control the 
diversion of precursor chemicals have been complicated 
by the fact that the chemicals in question have numerous 
legitimate uses. 
462. In order to continue to manufacture MDMA 
(“ecstasy”), traffickers in Canada obtain the required 
precursor chemicals from sources in other countries, 
mostly China and India. Most of the precursor chemicals 
smuggled into Canada are also used in that country. 
However, Canada is also increasingly being used as a 
transit country for some precursor chemicals, which are 
smuggled into the United States for use in the illicit 
manufacture of methamphetamine. In 2010, ephedrine 
replaced 3,4-MDP-2-P as the precursor chemical most 
commonly seized at points of entry into Canada. Given 
the scope of “ecstasy” manufacture in Canada, border 
authorities have concluded that either large quantities of 
3,4-MDP-2-P are entering the country undetected or 
alternative precursor chemicals are being used. 
 
 (d) Substances not under international control  
 
463. In 2011, precursor traffickers continued their 
widespread use of substances that are not under 
international control but that have similar uses to 
substances that are currently under international control. 
Those substances include derivatives of phenylacetic acid, 
particularly esters. Hundreds of tons of those substances 
have been reported seized in North America through 
Operation PAAD. 
464. In July 2011, the Mexican authorities reported a 
seizure of 60 tons of ethyl phenylacetate being 
transported in three containers having originated in 
China. Although the substance is not under international 
control, it is subject to national control measures and 
according to Mexican officials was intended to be used as 
a precursor chemical in the illicit manufacture of drugs. 
465. In 2010, 12.7 tons of khat was seized at the 
Canadian border, with an estimated street value of  
6.4 million Canadian dollars. Approximately 85 per cent 
of the substance was transited through the United 
Kingdom on its way to Canada, twice the proportion in 
2009. In addition, Canadian border officials reported 
seizures of 1.8 tons of ketamine in 2010, the largest 
amount in six years. Of that amount, approximately  
99 per cent originated in China and India. 
466. Despite increased national regulatory and legislative 
action aimed at prohibiting the sale and distribution of 
designer cathinones and synthetic cannabinoids, many of 
those substances remain uncontrolled in parts of North 
America and continue to be widely available to abusers. 
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 5. Abuse and treatment 
 
467. The Board notes that the human, economic and 
social costs of widespread illicit drug use in North 
America are staggering. In the United States, drug-related 
deaths now outnumber deaths caused by firearms in the 
country as a whole, while drug-induced deaths have now 
surpassed motor vehicle accidents as the single leading 
category of injury-related death in 17 states and the 
District of Columbia. 
468. As mentioned above, the estimated economic 
impact of illicit drug use on United States society, taking 
into account expenditure related to criminal justice and 
health care, as well as losses of economic competitiveness, 
military readiness, educational outcomes and 
productivity, exceeded $193 billion in 2007. According to 
the National Drug Intelligence Center, this figure 
validates the approach taken in the United States 
Administration’s National Drug Control Strategy, which is 
based on the reduction of supply through law 
enforcement activities; community-based prevention 
programmes; and the diversion of non-violent drug users 
to special treatment programmes. 
469. As the United States is the largest cocaine market in 
the world, the decrease in demand there has had a 
tangible effect on global consumption, which has 
continued to decrease. However, 37 per cent of all cocaine 
abusers worldwide are still found in North America. 
While a steady decline in the use of cocaine has been 
noted in the region since 2006, the prevalence rate among 
the population aged 15-64 remains nearly five times the 
global average.  
470. In addition to the threat posed by prescription 
drugs containing psychotropic substances, North 
America continues to be affected by widespread illicit 
synthetic drug manufacture and abuse. According to the 
most recent data reported in the World Drug Report 
2011,25 an estimated 3.5 million North Americans used 
amphetamine-type stimulants in the previous year, the 
third highest prevalence rate in the world. 
471. In April 2011, the United States Department  
of Health and Human Services released its Treatment 
Episode Data Set regarding national admissions  
to substance abuse treatment services for the  
period 1999-2009.26 The data reveal that 96 per cent of 
__________________ 
 25 United Nations publication, Sales No. E.11.XI.10. 
 26  United States of America, Department of Health and 
Human Services, Treatment Episode Data Set (TEDS): 1999-
2009 — National Admissions to Substance Abuse Treatment 
Services (Rockville, Maryland, Substance Abuse and Mental 
Health Services Administration, 2011). 
the 1,963,089 admissions to treatment for substance 
abuse were attributable to the following five substance 
groups: alcohol (42 per cent), opiates (21 per cent), 
cannabis (18 per cent), cocaine (9 per cent)  
and methamphetamine/amphetamines (6 per cent). 
According to the data, only 8 per cent of admissions into 
treatment for opiate abuse in 1999 were related to 
substances other than heroin. By 2009, that figure had 
increased to 33 per cent. Also in the period 1999-2009, 
the proportion of admissions for cannabis abuse rose 
from 13 to 18 per cent. The average age of those admitted 
for cannabis abuse was 24 years, and 74 per cent of those 
admitted were male. The proportion of admissions for 
cocaine or “crack” abuse declined by 5 per cent, from  
14 per cent in 1999 to 9 per cent in 2009. The average age 
of those admitted for cocaine or “crack” abuse was also 
significantly higher than those admitted for cannabis 
abuse (40 years of age for individuals who smoked 
cocaine; 36 years of age for all others). Admissions for the 
abuse of methamphetamine/amphetamines represented  
4 per cent of total admissions in 1999, and, after reaching 
9 per cent in 2005, declined to 6 per cent in 2009. Among 
adolescents (persons aged 12-17), 86 per cent of 
admissions related to cannabis as a primary or secondary 
substance of abuse. Nearly half (49 per cent) of all 
adolescents entering treatment were referred through the 
criminal justice system.  
472. Recent data suggest that Canada’s five-year National 
Anti-Drug Strategy, launched in 2007 with the aim of 
reducing the illicit supply of and demand for drugs, has 
begun to show results. Health Canada released the results 
of the Canadian Alcohol and Drug Monitoring Survey for 
2010. According to the Survey’s findings, substance abuse 
in Canada has decreased for most substances while 
remaining stable for psychoactive pharmaceuticals. The 
proportion of Canadians 15 years of age or older reported 
having used cannabis in their lifetime decreased from 
42.4 per cent in 2009 to 41.5 in 2010. Although the 
percentage of respondents acknowledging cannabis abuse 
in the past year increased slightly, from 10.6 per cent in 
2009 to 10.7 per cent in 2010, the latter figure represents a 
3.4 per cent decrease from 2004 figures. Moreover,  
past-year cannabis abuse by youth (persons 15-24 years of 
age) saw a significant decrease of just under 12 per cent, 
from 37.0 per cent in 2004 to 25.1 per cent in 2010. 
Among the same age group, use of cocaine or “crack”, 
“speed”, hallucinogens, “ecstasy” and heroin also dropped 
significantly, from 11.3 per cent in 2004 to 7.0 per cent in 
2010. Despite these positive developments, the rate of 
drug abuse by persons in the age group 15-24 remains 
significantly higher than the rates reported for adults 
aged 25 years or older, including three times as high for 
cannabis (25.1 per cent, compared with 7.9 per cent) and 
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nine times as high for all other drugs (7.9 per cent, 
compared with 0.8 per cent). 
473. The Board notes the growing evidence to suggest 
that already high and rising prevalence rates of cannabis 
abuse among youth are in large part attributable to 
decreases in the perception of risks associated with 
cannabis abuse. According to survey data from the United 
States, among students in their final year of secondary 
school (ages 17-18), the perception that regular cannabis 
use is harmful decreased from 52.4 per cent in 2009 to 
46.8 per cent in 2010. Among those aged 12-17, only  
30 per cent perceived a “great risk” in smoking cannabis 
once a month, while 24.1 per cent of respondents in the 
same age group reported not being exposed to drug abuse 
prevention messages other than those in schools. 
According to the United States Department of Health and 
Human Services, that perception may be influenced by 
the debate surrounding the use of cannabis for 
purportedly medical purposes. 
474. Police-reported crime statistics in Canada for 2010 
indicate that although the country’s overall crime rate 
declined by 5 per cent from that of 2009, drug-related 
crime in the same period increased by approximately 10 
per cent, owing primarily to a greater number of cannabis 
offences. Of the 108,600 police-reported drug offences 
committed in Canada in 2010, 52 per cent were related to 
cannabis possession, representing a 13 per cent increase 
over 2009. In contrast, police observed a decrease of 
approximately 10 per cent in drug-impaired driving cases, 
as well as a 5 per cent decrease in cocaine offences. 
475. Approximately 25 tons of pure heroin was 
consumed by abusers in the Americas in 2009. Of that 
amount, 22 tons, representing 88 per cent of the total, is 
estimated to have been abused in North America. Heroin 
consumption in the United States alone was pegged at  
21 tons, making the United States the third top consumer 
of heroin. In Canada, 1.3 tons of heroin was reportedly 
consumed.  
476. The amount of opium abused in Mexico was 
relatively small, at 100-150 kg. While the number of 
heroin abusers in the Americas as a whole is estimated by 
UNODC to be 1.67 million, the vast majority of them are 
found in North America, including 1.2 million in the 
United States, 114,000 in Canada and 50,000-60,000 in 
Mexico. 
477. Data from the United States relative to the abuse of 
oxycodone reveal that there were just under 600,000 new 
non-medical users of the drug aged 12 years or older in 
2010, with an average age of first use of 22.8 years, in line 
with 2009 figures. 
478. In May 2011, the Arrestee Drug Abuse Monitoring 
Program (ADAM II) released its 2010 annual report. The 
programme, sponsored by the United States Office of 
National Drug Control Policy, is a drug-related survey 
aimed at collecting information on individuals who have 
recently been arrested, a group often not adequately 
represented in other surveys but whose importance for 
drug control policymakers is great. The survey reveals 
that 50 per cent of federal and state inmates had used 
drugs within the one-month period prior to committing 
the offence for which they were arrested and that nearly 
one third of state prisoners and one quarter of federal 
prisoners had taken drugs at the time of the offence. The 
report also highlights important differences between 
respondents to ADAM II and members of the population 
at large having participated in the National Survey on 
Drug Use and Health. Among those differences is the fact 
that recent arrestees participating in ADAM II were much 
more likely to be unemployed, to be living in transient 
housing, to be more involved with crime and to have had 
more exposure to illegal drugs. 
 
 
  South America 
 
 
 1. Major developments 
 
479. In 2010, the total area under illicit coca bush 
cultivation in South America was 154,200 ha, 9,600 ha or 
6 per cent less than in 2009 (163,800 ha). The area under 
illicit cultivation in Colombia decreased by 11,000 ha 
from 2009, to 62,000 ha (a decrease of 15 per cent). In 
Peru, the area under illicit coca bush cultivation increased 
by 1,300 ha to 61,200 (an increase of 2 per cent). There 
was no significant change in coca bush cultivation in the 
Plurinational State of Bolivia: in 2010, the area under 
illicit coca bush cultivation in the country was 31,000 ha, 
accounting for 20 per cent of illicit coca bush cultivation 
in South America. 
480. INTERPOL and UNODC estimate the global illicit 
cocaine market to be worth more than $80 billion. In the 
past decade, there has been a significant change in the 
size of the main illicit markets for cocaine. In 1998, the 
value of the illicit market for cocaine in the United States 
was four times that of Europe’s. Since then, the size of the 
illicit cocaine market in North America as a whole has 
declined, while illicit demand for cocaine in Europe has 
increased; as a result, the difference in the values of those 
two cocaine markets has narrowed.  
481. In recent years, the main cocaine-manufacturing 
countries, in particular the Plurinational State of Bolivia, 
have reported increasing seizures of cannabis. In 2010, 
total seizures of cannabis herb/plant in that country 
REPORT OF THE INTERNATIONAL NARCOTICS CONTROL BOARD  
 
66 
amounted to about 1,100 tons. In the past few years, 
increased seizures of cannabis herb were reported by 
Colombia and Peru. The Board calls upon the 
Governments of those countries to determine, to the 
extent possible and in cooperation with UNODC, the 
magnitude of and current trends in the illicit cultivation 
of cannabis plant in their territories and to further 
strengthen their efforts to combat such cultivation.  
482. Trafficking organizations operating in South 
America have continued to use self-propelled submersible 
and semi-submersible vessels to minimize the risk of 
detection of the smuggling of cocaine from the region. 
The Board noted with satisfaction that in 2011 the 
CICAD Group of Experts on Maritime Narcotrafficking 
drafted model legislation on self-propelled submersible 
and semi-submersible vessels in order to assist the 
Governments of the countries in the region to address the 
problem. 
483. The Plurinational State of Bolivia made a proposal 
to amend article 49 of the 1961 Convention as amended 
by the 1972 Protocol, concerning the abolishment of coca 
leaf chewing. Following the rejection of its proposal by 
the parties to the Convention, the Bolivian Government 
in June 2011 deposited with the Secretary-General an 
instrument of denunciation of the Convention, to which 
it had acceded in 1976. The denunciation will come into 
force in January 2012. The Bolivian Government has 
announced its intention to accede again to the 
Convention, with a reservation. The Board’s concern 
about this development is heightened by reports that in 
2010 coca leaf prices increased by 22 per cent in 
authorized markets and by 37 per cent in illicit markets in 
the country (see paras. 270-280 above). 
484. The Board welcomes the adoption by CICAD of the 
Hemispheric Plan of Action on Drugs, 2011-2015, at its 
forty-ninth regular session, held in Paramaribo, 
Suriname, in May 2011. The Plan of Action is aimed at 
supporting implementation of the Hemispheric Drug 
Strategy adopted by CICAD in 2010. In the area of 
demand reduction, the Plan of Action, inter alia, proposes 
the strengthening of the relationship between national 
authorities, academic institutions, research and 
specialized non-governmental organizations in order to 
generate evidence regarding demand for drugs. 
Developing effective and sustainable measures to reduce 
illicit drug crop cultivation and promoting alternative 
development and environmental protection programmes 
were among the objectives of the Plan of Action in the 
area of reducing drug supply. 
 
 2. Regional cooperation 
 
485. In 2010, CICAD, UNODC and the subregional 
system for information and research on drugs, 
comprising Argentina, Bolivia (Plurinational State of), 
Chile, Colombia, Ecuador, Peru and Uruguay, jointly 
published a comparative study on the relationship 
between drugs and crime among adolescent law 
offenders. The study presented, for the first time in the 
region, an assessment of the problem of drug use in 
relation with criminal offences committed by the 
adolescent population in Bolivia (Plurinational State of), 
Chile, Colombia, Peru and Uruguay. The study 
underlined the lifetime prevalence of drug use among 
juvenile law offenders, which is significantly higher than 
the lifetime prevalence of drug use among youth in 
general. The highest lifetime prevalence of cannabis use 
among juvenile law offenders (80 per cent) was reported 
in Chile and Peru. 
486. Guyana and Suriname participated in the 
comparative study of drug use among secondary school 
students in the Caribbean countries. According to the 
results of the study, published in 2010, of all the countries 
surveyed, Guyana reported the highest past-year 
prevalence rates for the use of MDMA (“ecstasy”), 
cocaine and “crack”.  
487. CICAD and EMCDDA released Building a National 
Drugs Observatory: a Joint Handbook in October 2010. 
The handbook, based on the experience of the two bodies 
in their respective geographical areas, provides a practical 
guide relevant for all regions and adaptable to a wide 
range of national and institutional settings. 
488. In addition, CICAD and EMCDDA signed a 
workplan for cooperation covering the period 2011-2013 
whose objectives include strengthening regional and 
international monitoring systems; harmonizing and 
developing indicators in the areas of drug supply and 
demand; and supporting the establishment of national 
drug monitoring centres and drug information networks. 
489. In 2011, CICAD released a hemispheric report that 
evaluates progress in drug control in the Americas in the 
period 2007-2009. According to the report, almost all 
countries in the Americas conducted surveys to 
determine the prevalence of drug use in at least one 
specific population, including the student population. In 
particular, the country surveys warn of a low age of 
initiation in drug use, as well as a low degree of 
perception among young people of the risk of drug use, in 
particular recreational use of cannabis herb and cocaine. 
In addition, the CICAD secretariat compiled drug laws 
and regulations from 34 countries in the Americas and 
made that compilation available on the CICAD website. 
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490. A technical coordination meeting, organized by 
CICAD and UNODC, was held in Santiago in  
March 2011. Argentina, Chile and Uruguay were among 
those represented at the meeting. Participants in the 
meeting reviewed the situation with respect to trafficking 
in and abuse of amphetamine-type stimulants, available 
data on the phenomenon and strategies to enhance 
existing structures for sharing pertinent information. 
While the problem of illicit manufacture of, trafficking in 
and abuse of amphetamine-type stimulants had not yet 
reached large proportions in those countries, participants 
in the meeting agreed that it was necessary to closely 
monitor the situation. The Board supports the efforts of 
UNODC and CICAD to assist Governments in their 
efforts to generate, manage, analyse and report data on 
the illicit manufacture of, trafficking in and abuse of 
amphetamine-type stimulants. The Governments of the 
countries in South America are encouraged to commit 
adequate resources to support their capacity to identify 
synthetic drugs, including psychoactive substances that 
are not currently internationally controlled. 
491. In December 2010, the European Commission 
approved the Cooperation Programme on Drug Policies 
between Latin America and the European Union 
(COPOLAD). The 42-month programme supports a 
number of complementary activities, including training 
in the areas of farming and integrated rural development; 
prevention and investigation of the diversion of 
precursors; drug abuse prevention; and treatment of drug 
abusers. At the coordination meeting held in Buenos 
Aires in May 2011, Argentina, Brazil, Chile, Peru and 
Uruguay adopted a work agenda for 2011 aimed at the 
development of the Programme’s component on 
strengthening national drug observatories. 
492. In the period 2010-2011, UNODC, through its 
project on prevention of the diversion of drug precursors 
in Latin America and the Caribbean, promoted 
cooperation between the private sector and competent 
national authorities and supported the implementation of 
a training programme on investigation and cross-border 
cooperation among the law enforcement authorities of 
the countries in the region, including Argentina, Bolivia 
(Plurinational State of), Brazil, Colombia, Ecuador and 
Venezuela (Bolivarian Republic of).  
493. At the Twentieth Meeting of Heads of National 
Drug Law Enforcement Agencies, Latin America and the 
Caribbean, held in Lima from 4 to 7 October 2010, 
participants reported on the latest drug trafficking trends 
and distribution networks and links between drug 
trafficking and other forms of organized crime. In the 
area of combating drug trafficking and corruption, the 
Meeting, inter alia, recommended that Governments in 
the region put forward initiatives to promote and develop 
transparent electoral competition with a view to 
preventing drug trafficking from interfering in politics. 
The Meeting’s working group on trafficking in synthetic 
drugs and control of precursors recommended that 
Governments should take steps to evaluate existing 
legislation and procedures for managing the import, 
export and sale of pharmaceutical preparations 
containing ephedrine and pseudoephedrine in countries 
where such controls were not already in place. 
494. In 2011, the Governments of Argentina, Brazil, 
Paraguay and Venezuela (Bolivarian Republic of) 
participated in Operation PAAD, focusing on monitoring 
trade in precursors of amphetamine-type stimulants, 
including phenylacetic acid and its derivatives. 
 
 3. National legislation, policy and action 
 
495. Pursuant to its national comprehensive plan to 
combat abuse of “crack” and other drugs, the 
Government of Brazil in 2011 initiated the deployment of 
regional reference centres that will promote the training 
and certification of professionals engaged in networks for 
comprehensive health care and social assistance, working 
with users of both “crack” and other drugs and with their 
families.  
496. The National Strategy on Drugs and Alcohol,  
2011-2014, launched by the Government of Chile, seeks 
both to reduce illicit drug use in the country and to 
mitigate the social and health consequences of drug 
abuse. In particular, the strategy’s goals include the 
reduction by 15 per cent of the annual prevalence rate for 
cannabis use among the school-age population and the 
reduction by 10 per cent of the annual prevalence of 
cocaine use among the school-age population. 
497. In August 2010, the Government of Chile launched 
the National Security Plan 2010-2014 (“Safe Chile”). In 
the period 2010-2011 in the framework of the National 
Security Plan, the Government sponsored several 
initiatives to counter drug trafficking, including the 
development of a new national strategy addressing drug 
trafficking. The drug control strategy, among other 
things, is aimed at substantially reducing the availability 
of drugs in Chile by effectively hampering their entry into 
the country and dismantling drug trafficking 
organizations. 
498. In 2010, an amended law on the prevention, 
detection and eradication of money-laundering and the 
financing of crime entered into force in Ecuador. In 
addition, a national plan for drug abuse prevention for 
the period 2011-2015 has been drafted and is before the 
Government of Ecuador for its approval. 
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499. In May 2011, the Government of Paraguay and 
UNODC presented a national integrated plan  
for 2011-2014 aimed at increasing the responsiveness, 
effectiveness and efficiency of the country in facing the 
challenges posed by organized crime and drug trafficking. 
The goals of the plan include reducing illicit cannabis 
cultivation and strengthening border controls. 
500. In December 2010, the National Commission  
for Development and Life without Drugs (DEVIDA) of 
Peru published a study on the social and economic 
impact of the abuse of psychoactive substances in Peru. 
The study estimated the cost of the illicit use of drugs 
(excluding alcohol and tobacco) in Peru to be  
$192 million per year. The cost attributable to licit and 
illicit drug use includes lost labour costs and lost 
productivity, direct governmental costs and health-care 
costs. In 2011, the Government of Peru approved the 
national plan against money-laundering and the 
financing of terrorism in order to further strengthen, in 
cooperation with the private sector, the prevention and 
investigation of money-laundering and related crime. 
501. The stated objectives of the drug abuse prevention 
programme entitled “For Sports” launched by the 
Government of Uruguay in April 2011 are to encourage 
teenagers and young athletes to develop their athletic 
ability and realize their psychological potential, thus 
reducing the risk factors liable to lead to drug abuse. The 
programme will be sponsored by competent national 
authorities, in cooperation with a non-governmental 
organization and UNODC, and will be implemented by 
national sport associations. 
502. In 2011, the National Drug Board of Uruguay 
approved the national drug control strategy for the  
period 2011-2015. The strategy, among other things, 
proposes to promote international debate on current drug 
control policies. 
503. In 2010, the Government of the Bolivarian Republic 
of Venezuela promulgated the Organic Law on Drugs. 
The law, among other things, recognizes drug abuse as a 
medical condition requiring treatment and includes 
treatment and social integration measures within the 
ambit of the applicable penal procedure. 
 
 4. Cultivation, production, manufacture and 
trafficking 
 
 (a) Narcotic drugs 
 
504. Due to the lack of relevant data, the area of illicit 
cannabis cultivation in South America could not be 
accurately assessed. Indirect indicators, including 
eradication reports, seizures and drug abuse reports, have 
been used to determine approximately the magnitude of 
the cannabis problem in the region. In 2009, seizures in 
South America accounted for 10 per cent of global 
seizures of cannabis herb. Most cannabis illicitly 
produced in the region seems to be destined for domestic 
markets of the producing countries, while a portion of the 
cannabis is trafficked within other countries of the 
region. 
505. Paraguay is considered to be the largest cannabis 
producer in South America, accounting for over half of 
the assessed total production of cannabis in the region. In 
2010, Paraguayan authorities eradicated more than  
1,000 ha of illicitly cultivated cannabis plants and seized 
almost 130 tons of cannabis herb, 45 tons more than  
in 2009. 
506. About 20 per cent of the cannabis abused in Brazil 
is of domestic origin. According to UNODC, the 
remaining 80 per cent of the cannabis abused in Brazil 
enters the country from Paraguay. In 2010, Brazilian 
authorities destroyed 2.8 million cannabis plants, 
including seedlings, and seized a further 155 tons of 
cannabis herb. 
507. In the period 2004-2006, Colombian authorities 
seized an average of 130 tons of cannabis herb per year; in 
the period 2007-2009, that figure rose to about 215 tons 
per year. In 2010, such seizures of cannabis herb further 
increased, amounting to 262.5 tons, 53.5 tons more than 
in 2009. According to the National Narcotics Directorate 
(DNE) of Colombia, the level of tetrahydrocannabinol 
(THC) in cannabis seized in the department of Cauca 
ranged from 8 to 20 per cent.  
508. The area under illicit cannabis cultivation in Peru is 
not known. However, seizures of cannabis plants 
increased gradually in the country, from 20 tons in 2005 
to 137.5 tons in 2009. In 2010, that figure dropped to  
9 tons, the lowest amount of cannabis plant seized in the 
country in a decade. Seizures of cannabis plant increased 
in 2011, totalling 133 tons from January to mid-August. 
Contrary to the situation with cannabis plant, seizures of 
cannabis herb almost doubled in Peru, from 2.1 tons in 
2009 to 3.9 tons in 2010. 
509. In the Plurinational State of Bolivia, seizures of 
cannabis plant and cannabis herb rose gradually, from 
125 tons in 2006 to 1,900 tons in 2009. In 2010, seizures 
amounted to about 1,100 tons.  
510. In 2010, seizures of cannabis herb declined in 
Ecuador (to 2.5 tons) and Uruguay (to 0.4 tons). 
511. Although more research is needed to improve 
comparability of data for all components of cocaine 
manufacture, analysis of data published by UNODC 
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indicates a gradual decrease in the total area under illicit 
coca bush cultivation in the past 25 years, from a peak of 
288,400 ha reported in 1990 to an estimated 154,200 ha in 
2010. To increase the accuracy and comparability of the 
data published in its reports, UNODC, in cooperation 
with Governments, is reviewing coca leaf to cocaine 
conversion ratios.  
512. In 2010, the use of higher-resolution imagery 
enabled the Colombian authorities, for the first time, to 
include in their calculation of the area of illicit coca bush 
cultivation fields smaller than 0.25 ha. According to 
UNODC, the area under illicit coca bush cultivation 
(adjusted to include small fields) decreased in Colombia, 
from 73,000 ha in 2009 to 62,000 ha in 2010 (a decrease of 
15 per cent). Illicit coca bush cultivation decreased in all 
major growing areas of the country. In 2010, 43,792 ha of 
illicitly cultivated coca bush were manually eradicated in 
the country (a decrease of 27 per cent), and an additional 
101,939 ha were subject to aerial spraying. 
513. In Peru, the area under illicit coca bush cultivation 
in 2010 was approximately the same as in Colombia: the 
area under illicit coca bush cultivation in Peru increased 
for the fifth year in a row, from 48,200 ha in 2005 to 
61,200 ha in 2010 (about 1,300 ha, 2 per cent more than 
in 2009). According to DEVIDA, the increased illicit 
cultivation of coca bush in Peru in recent years can be 
attributed to increased global demand for cocaine and the 
intensive eradication of coca bush in neighbouring 
countries, which has caused the displacement of coca 
bush cultivation to Peru. 
514. From 2006 to 2009, the area of eradicated illicit coca 
bush in Peru ranged from 10,025 ha to 11,056 ha per year, 
and thus exceeded the minimum eradication goal  
(10,000 ha per year). In 2010, 12,033 ha of illicit coca 
bush were eradicated in the country. According to the 
Government of Peru, the portion of the national budget 
allocated to addressing the drug problem increased 
sharply, from $7.4 million in 2008 to $69 million in 2010. 
The Government increased the 2011 budget for the fight 
against illicit drugs to almost $100 million. However, the 
Government is concerned that, due to limited financial 
support from the international community, the national 
resources allocated for activities to counter illicit drugs 
may not be sufficient to contain the displacement of illicit 
coca bush cultivation to Peru. 
515. In the Plurinational State of Bolivia, illicit coca bush 
cultivation gradually increased in the period 2005-2009, 
from 25,400 to 30,900 ha. In 2010, the area under illicit 
coca bush cultivation in the country remained stable, at 
31,000 ha. The small decrease of 2 per cent in the region 
of Yungas (accountable for 66 per cent of the illicit coca 
bush cultivation in the country) was offset by an increase 
of 4 per cent in the Chapare region. Bolivian Law  
No. 1008 of 19 July 1988 sets 5,000 ha as the minimum 
area of illicitly cultivated coca bush to be eradicated per 
year. From 2006 to 2009, the area of eradicated illicitly 
cultivated coca bush in the Plurinational State of Bolivia 
ranged from 5,070 to 6,340 ha per year. In 2010, the total 
area of eradicated coca bush increased to 8,200 ha. 
516. The Board reiterates its call for the international 
community to enhance its assistance, including expertise 
and financial resources, provided to countries in South 
America in order to overcome the problem of illicit drug 
crop cultivation and the illicit manufacture of cocaine. 
The Board urges the Governments of Bolivia 
(Plurinational State of), Colombia and Peru to step up the 
measures to reduce the total area under illicit coca bush 
cultivation and to counter illicit cocaine manufacture and 
trafficking, in cooperation with the Governments of other 
countries and international organizations, including 
United Nations entities. 
517. Global seizures of cocaine were stable in the period 
2006-2009, ranging between 690 and 732 tons per year 
(amounts unadjusted for purity). Since 2006, the location 
of cocaine seizures has shifted from the consumer 
markets in North America and Europe to the source areas 
in South America. South America accounted for a total of 
317 tons of seized cocaine in 2006 (44 per cent of the 
world total for that year) and 442 tons in 2009 (60 per 
cent of the world total). Some secondary distribution 
countries in South America seem to have increased in 
importance as transit countries for cocaine shipments. 
The smuggling of cocaine through West Africa continues 
to be significant, although the amount of cocaine seized 
in that subregion each year has decreased since 2007. 
518. Countries in North America, notably the United 
States, Europe and South America are the largest illicit 
markets for cocaine. Cocaine manufactured in Colombia 
is mainly shipped to illicit markets overseas. Cocaine 
manufactured in Bolivia (Plurinational State of) and 
Peru, in addition to being used to supplying the illicit 
markets in Europe, is widely used within South America, 
notably in the countries of the Southern Cone. The illicit 
market for cocaine in the United States has declined 
significantly in recent years. Nevertheless, with an 
estimated annual consumption of 150-160 tons of 
cocaine, it continued to be the largest illicit market for 
cocaine in 2009. Authorities of the United States estimate 
that some 90 per cent of the cocaine used in North 
America originates in Colombia. The amount of cocaine 
used in Europe has doubled over the past decade, even 
though data for the past few years show that there are 
signs of use levelling off at the recent, higher levels 
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(estimated at about 120 tons). The origin of the cocaine 
used in Europe seems to be more evenly distributed 
among the main cocaine-manufacturing countries; 
Bolivia (Plurinational State of), Colombia and Peru. 
519. In 2010, seizures of cocaine (base and salts) 
decreased in several countries in the region, including 
Argentina, Colombia, Ecuador, Uruguay and Venezuela 
(Bolivarian Republic of), compared with the previous 
year. The total amount of seized cocaine decreased from 
253 to 211 tons in Colombia and from 65.1 to 15.5 tons in 
Ecuador. From 2009 to 2010, the total amount of seized 
cocaine (base and salts) in Peru increased by almost  
50 per cent, from 20.7 to 30.8 tons. In 2010, an increase in 
the amount of cocaine seized was also reported by Bolivia 
(Plurinational State of) (29.1 tons), Brazil (27.1 tons), 
Chile (9.9 tons) and Paraguay (1.4 tons).  
520. Although the total amount of cocaine seized in 
Colombia declined to 211 tons in 2010, that was the 
largest amount for any country in South America. About 
40 per cent of all the seizures of cocaine hydrochloride 
recorded in Colombia were made in territorial or 
international waters, mostly in the Pacific Ocean. 
According to estimates by UNODC, each year between  
30 and 40 tons of cocaine, from Bolivia (Plurinational 
State of), Colombia and Peru pass through Paraguay. 
521. According to the Venezuelan authorities, the 
amount of cocaine seized in their country gradually 
decreased from a peak of 58.4 tons in 2005 to 24.8 tons in 
2010. The decline in seizures can be partly attributed to a 
substantial decrease in the potential manufacture of 
cocaine in neighbouring Colombia in the same period. In 
2011, the Venezuelan National Anti-Drug Office (ONA) 
stated that it expected cocaine trafficking through the 
Bolivarian Republic of Venezuela to decrease. The Board 
wishes to encourage the Government to continue its 
efforts to combat drug trafficking at the national and 
regional levels. 
522. In countries in South America, in particular 
Colombia, traffickers have continued using self-propelled 
submersible and semi-submersible vessels of unorthodox 
construction to minimize the risk of being detected while 
smuggling cocaine from the region. Vessels seized by the 
authorities are capable of transporting as much as 12 tons 
of contraband more than 2,000 kilometres. The vessels 
were designed to enable the crew, upon detection, to 
easily destroy the contraband, usually by scuttling the 
vessels or sinking the contraband, thereby making it more 
difficult to prosecute the smugglers owing to the lack of 
evidence. In February 2011, the Colombian navy seized 
such a submersible before it could be loaded. Advanced 
technology, including a modern navigation system, would 
enable the submersible, which was made of fibreglass and 
reinforced with carbon fibre, to navigate completely 
submerged under the sea surface and thus make it 
virtually undetectable. Attempts to use submersible and 
semi-submersible vessels for drug trafficking continued 
throughout 2011, as corroborated by the seizure of  
two submersibles and one semi-submersible in Colombia 
in September and October 2011.  
523. In 2009, 319 laboratories illicitly manufacturing 
cocaine hydrochloride were dismantled in Bolivia 
(Plurinational State of), Colombia and Peru. Clandestine 
cocaine laboratories were also reported in other countries 
in South America, including Argentina (36 laboratories), 
Ecuador (10 laboratories) and Venezuela (Bolivarian 
Republic of) (26 laboratories). 
524. Maceration pits and coca paste and coca base 
laboratories continued to be detected in all three of  
the main countries used for illicit coca production; 
however, cocaine hydrochloride laboratories were found 
mainly in Colombia. Of a total of 2,651 illicit drug and 
precursor laboratories dismantled in Colombia in 2010,  
2,369 laboratories had been processing coca paste or coca 
base and a further 254 had been manufacturing cocaine 
hydrochloride. Many of the cocaine hydrochloride 
laboratories were found near areas used for producing 
coca leaf. 
525. In Peru, the number of dismantled laboratories for 
processing coca paste increased from about 650 in 2007 
to about 1,200 in 2009. In 2010, that number rose even 
further, to 1,300. 
526. In the Plurinational State of Bolivia, the number of 
destroyed maceration pits and laboratories for processing 
coca paste and manufacturing cocaine hydrochloride 
increased from 2009 to 2010. There are indications that 
the efficiency of clandestine laboratories manufacturing 
cocaine in that country has increased in recent years. 
However, further research is needed to determine the 
ratios for the conversion of coca leaf to cocaine in order 
to better assess the current efficiency of those laboratories 
not only in the Plurinational State of Bolivia but also in 
Colombia and Peru. 
527. In 2010, five illicit laboratories processing coca 
paste originating in Colombia and Peru were dismantled 
in Ecuador. That development and the seizure of semi-
submersible vessels close to the coast of the country in 
recent years indicate a further integration of the country 
into the regional drug trafficking networks. 
528. Illicit opium poppy cultivation continues to take 
place in South America on a small scale. According to the 
Government of Colombia, such cultivation decreased 
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gradually in that country, from 6,500 ha in 2000 to 341 ha 
in 2010. The area of illicitly cultivated opium poppy in 
2010 (341 ha) could yield a maximum of 1 ton of heroin, 
which is less than the estimated amount of the drug used 
in the region in one year (2 tons). Illicit opium poppy 
cultivation was also reported to be taking place on a small 
scale in Ecuador and Peru. 
529. In South America, seizures of both opium and 
heroin declined from 2005 to 2009. Laboratory analysis of 
heroin seized in Colombia in 2009 indicates that a 
portion of the 735 kg seized that year came from the 
stocks accumulated in past years in the country. In 2010, 
seizures of heroin were reported by Argentina (6 kg), 
Colombia (337 kg) and Venezuela (Bolivarian Republic 
of) (53 kg). In Ecuador, a total of 853 kg of heroin was 
seized — the largest total amount of seized heroin 
reported in the region in 2010. According to the 
Ecuadorian authorities, about 50 per cent of the heroin 
seized in the country had been destined for the United 
States and a further 20 per cent had been destined for 
Spain. 
 
 (b) Psychotropic substances 
 
530. In South America, the drug problem is mostly 
associated with the illicit manufacture of plant-based 
drugs, in particular cocaine. However, in recent years, 
authorities of countries in South America have detected 
attempts by traffickers to illicitly manufacture 
amphetamine-type stimulants, including MDMA 
(“ecstasy”) and methamphetamine, in the region. The 
most recent seizure of a laboratory illicitly manufacturing 
“ecstasy” in the region was reported in Argentina in 2010. 
In 2008, the World Customs Organization reported that 
South America was not only the destination of 
amphetamine-type stimulants smuggled from other 
regions but also the source of amphetamine-type 
stimulants seized in Europe. Although currently there is 
insufficient information to confirm that the illicit 
manufacture of amphetamine-type stimulants in the 
region has continued, seizures of methamphetamine, 
purportedly smuggled out of South America, via Europe, 
for a destination in East Asia in 2010, indicate that the 
threat of the illicit manufacture of and trafficking in 
amphetamine-type stimulants in South America cannot 
be underestimated. 
531. The Board continues to be concerned over  
the unusually high levels of consumption of  
licitly manufactured stimulants (anorectics) and 
benzodiazepines in some countries in South America, 
particularly Argentina (stimulants and benzodiazepines) 
and Uruguay (benzodiazepines). There are indications 
that pharmaceutical preparations containing such 
substances not only are abused in those countries but are 
also smuggled into neighbouring countries. The Board 
requests the Governments concerned to remain vigilant, 
ensure the implementation of the prescription 
requirement, educate doctors about the rational use of 
controlled drugs and use prescription monitoring 
programmes to identify unethical behaviour by doctors 
or patients. 
 
 (c) Precursors  
 
532. Potassium permanganate remains the key oxidizing 
agent used in the manufacture of cocaine hydrochloride. 
However, the extent of its illicit use and the methods of its 
diversion in South America seem to have changed in the 
past few years. 
533. Several indirect indicators suggest that the amount 
of potassium permanganate destined for use in the illicit 
manufacture of cocaine might have declined in the main 
cocaine-manufacturing countries, owing in particular to 
decreased coca bush cultivation in South America, the 
apparent emergence of cocaine laboratories in other 
countries in the region and recent changes in the methods 
used for processing coca leaf into cocaine. The suspected 
decline in traffickers’ demand for potassium 
permanganate can partly be corroborated by the 
detection in Peru of the use of a modified process for the 
illicit manufacture of cocaine, which, according to the 
competent national authorities, leaves out the oxidation 
phase, in which potassium permanganate is required. 
534. In the past five years, no diversion of potassium 
permanganate from international trade involving a 
country in South America has been reported to  
the Board. In Colombia, most of the potassium 
permanganate used by traffickers is illicitly 
manufactured. 
535. In the period 2004-2007, an average of  
13 laboratories illicitly manufacturing potassium 
permanganate were dismantled in Colombia each year, 
and 100-170 tons of potassium permanganate were 
seized. In the period 2008-2010, the number of 
dismantled potassium permanganate laboratories in 
Colombia declined, ranging from two to four each year. 
In that period, Colombia seized an average of 30.3 tons of 
potassium permanganate per year, while Peru seized  
0.9 tons and Ecuador seized 0.6 tons. 
536. The diversion of ephedrine and pseudoephedrine, 
in the form of raw material as well as pharmaceutical 
preparations, continues to present a risk in the Americas. 
Since 2009, seizures of ephedrine or pseudoephedrine 
have been reported by Argentina, Brazil, Chile, Colombia 
and Venezuela (Bolivarian Republic of). Pursuant to the 
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CICAD Hemispheric Plan of Action on Drugs,  
2011-2015, countries in the Americas committed 
themselves to adopt measures to prevent the diversion of 
pharmaceutical preparations used in the illicit 
manufacture of amphetamine-type stimulants. 
 
 5. Abuse and treatment 
 
537. Cannabis has remained the primary drug of abuse 
throughout South America. The annual prevalence of 
cannabis abuse among the population aged 15-64 years 
was in the range of 2.9-3.0 per cent in 2009, 
corresponding to between 7.4 million and 7.6 million 
cannabis abusers. The prevalence of cannabis abuse in 
South America, as in other regions, tends to be higher 
among youth than among the general population. 
According to a national survey on drug abuse among 
secondary school students published in Uruguay in 
October 2010, of students who had abused cannabis, 
about 40 per cent had abused the substance before the age 
of 15 years. The survey also found that about 40 per cent 
of those students who had experimented with cannabis 
use at least once in their life had continued abusing the 
substance. 
538. The prevalence of cocaine abuse in South America 
is higher than the global average. The latest data indicate 
that following years of increases, the abuse of cocaine in 
the region has started to stabilize, although at a higher 
level. In 2009, UNODC estimated the annual prevalence 
of cocaine abuse among the general population 
worldwide aged 15-64 years to be between 0.3 and 0.5 per 
cent. In South America, the annual prevalence of cocaine 
abuse was in the range of 0.9-1.0 per cent, corresponding 
to about 2.4 million cocaine abusers. According to 
UNODC, the highest rates of annual prevalence of 
cocaine abuse in South America were reported by 
Argentina (2.6 per cent in 2006), Chile (2.4 per cent in 
2008) and Uruguay (1.4 per cent in 2006). 
539. According to the ninth national survey on drug 
abuse among the general population (persons 12-64 years 
old) in Chile published in June 2011, the past-year 
prevalence of abuse for most drugs, including cannabis 
and cocaine, decreased from 2008 to 2010. The past-year 
prevalence of cocaine abuse (including abuse of cocaine 
paste) declined from 2.2 to 0.9 per cent. 
540. Despite the indications that its abuse is stabilizing, 
cocaine continues to be the primary drug of abuse among 
persons treated for drug problems and ranks as the 
substance most frequently cited as cause of drug-induced 
or related death in South America. 
541. The annual prevalence of opioid abuse (mainly non-
medical use of prescription opioids) in South America is 
estimated to be between 0.3 and 0.4 per cent of the adult 
population, corresponding to 850,000-940,000 people 
aged 15-64. The Plurinational State of Bolivia (0.6 per 
cent), Brazil (0.5 per cent) and Chile (0.5 per cent), 
continue to have high rates of opioid abuse. In South 
America, codeine-based preparations are among the most 
commonly abused opioids. Demand for treatment for 
opioid abuse in the entire region has remained stable over 
the past few years. In 2009, 9.6 per cent of treatment cases 
were related to opioid abuse. 
 
 
 C. Asia 
 
 
  East and South-East Asia 
 
 
 1. Major developments 
 
542. Illicit opium poppy cultivation and opium 
production continued to increase in East and South-East 
Asia in 2010. In Myanmar, the world’s second largest 
opium producer, illicit opium poppy cultivation had 
increased for four consecutive years since 2007. Illicit 
opium production increased from 330 tons in 2009 to  
580 tons in 2010, representing 16 per cent of global 
opium production in 2010. The Lao People’s Democratic 
Republic also reported a significant increase in illicit 
opium poppy cultivation in 2010. The lucrative profits 
associated with such cultivation were the main driving 
force behind the increased opium poppy cultivation. 
Moreover, according to UNODC, in Myanmar the 
erosion of food security in rural areas might trigger a 
further increase in such cultivation. The Board urges the 
Governments of the Lao People’s Democratic Republic 
and Myanmar to take the necessary action to reduce illicit 
opium poppy cultivation. The Board also calls upon the 
international community to provide assistance to those 
two countries in order to effectively address that 
challenge. 
543. Seizures of methamphetamine in East and South-
East Asia continued to increase in 2010. Large-scale illicit 
trafficking in methamphetamine was reported, 
particularly in the area encompassing China, the Lao 
People’s Democratic Republic, Myanmar and Thailand. In 
China, methamphetamine seizures increased by 50 per 
cent from 2009 to 2010; approximately 45 per cent of the 
total seizures in the country were effected in Yunnan 
Province, bordering Myanmar, which suggests that 
methamphetamine is being smuggled out of Myanmar. In 
the Lao People’s Democratic Republic, methamphetamine 
seizures reached a record 24.5 million tablets in 2010, 
most of which originated in Myanmar and was smuggled 
into Thailand through that country’s border with the Lao 
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People’s Democratic Republic. In Thailand, a record 
number of 50 million methamphetamine tablets were 
seized in 2010, an increase of 88 per cent over 2009. Most 
of the methamphetamine had been smuggled out of 
neighbouring countries, entering Thailand through the 
country’s northern and north-eastern borders.  
544. There is serious concern over the increased level of 
drug trafficking through East and South-East Asia by 
West African and Iranian organized criminal groups. 
China (including Hong Kong), Indonesia, Japan, 
Malaysia, the Philippines, the Republic of Korea, 
Singapore and Thailand reported trafficking in heroin, 
cocaine and methamphetamine by traffickers with 
connections to organized drug trafficking groups from 
West Africa and the Islamic Republic of Iran. Those 
criminal groups established trafficking networks in 
South-East Asia and usually used drug couriers from 
Ghana, Nepal, Nigeria, Pakistan, the Philippines and 
Thailand. 
545. Trafficking in and increasing abuse of ketamine, a 
substance not under international control, is a prominent 
problem in East and South-East Asia. Ninety-nine per 
cent of all ketamine seizures worldwide in 2009 took 
place in Asia. In 2010, China reported ketamine seizures 
totalling nearly 5 tons. Indonesia, Japan, Malaysia, 
Singapore, Thailand and Viet Nam also reported seizures 
of ketamine. Ketamine is illicitly manufactured in China, 
although India is also an important source of ketamine 
seized in the region. The growing abuse of ketamine is of 
particular concern in Hong Kong, China, where ketamine 
is the second most widely abused drug following heroin. 
The growing popularity of ketamine in the region may be 
partly attributed to its low price compared with MDMA 
(“ecstasy”) and its wide availability due to the fact that few 
States have placed it under national control. 
546. Indonesia is facing an emerging challenge posed by 
the illicit manufacture and abuse of MDMA (“ecstasy”). 
According to a recent survey, “ecstasy” is the third most 
commonly abused drug in the country. Seizures of 
“ecstasy” tablets increased by 38 per cent from 2009 to 
2010. Fifteen clandestine “ecstasy” laboratories were 
dismantled in 2010. It appears that 90 per cent of the 
“ecstasy” seized in the country was supplied by domestic 
illicit manufacture. The scale of illicit manufacture of 
“ecstasy” in Indonesia raises concern that the country 
may become a main source of that drug in the region. 
 
 2. Regional cooperation 
 
547. In May 2011, the ministerial meeting of the 
Signatory Countries of the 1993 Memorandum of 
Understanding on Drug Control was held in Vientiane. 
At the meeting, representatives of Cambodia, China, the 
Lao People’s Democratic Republic, Myanmar, Thailand 
and Viet Nam reviewed the latest trends in drug 
trafficking and abuse in the region and endorsed the 
Subregional Action Plan on Drug Control (revision VIII) 
for the period 2011-2013, which provides a strategic 
outline for the collaborative efforts of the six signatory 
countries and UNODC in addressing the challenges 
posed by illicit drugs.  
548. The twenty-first Anti-Drug Liaison Officials’ 
Meeting for International Cooperation was held in Jeju 
Province, Republic of Korea, in May 2011. The meeting 
was attended by drug control officials from 21 countries 
in East and South-East Asia, Europe and North America, 
as well as experts from the Association of Southeast Asian 
Nations (ASEAN), the Colombo Plan for Cooperative 
Economic and Social Development in Asia and the 
Pacific, the Board, UNODC and the World Customs 
Organization. The annual meeting provided participants 
with an important forum in which to share the latest 
developments and trends in trafficking in illicit drugs and 
precursors and to examine ways to strengthen 
intelligence-sharing and regional and international 
cooperation in drug control. 
549. ASEAN continued to promote cooperation 
pertaining to drug control in the region. At the eleventh 
meeting of ASEAN Senior Officials on Transnational 
Crime, held in Singapore in July 2011, combating  
drug trafficking, in particular trafficking in 
methamphetamine, was highlighted as a priority of 
ASEAN in the near future. Participants in the meeting 
also called for strengthening cooperation between 
ASEAN and INTERPOL. In addition, ASEAN and India 
and Pakistan are holding ongoing consultations on how 
to effectively combat trafficking in opiates and 
precursors. 
550. Countries in East and South-East Asia continue to 
enhance cooperation and share expertise in treatment 
and rehabilitation for drug abusers. The Regional 
Conference on Drug Prevention Best Practices was held 
in Hanoi in October 2010. Representatives from  
20 countries in the Asia-Pacific region attended the 
Conference, which was aimed at sharing good practices in 
drug abuse prevention and providing a forum for 
prevention practitioners to use to exchange information. 
At the fifth Asian Recovery Symposium, held in Jakarta in 
December 2010, 250 participants from 16 countries in 
Asia worked to develop strategies to enhance knowledge 
and skills relating to the treatment and rehabilitation of 
drug abusers. 
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551. Regional training for law enforcement authorities 
that combat illicit drugs plays an important role in 
capacity-building and intelligence-sharing in East and 
South-East Asia. In November 2010, a regional seminar 
on cooperation against West African syndicate operations 
was organized by UNODC in Bangkok. Seminar 
participants reviewed the serious threat posed to the 
region by drug traffickers and established a network of 
senior law enforcement officials for sharing information 
on the operations of transnational organized criminal 
groups. In August 2011, the eighth Regional Training 
Course on Precursor and Chemical Control was held in 
Bangkok. The course provided participants with an 
overview of the latest trends in trafficking in precursors 
in Asia and facilitated the exchange of information and 
intelligence among law enforcement officers responsible 
for precursor control. 
552. China continued to enhance bilateral cooperation 
with the Lao People’s Democratic Republic and Myanmar 
in alternative development initiatives to replace illicit 
opium poppy cultivation. By the end of 2010, China had 
assisted the Lao People’s Democratic Republic and 
Myanmar in the implementation of 200 alternative 
development programmes. At the tenth China-Thailand 
Bilateral Meeting on Drug Control Cooperation, held in 
June 2011, the two countries reviewed the recent drug 
trafficking threat posed by West African drug traffickers 
and identified a drug trafficking route by air from 
Bangkok to Kunming, China, which was increasingly 
being used by traffickers. In November 2010, a 
memorandum of understanding was signed between the 
Republic of Korea and Viet Nam to establish the  
Asia-Pacific Information and Coordination Centre for 
Preventing and Combating Drug Crimes in Viet Nam.  
In 2010 and 2011, Japan, the Republic of Korea and 
Thailand provided technical training on drug control and 
drug abuse prevention to officers from Cambodia, 
Indonesia, the Lao People’s Democratic Republic and  
Viet Nam.  
 
 3. National legislation, policy and action 
 
553. In November 2010, the Government of Cambodia 
and UNODC jointly organized the country’s first 
workshop on capacity-building for community-based 
drug abuse treatment services, including HIV/AIDS 
prevention.  
554. China adopted legislation and control measures to 
promote the treatment of drug abuse and prevent the use 
of the Internet in trafficking precursors. In  
September 2010, the Government of China strengthened 
measures to control online trading in precursors, 
requiring entities that sell precursors through the Internet 
to be registered. In June 2011, China adopted legislation 
on treatment and rehabilitation for drug abusers, 
replacing regulations on compulsory treatment for drug 
abusers that had been adopted in 1995. The new 
legislation encourages drug addicts to voluntarily 
undergo treatment and enter rehabilitation programmes 
and encourages the strengthening of the role of 
communities and families in the rehabilitation of drug 
abusers. The new legislation also requires rehabilitation 
centres to provide drug addicts with consultation and 
education on the prevention of HIV/AIDS and other 
contagious diseases. 
555. Indonesia adopted its national drug control strategy 
for the period 2010-2014, focusing on three areas: 
preventing drug abuse, enhancing treatment and 
rehabilitation services and combating drug trafficking in 
particular by organized criminal organizations. In that 
framework, a national policy on rehabilitation was 
formulated. In addition, programmes for alternative 
development and community empowerment were 
launched in 2010 and 2011 in the areas affected by illicit 
cultivation of cannabis plant.  
556. In November 2010, the National Police Agency of 
Japan adopted the “Major enhancement plan on anti-drug 
measures” to effectively combat the problem of increasing 
trafficking in and abuse of methamphetamine. The main 
objectives of the plan were to fight drug trafficking 
involving the use of the Internet and couriers and to 
strengthen international cooperation aimed at disrupting 
organized drug trafficking groups. 
557. The Government of the Lao People’s Democratic 
Republic adopted a national drug control master plan for 
the period 2009-2013 with the assistance of UNODC. The 
plan comprises nine components including drug demand 
reduction and HIV prevention, control of precursor 
chemicals, institutional capacity-building and 
international cooperation to address transnational drug 
trafficking. A national drug law enforcement strategy is 
being developed by the Government of the Lao People’s 
Democratic Republic with the assistance of UNODC. 
558. Since 2009, the Government of Myanmar has been 
implementing the final five-year phase of its 15-year Drug 
Elimination Plan, aimed at eliminating illicit opium 
poppy cultivation. In view of the emerging challenges 
posed by increased illicit opium poppy cultivation and 
the illicit manufacture of and trafficking in 
amphetamine-type stimulants in Myanmar, the Board 
urges the Government of Myanmar to continue its efforts 
and take additional measures to ensure the successful 
implementation of the Drug Elimination Plan. 
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559. In November 2010, the Government of Thailand 
launched the third phase of its “Five Fences” national 
drug control strategy, a comprehensive strategy targeting 
drug-related issues in border areas, communities, schools 
and families. Other initiatives were carried out in 2010 by 
the Government of Thailand in cooperation with private 
organizations and civil society, including the “To Be 
Number One” awareness-raising campaign and the 
creation of a national demand reduction task force to 
promote drug treatment services for drug abusers. 
560. In September 2010, the Government of Viet Nam 
issued a decree on the strengthening of family-based and 
community-based drug treatment and rehabilitation 
services. In March 2011, the Ministry of Public Security 
of Viet Nam adopted measures to improve the collection 
and analysis of drug-related data. In June 2011, the 
Government of Viet Nam adopted the national strategy 
on drug control and prevention for the period ending in 
2020. Based on that strategic document, the national 
target programme for the period 2011-2015 was 
developed to address drug-related issues in the country. 
561. Several countries in the region have adopted  
control measures for substances not under international 
control. Hydroxylamine hydrochloride, a precursor  
used in the manufacture of ketamine, was  
placed under national control in China in 2009. 
Singapore has placed N-benzylpiperazine (BZP),  
3-Trifluoromethylphenylpiperazine and mephedrone 
under national control. The Republic of Korea has  
added mephedrone, BZP derivatives such as 
methylbenzylpiperazine and a number of synthetic 
cannabinoid receptor agonists, notably JWH-018,  
CP 47497 and homologues, to the list of nationally 
controlled substances. Benzyl cyanide, a substance found 
to have been used in the illicit manufacture of 
amphetamine-type stimulants, was also placed under 
national control in the Republic of Korea. The 
Government of the Philippines has included nalbuphine 
hydrochloride in its list of controlled drugs. 
 
 4. Cultivation, production, manufacture and 
trafficking 
 
 (a) Narcotic drugs 
 
562. Illicit opium poppy cultivation in Myanmar, the Lao 
People’s Democratic Republic and Thailand continued to 
increase in 2010. A survey jointly conducted by the 
Government of Myanmar and the Government of China 
revealed that illicit opium poppy cultivation in Myanmar 
in 2010 was estimated at about 29,000 ha, representing an 
increase of 18 per cent over 2009 (while a UNODC survey 
showed a higher estimate of 38,100 ha). As a result of that 
increased cultivation, opium production in Myanmar 
increased significantly in 2010. In the Lao People’s 
Democratic Republic, an estimated 3,000 ha of illicit 
opium poppy were cultivated in 2010, an increase of  
58 per cent compared with 2009. Thailand also reported 
an increase in illicit opium poppy cultivation, from  
211 ha in 2009 to 289 ha in 2010.  
563. Opium poppy eradication continued to be carried 
out in East and South-East Asia. In Myanmar, a total of 
8,268 ha were eradicated in the period 2009-2010; that 
was twice the area eradicated in the period 2008-2009. 
About 65 per cent of the total eradication took place in 
Shan State, which accounted for more than 90 per cent of 
opium production in Myanmar. Difficulty in reaching 
some areas of opium poppy cultivation remained a 
challenge for local law enforcement authorities. The 
authorities of the Lao People’s Democratic Republic 
eradicated approximately 580 ha of illicit opium poppy 
cultivation in 2010, comprising nearly 20 per cent of that 
year’s estimated total cultivation. In Thailand, 278 ha 
were eradicated, an increase of 38 per cent compared  
with 2009.  
564. Illicit cannabis cultivation and cannabis seizures 
were reported by many countries in East and South-East 
Asia. In Indonesia, illicit cannabis cultivation was 
concentrated mainly in the area of Aceh Province. In 
2010, 178 ha of cannabis were eradicated, a decrease of  
25 per cent from 2009. Approximately 22 tons of cannabis 
herb were seized in the country. In Japan, there were an 
increasing number of incidents of people obtaining 
cannabis seeds through the Internet for indoor 
cultivation. In the past decade, identified cases of illicit 
cultivation of cannabis grew significantly, from 57 cases 
in 2001 to 254 cases in 2009. In the Lao People’s 
Democratic Republic, seizures of cannabis amounted to 
3.5 tons in 2010, an increase of 260 per cent from 2009. In 
the Philippines, illicit cannabis cultivation is usually 
located in the mountainous areas of the country. In 2010, 
207 illicit cannabis cultivation sites were eradicated, the 
greatest number since 2005. Approximately 2,400 kg of 
cannabis were seized. Viet Nam reported small-scale 
cannabis cultivation. In addition to illicit domestic 
cultivation, cannabis continued to be smuggled from 
North America and South Asia into China (including 
Hong Kong), Japan and Thailand.  
565. Heroin smuggled within East and South-East Asia 
and West Asia continues to be a significant problem. In 
recent years, heroin originating in West Asia has been 
smuggled by air via South Asia or the Middle East to East 
and South-East Asia. In some cases, heroin was smuggled 
from countries in West Africa, notably Nigeria. West 
African criminal groups were increasingly using female 
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drug couriers from Thailand to smuggle heroin from 
Thailand into other countries in East and South-East 
Asia. Heroin from the area known as the Golden Triangle 
was smuggled primarily by land routes into cities in 
southern China; part of the heroin was smuggled onward 
to Hong Kong, China. In 2010, approximately 5.3 tons of 
heroin were seized in China, of which about 19 per cent 
(580 kg) originated in West Asia. In Myanmar, most of 
the illicit manufacture and seizures of heroin took place 
in Shan State, which borders China, the Lao People’s 
Democratic Republic and Thailand. In 2010, only one 
clandestine heroin laboratory was dismantled in 
Myanmar.  
566. Reported cocaine seizures in Asia accounted for 
only 0.1 per cent of the global total. However, recent 
seizures in China (including Hong Kong), Indonesia, 
Japan and the Philippines indicate that traffickers have 
been targeting emerging markets in the region. South 
America is the primary source of cocaine seized in the 
region. In 2010, China seized a shipment of 2 tons  
of cocaine that was being transported by sea to provinces 
on its south-eastern coast. In September 2011, authorities 
in Hong Kong, China, seized over 560 kg of cocaine 
concealed in shipping containers, the largest cocaine 
seizure ever reported in Hong Kong. Part of the seized 
cocaine is believed to have been destined for the illicit 
market in mainland China. Indonesia reported seizures in 
2010 of cocaine originating in Colombia. The seized 
cocaine shipments had departed from Australia and the 
United States. In Japan, while cocaine abuse is not 
common, seizures of cocaine have slowly increased  
since 2006.  
567. In the Philippines, a record 342 kg of cocaine were 
seized in 2010, an increase of 32 per cent over 2009. In 
view of the country’s limited illicit market for cocaine, the 
Philippines may be at risk of becoming a transit country 
for cocaine consignments destined for other countries. 
 
 (b) Psychotropic substances 
 
568. The region of East and South-East Asia continues to 
be one of the main regions used for the illicit 
manufacture of methamphetamine. There are indications 
of large-scale methamphetamine manufacture in the  
so-called Golden Triangle. In 2010, China reported the 
seizure of 378 clandestine laboratories, the majority of 
which had been illicitly manufacturing 
methamphetamine and other synthetic drugs such as 
ketamine. In Indonesia, 13 clandestine drug laboratories 
were dismantled in 2010, some of which had been 
simultaneously manufacturing methamphetamine and 
other drugs, such as MDMA (“ecstasy”). In June 2010, 
authorities in Japan arrested two non-nationals on 
suspicion of illicitly manufacturing methamphetamine — 
the first such incident in Japan since 1995. Philippines 
also reported the seizure in 2010 of small clandestine 
laboratories illicitly manufacturing methamphetamine on 
a small scale.  
569. The amount of methamphetamine seized in East 
and South-East Asia increased significantly, from  
94 million tablets in 2009 to 133 million tablets in 2010. 
In China, a record 9.9 tons of methamphetamine were 
seized in 2010, a significant increase of 50 per cent 
compared with the amount seized in 2009. 
Methamphetamine originating in Myanmar constituted a 
significant portion of the total amount of 
methamphetamine seized. In Yunnan Province of China, 
which borders Myanmar, a record 4.3 tons of 
methamphetamine were seized in 2010, an increase of  
36 per cent compared with 2009. In Thailand, a record  
50 million methamphetamine tablets were seized in 2010, 
an increase of 88 per cent from 2009. Seizures of 
crystalline methamphetamine in Thailand tripled, from 
210 kg in 2009 to 680 kg in 2010, the largest amount 
reported since 1998. There are indications that large 
quantities of methamphetamine had been trafficked from 
Myanmar to China and Thailand. Along the porous 
northern and north-eastern borders of Thailand, many 
“drug shelters” were used by drug traffickers to store illicit 
drugs temporarily after they were smuggled into Thailand 
and before they were transported to other parts of the 
country. The Government of the Lao People’s Democratic 
Republic reported having seized a total of 24.5 million 
methamphetamine tablets in 2010, the largest amount 
ever reported in the country. 
570. Methamphetamine smuggling routes appear to  
have diversified. In Thailand, methamphetamine was 
smuggled into the country not only through the  
well-established northern routes, but also increasingly 
through the Lao People’s Democratic Republic, across the 
Mekong river. Additionally, the Lao People’s Democratic 
Republic was used as a transit country for smuggling 
methamphetamine from Myanmar into Cambodia, where 
the drugs then entered Thailand across the Thai-
Cambodian border. In addition to being smuggled within 
East and South-East Asia, methamphetamine from North 
America, West Africa and West Asia is increasingly being 
smuggled. Authorities in East and South-East Asia 
reported smuggling of methamphetamine by air 
passengers and in air cargo in large quantities. The Lao 
People’s Democratic Republic, Malaysia, the Republic of 
Korea, Singapore and Thailand have been used as transit 
countries for methamphetamine shipments destined for 
other countries in the region. Female drug couriers were 
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identified in several seizures in Japan, Malaysia, the 
Philippines and Thailand. 
571. In Indonesia, the amount of MDMA (“ecstasy”) 
seized has fluctuated in recent years, reaching a peak of 
over 1 million tablets in 2007 and 2008. Seizures 
decreased significantly, to 0.3 million tablets in 2009 but 
increased by 38 per cent, to 0.42 million tablets, in 2010. 
Domestic illicit manufacture continued to account for 
most of the “ecstasy” tablets seized in Indonesia. In 2010, 
15 “ecstasy” clandestine laboratories were destroyed in the 
country. In Malaysia, 110 kg of “ecstasy” were seized in 
2010. 
572. Another growing concern in East and South-East 
Asia relates to trafficking in benzodiazepines, owing to 
the growing demand for the use of these substances for 
non-medical purposes. In Malaysia, a total of 350 kg of 
benzodiazepine tablets were seized in 2010; most of the 
tablets had been smuggled out of India. Also in 2010, 
Thailand reported frequent seizures of diazepam and 
nimetazepam tablets smuggled in postal parcels or sold 
through illegally operating Internet pharmacies. In 2010 
and the first quarter of 2011, authorities in Hong Kong, 
China, seized about 220,000 benzodiazepine tablets, a 
portion of which had been concealed in a parcel sent 
from Taiwan Province of China. 
 
 (c) Precursors 
 
573. China continues to report significant seizures of 
precursor chemicals. In 2010, about 870 tons of 
precursors under national control were seized in China. 
In an operation in Sichuan Province, Chinese authorities 
dismantled four drug syndicates involved in the illicit 
manufacture of methamphetamine using pharmaceutical 
preparations containing ephedrine. During the operation, 
four clandestine laboratories were destroyed and 12 tons 
of pharmaceutical preparations containing ephedrine and 
58 kg of methamphetamine were seized.  
574. In response to stricter control over raw ephedrine 
and raw pseudoephedrine, traffickers have increasingly 
resorted to pharmaceutical preparations containing 
ephedrine and pseudoephedrine. In Myanmar, 
approximately 4.5 million tablets containing ephedrine 
and pseudoephedrine were seized in 2010. The majority 
of those precursors had been smuggled out of other 
countries, including China, India and Thailand. Large 
quantities of tablets containing pseudoephedrine were 
seized in Thailand, mainly along its border with 
Myanmar.  
 
 (d) Substances not under international control 
 
575. Large seizures of ketamine continued to  
be reported. In 2010, approximately 5 tons of ketamine 
were seized in China, accounting for most of the total 
seizures in East and South-East Asia. In an operation  
in 2010, Chinese authorities dismantled two clandestine 
laboratories for processing ketamine and seized over  
200 kg of ketamine.  
576. Traffickers continue to obtain and use precursors 
not under international control for the illicit manufacture 
of drugs. In 2010, China seized 49 tons of precursors not 
under international control. Since 2010, there have  
been significant seizures of phenylacetic acid esters, 
which are not under national control and can be easily 
transformed into phenylacetic acid for use in  
the manufacture of amphetamine-type stimulants. Most 
of the seized shipments had departed from China and 
had been destined for Mexico and countries in Central 
America. The Republic of Korea detected the use of 
benzyl cyanide in a clandestine laboratory manufacturing  
amphetamine-type stimulants; the laboratory was 
dismantled in 2010. 
 
 5. Abuse and treatment 
 
577. Cannabis abuse is reported by many countries in 
East and South-East Asia. It is the most commonly 
abused drug in Indonesia, mainly due to its easy 
availability, and the second most commonly abused drug 
in Brunei Darussalam, Japan and Thailand. The 
increasing abuse of cannabis among young people is of 
particular concern in Brunei Darussalam and Japan. 
578. The abuse of heroin has been declining in the 
region. However, it continues to be the most widely 
abused drug in China, Malaysia, Myanmar, Singapore and 
Viet Nam. In China, a 2010 national survey revealed  
that heroin was the primary drug of abuse for 69 per cent 
of all registered drug abusers in the country. In Viet Nam, 
heroin is the first drug of abuse among the  
149,900 registered drug abusers; about 83 per cent of drug 
addicts in the country abused heroin, and more than  
54 per cent of those who abused heroin were between  
30 and 45 years old. 
579. Methamphetamine remains the most common  
drug of abuse in several countries in the region, including 
Brunei Darussalam, Cambodia, Japan, the Lao  
People’s Democratic Republic, the Philippines, the 
Republic of Korea and Thailand. Growing abuse of 
methamphetamine, particularly among young people, is 
reported by China, Malaysia, Myanmar, Singapore and 
Viet Nam. In Brunei Darussalam, a 2010 school survey 
revealed that methamphetamine was the most common 
REPORT OF THE INTERNATIONAL NARCOTICS CONTROL BOARD  
 
78 
drug of abuse among students. In China, of a total  
1.5 million registered drug abusers in 2010, 28 per  
cent abused synthetic drugs, in particular crystalline 
methamphetamine; that percentage has been  
steadily increasing since 2007. In Japan, crystalline 
methamphetamine is the most common drug of abuse;  
in 2010, about 75 per cent of all drug-related offences 
involved methamphetamine abuse. In Myanmar, there 
has been a continued increase in the abuse of 
amphetamine-type stimulants, which is the third most 
commonly abused drug in the country. In Thailand, the 
growing abuse of crystalline methamphetamine has been 
a worrying trend, partly due to the increasing availability 
of the drug in the region. In 2010, approximately 88 per 
cent of all drug abusers who received treatment in 
Thailand were methamphetamine abusers.  
580. The abuse of benzodiazepines (such as alprazolam, 
estazolam, midazolam, nimetazepam) continues to be a 
concern in Brunei Darussalam; Hong Kong, China; 
Indonesia; Malaysia; and the Philippines. In Hong Kong, 
China, the abuse of these substances is particularly 
common among young heroin addicts, who wish to 
prolong the effect of heroin and ease withdrawal 
symptoms. In Indonesia, benzodiazepines are the third 
most commonly abused drug group. In Malaysia, 
benzodiazepines are becoming more popular among 
young drug abusers. The abuse of benzodiazepines, in 
particular nimetazepam, rank fifth among the most 
commonly abused drugs in Malaysia. 
581. The high prevalence of HIV among people who 
abuse drugs by injection is a serious concern in China, 
Myanmar, Thailand and Viet Nam. In China, 24 per cent 
of people infected with HIV were infected through drug 
abuse by injection. In Myanmar, the prevalence of HIV 
among people who abused drugs by injection was 
estimated at 36-38 per cent. In Thailand, the prevalence 
rate among that group stood at 48-52 per cent for the 
period 2008-2009.  
582. The abuse of ketamine is an ongoing problem in the 
region. Ketamine is the second most commonly abused 
drug in Hong Kong, China, and the third most commonly 
abused drug in mainland China. In Hong Kong, China, 
ketamine is the primary drug of abuse among young drug 
abusers under the age of 21: nearly 84 per cent of drug 
abusers of that age group abused ketamine in 2009. 
Indonesia, Malaysia, Myanmar and Viet Nam also 
reported abuse of ketamine, in particular among young 
people. 
583. In China, compulsory treatment centres, together 
with community-based treatment units, provided  
drug treatment and rehabilitation services to about  
360,000 drug abusers in 2010, a significant increase from 
2009. In Japan, as at June 2010, there were about 560 
health and mental health centres, which had provided an 
average of 11,000 drug-related consultations per year 
since 2007. In Myanmar, there are 66 drug treatment 
centres with a total daily bed capacity of 450. Between 
1999 and 2009, a total of 11,100 registered drug abusers in 
the country were treated, mostly for heroin and opium 
abuse. In recent years there have been an increasing 
number of admissions to the Yangon Mental Health 
Hospital for psychiatric problems related to abuse of 
amphetamine-type stimulants. In the Philippines, about 
70 per cent of drug abusers were treated for 
methamphetamine abuse in 2010. In Viet Nam, most 
drug treatment services are provided by the more than 
120 compulsory treatment centres throughout the 
country. In 2010, approximately 35,000 drug abusers 
received treatment in Viet Nam. 
584. Opioid substitution treatment (mainly methadone 
maintenance treatment) is available in many countries in 
the region, including Cambodia, China, Indonesia, 
Malaysia, Myanmar, Thailand and Viet Nam. Cambodia 
opened its first methadone maintenance treatment centre 
in 2010. In China, there are a total of 700 methadone 
maintenance treatment clinics and over 200 methadone 
dispensary services, which have provided treatment to 
over 290,000 drug abusers. Mobile methadone treatment 
vehicles have been put into service in remote areas. In 
Myanmar, eight methadone maintenance treatment sites 
have been established since 2006 and have provided 
treatment to over 1,100 heroin abusers. In Viet Nam, 
methadone maintenance treatment is expected to provide 
treatment to 80,000 heroin addicts by 2015. 
585. Limited drug treatment services and the shortage of 
qualified health-care professionals have greatly restricted 
the development of programmes for the prevention and 
treatment of drug abuse in many countries in the region. 
In particular, there seems to be a lack of specific 
treatment facilities for abusers of amphetamine-type 
stimulants, although the number of methamphetamine 
abusers is growing in several countries. 
586. Another challenge for countries in the region is the 
lack of monitoring and reporting of data on drug abuse 
among the general population, mainly due to limited 
resources and lack of expertise. Drug abuse surveys 
undertaken have often targeted specific populations, such 
as drug abusers that registered with authorities or entered 
treatment and rehabilitation services, thus leaving large 
sectors of the population unexamined. Although the 
amount and the quality of drug abuse information in the 
region have greatly improved in recent years, more 
research and analysis on trends in drug abuse are needed 
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to tailor prevention and treatment initiatives. The Board 
notes that UNODC has established the Drug Abuse 
Information Network for Asia and the Pacific in 
cooperation with ASEAN and China Cooperative 
Operations in Response to Dangerous Drugs and has 
received valuable drug-related data from participating 
countries. The Board encourages UNODC to continue to 
provide technical assistance in drug abuse data collection 
and analysis and encourages greater regional cooperation 
in that respect. 
 
 
  South Asia 
 
 
 1. Major developments 
 
587. South Asia is experiencing increasing problems 
related to the abuse of and trafficking in prescription 
drugs and over-the-counter pharmaceutical preparations 
containing narcotic drugs and psychotropic substances. 
Their low cost, high profit margin and easy availability, as 
well as the misperception that they are less harmful than 
illicitly manufactured drugs, are the main reasons for the 
increasing abuse and trafficking. Most of the prescription 
and over-the-counter drugs that are abused are obtained 
in local pharmacies. However, some of the drugs are 
smuggled, in particular out of India and into 
neighbouring countries. In addition, South Asia is a 
major source of most of the pharmaceutical preparations 
containing narcotic drugs and psychotropic substances 
that are sold throughout the world by illegally operating 
Internet pharmacies. Although all the countries of South 
Asia have a regulatory regime in place that includes 
prescription requirements for controlled pharmaceuticals, 
gaps still remain in the proper implementation and 
monitoring of compliance by pharmacies.  
588. The majority of the heroin found in South Asia has 
been smuggled out of Afghanistan, although a small 
amount has been illicitly manufactured locally. Most of 
the opium that is illicitly produced in the region is abused 
by inhalation or smoking. However, the abuse of drugs by 
injection is increasing in South Asia and has reached 
significant proportions in Bangladesh, India and Nepal. 
Drugs abused by injection in the region include heroin, 
prescription opioids and mixtures with other controlled 
substances. The abuse of drugs by injection has 
contributed to an increase in the HIV and hepatitis C 
infection rates. In response to that development, drug 
substitution treatment programmes have been introduced 
in Bangladesh, India, Maldives and Nepal, although they 
remain limited in scope. 
589. International drug trafficking organizations 
continue to use South Asia as a base for illicit 
manufacture of and trafficking in amphetamine-type 
stimulants, largely because of the wide availability of 
precursor chemicals in that region. Abuse of 
amphetamine-type stimulants in the region is also 
increasing, and that has caused a great deal of public 
concern. Illicit manufacture of all types of amphetamine-
type stimulants has been detected; the detected 
manufacturing sites have ranged from small-scale kitchen 
laboratories to large-scale manufacturing facilities. 
Bangladesh and India continue to be used by 
transnational organized criminal groups to divert 
precursors of amphetamine-type stimulants, because of 
the wide availability of the precursors ephedrine and 
pseudoephedrine in those countries. However, possibly as 
a result of existing national and international mechanisms 
for the control of legitimately manufactured precursors or 
because of increased demand, drug traffickers have begun 
to looking for additional supply channels. A more recent 
development is the extraction of ephedrine and 
pseudoephedrine from pharmaceutical preparations in 
clandestine laboratories. 
 
 2. Regional cooperation 
 
590. South Asian countries continue to participate in 
cooperative drug control activities organized by the 
Colombo Plan for Cooperative Economic and Social 
Development in Asia and the Pacific. In November 2010, 
the eleventh Training for Women Counsellors on 
Treatment and Rehabilitation took place in Chennai, 
India. A total of 27 female drug treatment practitioners 
from South-East Asia and South Asia attended the 
training, which covered topics ranging from 
detoxification methodology and addiction counselling to 
group therapy and ethical issues. In June 2011, the 
Colombo Plan, together with the Bureau of International 
Narcotics and Law Enforcement Affairs of the United 
States and UNODC, organized a South Asia regional 
training course for addiction treatment professionals on 
treatment and rehabilitation in Male. 
591. The Narcotics Control Bureau of India has entered 
into a bilateral agreement on mutual cooperation with  
the authorities in Bangladesh, with the aim of reducing 
illicit demand for and preventing trafficking in narcotic 
drugs, psychotropic substances and precursors. The  
two countries will cooperate and exchange information to 
suppress the activities of international criminal syndicates 
engaged in drug trafficking.  
592. Cooperation between India and Pakistan in  
drug-related matters continues. At a meeting held in  
March 2011 in New Delhi, the Home Minister of India 
and the Minister of the Interior of Pakistan agreed that, as 
part of their cooperation in combating drug trafficking, 
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the Narcotics Control Bureau of India and the Anti-
Narcotics Force of Pakistan would hold annual talks. A 
memorandum of understanding on the reduction of illicit 
drug demand and the prevention of trafficking in 
narcotic drugs, psychotropic substances and precursor 
chemicals was signed in Rawalpindi, Pakistan, by the 
Narcotics Control Bureau and the Anti-Narcotics Force in 
September 2011.  
593. India has established joint working groups on 
counter-terrorism with 26 partner countries, the Bay of 
Bengal Initiative for Multi-Sectoral Technical and 
Economic Cooperation, of which Bangladesh, Bhutan, 
Nepal and Sri Lanka are members, and the European 
Union; drug-related offences are one of the key issues 
discussed at the meetings of the working groups.  
594. The United Nations Regional Task Force on 
Injecting Drug Use and HIV/AIDS for Asia and  
the Pacific held a meeting on the abuse of drugs by 
injection and HIV/AIDS in New Delhi in February 2011. 
The topics covered included the regional strategy  
for harm reduction in Asia and the Pacific for  
the period 2010-2015 and the increasing abuse of 
pharmaceutical drugs in the region.  
595. The World Bank organized a regional workshop  
on opioid substitution therapy in Maldives in  
September 2011. The objective of the workshop was  
to identify the critical factors contributing to effective  
and sustainable opioid substitution therapy programmes 
and allowing for the scaling up of those programmes.  
 
 3. National legislation, policy and action 
 
596. In March 2011, the Demand Reduction Division of 
the Bhutan Narcotic Control Agency organized an 
awareness-raising programme for school principals and 
school counsellors in order to explain key aspects of  
the Narcotic Drugs, Psychotropic Substances and 
Substance Abuse Act of 2005; to educate them on the 
dangers of drug abuse, with the aim of incorporating a 
programme for drug abuse prevention in the school 
activities; and to enable them to facilitate the early 
detection of drug abuse and provide counselling services 
for students. A workshop for participants from treatment 
centres, drop-in centres and a hospital for the treatment 
and rehabilitation of drug abusers was held in Thimphu 
in May 2011.  
597. In Bangladesh, the authorities are conducting a 
campaign to raise public awareness about the dangers of 
abusing narcotic drugs. As part of the campaign,  
10,000 copies of materials on behavioural change, 
covering, among other subjects, drug abuse, have already 
been distributed in Bangladesh. The material is being 
distributed at national drop-in centres for educating 
female drug abusers and female sexual partners of male 
drug abusers. Bangladesh has also started to use mobile 
courts to try drug-related cases.  
598. The Narcotics Control Bureau of India carries out 
capacity-building for drug law enforcement authorities in 
various government agencies at the state and national 
levels. The subjects covered include investigative 
techniques, financial investigations and precursor control. 
In 2010, the Bureau organized 54 such training courses, 
which were attended by 2,311 persons from various 
agencies, including state police forces, the Central Board 
of Excise and Customs and the Border Security Force.  
599. The Department of Revenue of the Ministry of 
Finance of India has been developing a national policy on 
narcotic drugs and psychotropic substances, in 
consultation with other relevant ministries and 
Government agencies and state governments. The policy 
will set out a strategy for tackling the illicit drug trade and 
will provide guidance to the various Government bodies 
and non-governmental organizations. The Ministry of 
Social Justice and Empowerment of India is also 
developing a national policy on the reduction of illicit 
drug demand.  
600. In February 2011, a notification from the 
Government of India resulted in ketamine being added to 
the list of psychotropic substances controlled under the 
Narcotic Drugs and Psychotropic Substances Act, 1985.  
601. In October and November 2010, the Department of 
Drug Prevention and Rehabilitation Services of Maldives, 
UNODC and non-governmental organizations held a 
workshop in Male that provided training on,  
inter alia, understanding, preventing and treating drug 
abuse. Furthermore, the Department’s Methadone 
Maintenance Treatment Clinic and UNODC organized a 
training programme on methadone maintenance 
treatment in Male at the end of November 2010. The 
Department, with support from UNODC, organized 
training programmes on outpatient treatment for  
non-governmental and community-based organizations 
at various locations throughout the country in June and 
October 2010.  
602. The Government of Maldives recently launched the 
country’s first national drug abuse survey; a national 
research organization will carry out the survey in 
partnership with the Ministry of Health and Family.  
603. The Drug Control Law Enforcement Unit of the 
Ministry of Home Affairs of Nepal, in association with 
UNODC, held a national narcotic control orientation 
programme in Kathmandu in June 2011. The programme 
 CHAPTER III. ANALYSIS OF THE WORLD SITUATION
 
81 
was designed to provide drug law enforcement personnel 
with the knowledge and skills needed to identify 
controlled drugs and to use investigative techniques, as 
well as with information on legal issues pertaining to 
drug law enforcement.  
604. The National Dangerous Drugs Control Board of 
Sri Lanka is implementing a series of programmes on 
drug abuse prevention that includes the use of local 
administrators to raise the awareness of all sectors of 
society about the problems associated with drug abuse. It 
has also expanded its counselling and outreach 
programmes for drug abusers. The outreach programme 
is designed to provide treatment services for drug abusers 
and members of high-risk groups. Among other things, 
outreach officers encourage drug abusers to seek 
treatment; outreach officers also gather information on 
drug abuse and conduct activities aimed at raising 
awareness of and preventing drug abuse. In 2010,  
Sri Lanka established the Precursor Control Authority, 
which regulates, monitors and issues licences for 
international trade in and use of precursors.  
605. With the support of international agencies such as 
WHO and UNODC, the Governments of countries in 
South Asia are taking steps to strengthen capacity in the 
area of illicit drug demand reduction. In addition to 
preventing drug abuse and raising awareness about the 
dangers of drug abuse, Governments of South Asian 
countries have provided training courses on illicit drug 
demand reduction for a range of professionals working in 
the areas of prevention and treatment of drug abuse. 
 
 4. Cultivation, production, manufacture and 
trafficking 
 
 (a) Narcotic drugs 
 
606. The illicit cultivation of cannabis plants is 
widespread in South Asia. In India, 681 ha of cannabis 
plants were eradicated in 2010, and 95 ha were eradicated 
in the first half of 2011. In Sri Lanka, the authorities have 
estimated that about 500 ha of land are used for illicit 
cannabis cultivation. India reported having seized a total 
of 173 tons of cannabis herb in 2010. The authorities of 
countries that have significant illicit markets for cannabis 
resin have identified Nepal as one of the major sources of 
the cannabis resin found on those illicit markets. Illicit 
consignments of cannabis resin from Nepal are 
transported overland to India and China and then by 
cargo couriers from India to Bangladesh and then to 
Europe and North America. According to estimates by 
the Indian authorities, half of the cannabis resin in India 
in 2009 originated in that country, and the other half had 
been smuggled out of Nepal. Significant quantities of 
cannabis resin continue to be seized in India. In 2010, 
India reported having seized a total of 4.3 tons of 
cannabis resin; for the first half of 2011, 2.66 tons were 
reported to have been seized in that country.  
607. In Bangladesh, the total amount of seized cannabis 
increased from about 2.1 tons to about 3.7 tons between 
2009 and 2010. In Sri Lanka, cannabis accounts for the 
majority of drug-related arrests. In 2010, Sri Lankan 
authorities seized 114 tons of cannabis plants and 23 kg of 
cannabis resin.  
608. Heroin originating in Afghanistan is smuggled 
through Pakistan into South Asian countries. According 
to UNODC, of the 40 tons of heroin available in South 
Asia in 2009, 25 tons had been smuggled out of 
Afghanistan, and the remaining 15 tons had been illicitly 
manufactured in India; moreover, nearly two thirds of 
those 40 tons of heroin were abused in the region, and the 
remainder was smuggled into Africa, Europe, East and 
South-East Asia and North America. Drug traffickers in 
South Asia prefer to traffic Afghan heroin, due to its 
higher purity level, rather than heroin illicitly 
manufactured in South Asia.  
609. Illicit cultivation of opium poppy takes place in 
several parts of India. Virtually all of the opium abused in 
India has been illicitly produced in that country. In India, 
the total area under illicit opium poppy cultivation is 
estimated to be at least 7,500 ha. In 2010, a total of  
1,022 ha of illicitly cultivated opium poppy were 
eradicated by Indian authorities. According to UNODC, 
there is some diversion from licit opium production. 
India reported having seized a total of 1.83 tons of opium, 
25 kg of morphine and 766 kg of heroin in 2010; for the 
first half of 2011, 871 kg of opium, 26 kg of morphine and 
230 kg of heroin were reported to have been seized.  
610. In 2009, almost all of the heroin in Bangladesh and 
the vast majority of the heroin in Nepal originated in 
India; in Sri Lanka, some of the heroin originated in 
Afghanistan and some originated in India. In Bangladesh, 
148 kg of heroin were seized in 2010, an increase of 9 per 
cent compared with 2009. In Sri Lanka, it is estimated 
that, during the period 2005-2009, an average of 763 kg  
of heroin were available on the street each year. In  
Sri Lanka, 143 kg of heroin were seized in 2010, an 
increase of 76 per cent compared with 2009. Most of the 
heroin in Sri Lanka has entered that country from India 
or Pakistan and has been smuggled via south India to the 
western coast of Sri Lanka aboard fishing boats. Illicit 
heroin consignments are also transported from Sri Lanka 
to Maldives.  
6.11 Cocaine trafficking remains limited in South Asia. 
In India, cocaine is trafficked in small quantities by 
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courier; Indian authorities reported having seized a total 
of 23 kg of cocaine in 2010 and 3 kg in the first half of 
2011. Sri Lankan authorities seized a total of 4 kg of 
cocaine in 2010.  
612. In South Asia, trafficking in pharmaceutical 
preparations containing narcotic drugs is on  
the rise. Pharmaceutical preparations containing 
dextropropoxyphene and cough formulations containing 
codeine are smuggled out of India and into neighbouring 
countries, mainly Bangladesh, Bhutan and Nepal. The 
Board requests the Governments of countries in  
South Asia to cooperate in order to prevent the smuggling 
of pharmaceutical preparations. 
 
 (b) Psychotropic substances 
 
613. Illicit manufacture of amphetamine-type stimulants 
has been reported in Bangladesh, India and Sri Lanka. 
Those illicitly manufactured amphetamine-type 
stimulants are, at least in part, trafficked to destinations 
outside of South Asia; for example, crystalline 
methamphetamine (commonly called “ice”) illicitly 
manufactured in the region is trafficked to East and 
South-East Asia and Oceania. Countries in South Asia 
regularly report seizures of amphetamine, 
methamphetamine and MDMA (“ecstasy”). South Asia is 
also used as a transit area for transporting illicit 
consignments of amphetamine-type stimulants from 
South-East Asia to other destinations. Methamphetamine 
tablets originating in Myanmar are increasingly being 
smuggled into Bangladesh, India and Nepal; almost all of 
the methamphetamine available on the illicit market in 
Sri Lanka has been smuggled into the country by air. In 
Bangladesh, seizures of tablets known as “yaba”, 
containing methamphetamine and caffeine, increased  
in 2010.  
614. In India, most of the amphetamine and 
methamphetamine available on the illicit market in tablet 
form has been smuggled into the country. By contrast, 
most of the amphetamine and methamphetamine 
available on the illicit market in powder form has been 
illicitly manufactured in the country. Two laboratories 
that had been illicitly manufacturing amphetamine-type 
stimulants were dismantled in Mumbai in August 2010. 
East and South-East Asia, Europe and North America 
have all been cited as the final destinations of the illicitly 
manufactured amphetamine-type stimulants that are 
smuggled out of India. Courier and postal services have 
been used for smuggling amphetamines.  
615. In India, a total of 47 kg of amphetamine were 
seized in 2010; and 4 kg were seized in the first half  
of 2011. Most of the seizures of amphetamine and 
methamphetamine tablets in India are effected in the 
north-eastern part of the country, in the area bordering 
Myanmar. Most of the seizures of MDMA (“ecstasy”) in 
India are reported in Goa, a popular tourist destination in 
the south-western part of the country.  
616. Pharmaceutical preparations containing 
benzodiazepines such as diazepam, alprazolam and 
lorazepam, as well as buprenorphine, are abused in and 
smuggled out of India into neighbouring countries, in 
particular Nepal, and into the United States and countries 
in Europe. Alprazolam and diazepam are also used as 
adulterants and cutting agents in the illicit manufacture 
of heroin in India. The authorities in India reported 
having seized a total of 20 kg of illicitly manufactured 
methaqualone in 2010 and 14 kg in the first half of 2011. 
Bangladesh reported an increase in the amount of 
buprenorphine seized, from about 19,000 ampoules in 
2009 to about 23,000 in 2010.  
 
 (c) Precursors 
 
617. The fact that India is one of the world’s largest 
manufacturers of ephedrine and pseudoephedrine and 
the chemical and pharmaceutical industries in other 
countries in South Asia are growing has resulted in the 
region being targeted for diversion by traffickers, 
although the number and volume of reported cases 
involving diversion of precursors are now smaller than in 
the past. India continues to be among the countries most 
often cited as a source of seized illicit shipments of 
ephedrine and pseudoephedrine. Pharmaceutical 
preparations containing ephedrine and pseudoephedrine 
originating in India and Bangladesh continue to be seized 
in, for example, Central America, although the volume of 
such seizures has decreased.  
618. India seized 1.85 tons of ephedrine, 0.36 ton of 
pseudoephedrine and 81 litres of acetic anhydride in 
2010; in the first half of 2011 it seized 402 kg of 
ephedrine. India has also reported the illicit manufacture 
of ephedrine: in October 2010, 93 kg of ephedrine were 
seized when an illegal factory in the state of Maharashtra 
was raided, and 238 kg of ephedrine were seized in a raid 
at an illegal factory in the state of Gujarat.  
619. In Nepal, the pharmaceutical industry is developing 
fast and the absence of legislative controls on precursor 
chemicals may be exploited by traffickers. Precursors of 
amphetamine-type stimulants have also been smuggled 
out of China into Nepal. The Board urges Governments 
of countries in South Asia to remain vigilant in their 
efforts to prevent the diversion of precursor chemicals 
and to ensure that regulatory capacity keeps pace with 
developments in industry.  
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 (d) Substances not under international control 
 
620. There has been an increase in the smuggling of 
ketamine, a substance not under international control, 
out of India and into countries in East and South-East 
Asia and North America. Licit manufacture of ketamine 
takes place in India and some ketamine is diverted from 
licit manufacture and trade into illicit channels;  
large-scale unlicensed manufacture is also taking place in 
the country. Ketamine is used as an adulterant in the 
illicit manufacture of MDMA (“ecstasy”) in East and 
South-East Asia and as an ingredient in tablets sold as 
“ecstasy” in East and South-East Asia. In response to 
those developments, India placed ketamine under 
national control as a psychotropic substance in  
February 2011.  
621. Authorities in India have seized ketamine 
uncovered at airports, during domestic transportation 
and sea cargo and parcels sent by courier. A single seizure 
of 5 kg of ketamine was made in Maldives in 2009. 
Ketamine is popular among drug traffickers because 
ketamine trafficking has a high profit margin and, until 
recently, ketamine could be transported freely within 
India, as there were no domestic controls over the 
substance.  
 
 5. Abuse and treatment 
 
622. The drug that is abused most often in South Asian 
countries is cannabis — usually in the form of cannabis 
herb and, to a lesser extent, cannabis resin. Recent data 
on the prevalence of cannabis abuse are available only for 
Bangladesh (3.3 per cent of the population aged 15-64) 
and Sri Lanka (1 per cent).  
623. Data on the prevalence of opioid abuse are currently 
available only for Bangladesh (0.4 per cent of the 
population aged 15-64) and Sri Lanka (0.1 per cent), 
although opioid abuse has also been reported in Bhutan, 
India and Nepal. The smoking of opium continues to be a 
traditional practice in India, a country in which the level 
of opium abuse is one of the highest in Asia. “Chasing” 
(inhaling the vaporized form) and smoking are the most 
popular routes of administration among drug abusers in 
South Asia, although some have switched to abusing 
drugs by injection and that practice is spreading rapidly. 
Drug abuse by injection has reached significant levels in 
Bangladesh, India (estimated at 0.02 per cent of the 
population) and Nepal (estimated at 0.01 per cent of the 
population); heroin and buprenorphine are commonly 
abused by injection in those countries. Other drugs of 
choice that are abused by injection in South Asia are 
either other opioids or a combination of buprenorphine 
and antihistamines or sedatives, mostly benzodiazepines. 
In Bhutan, Maldives and Sri Lanka, only a very limited 
number of cases of drug abuse by injection have been 
recorded. In Sri Lanka, it is estimated that only 2 per cent 
of the heroin-abusing population abuse that drug by 
injection. Drug abuse by injection is increasing in 
Maldives. The Board notes the plans of the Government 
of India to conduct a new national drug abuse survey and 
encourages the Government to carry out the survey as 
soon as possible. 
624. In India, the most abused pharmaceutical 
preparations are cough formulations containing codeine 
and various benzodiazepines, including diazepam, 
alprazolam, nitrazepam and lorazepam, and analgesics, 
including buprenorphine and dextropropoxyphene. The 
abuse of pharmaceutical preparations in India is 
facilitated by the failure of many pharmacies to comply 
with prescription requirements. In addition, some of the 
preparations abused in India are preparations in  
Schedule III of the 1961 Convention, for which a 
prescription is not mandatory. The Board urges the 
Government of India to strengthen measures to ensure 
that pharmacies comply with prescription requirements 
and ensure that over-the-counter pharmaceutical 
preparations are not diverted to be used for non-medical 
purposes. Dextropropoxyphene is abused to a significant 
extent in Nepal and to a much lesser extent in 
Bangladesh, Bhutan and Sri Lanka. In Bangladesh, the 
abuse of phensedyl (codeine-based cough syrup) 
continues.  
625.  “Yaba”, a methamphetamine tablet that also 
contains caffeine, is the synthetic drug most commonly 
abused in Bangladesh; its abuse has reportedly become 
widespread in urban areas of the country, particularly in 
Dhaka. The growing abuse of amphetamine-type 
stimulants has also been reported in metropolitan areas 
of India. There has been some increase in the abuse of 
amphetamine-type stimulants in Sri Lanka.  
626. Cocaine abuse in South Asia is still limited and 
mostly reported to occur among members of the more 
affluent segments of society. Polydrug abuse is common 
among drug abusers in most countries in the region.  
627. The Ministry of Health and Family Welfare of India 
runs, through its hospitals, 122 detoxification centres for 
drug abusers. India currently has 376 detoxification and 
rehabilitation centres and 68 counselling centres for drug 
abusers, which are run by voluntary organizations funded 
by the Ministry of Social Justice and Empowerment. The 
Government supports a further 100 counselling centres at 
its primary health centres and hospitals for drug abusers 
who require long-term rehabilitation. Buprenorphine 
maintenance treatment is available to about 4,800 patients 
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in India. India is currently conducting a feasibility study 
on methadone maintenance treatment. As part of the 
study, such treatment will be provided to 500 drug 
abusers.  
628. In June 2011, the Ministry of Health and Family of 
Maldives launched a toll-free national helpline for drug 
abusers and their families and communities. The 
Maldives Department of Drug Prevention and 
Rehabilitation Services, in collaboration with UNODC, 
opened the first rehabilitation centre for female drug 
abusers in the country. The centre provides both 
outpatient and inpatient treatment services for drug 
abuse.  
629. The National Dangerous Drugs Control Board of 
Sri Lanka operates four residential treatment centres and 
outreach programmes for drug-dependent persons, 
providing services for 80 per cent of those receiving 
treatment for drug addiction in the country. Treatment at 
the centres consists of a residential stay of three months, 
which includes activities consistent with a drug-free 
lifestyle.  
630. Treatment for drug abuse is generally not provided 
in prisons in South Asia. One exception is a prison in 
Tihar, India, where opioid substitution therapy is 
provided.  
 
 
  West Asia 
 
 
 1. Major developments 
 
631. West Asia remains the epicentre of illicit opium 
poppy cultivation; it is also a significant hub for cannabis 
cultivation. In 2010, 125,000 ha of opium poppy were 
cultivated in West Asia, which accounted for nearly  
two thirds of global opium poppy cultivation. Nearly all 
of the opium poppy cultivation in the region occurs in 
Afghanistan, with a small amount taking place in the 
bordering areas of Pakistan. In Afghanistan, opium 
poppy cultivation increased somewhat in 2011 over 2010; 
however, opium production increased by more than  
60 per cent during the same period, as the 2010 yields had 
been affected by an opium poppy disease. Large increases 
in opium prices, combined with planned decreases in the 
International Security Assistance Force (ISAF), could lead 
to increases in both the cultivation of opium poppy and 
the production of opium beyond 2011, in particular as 
opium poppy yields return to normal levels.  
632. According to the second survey of cannabis 
cultivation, conducted jointly by UNODC and the 
Ministry of Counter-Narcotics of Afghanistan, 
Afghanistan: Cannabis Survey 2010, the number of 
households cultivating cannabis plants increased by 
nearly one fifth in 2010 in relation to 2009. The results of 
the survey indicate that Afghanistan most likely produces 
more cannabis resin (“hashish”) than any other country 
in the world, with more than half of the country’s 
provinces producing cannabis. Lebanon has become an 
important source of cannabis resin. According to 
UNODC, Lebanon was the world’s third largest source of 
cannabis resin during the period 2007-2009. 
633. The prolonged political instability and the 
escalating security concerns that prevail in parts of West 
Asia could indirectly contribute to a worsening of the 
drug trafficking situation in the countries concerned, 
resulting in less vigilance and awareness of illegal 
activities. Criminal organizations are quick to take 
advantage of such situations, intensifying illegal activities 
of all kinds, including drug trafficking.  
634. There are indications of increased trafficking in 
various types of stimulants in West Asia. Trafficking in 
cocaine has been reported throughout the region. The 
total amount of seized cocaine quadrupled to 289 kg 
between 2000 and 2009. Several countries in the region 
reported large seizures of cocaine in 2010 and in the first 
quarter of 2011. Authorities identified new routes used 
for smuggling methamphetamine consignments through 
West Asia; those consignments were destined primarily 
for East Asia. The Islamic Republic of Iran reported a 
sharp increase in the number of illicit methamphetamine 
laboratories dismantled in 2010. Countries in the Middle 
East, in particular Jordan and Saudi Arabia, continue to 
be affected by large-scale amphetamine trafficking; 
sizeable seizures of amphetamine tablets sold as Captagon 
tablets continue to be reported. In Saudi Arabia, which 
remains the main country of destination for Captagon 
tablets, clandestine manufacture of Captagon tablets has 
been detected for the first time. 
635. The non-medical use of prescription drugs 
containing internationally controlled substances is a 
growing problem reported in many countries in the 
Middle East. Prescription drugs containing psychotropic 
substances, including sedatives such as diazepam and 
alprazolam, are being diverted from licit distribution 
channels in those countries.  
 
 2. Regional cooperation  
 
636. The annual ministerial meeting of the UNODC-
facilitated Triangular Initiative, held in Islamabad in 
November 2010, brought together ministers from 
Afghanistan, Iran (Islamic Republic of) and Pakistan to 
strengthen cooperation in addressing drug trafficking. 
The participants committed themselves to expanding the 
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sharing of information on drug trafficking via the joint 
planning cell in Tehran; organizing additional joint 
operations along border areas; enhancing legal 
cooperation in drug-related matters; and the establishing 
of fully operational border liaison offices to increase law 
enforcement cooperation. In February 2011, the first 
inter-agency border liaison office aimed at curbing the 
flow of illicit drugs was opened at the Khyber Pass border 
between Afghanistan and Pakistan. 
637. As part of the Triangular Initiative, the 
Governments of Afghanistan, Iran (Islamic Republic of) 
and Pakistan held the sixth meeting of senior officials in 
Tehran in May 2011. The goal of the meeting was to 
review the progress made in implementing the 
recommendations and actions agreed upon at the 
ministerial meeting held in November 2010, to discuss 
joint operations and the establishment of various border 
liaison offices and to present a comprehensive  
cross-border communication plan to participants. Since 
2009, 10 joint or simultaneous drug control operations 
have been conducted under the auspices of the Triangular 
Initiative, resulting in the seizure of 6 tons of drugs. 
638. Drug control and crime prevention are part of the 
agenda of the Cooperation Council for the Arab States of 
the Gulf (also known as the Gulf Cooperation Council), 
whose member States have developed common strategies 
to curb drug trafficking and have stepped up their efforts 
in that area. Country representatives meet annually to 
coordinate and strengthen their efforts to combat various 
forms of organized crime, including drug trafficking. In 
particular, representatives of the drug control 
departments of the member States of the Gulf 
Cooperation Council gather to share intelligence they 
have compiled. 
639. The twenty-first joint council and ministerial 
meeting of the European Union and the Gulf 
Cooperation Council was held in Abu Dhabi in  
April 2011. During the meeting, ministers underlined the 
importance of strengthening cooperation in various areas, 
including in drug control, in order to contribute to 
security and stability in the Middle East.  
640. During a meeting of the Board of Directors of the 
Gulf Cooperation Council’s Criminal Information Centre 
to Combat Drugs, held in Doha in June 2011, discussions 
focused on drug trafficking and cooperation among the 
member States of the Gulf Cooperation Council in 
combating drug-related problems. In particular, 
participants stressed the need to strengthen the collection 
of information, the exchange of law enforcement 
information, and the storage, analysis and sharing of such 
information between members, which all assist 
considerably in the criminal investigation of drug-related 
cases. In that context, the establishment of an information 
technology platform for member States of the Gulf 
Cooperation Council, with the support of UNODC, was 
considered a positive step towards enhanced cooperation. 
641. UNODC also intends to establish cooperation 
between the Gulf Cooperation Council and other regional 
organizations, such as the Central Asian Regional 
Information and Coordination Centre (CARICC), the 
joint planning cell (Afghanistan, Iran (Islamic Republic 
of) and Pakistan) and the Paris Pact initiative, in order to 
prevent organized crime and drug trafficking in  
West Asia. 
642. As part of its activities aimed at combating 
trafficking in narcotic drugs, psychotropic substances and 
their precursors, CARICC held the third session if its 
Council of National Coordinators in Bishkek in  
March 2011. The member States of CARICC — 
Azerbaijan, Kazakhstan, Kyrgyzstan, the Russian 
Federation, Tajikistan, Turkmenistan and Uzbekistan — 
coordinate their fight against drug trafficking at the 
national and regional levels. The Council adopted 
decisions on enhancing operational cooperation among 
the competent authorities of CARICC member States in 
combating drug-related crime, focusing on transnational 
criminal groups active in running the illicit supply chains 
for Afghan opiates through CARICC member States. As a 
result of those decisions, a number of international 
operations, including controlled delivery operations, were 
coordinated by CARICC. In addition to CARICC 
member States, authorities from many other countries, in 
the Americas, Asia and Europe participated in the 
operations. 
643. In May 2011, an agreement was signed by the 
ministers of the interior of Bahrain and the United Arab 
Emirates to promote security cooperation between the 
two countries in many areas, including drug control.  
644. Under the auspices of the Paris Pact initiative, an 
expert group on addressing legal frameworks and  
cross-border cooperation held a meeting in Islamabad in 
June 2011. The meeting was attended by 71 experts 
representing 23 Governments and five regional and 
international organizations. The objective of the meeting 
was to identify existing legal and operational gaps and to 
support cross-border controlled deliveries and joint 
operations at the regional level. The experts noted that 
there was no legal framework in place for the use of 
special investigative techniques, including controlled 
delivery; that technical working groups needed to prepare 
standard operating procedures; and that there was a need 
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to establish secure communication links to ensure real-
time sharing of information.  
645. The UNODC regional programme on drug control, 
crime prevention and criminal justice reform for the Arab 
States (covering the period 2011-2015) was launched in 
December 2010. Partnerships essential to successful 
implementation of programmes have been created 
between UNODC and various regional organizations 
such as the League of Arab States and the Gulf 
Cooperation Council. Within the framework of the 
programme, steps are being taken to address the needs of 
States in terms of security and development. In that 
context, UNODC was specifically requested to develop an 
integrated cooperation programme for the Occupied 
Palestinian Territory and Yemen.  
646. The International Drug Policy Consortium and the 
National Rehabilitation Centre of Abu Dhabi organized a 
seminar on drug control policy in the Middle East and 
North Africa in January 2011. Participants — including 
non-governmental organizations, academics and 
government representatives from Afghanistan, Egypt, 
Lebanon, Pakistan, Saudi Arabia, Tunisia, the United 
Arab Emirates and Yemen, together with a representative 
of the Palestinian Authority — exchanged views on drug 
control policy challenges facing the region.  
647. UNODC and the Organization for Security and 
Cooperation in Europe hosted the Second Regional 
Workshop on International Cooperation in Criminal 
Matters, in Almaty in July 2011. The Workshop was 
attended by representatives of Afghanistan, Australia, 
Iran (Islamic Republic of), Kazakhstan, Kyrgyzstan, the 
Netherlands, Pakistan, the Russian Federation, Tajikistan 
and Uzbekistan, and facilitated capacity-building of 
national criminal justice systems to improve national and 
international legal cooperation and information exchange 
between law enforcement agencies in countries in West 
Asia and Central Asia. The workshop also provided 
further capacity-building and technical assistance on 
extradition, mutual legal assistance, measures to prevent 
money-laundering, and the locating, tracing, freezing and 
seizing of the proceeds of crime.  
648. The quadrilateral meeting of the Presidents of 
Afghanistan, Pakistan, the Russian Federation and 
Tajikistan was held in Dushanbe in September 2011. At 
this, the third in a series of meetings, the Heads of State 
discussed issues and cooperation in areas such as security, 
and combating drug trafficking and transnational 
organized crime. The Presidents agreed to cooperate with 
each other in the fight against the illicit production, 
smuggling and abuse of drugs and to prevent traffickers 
from using Afghanistan as a transit country and country 
of destination for precursors. A commitment was made to 
expand cooperation to include other regional and 
international organizations, including the United Nations, 
the Organization of Islamic Cooperation and the 
Shanghai Cooperation Organization. 
 
 3. National legislation, policy and action  
 
649. In 2010, the Government of Afghanistan amended 
article 41 of the Counter-Narcotics Law criminalizing the 
use of land for illicit drug crop cultivation. Under the new 
law, any person guilty of cultivating one acre (0.405 ha) of 
opium poppy could face up to three months’ 
imprisonment, while the cultivation of one acre of 
cannabis plants could result in up to two months’ 
imprisonment. Cultivating larger areas of drug crops 
could result in longer sentences. In addition, anyone who 
organizes, encourages or compels another person to 
illicitly cultivate opium poppy and/or cannabis plant 
could receive prison sentences that are twice as long as 
those outlined above. 
650. Lebanon is in the process of drafting a new national 
HIV/AIDS strategy that will include the provision of 
comprehensive harm reduction services for drug addicts. 
The strategy will focus on the population groups that are 
most at risk, including prisoners and those abusing drugs 
by injection, and will facilitate access to services, in 
addition to fighting stigma and discrimination. 
651. A workshop aimed at developing an integrated 
cooperation programme on drug control, crime 
prevention and criminal justice reform (covering the 
period 2011-2015) for the Occupied Palestinian Territory 
was organized by the Palestinian Authority and UNODC 
in January 2011.  
652. Non-medical use of prescription drugs containing 
internationally controlled substances is a growing 
problem, and some measures have been taken to address 
it. The Board notes with satisfaction the preparation by 
the health authorities of the Occupied Palestinian 
Territory of a protocol that will deal in particular with 
narcotic drugs and psychotropic substances.  
653. Representatives of UNODC and the Government of 
the Islamic Republic of Iran met in Tehran to develop, in 
consultation with members of the Mini-Dublin Group 
and the Presidency of the European Union, a multilateral 
programme of technical cooperation in drug and crime 
control for the period 2011-2014. In addition, UNODC 
launched a new country programme in March 2011 to 
support national efforts to counter problems related to 
drugs and crime by promoting United Nations standards 
and international best practices and by facilitating 
bilateral, regional and international cooperation. The 
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programme focuses on three areas: trafficking and border 
management; drug demand reduction and HIV control; 
and crime, justice and corruption. 
 
 4. Cultivation, production, manufacture and 
trafficking  
 
 (a) Narcotic drugs  
 
654. Seizures reported in West Asia increased greatly for 
most classes of controlled drugs between 2000 and 2009. 
During that period, the amount of opium seized more 
than tripled, from 199 to 645 tons; seizures of heroin 
more than doubled, from 23 to 50 tons; seizures of 
cannabis resin increased from 170 to 311 tons; and 
seizures of cocaine quadrupled (albeit at a much lower 
level) from 68 to 289 kg.  
655. According to UNODC, there were 131,000 ha of 
illicitly cultivated opium poppy in Afghanistan in 2011, 
an increase of 7 per cent over 2010. Afghanistan alone 
accounted for nearly two thirds of global opium poppy 
cultivation. In 2011, only 17 of the country’s 34 provinces 
were poppy-free,27 compared with 20 in 2010. The 
decrease in the number of opium-free provinces was the 
result of increased opium poppy cultivation in Baghlan 
and Faryab provinces, in the north, and Kapisa province, 
in the east. In some provinces, the increase in opium 
poppy cultivation was related to the deteriorating security 
situation. 
656. An estimated 5,800 tons of opium were produced in 
2011, significantly more than in 2010 (3,600 tons). In 
2010, opium production reached only half the level of 
2009 due to significantly lower crop yields: opium poppy 
capsules were fewer in number and smaller because of a 
combination of an opium poppy disease and poor 
weather. 
657. After many years of decreasing, the price of opium 
increased sharply in 2010, continuing through mid-2011, 
and that made the cultivation of opium poppy more 
attractive to farmers. In mid-2011, the farm-gate price of 
dry opium28 increased to $241 per kilogram, an increase 
of 43 per cent over 2010. This is the highest price per 
kilogram since 2004. However, gross income from opium 
poppy cultivation more than doubled between 2010 and 
2011, increasing from $4,900 to $10,700 per hectare. 
Nearly 60 per cent of the farmers surveyed in 2011 cited 
__________________ 
 27  “Poppy-free provinces” are provinces in which the total area 
under opium poppy cultivation is less than 100 ha. 
 28  Average farm-gate price weighted by the production of dry 
opium at harvest time, whereby “harvest time” represents 
differing periods in mid-2011 depending on the region, 
typically occurring from May to July. 
the high price of opium as the main reason for growing 
opium poppy. It was also noted that villages that had not 
received agricultural assistance from the government in 
2011 were more likely to grow opium poppy than villages 
that had received such assistance. 
658. Security conditions in Afghanistan continued to be 
linked to illicit cultivation of opium poppy, in particular 
in the southern and western provinces of Afghanistan. 
According to UNODC, most villages with poor security 
were involved in such cultivation. The number of security 
incidents in Afghanistan has increased every year since 
2003; most of the incidents have occurred in the southern 
and south-western provinces. Planned decreases in ISAF 
in 2011 could affect security in parts of the country and, 
combined with opium price increases, could result in 
increased opium production beyond 2011. The Board 
calls upon the international community to continue to 
assist, in a coordinated manner, the Government of 
Afghanistan in its drug control efforts. 
659. The second survey of cannabis cultivation in 
Afghanistan, conducted jointly by the Ministry of 
Counter-Narcotics and UNODC, was released in  
June 2011. The survey found that the number of 
households cultivating cannabis plants had increased by 
18 per cent in 2010 from 2009. The results of the survey 
suggest that it is likely that Afghanistan produced more 
cannabis resin than any other country, with yields 
estimated at 127 kg per hectare, significantly higher than 
the yields of other large producers of cannabis resin such 
as Morocco (40 kg per hectare). Although overall 
cannabis production levels had remained unchanged 
since 2009, the number of provinces producing cannabis 
increased from 17 to 19 in 2010, or more than half of the 
country’s 34 provinces. Farm-gate prices of cannabis 
increased dramatically in 2010, regardless of the grade of 
the product. In 2010, farmers’ gross income from 
cannabis cultivation was estimated at $9,000 per hectare, 
resulting in a comparably lucrative product when 
compared with opium poppy ($10,700 per hectare) or 
alternative crops such as wheat ($770 per hectare). Most 
cannabis is cultivated in the insecure southern part of the 
country, where most opium is also produced. 
660. According to the report on the eradication of 
illicitly cultivated crops, issued jointly by the Ministry of 
Counter-Narcotics and UNODC, by mid-2011 more than 
3,810 ha of opium poppy had been eradicated in 
Afghanistan, a significant increase over the figure for the 
first half of 2010. Increased eradication efforts were noted 
in the southern provinces of Helmand and Kandahar. In 
2010, only 2,316 ha of illicitly cultivated opium poppy 
were eradicated, the lowest level in five years. In 2010, in 
contrast with previous years, no illicit crop eradication 
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campaigns were carried out in Afghanistan by national 
authorities; such eradication efforts were initiated only by 
provincial governors. The Government of Pakistan 
reported having eradicated 1,053 ha of opium poppy 
during the growing season 2010/2011. 
661. Illicit cultivation of cannabis plants continued in 
some areas throughout the Middle East, in particular in 
Lebanon. According to officials in the Occupied 
Palestinian Territory, some illicit cultivation of cannabis, 
although limited, occurred in the West Bank.  
662. While the number of reported seizures of cannabis 
resin continued to increase in the Middle East, the 
quantities seized have decreased since 2008. In addition 
to Lebanon, Yemen has become an important source of 
cannabis resin, as revealed by the seizures made in some 
countries. In Kuwait, however, almost all the seized 
cannabis resin originated in Iraq. 
663. Trafficking in and abuse of cannabis herb are still 
relatively limited in the Middle East. Almost all seizures 
of cannabis in that subregion were made in Saudi Arabia, 
followed by Jordan. All of the cannabis herb seized in 
Saudi Arabia originated in Yemen. 
664. Opiates from Afghanistan are smuggled via Iran 
(Islamic Republic of), Pakistan or countries in Central 
Asia. Of the estimated 365 tons of heroin smuggled out of 
Afghanistan in 2009, about 44 per cent was smuggled via 
Pakistan, 32 per cent via the Islamic Republic of Iran and 
25 per cent via various Central Asian countries. An 
estimated 1,050 tons of opium were also smuggled into 
the Islamic Republic of Iran. 
665. Most of the opium seized in countries in the Middle 
East, predominantly in the United Arab Emirates, had 
been smuggled out of the Islamic Republic of Iran in 
passenger luggage.  
666. Although the number of heroin seizures in the 
Middle East increased in 2010, the quantities seized more 
than halved compared with previous years. Most of the 
heroin seizures involved persons travelling from Pakistan 
to Saudi Arabia and the United Arab Emirates. 
667. Several countries in Central Asia reported a 
deteriorating drug control situation, citing increased 
trafficking in opiates and cannabis from Afghanistan as 
the main problem. Uzbekistan reported increased drug 
trafficking, as the total number of drug seizures in 2010 
increased by 35 per cent over the previous year, owing in 
large part to cannabis seizures totalling 1,732 kg and  
565 kg of cannabis resin. The sharp rise in seizures of 
cannabis stems from production in Afghanistan, as most 
of the seizures have occurred in border areas. A total of 
1,004 kg of heroin were seized, an increase of 33 per cent 
from 2009. 
668. There are indications that cocaine trafficking is 
increasing throughout West Asia, with cocaine seizures 
increasing by 76 per cent from 2000 to 2009. Several 
countries in the region reported significant cocaine 
seizures in 2010 and the first part of 2011. Turkish 
authorities seized a total of 302 kg of cocaine in 2010, an 
increase of 226 per cent over the previous year. Further 
increases in cocaine seizures were reported by the Turkish 
authorities in the first five months of 2011. According to 
the World Customs Organization, Lebanese authorities 
seized 133 kg of cocaine in 2010 in a maritime freight 
consignment originating in Colombia that had transited 
through Belgium, representing one of the single largest 
reported seizures of cocaine in West Asia. Colombian 
cocaine also reaches Israel by boat: in April 2011,  
250 kg of cocaine were seized by Israeli law enforcement 
services and customs. In Pakistan, the first significant 
seizure of cocaine was reported in October 2010, when 
authorities in the port of Karachi seized a container with 
226 kg of cocaine coming from Suriname and destined 
for Lahore, Pakistan. While the amounts are not large 
when compared with seizures in some other regions,  
the increase is cause for concern as to the potential 
development of a future market. 
 
 (b) Psychotropic substances  
 
669. West Asia has experienced considerable growth in 
trafficking and seizures of amphetamines, with seizures 
increasing between 2000 and 2009 from 4 to 27 tons. One 
matter of particular concern is the emergence of  
illicit methamphetamine manufacture, trafficking and 
abuse in the region. The emergence of several new 
methamphetamine trafficking routes in West Asia, used 
for smuggling the drug into countries in East Asia, has 
also been reported.  
670. The Islamic Republic of Iran reported a significant 
increase in the number of clandestine methamphetamine 
laboratories dismantled in the country: 166 such 
laboratories were dismantled in 2010. The abuse of 
methamphetamine in the country has also spread, as has 
major drug trafficking. Methamphetamine continues to 
flow from the country both directly and via routes 
through neighbouring countries (the Syrian Arab 
Republic, Turkey and the United Arab Emirates), bound 
primarily for Indonesia, Japan, Malaysia and Thailand.  
671. According to seizure data reported by law 
enforcement authorities in the United Arab Emirates, the 
amount of crystalline methamphetamine smuggled into 
the country has increased. Between January and  
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May 2011, such seizures amounted to 122 kg, compared 
with 41 kg in 2010. The number of nationals of African 
countries involved in the smuggling of crystalline 
methamphetamine through Dubai, United Arab 
Emirates, seems to be growing; in most cases, the drug 
was concealed in luggage destined for East Asia. 
672. Countries in the Middle East, in particular Saudi 
Arabia, continue to be the main market for amphetamine 
sold as counterfeit Captagon tablets. In 2010, the volume 
of amphetamines seized in those countries amounted to 
10 tons, mainly reported by Saudi Arabia (8 tons 
compared with 13 tons the previous year) and the Syrian 
Arab Republic. Saudi Arabia thus accounted for 80 per 
cent of the total weight seized, followed by the Syrian 
Arab Republic (15 per cent). In 2010, Jordan, the United 
Arab Emirates, Bahrain, Qatar and Kuwait (in ascending 
order) reported seizures of quantities ranging between  
9 and 267 kg. 
673. Jordan and the Syrian Arab Republic are reportedly 
the main countries of origin of the seized amphetamine, 
whereas Saudi Arabia was the main country of 
destination, as in previous years. Captagon tablets are 
mostly detected in vehicles or in freight consignments.  
674. Cooperation between the Saudi Arabian Anti-
Narcotics Administration and the Turkish security 
services led to the seizure and destruction in September 
2009 of a large laboratory in Turkey that had been illicitly 
manufacturing Captagon tablets. The laboratory had a 
production capacity of 200 million Captagon tablets per 
year.  
675. In Saudi Arabia, the first clandestine laboratory for 
illicit manufacture of Captagon tablets was dismantled in 
June 2010. Tabletting machines, punches, chemicals and 
Captagon tablets were seized during the operation. The 
Board is concerned about illicit manufacture of 
amphetamine in the Middle East.  
676. Benzodiazepines such as diazepam, clonazepam 
and nitrazepam are trafficked in West Asia. Seizures of 
tablets containing those substances were made in Kuwait, 
Qatar and Saudi Arabia. In Kuwait, 16 per cent of the 
demand for treatment for drug abuse is associated with 
the abuse of sedatives, including those under 
international control. 
 
 (c) Precursors 
 
677. In West Asia, there continues to be significant illicit 
demand for acetic anhydride for use in heroin 
manufacture. However, the amount of acetic anhydride 
that is reported to be seized each year is but a tiny 
fraction of the amount needed to manufacture the  
375 tons of heroin estimated to be abused worldwide each 
year. This may be partly attributable to the difficulties in 
reporting seizures during the ongoing conflict. For 
example, official press releases from ISAF cite several 
multi-ton seizures of precursor chemicals commonly 
found in illicit drug manufacturing laboratories 
throughout Afghanistan. However, in most cases, specific 
details, such as the type and quantity, are not reported. As 
seized precursor chemicals are typically burned on site, 
the opportunity to collect forensic and other information 
to support backtracking investigations, is lost. The Board 
urges the Government of Afghanistan, with assistance 
from the international community, to improve systems 
for the collection, management and reporting of 
information in accordance with article 12 of the  
1988 Convention with regard to seized precursor 
chemicals. Until such time, the Board calls on the 
Governments concerned and regional and international 
entities (e.g. CARICC, ISAF and UNODC) operating in 
and around Afghanistan to share such information with 
the Board via the established Project Cohesion 
mechanism so as to facilitate international efforts to 
counter trafficking in precursors. 
678. In December 2010, cooperation between Slovak and 
Turkish authorities resulted in the seizure of 10 tons of 
acetic anhydride — enough to manufacture between  
2.5 and 10 tons of heroin, depending on the processing 
method used. That was one of the largest reported 
seizures of that precursor chemical since the publication 
of the report of the Board for 2010.  
679. In March 2011, authorities in Tajikistan seized  
404 kg of acetic anhydride and 7.3 tons of sulphuric acid 
destined for Afghanistan. In that same month, authorities 
in the Russian Federation arrested members of an 
organized criminal group and seized 800 kg of acetic 
anhydride en route to Afghanistan via Tajikistan. Tajik 
authorities are cooperating with Russian authorities  
in the prosecution of those responsible for the illicit 
consignments.  
680. Since 2006, many countries in West Asia have 
reported considerable increases in their annual legitimate 
requirement for imports of ephedrine and 
pseudoephedrine, precursors that can be used in the illicit 
manufacture of methamphetamine. For example, Iran 
(Islamic Republic of), Pakistan and the Syrian Arab 
Republic are now among the countries with the highest 
annual legitimate requirements for pseudoephedrine in 
the world. In 2010, Iranian and Pakistan authorities 
reported a growing number of significant seizures of 
ephedrine; that increasing trend continued into 2011. 
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681. In recent years, countries in the Middle East, in 
particular Iraq, have been targeted for the diversion of 
precursor chemicals such as ephedrine, pseudoephedrine 
and acetic anhydride. Numerous suspicious shipments to 
the subregion have been stopped.  
682. The Board continues to be concerned by the high 
annual legitimate requirements for the import of P-2-P 
reported by the Government of Jordan. Jordan’s annual 
legitimate requirements, amounting to 60 tons, are the 
highest of any country, and three times that of the next 
largest requirement, that of the United States (18 tons). Of 
the 70 countries reporting to the Board annual legitimate 
requirements for P-2-P, 52 require the substance in 
quantities of only 1 kg or less. The Board urges the 
Government of Jordan to review its annual legitimate 
requirements for P-2-P and ensure that those 
requirements are based on legitimate end-use.  
683. The Board encourages countries in West Asia to 
review their annual legitimate requirement 
methodologies and estimates for the import of precursors 
of amphetamine-type stimulants and to ensure that their 
requirements are for legitimate end-use. 
 
 (d) Substances not under international control 
 
684. Seizures of substances not under international 
control, in particular khat, continue to be reported in the 
Middle East. A total of 246 kg of khat was seized in 2010, 
almost all by the customs services in Yemen. Air freight 
consignments of khat were destined for Malaysia, the 
Sudan and the United States. 
 
 5. Abuse and treatment  
 
685. The estimated annual prevalence of opiate abuse in 
West Asia is one of the highest in the world. The abuse of 
opiates continues to be a significant problem in countries 
in the region, in particular Afghanistan and neighbouring 
countries. According to UNODC estimates, in 2009 the 
prevalence of opiate abuse in Afghanistan was among the 
highest in the region. Past year prevalence of opiate abuse 
among the general population aged 15-64 was 2.3-3 per 
cent. Comparable levels were also found in the 
neighbouring Islamic Republic of Iran, where UNODC 
estimates that, in 2010, 1.8-2.8 per cent of the general 
population had abused opiates in the past year. 
686. Many countries in Central Asia have high levels of 
opiate abuse, as shown by data on persons admitted for 
treatment, and the proportion of persons who abuse 
opiates in the form of heroin is increasing. In Central 
Asia, between 75 and 97 per cent of persons entering 
facilities for the treatment of drug abuse do so primarily 
for the abuse of opiates. The proportion of heroin abusers 
among officially registered drug abusers in Central Asia 
has increased since 2004, with the proportion of those 
registered at dispensaries in 2009 ranging from 44 per 
cent in Kyrgyzstan to 81 per cent in Tajikistan. According 
to UNODC, drug abusers in countries in West Asia 
(excluding Turkey) consumed an estimated 43 tons of 
heroin in 2009, accounting for approximately 12 per cent 
of global consumption of that drug.  
687. Central Asian countries have some of the  
fastest-growing levels of HIV infection, with drug abuse 
by injection accounting for over 60 per cent of cases with 
HIV infection. The health of drug abusers is also affected 
by blood-borne infections such as hepatitis C; in some 
countries in the subregion, the prevalence of hepatitis C 
infection among persons who abuse drugs by injection is 
as high as 40 per cent.  
688. In Kyrgyzstan, the situation with respect to drug 
abuse worsened as a result of the increased availability of 
opium and heroin originating in Afghanistan, a spillover 
effect of the transit in that country. Abuse of drugs has 
become more widespread: the number of registered drug-
dependent persons has increased sharply in the past 
decade, totalling 10,171 in early 2011. Increasing abuse of 
opioids has been accompanied by increasing abuse by 
injection and increased infection with blood-borne 
diseases such as hepatitis and HIV/AIDS. According to 
the Government of Kyrgyzstan, in the first quarter of 
2011 there were 726 HIV-positive persons registered in 
the country, of whom 423 abused drugs by injection. Law 
enforcement officials reported an increase of 50 per cent 
in drug-related offences in the first half of 2011 compared 
with the first half of 2010.  
689. Since November 2009, UNODC has been 
implementing an evidence-based family skills training 
programme in selected Central Asian countries in order 
to prevent drug abuse, HIV/AIDS and crime and 
delinquency among young people by improving the 
capacity of families to take better care of their children. 
As a result of ongoing project activities, the texts of the 
evidence-based family skills training programme, 
Families and Schools Together, have been translated and 
culturally adapted and have been implemented at selected 
local institutions in Kazakhstan, Kyrgyzstan, Tajikistan 
and Turkmenistan. So far, 128 planners and practitioners 
from 15 pilot schools in the four countries have been 
trained in the effective implementation of the eight-week 
programme. 
690. Cannabis continued to be abused in most countries 
in the Middle East, with a rising trend reported in Jordan 
and Lebanon. 
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691. The prevalence rates for abuse of opiates remained 
low in the countries on the Arabian Peninsula, with 
heroin being the main opiate abused. Opiates were also 
the main substances causing drug-related deaths, with 
rates ranging from 4.6 per million people aged 15-64 in 
the United Arab Emirates to 44.3 per million in Bahrain. 
692. Programmes for the treatment and prevention of 
drug abuse, as well as for raising awareness about the 
risks of drug abuse by injection, are increasing in number 
in the Middle East. In coming years, UNODC intends to 
expand its programmes on HIV prevention and care for 
drug abusers, including in prison settings. 
693. In 2010, the Government of the Islamic Republic of 
Iran authorized the use of tincture of opium nationwide 
as part of an expansion of maintenance treatment, which 
also includes the use of methadone and buprenorphine. 
The expansion was approved after a pilot project had 
been evaluated by the Government. In 2009, the 
Government estimated that some 668,000 persons had 
received treatment for drug-related problems, of whom 
184,000 had received some form of maintenance 
treatment.  
694. The pilot programme initiated by the Ministry of 
Health of Lebanon, offering buprenorphine substitution 
treatment for persons addicted to opioids, continued. 
UNODC supported the development of clinical 
guidelines and operating procedures for the programme, 
including, in particular, monitoring activities to prevent 
any diversion from the treatment programme. 
695. The National Rehabilitation Centre in Abu Dhabi 
treats patients for poly-substance abuse that includes 
opiates, cannabis, psychotropic substances and alcohol. 
The Centre doubled its bed capacity in 2009, and an 
outpatient facility was launched in mid-2010. The 
outpatient clinic treats about 450 patients a month. The 
authorities are planning to open a 200-bed centre by 
2014, which will also include a section for women. Most 
patients come to the Centre voluntarily. 
696. A 2010 qualitative study by UNODC examining the 
social and economic impact of drug abuse on families in 
four cities in Pakistan pointed to the profound financial, 
physical and psychological burden on wives of drug-
abusing husbands. Most of the women interviewed had 
become the sole providers in their families, earning in 
most cases less than $60 a month, as their drug-abusing 
husbands were often unemployed. The financial situation 
of the families of drug abusers had a negative effect on 
family nutrition and education and prevented spouses 
from obtaining adequate treatment for their drug-abusing 
husbands. One quarter of the spouses of drug abusers 
interviewed reported being subjected to physical violence 
(26 per cent) or sexual violence (23 per cent) and were 
found to be extremely vulnerable to being infected with 
HIV. 
697. With the exception of Israel, few countries in West 
Asia have reported performing regular direct or indirect 
nationally representative surveys of drug abuse among 
the general population, making it difficult to assess the 
severity, comparability and change in drug abuse levels in 
the region. Although Turkey has never performed a 
nationally representative survey of drug abuse among the 
general population, a pilot study on the prevalence of 
drug abuse was carried out in the Ankara region in 2010. 
Results indicated that, among persons aged 15-64,  
past-month abuse of sedatives/tranquillizers without 
prescription was 2.9 per cent, and past-month abuse of 
cannabis was 0.8 per cent. A 2010 regional study of 
Istanbul students found lifetime prevalence of cannabis 
abuse to be 3.3 per cent, MDMA (“ecstasy”) abuse to be 
1.6 per cent, amphetamine abuse to be 1.4 per cent and 
cocaine abuse to be 1.0 per cent.  
698. The seventh national epidemiological survey on the 
prevalence of drug abuse among youth in Israel was 
conducted in 2009. It showed that, among other things, 
an increase in the proportion of persons aged 12-18 who 
reported having abused drugs in their lifetime. 
 
 
 D. Europe 
 
 
 1. Major developments 
 
699. There is not much evidence of a decrease in the 
level of cannabis abuse in most countries in Europe and 
indeed in a small number of countries an increasing trend 
in such abuse has been seen. The illicit cultivation of 
cannabis plants in Western and Central Europe has 
increased dramatically. Cannabis plants are increasingly 
being illicitly cultivated on an industrial scale, mainly 
indoors, and with the involvement of organized criminal 
groups. In such cases, the THC content of the cannabis 
plants has been high. Indoor cultivation of cannabis 
plants for personal use is tolerated in some countries, 
which is not in compliance with the international drug 
control conventions. Cannabis seizures in Europe have 
decreased in recent years, possibly as a result of increased 
numbers of seizures in North Africa, the key source of 
cannabis resin. A decreasing trend in seizures of cannabis 
resin was evident in many countries in Europe, while 
seizures of cannabis herb increased in some countries in 
recent years with trends varying between countries.  
700. The abuse of cocaine has stabilized in recent years, 
although at a relatively high level, in most countries in 
Western and Central Europe. The spread of cocaine abuse 
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in South-Eastern and Eastern Europe appears to have 
continued. Cocaine is the primary drug of abuse in 
almost one fifth of new treatment cases in the European 
Union, and Europe remains the world’s second-largest 
cocaine market. Diversification of the routes used for 
smuggling cocaine into Europe has been noted. Although 
the smuggling of drugs into Europe through West Africa 
has decreased in recent years, the total amount of cocaine 
smuggled into Europe has not decreased and is at the 
high level of previous years. Cocaine trafficking routes 
leading into Europe have diversified, and cocaine 
trafficking via North Africa has increased. While 
decreases in cocaine seizures in Portugal and Spain have 
been reported in recent years, cocaine is increasingly 
being smuggled through South-Eastern and Eastern 
Europe, in particular along the Balkan routes. Large illicit 
consignments of cocaine have arrived at ports on the 
coasts of the Adriatic Sea and the Black Sea, from where it 
is transported overland to the western part of Europe. 
The liberalization of trade in the region and the presence 
of established transnational criminal networks have 
facilitated that expansion. Criminal organizations from 
various subregions, including South-Eastern Europe, have 
established operational bases in South America, 
maximizing their profits by obtaining the cocaine directly 
from the producers.  
701. In Europe, there is no overall decreasing trend in 
the abuse of amphetamine-type stimulants; in fact, some 
increases have been reported in a small number of 
countries. The abuse of MDMA (“ecstasy”) has remained 
stable, with decreasing levels of abuse in some countries. 
In recent years, known manufacture of “ecstasy” in 
Europe has decreased. The illicit manufacture of 
amphetamine is increasing in Europe. While 
amphetamine remains the most abused amphetamine-
type stimulant in Europe, seizures of methamphetamine 
in Western and Central Europe increased fivefold 
between 2004 and 2009, and the substance is believed to 
be replacing amphetamine in the northern part of the 
region.  
702. The variety of substances abused in Europe 
continues to grow, with a record level of new substances 
identified in 2010, many of them not under international 
control. To address the situation, many countries in 
Europe have placed specific substances under national 
control. In December 2010, in response to the increased 
abuse of mephedrone, the Governments of States 
members of the European Union decided that the 
substance should be placed under national control.  
 
 2. Regional cooperation 
 
703. In June 2011, operation Channel West was carried 
out as part of operation Channel 2011, under the aegis of 
the Collective Security Treaty Organization. More than 
46,300 law enforcement officers and special service agents 
from Belarus, Kazakhstan, Latvia, Lithuania, Poland, the 
Russian Federation and Ukraine were involved in the 
operation, establishing 4,437 joint operational groups in 
border areas and at rail stations, airports and road 
transport facilities. Their joint efforts led to the seizure of 
about 3 tons of drugs and more than 197 kg of precursor 
chemicals during the operation. 
704. The third stage of Operation Sentinel 2010 took 
place in October 2010; it was aimed at counteracting the 
smuggling of narcotic drugs and psychotropic substances 
in Eastern Europe and Central Asia. Customs authorities 
of Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, 
the Republic of Moldova, the Russian Federation, 
Tajikistan, Ukraine and Uzbekistan participated in the 
operation. During the operation, seizures amounted to 
approximately 42 tons of narcotic drugs and psychotropic 
substances. 
705. In December 2010, the Fourth Meeting of the Civil 
Society Forum on Drugs in the European Union was held 
in Brussels, focusing on developments in the drug control 
situation in Europe and drug control policy.  
706. Under the aegis of EMCDDA, a number of regional 
events have been held recently to address drug-related 
issues, including a meeting in Lisbon in January 2011 on 
policies and practice in the treatment of cannabis abuse in 
Europe and also the first international multidisciplinary 
forum on new drugs, held in Lisbon in May 2011. 
707. At a meeting held in Naples, Italy, in February 2011, 
the Euro-African Conference of chiefs of police 
addressed, as a key priority, the issue of drug-trafficking 
routes. During the meeting, a working group on drug 
trafficking was established and recommendations were 
made to conduct joint capacity-building and training 
projects for law enforcement agencies, to facilitate the 
harmonization of legal provisions and to encourage the 
sharing of intelligence.  
708. In March 2011, a conference of ministers of justice 
and of the interior of the States participating in the South-
East European Cooperation Process was held in Budva, 
Montenegro, on the theme “Strengthening cooperation in 
the fight against organized crime in South-East Europe”. 
The participants adopted the Budva Declaration on 
Strengthening Regional Cooperation and Coordination 
in the Fight against Organized Crime in South-East 
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Europe, as well as the Common Declaration and Action 
Plan 2011-2013. 
709. In May 2011, the Transatlantic Symposium on 
Dismantling Transnational Illicit Networks, organized by 
the European Union and the United States in Lisbon, 
addressed, inter alia, drug-related problems. Participants 
highlighted the need for cooperation at all levels, 
including through a number of operational initiatives 
such as intelligence-sharing, mutual legal assistance, 
mechanisms for tracing proceeds of crime and promotion 
of the implementation of international instruments. 
710. The eighteenth European Cities against Drugs 
Mayors’ Conference on Drugs was held in Varna, 
Bulgaria, in May 2011. Under the theme “Europe against 
drugs: unity in diversity”, the participants discussed ways 
to enhance the effectiveness of measures taken to counter 
drug abuse and its related social and health consequences 
in European cities.  
711. In the political declaration adopted at the Group of 
Eight Ministerial Meeting on the Fight against 
Transatlantic Cocaine Trafficking, held in Paris in  
May 2011, States made a commitment to intensifying 
cooperation regarding the global drug problem, including 
drug trafficking and transatlantic trafficking in cocaine. 
The Meeting adopted an action plan aimed at 
strengthening cooperation, calling for effective 
implementation of the international drug control 
conventions as the cornerstone of the international drug 
control system, improving the sharing of intelligence, 
intensifying maritime cooperation, addressing the 
destabilizing effects of drug trafficking and improving 
international legal cooperation mechanisms to target and 
confiscate criminal assets. In addition to the Group of 
Eight countries, the Meeting was also attended by 
representatives of countries from regions and subregions 
directly affected by transatlantic trafficking in cocaine 
(Latin America and the Caribbean, West Africa and the 
Sahel, and Europe), as well as international and regional 
organizations.  
712. The European Commission hosted a conference on 
the theme “Building an EU consensus for minimum 
quality standards in the prevention, treatment and harm 
reduction of drugs” in Brussels in June 2011. The 
conference participants discussed the preliminary 
findings of a study by the Commission on the 
development of a European Union framework for 
minimum quality standards and benchmarks in drug 
demand reduction. 
 3. National legislation, policy and action 
 
713. In December 2010, the Government of Bulgaria 
issued an ordinance on the terms and procedure for 
issuing licences to conduct activities with narcotic drugs 
used for medical purposes, as regulated by the Law on the 
Control of Narcotic Substances and Precursors. The 
ordinance stipulates the terms and procedure for issuing 
licences to conduct activities involving manufacture, 
processing, storage, domestic trade, import, export and 
transit, transfer and transportation of narcotic drugs and 
medicinal products containing narcotic drugs. 
714. In May 2011, Croatia, with the support of 
EMCDDA, launched its first general population survey 
on drugs. The survey covered 4,000 individuals and 
examined the prevalence and patterns of abuse of 
psychoactive substances in Croatia, as well as attitudes 
towards drugs among different population groups. The 
analysis of the results and the final report are expected to 
be available by the end of 2011.  
715. In September 2011, the Ministry of Health of 
France banned the sale of gamma-butyrolactone (GBL) 
and 1,4 butanediol, two substances that metabolize in the 
body into gamma-hydroxybutyric acid (GHB) (one of the 
“date-rape drugs”), a substance that has been a scheduled 
narcotic drug in France since 1999. The decision was 
aimed at addressing the significant increase in the abuse 
of the two substances. 
716. In November 2010, the Parliament of Lithuania 
approved the National Programme on Drug Control and 
Prevention of Drug Addiction 2010-2016. In the same 
month, the Parliament passed a resolution on combating 
new psychoactive substances. In April 2011, the Drug, 
Tobacco and Alcohol Control Department was 
established as a Government body.  
717. In December 2010, the Government of the Republic 
of Moldova adopted the National Anti-Drug Strategy 
2011-2018 and the Action Plan for 2011-2013 to 
implement the National Anti-Drug Strategy. The Strategy 
was developed in line with European Union standards to 
strengthen the fight against drug trafficking and abuse. 
The drug policy of the Republic of Moldova is based on 
four pillars: primary prevention; treatment and 
rehabilitation; harm reduction; and drug supply 
reduction. In July 2011, the Government approved the 
creation of the National Anti-Drug Committee to oversee 
implementation of the Strategy.  
718. In May 2011, the Council of Ministers of the 
Netherlands expressed its agreement on planned 
measures to reduce nuisance and drug tourism by linking 
access to so-called “coffee shops” with a membership 
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pass, setting a maximum number of members per “coffee 
shop” and restricting membership to citizens of the 
Netherlands over 18 years of age. If the measures are 
implemented, the minimum permissible distance of 
“coffee shops” from schools will be increased to 350 
metres. However, at the time of publication of this report, 
the issue had not yet been regulated. While the Board 
notes that this would be a positive move, its position 
continues to be that such “coffee shops” are in violation of 
the provisions of the international drug control 
conventions.  
719. The Netherlands Expert Committee on the List 
System of the Opium Act, in its June 2011 report entitled 
“Drugs in lists”, recommended that cannabis with a THC 
content greater than 15 per cent be placed on List I of the 
Opium Act. If this recommendation is implemented, the 
punishment for trafficking in cannabis with a THC 
content exceeding that level would be increased and 
“coffee shops” would not be allowed to sell such cannabis. 
In October 2011, the Government of the Netherlands 
expressed its intention to place cannabis with a THC 
concentration of 15 per cent or greater on List I of the 
Opium Act. As at 1 November 2011, the Board had not 
yet been informed of any regulation on this issue.  
720. In November 2010, a new law came into force in 
Poland to address the rapidly growing supply of 
psychoactive substances not controlled under national 
legislation. The new law modifies the Act on Countering 
Drug Addiction, introducing a modified definition of 
“substitute drug” and prohibiting the manufacture, 
promotion and introduction of such substances. The law 
also modifies the Act on State Sanitary Inspection, 
enabling state sanitary inspectors to withdraw a substitute 
drug from the market for up to 18 months in order to 
assess the safety of the substance if there is a justified 
suspicion that the substance may pose a health threat.  
721. In December 2010, the Government of Romania 
approved the Action Plan 2010-2012 for the 
implementation of the National Anti-Drug Strategy  
2005-2012. The Strategy covers areas such as the 
reduction of illicit drug supply and demand, international 
cooperation, evaluation and inter-agency coordination.  
722. In Serbia, the Law on Psychoactive Controlled 
Substances, which came into effect in January 2011, 
stipulates the conditions under which controlled 
psychoactive substances can be imported, exported, 
cultivated, manufactured and traded. EMCDDA is 
currently implementing a project aimed at strengthening 
Serbia’s capacity in the area of collection of data on drug-
related issues, with the goal of establishing a national 
centre for monitoring drugs and drug addiction. 
723. In Slovakia, the law governing narcotic drugs and 
psychotropic substances was amended in February 2011, 
and over 40 substances identified in products freely sold 
as “legal highs”, mainly synthetic cannabinoids and 
mephedrone, were included in the schedules of controlled 
substances.  
724. In March 2011, the Government of Sweden adopted 
an integrated strategy for alcohol, narcotic drugs, doping 
and tobacco policy for the period 2011-2015. The overall 
objective of the strategy is a society free of drug abuse, 
with reduced alcohol-related medical and social 
consequences and reduced tobacco use. The strategy 
incorporates measures on supply and demand reduction, 
as well as measures on treatment and international 
cooperation. 
725. Drug Strategy 2010 of the United Kingdom, 
covering a four-year period, was released in  
December 2010. The Strategy focuses on reducing 
demand, restricting supply and assisting people in 
recovering from drug dependence. The Strategy covers 
prescription and over-the-counter medicines and 
provides for the establishment of a forensic early warning 
system for new psychoactive substances. A number of 
measures aimed at addressing precursor chemicals, 
organized crime, use of the Internet and  
money-laundering are also outlined in the document. The 
National Treatment Agency for Substance Misuse will 
cease to exist, its principal functions being transferred to 
Public Health England, a new public health service within 
the Department of Health. 
726. In July 2011, the Government of the United 
Kingdom introduced a temporary ban on the import of 
phenazepam, a benzodiazepine not under international 
control. The ban will remain effective until the substance 
is fully controlled under the Misuse of Drugs Act 1971. 
According to the assessment of the Advisory Council on 
the Misuse of Drugs, phenazepam has no medical use in 
the United Kingdom but is widely available through 
illegal Internet pharmacies and is sometimes sold as 
counterfeit diazepam tablets known as “Valium”. 
727. In December 2010, the ministers of justice of the 
European Union decided that mephedrone should be 
subject to control measures and criminal penalties. That 
decision was based on a report by the Scientific 
Committee of EMCDDA assessing the risks of 
mephedrone, which found that mephedrone could cause 
acute health problems and possibly lead to dependency 
and called for further research on that substance. At the 
time of the decision, 15 member States of the European 
Union had already placed the substance under national 
control. 
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728. In October 2011, the European Commission 
announced a number of steps to be taken to enhance the 
European Union drug control policy, including by, inter 
alia, proposing new legislation targeting cross-border 
drug trafficking, improving the definition of offences and 
sanctions and introducing stronger reporting obligations 
for European Union member States. The steps also 
include the presentation of indicators for monitoring 
drug markets, drug-related crime and supply reduction; 
examining means of strengthening European Union rules 
on production of and trade in precursor chemicals; and 
enhancing international cooperation against the diversion 
of precursor chemicals. The Commission recognized the 
need to extend and improve drug-related services, 
including prevention, and will promote improved 
implementation of key indicators in drug demand 
reduction. The Commission will propose strengthened 
legislation on new psychoactive substances aimed at 
enhancing the monitoring and assessment of substances, 
enabling a faster response to the emergence of substances, 
better aligning laws to cover the wide variety of 
substances and providing more sustainable responses to 
the emergence of new psychoactive substances. 
729. Also in October 2011, the Council of the European 
Union adopted a European pact against synthetic drugs, 
in which it recognized the problems posed by the 
consumption and illicit manufacture of and trafficking in 
synthetic drugs in the European Union. The pact outlines 
actions to be taken to counter the production of and 
trafficking in synthetic drugs, tackling new psychoactive 
substances and training for law enforcement services in 
detecting, examining and dismantling clandestine 
laboratories. 
 
 4. Cultivation, production, manufacture and 
trafficking 
 
 (a) Narcotic drugs 
 
730. In Western and Central Europe, the illicit 
cultivation of cannabis plants, especially indoors, has 
increased dramatically over the past few decades. It is an 
area in which the involvement of organized criminal 
groups is growing. As noted by the authorities of the 
Czech Republic and Slovakia, the indoor cultivation of 
cannabis plants on an industrial scale has been increasing 
in those countries. In the Czech Republic, the THC 
content of cannabis illicitly cultivated indoors may be as 
high as 30 per cent, and a record number of 145 indoor 
cultivation sites were detected in 2010 (compared with  
84 in 2009). In Germany, indoor cultivation of cannabis 
plants increased from 2009 to 2010, while outdoor 
cultivation decreased over the same period. Of the illicit 
cultivation sites detected in Germany, 22 indoor sites  
and 1 outdoor site had a capacity of more than 1,000 
cannabis plants. In Hungary, there was a large increase in 
the number of indoor sites in 2009, followed by a decrease 
in 2010.  
731. Cannabis illicitly produced from plants grown in 
Albania, as well as in Kosovo,29 is supplied by criminal 
groups in South-Eastern Europe and smuggled into 
Greece, Hungary, Italy, Slovenia and Turkey. Cannabis 
from Afghanistan, India and Pakistan is also being 
smuggled into Eastern and South-Eastern Europe via the 
Balkan routes. 
732. In 2009, Afghanistan and India were often reported 
as countries of origin of cannabis resin seized in Europe. 
According to the World Customs Organization, the 
amount of cannabis resin reported seized by customs 
authorities in Europe decreased to 180 tons in 2010 from 
203 tons in 2009, with Morocco being the main country 
of origin. Most of the cannabis resin reported to have 
been seized by customs authorities in Europe had been 
smuggled through Spain into Belgium, France, Germany, 
the Netherlands and the United Kingdom. The largest 
single seizure of cannabis resin reported to the World 
Customs Organization in 2010 (23.5 tons) was made in 
Spain on a vessel destined for the Netherlands. The 
amount of cannabis resin seized by customs authorities in 
Eastern and South-Eastern Europe increased significantly 
in 2010, to 813 kg (the result of eight seizures).  
733. According to the World Customs Organization, the 
largest single seizure of cannabis herb by customs 
authorities in Europe in 2010 (2.6 tons) was made  
in Belgium; the cannabis herb had arrived from Ghana 
and had been destined for Poland. According to  
the Organization, Albania and Serbia were the main 
sources of cannabis herb seized by customs authorities in 
Eastern and South-Eastern Europe. Hungarian customs 
authorities seized 312 kg of cannabis herb that had been 
concealed in a lorry arriving from Serbia; the 
consignment had been destined for Italy. In Albania,  
six seizures of cannabis herb, totalling 315 kg, were made 
by customs authorities.  
734. Europe is the world’s second-largest market for 
cocaine, accounting for almost a third of global cocaine 
consumption; Western and Central Europe account for  
95 per cent of Europe’s share. However, Europe’s share of 
global cocaine seizures — currently about 10 per cent — 
is declining. While the amount of cocaine seized has been 
decreasing in European countries in which the level of 
cocaine seizures has traditionally been high, such as 
__________________ 
 29  All references to Kosovo in the present publication should 
be understood to be in compliance with Security Council 
resolution 1244 (1999). 
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Portugal and Spain, an increasing trend in cocaine 
seizures has been reported in other European countries, 
including Austria, the Czech Republic, Germany, Greece, 
Poland, Romania, the Russian Federation and Ukraine. 
735. Single seizures of more than one ton of cocaine 
were reported in some European countries, including the 
Netherlands and the United Kingdom. The significant 
increase in the amount of cocaine seized in Germany in 
2010 was partly attributable to a record single seizure of 
1.3 tons of cocaine, which had been shipped from 
Paraguay. In Spain, a large cocaine-processing laboratory 
was identified in January 2011, resulting in the seizure of 
300 kg of cocaine and 33 tons of precursor chemicals.  
736. According to the World Customs Organization, the 
volume of cocaine seized by the customs authorities in 
Eastern Europe rose dramatically in 2010. Ukraine and 
the Russian Federation were the main countries of 
destination for cocaine shipments in Eastern and South-
Eastern Europe. In July 2010, more than 582 kg of cocaine 
was seized in the port of Odessa, Ukraine, having arrived 
from the port of Arica in Chile. Also in July 2010, 
customs authorities in Ukraine uncovered 1,193 kg of 
cocaine in a consignment that had been sent from the 
Bolivarian Republic of Venezuela. Bolivia (Plurinational 
State of), Chile and Venezuela (Bolivarian Republic of) 
were the main countries from which cocaine was shipped 
to Eastern Europe in 2010. Cocaine shipments from 
Ecuador to the Russian Federation appear to be an 
ongoing trend.  
737. Most of the cocaine entering Europe arrives by sea, 
mainly in Spain, where half of the cocaine seizures in the 
region are made, and in the Netherlands. Spain reported 
the largest single seizure of cocaine by customs 
authorities in Europe in 2010: 2.6 tons of cocaine were 
detected on a vessel near the Canary Islands. However, 
cocaine is increasingly being trafficked through South-
Eastern Europe by air freight. In May 2011, nearly 1 ton 
of cocaine and 160 kg of cannabis resin were seized in 
Albania; the cocaine had been diluted in 13 tons of palm 
oil and shipped from Colombia via Belgium.  
738. In 2010, 6 per cent of the cocaine seized at airports 
in Europe had transited West Africa, whereas 93 per cent 
had come from the Americas. In addition, there was an 
increase in the smuggling of cocaine into Europe via 
North Africa or along the Balkan routes. Countries in the 
Caribbean have been increasingly used for the secondary 
distribution of cocaine destined for Europe. 
739. Almost 90 per cent of the heroin originating in 
Afghanistan and seized in Central Asian countries in 
2010 had been destined for the Russian Federation. Other 
countries in Eastern Europe receive heroin mainly from 
the Russian Federation and, to a smaller extent, the 
Balkan routes, which remain the main corridor used for 
smuggling heroin into European countries. About 63 per 
cent of all heroin seizures in Europe are made in South-
Eastern Europe. While heroin seizures in Western and 
Central Europe have remained largely stable since 2005, 
they have doubled in South-Eastern Europe.  
740. There is increasing diversity in the methods and 
routes used for smuggling heroin into Europe. According 
to the World Customs Organization, in 2010 the quantity 
of heroin seized in Europe that had been smuggled along 
the northern Balkan route (via Turkey to Bulgaria, 
Romania, Hungary and then Austria) decreased 
compared with the quantity that had been smuggled 
along the southern Balkan route (into Italy via Greece, 
Albania or the former Yugoslav Republic of Macedonia), 
whereas the quantity that had been smuggled into Europe 
along the so-called “silk route” (via Central Asia) 
remained relatively stable. Africa is becoming the 
predominant transit area for smuggling heroin by air into 
Europe, while some heroin consignments from Turkey 
have been trafficked by air into Western and Central 
European countries.  
741. The opium seized by customs authorities in 
Western and Central Europe was mainly from Iran 
(Islamic Republic of) and Turkey. In 2010 French 
authorities seized opium-saturated twigs sent in several 
postal and courier shipments from the Lao People’s 
Democratic Republic and Thailand. The largest seizure of 
opium poppy straw (661 kg) in Eastern Europe in 2010 
was made by the customs authorities of Belarus; the 
opium poppy straw was uncovered in a lorry arriving 
from Poland. Seizures of opium poppy straw in small 
quantities were reported by customs authorities in Poland 
and the Russian Federation in 2010.  
 
 (b) Psychotropic substances 
 
742. The amount of amphetamines reported to have 
been seized by customs authorities in Western Europe in 
2010 was small compared with recent years. Between  
60 and 90 sites for the large-scale manufacture of 
synthetic drugs, especially amphetamine and MDMA 
(“ecstasy”), have been dismantled annually in member 
States of the European Union in recent years. The illicit 
manufacture of amphetamine in Europe is believed to be 
increasing. Illicit manufacture of amphetamine in Europe 
occurs mainly in Belgium, the Netherlands and Poland, 
though some also occurs in Estonia, Germany and 
Lithuania. Of the 16 clandestine drug laboratories 
dismantled in Poland in 2010, 14 had been used for the 
illicit manufacture of amphetamine. Seizures by customs 
authorities of amphetamines originating in Estonia, 
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Lithuania and Poland decreased in 2010, seizures of 
amphetamines in Austria decreased in 2010 by 65.7 per 
cent compared with 2009 and the quantity of the 
amphetamines seized in Germany decreased for the first 
time in eight years. Despite those decreasing trends, an 
increase in seizures of amphetamines was observed in 
Hungary in 2010. In May 2011, a group of 10 people, 
including 2 physicians, were arrested in Belgrade after a 
clandestine laboratory manufacturing amphetamine was 
uncovered near the city; the bulk of the illicitly 
manufactured amphetamine had been destined for the 
Middle East, and a small proportion was to be abused by 
the local population. 
743. The illicit manufacture of methamphetamine in 
Europe continues to be limited. However, EMCDDA 
reports that methamphetamine has appeared as a possible 
substitute for amphetamine in the northern part of the 
region. Over 300 sites used for illicit methamphetamine 
manufacture were dismantled in the Czech Republic in 
2010, a decrease from the record levels of over 400 sites in 
2006 and 2008; that decrease was partly attributable to the 
strengthened controls over pharmaceutical preparations 
containing ephedrine implemented since 2009. The illicit 
manufacture of methamphetamine also occurs in 
Lithuania and Poland. Facilities for the illicit manufacture 
of methamphetamine were also dismantled in Austria, 
Germany, Slovakia and Poland. Most of the 16 illicit drug 
laboratories dismantled in Germany in 2010 were small 
sites used for the synthesis of methamphetamine.  
744. A significant reduction in illicit manufacture  
of MDMA (“ecstasy”) is reported to have occurred in 
recent years in Europe; the reduction has been attributed 
by the European Police Office (Europol) to shortages  
of the precursor chemical 3,4-MDP-2-P and has been  
linked with the emergence of new psychoactive 
substances. However, there are concerns that the 
reduction in “ecstasy” manufacture may be only 
temporary. There is a trend towards replacing MDMA 
(“ecstasy”) with piperazine derivatives such as 1-(3-
chlorophenyl)piperazine (mCPP), as evidenced in Austria 
and the United Kingdom, where there has been an 
increase in the number of samples containing 
piperazines.  
 
 (c) Precursors  
 
745. In 2010, for the first time, two laboratories that had 
been illicitly manufacturing P-2-P, which is used  
in the illicit manufacture of amphetamine, were 
dismantled in Poland. In Bulgaria a total of 21 tons of 
acetic anhydride was seized in 2010. In April 2011,  
6.5 tons of acetic anhydride were seized in Hungary, 
resulting in the dismantling of an organized criminal 
group. The “masking” of P-2-P, a liquid used in the illicit 
manufacture of amphetamine, into the powder  
P-2-P bisulphate prior to importation into the European 
Union is a new method used by traffickers in the region. 
In some countries in the region, such as Poland, illicit 
manufacture of amphetamine involves the manufacture 
of P-2-P using “pre-precursors” such as phenylacetic acid 
and benzyl cyanide. 
746. Seizures of traditional precursor chemicals of 
MDMA (“ecstasy”) are reported to have declined in 
recent years in Europe. However, there recently have been 
numerous seizures of 3,4-MDP-2-P-glycidate, from which 
3,4-MDP-2-P, a precursor chemical of “ecstasy”, can be 
manufactured. Since the middle of 2010, seizures of  
3,4-MDP-2-P-glycidate have been made in several 
European countries, including Denmark, the Netherlands 
and Slovakia. In some of those cases, China was identified 
as the origin of the shipments.  
 
 (d) Substances not under international control  
 
747. The illicit manufacture, trafficking and abuse of 
“designer drugs” are of increasing concern in Europe. 
Some 41 new psychoactive substances were identified in 
2010 through the European Union early warning system, 
an increase over 2009 when 24 new substances were 
reported, and a record number for the early warning 
system. The substances identified in 2010 included 
synthetic cannabinoids, synthetic cathinones, arecoline  
(a plant-based substance) and synthetic derivatives of 
substances such as cocaine, phencyclidine and ketamine. 
In 2010, for the first time, a laboratory for the illicit 
manufacture of synthetic cannabinoids was uncovered in 
Germany. 
748. Retail outlets that specialize in selling new 
psychoactive substances have rapidly emerged in several 
countries in Europe. In 2010, EMCDDA identified 136 
Internet retail sites selling new psychoactive substances, 
most of which were based in Germany, the Netherlands 
and the United Kingdom, while some were based in 
France, Hungary and Poland. In Hungary, the rate of 
seizures of mephedrone increased from 1-5 seizures per 
month to over 100 seizures per month between April and 
June 2010. According to the World Customs 
Organization, the number of seizures of GBL reported by 
customs authorities continued to increase; in 2010, 
seizures of GBL were effected mostly in Norway and 
Switzerland, and the main countries of departure were the 
Netherlands and Poland.  
749. According to the World Customs Organization, the 
amount of khat reported seized by customs authorities in 
Europe in 2010 increased to about 49 tons, and over 1 ton 
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of khat was seized in each of the following countries: 
Denmark, Finland, Germany, Norway, Sweden and 
Switzerland. The seized khat had reportedly been shipped 
from countries where it is not under control, such as the 
Netherlands and the United Kingdom. The United 
Kingdom has been reported as the main source of 
shipments of khat seized by customs authorities in North 
America; those shipments were, for the most part, 
detected in the postal system. According to the World 
Customs Organization, khat shipped from the 
Netherlands has been transported mainly to Germany 
and Scandinavian countries. 
 
 5. Abuse and treatment  
 
750. Cannabis is the most commonly abused drug in the 
member States of the European Union: annual prevalence 
of cannabis abuse is estimated at 6.7 per cent among the 
population aged 15-64 (the rate ranges from 0.4 to  
14.3 per cent in various countries). The highest annual 
prevalence rates for cannabis abuse among adults in the 
European Union were reported in Italy (14.3 per cent), 
the Czech Republic (11.1 per cent) and Spain (10.6 per 
cent), while the lowest levels were reported in Romania 
(0.4 per cent), Malta (0.8 per cent) and Sweden (1.2 per 
cent). Monthly prevalence of cannabis abuse in the 
European Union is on average 3.6 per cent of adults and, 
in 14 countries for which data were reported, one fifth of 
those who had abused cannabis in the previous month 
had abused the drug on at least 20 of the preceding  
30 days. Cannabis abuse in the European Union is 
concentrated among persons aged 15-24 years (average 
annual prevalence: 16 per cent).  
751. The prevalence of cannabis abuse in Europe is 
relatively stable or declining in some countries, although 
increasing levels of cannabis abuse have been reported in 
recent years in countries such as Bulgaria, Estonia, 
Finland and Sweden. According to the latest information 
available to the Board, in the United Kingdom, annual 
prevalence of cannabis abuse among adults in England 
and Wales decreased from 7.9 per cent in the period 
2008-2009 to 6.6 per cent in the period 2009-2010. In 
Norway, the proportion of the population under 35 years 
of age who had abused cannabis within the previous  
30 days decreased from 4.5 per cent in 2004 to 2.1 per 
cent in 2009. 
752. Cocaine is the second most prevalent drug of abuse 
in Europe. Europe accounts for almost one third of global 
consumption of cocaine. The amount of cocaine abused 
in Europe, which almost doubled from 1999 to 2009, has 
stabilized in recent years. Some 90 per cent of the cocaine 
abuse in Europe is concentrated in Western and Central 
Europe, where 1.2 per cent of adults aged 15-64 have 
abused the drug in the past year. The prevalence of 
cocaine abuse ranged from 0 per cent to 2.7 per cent in 
various countries, the highest prevalence rates being in 
Italy, Spain and the United Kingdom, and lowest in 
Greece and Romania. According to the latest information 
available, in Eastern and South-Eastern Europe, the 
annual prevalence of cocaine abuse in 2009 ranged from 
0.1 to 0.3 per cent of the population aged 15-64.  
753. Europe represents the largest share of the global 
opiate market. The abuse of heroin is the biggest drug 
problem in Europe in terms of morbidity and mortality. 
The annual prevalence of abuse of opiates, mainly heroin, 
in Europe is estimated at 0.6 per cent of the population 
aged 15-64. The overall prevalence of abuse of opioids in 
Western and Central Europe is estimated to be stable to 
increasing. The number of new admissions for treatment 
for opiate abuse has been increasing in some countries. 
The number of drug-induced deaths have also increased. 
In Eastern and South-Eastern Europe, the annual 
prevalence of abuse of opiates is higher than in Western 
and Central Europe, estimated to be about 0.9-1.0 per 
cent of the population aged 15-64. According to the latest 
information available, in the Russian Federation, there 
were an estimated 1.7 million opiate abusers in 2010, 
consuming about 70 tons of the estimated total of 73 tons 
of opiates consumed in Eastern Europe. In Ukraine, there 
are about 370,000 opiate abusers.  
754. The abuse of amphetamines and MDMA (“ecstasy”) 
has been stable in Europe as a whole, with some increases 
in the abuse of those substances in a small number of 
countries, including Bulgaria and the Czech Republic. In 
Western and Central Europe, the annual prevalence of 
abuse of amphetamines is 0.7 per cent among the 
population aged 15-64 and 1.1 per cent among the 
population aged 15-34. In Eastern and South-Eastern 
Europe, the annual prevalence of abusers of 
amphetamines-group substances was 0.2-0.5 per cent in 
2009. Methamphetamine abuse in Europe is limited 
mainly to the Czech Republic, although the abuse of the 
substance also occurs in Austria, Germany, Slovakia, the 
Baltic countries and some Nordic countries. The annual 
prevalence of abuse of “ecstasy” in Europe is 0.7 per cent 
among those aged 15-64. In most countries in Europe, the 
abuse of “ecstasy” has remained stable or has declined.  
755. A survey published in 2011 of young people in 
Europe aged 15-24 found that 5 per cent of respondents 
had abused substances that were not under control, with 
higher rates reported for Ireland (16 per cent), Latvia  
(9 per cent), Poland (9 per cent), the United Kingdom  
(8 per cent) and Luxembourg (7 per cent). Sixty-four per 
cent of the respondents indicated that they would use the 
Internet to obtain information about illicit drugs. The 
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survey results indicated that the abused substances had 
been obtained from friends (54 per cent), purchased at 
specialized shops (33 per cent) or purchased over the 
Internet (7 per cent).  
756. According to EMCDDA, an estimated 1 million 
people receive treatment for drug abuse in the European 
Union each year. In the European Union, the average age 
of people entering treatment for drug abuse is increasing: 
20 per cent of people entering such treatment are over  
40 years of age.  
757. Opiates are the main problem drug among persons 
receiving treatment for drug abuse in Europe. According 
to EMCDDA statistics, in the European Union, opiates 
account for 51 per cent of new cases requiring such 
treatment; opiates are followed by cannabis (23 per cent), 
cocaine (17 per cent), stimulants other than cocaine  
(5 per cent) and other drugs. EMCDDA statistics 
covering 19 countries in Europe revealed that the demand 
for treatment for heroin abuse has been increasing in 
many countries in recent years and that about half of 
problematic opioid abusers receive opioid substitution 
treatment. The number of new treatment cases for which 
cannabis is the main drug of abuse is declining in most 
countries. In the United Kingdom, however, the number 
of people under 18 years of age who are being treated in 
England for cannabis abuse has increased by over  
40 per cent since the period 2005-2006.  
758. During the period 2004-2008, drug-induced deaths 
accounted for, on average, 4 per cent of all deaths among 
people aged 15-39 in the European Union, and three 
quarters of those drug-induced deaths were caused by 
opioids. According to the latest reports by EMCDDA, the 
decrease of 23 per cent in drug-related deaths in the 
period 2000-2003 was reversed between 2003 and  
2008-2009, with over half of the reporting countries in 
Western and Central Europe recording an increase in the 
number of drug-induced deaths between 2007 and 2008. 
In the United Kingdom, drug-related deaths decreased by 
6.2 per cent from 2008 to 2009; and the number of deaths 
caused by cocaine fell sharply in 2009 after peaking in 
2008. Deaths caused by the abuse of cocaine in 
conjunction with other drugs accounted for 21 per cent of 
drug-related deaths. According to EMCDDA, 30-50 per 
cent of HIV-positive persons who abuse drugs by 
injection in Western and Central Europe are unaware that 
they have been infected with HIV; and the prevalence of 
drug abuse by injection in Europe is estimated at 2.5 per 
1,000 adults aged 15-64.  
759. Polydrug abuse remains a key problem in Europe. 
In many European countries, more than a quarter of the 
people entering treatment for drug abuse reported having 
concurrently abused cocaine and heroin. In Europe, 
cocaine (including “crack” cocaine) was the most 
frequently reported secondary drug of abuse among 
persons entering treatment for drug abuse. Many people 
undergoing treatment for cannabis abuse also reported 
the abuse of alcohol or other drugs.  
760. The European Union Integrated Project Driving 
under the Influence of Drugs, Alcohol and Medicines,  
in which the degree of impairment caused by 
psychoactive drugs and their impact on road safety were 
studied, revealed that among all seriously injured drivers 
sampled between 2007 and 2010 in Belgium, Denmark, 
Finland, Italy, Lithuania and the Netherlands, the most 
prevalent substances identified after alcohol were THC 
(0.5-7.6 per cent) and benzodiazepines (0-10.2 per cent). 
The study also found that, among drivers killed in the  
period 2006-2009 in Finland, Norway, Portugal and 
Sweden, the most prevalent substances sampled were 
benzodiazepines (1.4-13.3 per cent), amphetamines  
(0-7.4 per cent) and THC (0-6.1 per cent). 
 
 
 E. Oceania 
 
 
 1. Major developments 
 
761. An increase in the smuggling of cocaine into 
Oceania has posed a new challenge to drug control efforts 
in that region. In Australia, the number of cocaine-related 
offences has increased significantly in the past decade. 
The 2010 National Drug Strategy Household Survey 
report of the Australian Institute of Health and Welfare 
reveals that the annual prevalence rate of cocaine abuse in 
that country is higher than ever before. Large shipments 
of cocaine from South and Central America continue to 
be detected at the Australian border. Furthermore, 
according to the Australian law enforcement authorities, 
availability of cocaine has increased nationwide, despite 
the fact that the price of cocaine in Australia is 
significantly higher than in many other countries of the 
region. New Zealand, Fiji and Tonga have also reported 
an increase in cocaine seizures.  
762. Organized crime syndicates are actively involved in 
drug trafficking in Oceania. Evidence shows that West 
African drug syndicates have established a significant 
presence in the region by trafficking heroin and 
methamphetamine into Australia and New Zealand. 
Furthermore, Mexican, Central American and South 
American crime syndicates have been identified as 
responsible for the smuggling of large shipments of 
cocaine into Australia. East and South-East Asian 
organized crime groups continue to maintain an 
advantage in smuggling crystalline methamphetamine 
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into Oceania. Sophisticated concealment methods used 
by organized crime syndicates are posing a significant 
challenge to detection by law enforcement authorities.  
763. Increased abuse of pharmaceutical preparations for 
non-medical purposes (mainly over-the-counter and 
prescription analgesics containing narcotic drugs) is 
another notable trend in Oceania. In Australia, the annual 
prevalence rate of abuse of such preparations among 
persons aged 14 years and older increased considerably, 
from 3.7 per cent in 2007 to 4.2 per cent in 2010, the 
second highest rate since 1995. The most widely abused 
preparations are analgesics: 73 per cent of abusers of such 
preparations used over-the-counter analgesics in the past 
12 months. The number of seizures of benzodiazepines 
for non-medical use has also increased significantly in the 
past two years. Illegal Internet pharmacies and diversion 
from licit distribution channels continue to be the main 
sources of supply of benzodiazepines. In New Zealand, 
the abuse of pharmaceutical preparations containing 
morphine or codeine is becoming more common. 
764. The Board welcomes the accession of the Marshall 
Islands to the United Nations Convention against Illicit 
Traffic in Narcotic Drugs and Psychotropic Substances of 
1988 in November 2010. However, the Board notes that 
nine States in Oceania have yet to become parties to the 
international drug control treaties. Many of those 
countries have become trans-shipment areas and 
destinations for trafficked drugs and precursors. Their 
long coastlines have facilitated drug trafficking activities, 
and the growing abuse of cannabis and amphetamines has 
also become a concern. The Board has urged all States 
concerned, namely the Cook Islands, Kiribati, Nauru, 
Palau, Papua New Guinea, Samoa, Solomon Islands, 
Tuvalu and Vanuatu, to accede to the international drug 
control treaties to which they are not yet parties without 
further delay. 
 
 2. Regional cooperation 
 
765. The Australasian Chemical Diversion Congress 
2010 was held in Perth, Australia, in December 2010. The 
Congress, which is held annually, brought together 
experts from countries in the region of Asia and the 
Pacific to develop effective solutions to the increase in the 
illicit manufacture of drugs, which is directly linked to 
the diversion of precursor chemicals. Participants in the 
Congress called for close cooperation between law 
enforcement authorities, other government agencies and 
the chemical and pharmaceutical industry. In February 
2011, a conference on the theme “Resilience in the 
Pacific: addressing the critical issues” was held in 
Wellington with the participation of senior officials of the 
Pacific Islands Forum secretariat and the Government of 
New Zealand. The conference highlighted drug 
trafficking as a threat to safety and security in the region 
and participants called for cohesive efforts in addressing 
that threat.  
766. The annual meeting of the Pacific Drug and 
Alcohol Research Network for 2011 was held in  
Fiji in August 2011. Representatives from 12 countries in 
the region and delegates from the World Health 
Organization and research institutes attended the 
meeting. Participants presented information on current 
drug- and alcohol-related issues affecting their countries. 
The meeting highlighted the importance of strengthening 
drug-related research and data collection and analysis  
in the region, including through the implementation of a 
regional cannabis survey with the assistance of UNODC 
and regional organizations. 
767. The Australian Federal Police continued to expand 
the Pacific Police Development Programme in 2010. The 
programme supports capacity-building initiatives in 
various countries in the region, including Nauru, Papua 
New Guinea, Samoa and Tonga. Under the programme, 
various training workshops on practice and procedures in 
the area of criminal investigation and forums to enhance 
forensic capacity have been held across the region. In 
2010, the Government of New Zealand continued to 
provide the drug control authorities of Fiji and Tonga 
with technical and financial assistance. 
768. The traffic in drugs and precursors from East and 
South-East Asia has a serious impact on Oceania. In 
2010, New Zealand and China signed a joint declaration 
with a view to reducing the smuggling of pharmaceutical 
preparations containing pseudoephedrine from China to 
New Zealand. In March 2011, the Australian Federal 
Police signed a memorandum of understanding with the 
National Narcotics Board of Indonesia with the aim of 
making efforts to combat drug trafficking more effective.  
 
 3. National legislation, policy and action 
 
769. In February 2011, the Government of Australia 
endorsed a national drug strategy for the period 2010-
2015, the three pillars of which are demand reduction, 
supply reduction and harm reduction. Within the 
framework of the strategy, seven “sub-strategies” will be 
updated or developed to address specific priorities, such 
as the abuse of pharmaceutical preparations for non-
medical purposes and the strengthening of drug-related 
data collection and analysis.  
770. Recognizing the serious threat posed by organized 
crime in Australia, the Government of Australia  
has introduced a series of countermeasures. In  
December 2010, the Commonwealth Organized Crime 
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Response Plan 2010-2011 was adopted with the aim of 
guiding national action to combat three forms of 
organized crime identified as priority risks, namely 
money-laundering, trafficking in and abuse of 
amphetamine-type stimulants and identity crime. In 
February 2011, the Government of Australia passed the 
Crimes Legislation Amendment Bill 2010 to ensure that 
law enforcement agencies have the powers necessary in 
order for them to carry out their tasks to disrupt 
organized crime. Furthermore, multi-agency teams 
responsible for investigating organized crime have been 
established across Australia. 
771. In April 2011, new national guidelines on the 
remediation of sites used for the illicit manufacture of 
drugs were introduced in Australia. The guidelines set out 
a step-by-step process to be followed by law enforcement 
agencies in determining the remediation of contaminated 
sites, since 71 per cent of clandestine laboratories in 
Australia are found in residential areas and thus pose 
serious potential health and environmental risks. In  
July 2011, the Customs Act was amended to allow 
accredited customs officers to use body-scanning 
technology as one of the means of detecting drug couriers 
who conceal drugs internally. 
772. In February 2011, the New Zealand Police updated 
its methamphetamine control strategy, which focuses on 
disrupting methamphetamine supply chains through 
intelligence-led operational activities. In August 2011, the 
Misuse of Drugs Amendment Act, which establishes that 
pharmaceutical preparations containing ephedrine or 
pseudoephedrine may be purchased only with a 
prescription, was approved by the Parliament of New 
Zealand.  
773. Although countries in Oceania have not reported 
widespread abuse of synthetic cannabinoid receptor 
agonists that are not under international control, a recent 
increase in the availability of such substances and in 
reports of adverse effects associated with their abuse have 
led to increased public concern. As a result, in  
August 2011, the Government of New Zealand 
temporarily banned 43 products containing synthetic 
cannabinoids for a period of 12 months pending 
assessment by the health authorities as to whether those 
substances should be controlled. Several states in 
Australia have prohibited the sale of products containing 
synthetic cannabinoid receptor agonists.  
774. In view of the increasing availability and abuse of 
new psychoactive substances, the Government of 
Australia has required import authorizations for  
11 substances not under international control as of 
December 2010. These substances included 
alkoxyamphetamines, BZP and 4-methylmethcathinone 
(mephedrone), the so-called “designer drugs” in the 
groups of stimulants and piperazines. Ketamine, a 
substance not under international control, was classified 
as a controlled substance in New Zealand in May 2010. 
775. The Government of Fiji, with the assistance of 
UNODC, has established a national learning centre 
against money-laundering that provides computer-based 
training to law enforcement officials in that country. The 
Government of the Marshall Islands is funding a project 
for the period 2009-2013 to reduce substance-abuse 
problems in communities and to develop prevention 
strategies at the national and community levels. In 
Solomon Islands, a national youth policy for the  
period 2010-2015 has been drawn up, of which one of the 
key pillars is to reduce youth crime, including drug-
related offences.  
 
 4. Cultivation, production, manufacture and 
trafficking 
 
 (a) Narcotic drugs 
 
776. Cannabis continues to be the most commonly 
seized drug in Oceania. In Australia, it accounted for  
70 per cent of drug seizures and for 76 per cent of the 
volume of drugs seized nationwide from July 2009 to  
June 2010. Nearly six tons of cannabis were seized, 
compared to 5.5 tons seized during the period July 2008-
June 2009. From July 2009 to June 2010, the Australian 
customs authorities seized about 20 kg of cannabis, most 
of which was concealed in mail. The United States was the 
main country of embarkation for those shipments, 
followed by the United Kingdom and Papua New Guinea. 
Widespread domestic cultivation remains the main 
source of cannabis in Australia. According to the 
Australian authorities, there is a well-established link 
between criminal groups and large-scale commercial 
cultivation of cannabis in Australia. Between July 2009 
and June 2010, three clandestine laboratories used for the 
extraction of cannabis oil were detected and dismantled. 
777. Illicit cultivation of cannabis plant is the primary 
source of cannabis supply in New Zealand. In 2010, 
nearly 160,000 cannabis plants were eradicated, a similar 
number having been seized in 2009. In addition, 820 kg of 
cannabis herb were seized. The Netherlands was the main 
country of embarkation for shipments of cannabis herb 
seized at the New Zealand border, followed by the United 
Kingdom and France. The New Zealand authorities 
indicate that organized criminal groups have been linked 
with the large-scale cultivation and distribution of 
cannabis in New Zealand. 
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778. According to UNODC, cannabis plant is cultivated 
widely in Fiji, Papua New Guinea, Samoa, Solomon 
Islands, Tonga and Vanuatu. Some varieties of cannabis 
illicitly cultivated in those countries are regarded as some 
of the most potent available worldwide. Eradication 
campaigns have been carried out in Fiji and Solomon 
Islands. 
779. The quantity of heroin seized in Australia decreased 
by 35 per cent from 295 kg during the period  
July 2008-June 2009 to 192 kg during the period  
July 2009-June 2010. However, preliminary data for the 
period from July 2010 to June 2011 indicated that heroin 
seizures had increased significantly compared with the 
period July 2009-June 2010. In November 2010, the 
Australian authorities detected and seized a shipment 
from Malaysia containing 168 kg of heroin, the  
fifth largest heroin seizure in Australian history.  
South-East Asia and West Asia remain the key source 
regions for heroin trafficked into Australia. Cambodia 
and Viet Nam have become major transit countries for 
heroin destined for the Australian market. Between  
July 2009 and June 2010, most seized shipments of heroin 
departed, in descending order, from Cambodia, Viet 
Nam, Afghanistan, Singapore and Pakistan. During the 
same period, shipments that had departed from 
Bangladesh, India and Nigeria were also seized, which 
indicates that traffickers are looking for new trafficking 
routes. 
780. West African criminal groups have developed a 
significant presence in smuggling heroin into Australia. 
They have established their networks in Pakistan,  
India and countries in South-East Asia. Furthermore, 
nationals of East and South-East Asian countries continue 
to be involved in the Australian heroin market. It is 
expected that organized criminal groups will continue  
to target Australia as a destination for heroin, mainly  
as a consequence of increased opium production in  
South-East Asia and high heroin prices in Australia.  
781. Large seizures of opium are not commonly reported 
in Oceania. However, recent seizures show that opium is 
increasingly being trafficked into Australia and New 
Zealand from the Islamic Republic of Iran. In  
March 2011, a shipment from the Islamic Republic of Iran 
containing 170 kg of opium was detected by the 
Australian customs authorities. The drug was concealed 
in 200 glass jars labelled as tomato paste. In May 2011, a 
further 10 kg of opium was detected in air cargo from the 
Islamic Republic of Iran. New Zealand also reported 
seizures of opium, the bulk of which had been trafficked 
from the Islamic Republic of Iran via India and Thailand. 
782. There are indications that the cocaine market in 
Australia is expanding. From July 2009 to June 2010, a 
total of 782 kg of cocaine was seized in Australia, most of 
which had originated in Colombia and Peru. Cocaine 
shipments seized at the Australian border arrived from a 
variety of countries, chiefly from countries in North 
America and to a lesser extent from Central America and 
South America. During the same period, Nigeria emerged 
as a major embarkation country for cocaine shipments 
destined for Australia. Mexican, Central American and 
South American criminal groups have been involved in 
trafficking cocaine into Australia. In a joint operation 
carried out in October 2010, the Australian law 
enforcement agencies seized 464 kg of cocaine at a small 
sea port in Queensland, the third largest quantity of 
cocaine ever seized in Australia. Three traffickers with 
links to organized crime syndicates in Australia and 
South America were arrested after the cocaine was 
transferred from a large vessel in the Pacific Ocean to a 
small craft, which was used to transport the drugs to a 
non-commercial port. In May 2011, a joint operation led 
to the disbanding of a drug syndicate operating in 
Australia, Colombia and Panama and the seizure of 50 kg 
of cocaine suspended in barrels of hydraulic oil. In 
September 2011, a shipment of 270 kg of cocaine that had 
departed from Brazil was seized in Melbourne, Australia. 
783. The quantity of cocaine seized in New Zealand has 
also increased, from 3 kg in 2009 to nearly 10 kg in 2010. 
Until recently, cocaine demand in New Zealand had been 
limited and New Zealand had been used as a transit 
country for cocaine shipments destined for Australia. 
However, it appears that the bulk of the cocaine seized in 
2010 was intended to supply the New Zealand market. 
Most of the cocaine seized was carried by drug couriers 
arriving on flights from South America. Internal 
concealment, a method not commonly seen in New 
Zealand previously, has become a common modus 
operandi. Between September 2010 and April 2011, the 
New Zealand Customs Service detected seven drug 
couriers who were carrying drugs, including cocaine, 
methamphetamine and opium, internally.  
784. In 2011, the law enforcement authorities of Fiji and 
Tonga seized small amounts of cocaine, some of which 
were believed to be destined for other countries. 
 
 (b) Psychotropic substances 
 
785. Trafficking in amphetamine-type stimulants 
continues to be a serious concern in Australia. The illicit 
domestic manufacture of such substances remains robust. 
A record 585 clandestine laboratories used for the 
manufacture of amphetamine-type stimulants (other than 
MDMA (“ecstasy”)) were dismantled between July 2009 
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and June 2010, compared with 297 during the period  
July 2008-June 2009, an increase of 97 per cent. In 
addition, 17 clandestine “ecstasy” laboratories were 
dismantled between July 2009 and June 2010. In  
June 2011, the Australian authorities dismantled one of 
the largest clandestine laboratories — with the capacity to 
manufacture up to 70 kg of methamphetamine and 
comparable quantities of “ecstasy” — ever to have been 
discovered in Australia. The operation resulted in the 
arrest of five criminals and the seizure of more than  
2.5 tons of precursors. The criminals operating the 
laboratory were identified as the principal organizers of a 
drug syndicate involved in the manufacture and 
distribution of methamphetamine and “ecstasy” in 
Australia.  
786. A small proportion of amphetamine-type 
stimulants seized in Australia continues to be smuggled 
from abroad. From July 2009 to June 2010, South Africa 
and Spain were the two main embarkation countries for 
shipments of such substances destined for Australia, 
followed by China (including Hong Kong). Seizure data 
for the period July 2009-June 2010 indicate that Singapore 
was used as a significant transit point for such shipments 
en route to Australia. Crystalline methamphetamine was 
smuggled primarily by post and by drug couriers 
travelling on commercial flights. Australian criminal 
groups with links to criminal groups based in East and 
South-East Asia maintain an advantage in trafficking 
crystalline methamphetamine into Australia. The 
quantity of amphetamine-type stimulants seized in 
Australia fell from 1,640 kg during the period July 2008-
June 2009 to 671 kg during the period July 2009- 
June 2010, a decrease of 59 per cent. However, in May 
2011, the Australian authorities seized 239 kg of 
methamphetamine, the largest quantity of that substance 
ever seized in Australia. 
787. In New Zealand, the quantity of methamphetamine 
seized in 2010 reached 30 kg, about 65 per cent of which 
was trafficked from abroad. For the first time, the United 
Arab Emirates was identified as the main embarkation 
country for methamphetamine shipments bound for New 
Zealand via Australia, Hong Kong and Indonesia in 2010. 
In 2011, two shipments of methamphetamine, one from 
South Africa and the other from Hong Kong, China, were 
found to have been smuggled with the involvement of 
West African criminal groups. In addition, drug couriers 
from South-East Asia continue to smuggle crystalline 
methamphetamine into New Zealand. Given that New 
Zealand legislation on precursors used in the 
manufacture of amphetamine-type stimulants has been 
strengthened, it is likely that the smuggling of 
methamphetamine into New Zealand will continue to 
increase. 
788. In New Zealand, clandestine laboratories are 
another important source of illicitly manufactured 
amphetamine-type stimulants. In 2010, a total of  
130 clandestine laboratories were dismantled, the 
majority of which had manufactured methamphetamine. 
Some were used for the extraction of pseudoephedrine 
from pharmaceutical preparations. Operation 
Hammerhead of the New Zealand Police led to the 
detection of laboratories used for the manufacture of 
methamphetamine, MDMA (“ecstasy”) and other drugs. 
In a separate operation carried out by the New Zealand 
Police in February 2011, a large methamphetamine 
manufacturing and supply chain was successfully 
disrupted, a clandestine methamphetamine laboratory 
was dismantled, 30 people were arrested and large 
quantities of methamphetamine were seized.  
789. During the period 2009-2010, more than  
15,000 methamphetamine tablets were seized by 
authorities in Fiji. Samoa and Tonga also reported 
methamphetamine seizures during the same period. 
790. The quantity of MDMA (“ecstasy”) seized in 
Australia decreased by 50 per cent from the period  
July 2008-June 2009 to the period July 2009-June 2010, 
consistent with falling demand for the substance in that 
country. All of the shipments seized were of less than  
1 kg. Canada was the primary embarkation country for 
“ecstasy” shipments destined for Australia, followed by 
Taiwan Province of China, the United States and Ireland. 
Domestic manufacture of “ecstasy” continues to be 
reported in Australia. Between July 2009 and June 2010, 
17 clandestine “ecstasy” laboratories were destroyed.  
791. In Australia, the non-medical use of 
benzodiazepines is an ongoing problem. The number of 
seizures of unauthorized imports of benzodiazepines 
increased substantially from 206 seizures during the 
period July 2008-June 2009 to 585 during the period  
July 2009-June 2010. Most of those shipments were 
ordered through illegal Internet pharmacies and 
dispatched by mail from India, Thailand, the United 
Kingdom and Pakistan. Benzodiazepines were also 
diverted from domestic licit distribution channels, inter 
alia, through over-prescription, forged prescriptions and 
the practice of obtaining prescriptions for controlled 
substances from multiple physicians (“doctor shopping”). 
 
 (c) Precursors 
 
792. In Australia, legislative changes are making it 
increasingly difficult for traffickers to divert ephedrine 
and pseudoephedrine. Trafficking in ephedrine and 
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pseudoephedrine into Australia decreased significantly 
from July 2009 to June 2010. While East and  
South-East Asian countries (mainly China and Viet Nam) 
continue to be the main source countries of ephedrine 
and pseudoephedrine seizedat the Australian border, 
Egypt was identified as the embarkation country of  
two shipments of ephedrine and pseudoephedrine seized 
in 2009 and 2010. In spite of a decrease in the quantity of 
those substances seized at the border, the large number of 
clandestine laboratories manufacturing amphetamine-
type stimulants that have been detected in Australia 
shows that precursors continue to be diverted from 
various domestic sources. Between July 2009 and  
June 2010, 44 clandestine laboratories used solely for the 
extraction of ephedrine and pseudoephedrine from 
pharmaceutical preparations were identified. 
793. The New Zealand national action plan for tackling 
methamphetamine resulted in fewer seizures of ephedrine 
and pseudoephedrine in 2010. A total of 967 kg was 
seized at the New Zealand border during that year, 
representing a decrease of 20 per cent from the record  
1.2 tons seized during 2009. However, seizure data for the 
first four months of 2011 showed that ephedrine and 
pseudoephedrine continued to be trafficked from abroad 
in the form of pharmaceutical preparations. Between 
January and April 2011, at least 194 kg of ephedrine and 
pseudoephedrine were seized by the New Zealand 
Customs Service. In April 2011, a large shipment of 
tablets containing a total of 68 kg of pseudoephedrine was 
seized in New Zealand. While China remains a major 
source country, there are signs of an increasing diversity 
of sources for ephedrine and pseudoephedrine smuggled 
into New Zealand. At the same time, it appears that 
traffickers are adapting their modi operandi, increasingly 
smuggling small but multiple packages. Another notable 
trend is that some clandestine laboratories manufacturing 
amphetamine-type stimulants that were dismantled in 
New Zealand used alternative methods that do not 
require the use of ephedrine or pseudoephedrine, such as 
the use of P-2-P and the extraction of ephedrine from 
ephedra. 
794. Evidence shows that Fiji is emerging as both a 
transit area and a final destination for illicit shipments of 
pseudoephedrine. Over the course of 2009 and 2010, at 
least eight shipments of pharmaceutical preparations 
containing pseudoephedrine were seized in Fiji en route 
to New Zealand. In July 2010, one of the largest recorded 
shipments of pharmaceutical preparations containing 
pseudoephedrine was seized in Fiji. The shipment had 
arrived from China via Australia and New Zealand. That 
seizure pointed to the possibility of domestic 
manufacture of amphetamine-type stimulants in Fiji. 
Very few seizures of precursors have been reported by 
countries in Oceania other than Australia, Fiji and New 
Zealand, and the extent of precursor trafficking in those 
other countries is unknown.  
 
 (d) Substances not under international control  
 
795. While demand for ketamine and GBL is very 
limited in Oceania, seizures of those substances continue 
to be reported. In Australia, 22 shipments of ketamine 
and 44 of GBL were seized between July 2009 and  
June 2010, most of which had been smuggled in mail. In 
New Zealand, abuse of GBL is particularly common both 
in nightclubs and at private parties. In April 2011, New 
Zealand customs officers detected two packages 
containing a total of 1.2 litres of GBL concealed in nail 
polish bottles that had arrived from the United States. 
796. In New Zealand, some 45,000 “ecstasy” tablets were 
seized in 2010, nearly three times as many as in 2009. 
However, forensic analysis continues to show that such 
tablets contain very little or no MDMA; instead, they 
consist mainly of other substances, such as BZP, 
mephedrone, ketamine and caffeine. A clandestine 
laboratory dismantled in New Zealand in 2010 was found 
to have manufactured “ecstasy” tablets containing 
substances other than MDMA. The laboratory appeared 
to have been supplying significant quantities of “ecstasy” 
tablets on the New Zealand market.  
 
 5. Abuse and treatment 
 
797. Cannabis remains the drug most commonly abused 
in Oceania, mainly owing to its availability and low price. 
In Australia, the annual prevalence rate of cannabis abuse 
increased from 9.1 per cent in 2007 to 10.3 per cent in 
2010, following a steady decline between 1998 and 2007. 
A total of 1.9 million people were estimated to have 
abused cannabis in 2010. More than 50 per cent of the 
population aged 30-39 years had abused cannabis at some 
time in their lives, a proportion similar for both males 
and females within that group and higher than that of any 
other age group. In New Zealand, while there has been a 
decline in cannabis abuse among the general population 
in the past few years, the annual prevalence rate of such 
abuse among persons aged 15-45 years stands at 18 per 
cent.  
798. MDMA (“ecstasy”) is the second most widely 
abused drug in Australia. For the first time since 1995, 
the annual prevalence of “ecstasy” abuse in Australia 
decreased from its peak of 3.5 per cent in 2007 to 3 per 
cent in 2010, a rate nonetheless among the highest 
worldwide. Such abuse was highest among the population 
aged 20-29 years, of whom some 10 per cent had used 
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“ecstasy” in the previous 12 months. Abuse of 
amphetamine and methamphetamine has continued to 
decrease in Australia in recent years, the annual 
prevalence rate of such abuse falling slightly from 2.3 per 
cent in 2007 to 2.1 per cent in 2010.  
799. In New Zealand, MDMA (“ecstasy”) is the second 
most commonly abused drug. A survey conducted in 
2009 showed that persons who frequently abused 
“ecstasy” had used several other illicit drugs in the 
previous six months, including cannabis (89 per cent of 
respondents) and lysergic acid diethylamide (LSD)  
(47 per cent of respondents).  
800. Cocaine abuse in Australia has been increasing 
steadily since 2004 and reached its highest level in 2010. 
Among persons aged 14 or older, the annual prevalence 
rate of cocaine abuse rose significantly, from 1.6 per cent 
in 2007 to 2.1 per cent in 2010 (i.e., the number of abusers 
of cocaine increased by 100,000). That increase was 
largely the result of an increase in abuse of that substance 
among females aged 20-29 years, from 3.1 per cent in 
2007 to 5 per cent in 2010. A recent survey in Australia 
also reveals that cocaine abuse has increased significantly 
among persons living in large cities, persons with higher 
academic qualifications, employed persons and persons 
of the highest socio-economic status. In New Zealand, 
cocaine abuse has increased since 2003. Fiji, Samoa and 
Solomon Islands also reported abuse of cocaine.  
801. The Australian authorities reported increased abuse 
of pharmaceutical preparations for non-medical purposes 
in 2010. In terms of lifetime prevalence, males are more 
likely than females to have used such preparations for 
non-medical purposes. The rate of abuse of tranquillizers 
is high among persons aged 20-29 years. In New Zealand, 
abuse of heroin illicitly manufactured using 
pharmaceutical preparations containing morphine or 
codeine (known as “homebake heroin”) is becoming more 
common. 
802. It is estimated that between 14,500 and  
25,000 persons abuse drugs by injection in countries of 
Oceania other than Australia and New Zealand; of that 
total, an estimated 1.4 per cent are infected with HIV. In 
French Polynesia, persons who abuse drugs by injection 
account for 11.7 per cent of the total population infected 
with HIV; in New Caledonia, they account for 10 per cent 
of that total and in the Federated States of Micronesia,  
3.2 per cent. 
803. In Australia, cannabis was the second most 
common substance of abuse (after alcohol) for which 
treatment was sought during the period July 2008- 
June 2009, accounting for 23 per cent of the total  
number of persons treated, followed by heroin (10 per 
cent), amphetamine-type stimulants (9 per cent), 
benzodiazepines (1.5 per cent), methadone (1.5 per cent), 
MDMA (“ecstasy”) (1 per cent) and cocaine (0.3 per 
cent). The majority of persons who received treatment 
were aged 20-39 years. Overall, counselling has remained 
the most common treatment type (37 per cent), followed 
by detoxification (16 per cent). Of those who received 
treatment, 67 per cent were male, except in the case of 
treatment for abuse of benzodiazepines.  
804. The number of Australians receiving opioid 
substitution treatment continues to rise, and the 
proportion of older persons within that group is 
increasing. On a randomly selected day in June 2010, a 
total of 46,000 persons were receiving opioid substitution 
treatment, an increase of more than 2,600 persons 
compared with 2009, consistent with the increase in 
substitution treatment in recent years. Of the total 
number of persons receiving such treatment, the 
proportion of persons aged 30 years and older increased 
from 72 per cent in 2006 to 82 per cent in 2010. Males 
accounted for about two thirds of the total number of 
persons treated in 2010. Consistent with previous years, 
approximately 70 per cent of persons treated in 2010 
received methadone, while 30 per cent received 
buprenorphine or a combination of buprenorphine and 
naloxone. Opioid substitution treatment is also available 
in prisons in Australia. 
805. In New Zealand, there are a variety of drug abuse 
treatment services targeting different population groups, 
including hospital-based or specialized services that 
incorporate detoxification and substitution therapy and 
services offered by non-governmental organizations that 
provide counselling, support and residential and intensive 
day treatment programmes. The Department of 
Corrections funds drug treatment units in prisons. There 
are also some services for the treatment of children and 
youth who abuse alcohol or drugs. In addition, the 
Community Alcohol and Drug Services (CADS) provides 
cost-free services relating to the abuse of alcohol and 
other drugs to people living in the Auckland region. 
806. The Government of New Zealand has taken 
initiatives to increase the capacity of services for the 
treatment of drug abuse to treat abusers of 
methamphetamine. Since November 2009, a total of  
80 additional residential treatment beds have been 
established and have served nearly 280 new admissions. 
In November 2010, the Government of New Zealand 
developed guidelines for interventions and treatment for 
the problematic use of methamphetamine and other 
amphetamine-type stimulants. The purpose of the 
guidelines is to provide health-care workers with practical 
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information on potential treatment options that can be 
used in a variety of settings and contexts.  
807. With regard to other countries in Oceania, data 
from UNODC and school surveys conducted in some of 
those countries indicate that the abuse of cannabis and 
amphetamine-type stimulants, in particular among young 
people, remains a concern. School-based prevention 
activities appear to be developing, and treatment, where 
available, appears to be part of services relating to general 
and mental health. However, no comprehensive data are 
available with regard to the extent and nature of drug 
abuse among the general population in those countries. 
Lack of drug abuse research and surveillance makes it 
difficult for the Governments of those countries to devise 
effective and targeted prevention and treatment policies 
and strategies. The Board therefore encourages the 
Governments of Australia and New Zealand to continue 
to share expertise and provide assistance in establishing 
routine monitoring of patterns and trends in drug abuse 
in other parts of Oceania. 
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IV. Recommendations to Governments, the United Nations and other 
relevant international and regional organizations 
 
 
808. The Board monitors the implementation by 
Governments of the three international drug control 
conventions and examines the functioning of  
the international drug control system at the national  
and international levels. Based on its assessment, the 
Board makes recommendations to Governments  
and international organizations to support the 
implementation of the conventions. 
809. The present chapter highlights the key 
recommendations contained in chapters II and III of this 
report. The recommendations contained in chapter I are 
not included in chapter IV. Additional specific 
recommendations to address the control of precursors are 
contained in the 2011 report of the Board on the 
implementation of article 12 of the 1988 Convention.30 
The Board encourages Governments and relevant 
international and regional organizations to examine all 
the recommendations made by the Board and to 
implement them without delay, as appropriate. The Board 
calls on the Governments concerned to inform the Board 
of their action in response to the recommendations. 
 
 
 A. Recommendations to Governments 
 
 
810. The recommendations to Governments are grouped 
according to the following subject areas: treaty accession; 
treaty implementation and control measures; and 
prevention of illicit drug production, manufacture, 
trafficking and abuse. 
 
 1. Treaty accession 
 
811. The 1961 Convention as amended by the  
1972 Protocol, the 1971 Convention and the  
1988 Convention are the framework of the international 
drug control system. The accession of all States and the 
universal implementation of the provisions of the 
conventions are a basic prerequisite for effective drug 
control worldwide. 
__________________ 
 30  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic Substances: 
Report of the International Narcotics Control Board for 2011 
(United Nations publication, Sales No. E.12.XI.4). 
Recommendation 1: The Board notes that a total of  
16 States31 have not yet become parties to all of the 
international drug control treaties. In addition, 
Afghanistan and Chad need to accede to the  
1972 Protocol. The Board urges the Governments 
concerned to take the steps necessary to accede to all the 
international drug control treaties without further delay. 
Recommendation 2: The Board welcomes the accession  
of the Marshall Islands to the 1988 Convention in  
November 2010. However, the Board notes that  
nine States in Oceania have yet to become parties to the 
international drug control treaties. Many of those 
countries have become trans-shipment areas and 
destinations for trafficked drugs and precursors. Abuse of 
cannabis and amphetamines has also increased in the 
region. The Board therefore urges again the Cook 
Islands, Kiribati, Nauru, Palau, Papua New Guinea, 
Samoa, Solomon Islands, Tuvalu and Vanuatu to accede, 
without further delay, to those international drug 
control treaties to which they are not yet parties. 
 
 2. Treaty implementation and control measures 
 
812. Universal accession to the three international drug 
control treaties is necessary but not sufficient to address 
drug-related problems. In addition, it will require 
universal implementation of all the provisions of the 
treaties and the effective application of the necessary 
control measures by all Governments. 
Recommendation 3: Some Governments do not submit 
statistical reports on internationally controlled substances 
as required under the international drug control treaties. 
This lack of compliance with reporting obligations could 
be an indication that those Governments are not fully 
able to exercise the treaty-mandated controls over the 
movement of scheduled substances. The Board reminds 
those Governments of their treaty obligations and 
encourages them to take steps that would allow them to 
improve their reporting performance in the future.  
Recommendation 4: Certain parties have not fully 
complied with their obligations under the international 
drug control treaties, as some of their state and/or 
provincial legislative and judicial structures have 
implemented action contrary to the treaties. The Board 
__________________ 
 31  Cook Islands, Equatorial Guinea, Haiti, Holy See, Kiribati, 
Liberia, Nauru, Palau, Papua New Guinea, Samoa, Solomon 
Islands, Somalia, South Sudan, Timor-Leste, Tuvalu and 
Vanuatu. 
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calls upon the States parties concerned to take all 
necessary measures to ensure that state and/or 
provincial policies and measures do not undermine 
efforts to combat drug abuse and trafficking in narcotic 
drugs, psychotropic substances and precursor chemicals. 
 
 (a) Narcotic drugs and psychotropic substances 
 
Recommendation 5: In March 2011, the Board launched a 
special report entitled Report of the International 
Narcotics Control Board on the Availability of 
Internationally Controlled Drugs: Ensuring Adequate 
Access for Medical and Scientific Purposes,32 as a 
supplement to its annual report for 2010. In its special 
report, the Board brought to the attention of 
Governments and the general public the stark contrast in 
consumption levels in the different regions of the world. 
The special report also contained recommendations on 
availability, appropriate use, national control systems and 
prevention of diversion and abuse of controlled drugs. 
The Board encourages Governments to implement those 
recommendations contained in the special report which 
are relevant to their country. The Board will in due time 
analyse, in cooperation with Governments and WHO, 
the level of implementation of those recommendations.  
Recommendation 6: The Board has developed, in 
cooperation with WHO, a guide on estimating 
requirements for substances under international control, 
which will be launched in 2012. The intent of the guide is 
to assist competent national authorities in identifying the 
most appropriate method for calculating the quantities of 
internationally controlled substances required for medical 
and scientific purposes in their country. The Board 
expects the guide to be used by all Governments, in 
particular those that until now were not in a position to 
calculate their estimates of narcotic drugs and 
assessments of psychotropic substances, for lack of 
technical expertise. 
Recommendation 7: The Board notes with appreciation 
that some Governments had submitted for 2010 data on 
the consumption of some or all psychotropic substances 
used on their territory for medical and scientific 
purposes, pursuant to the Board’s recommendation and 
Commission on Narcotic Drugs resolution 54/6. The 
Board encourages all other Governments to follow suit 
and take measures that would allow them to collect 
reliable data on consumption levels of psychotropic 
substances on their territory and to report those data to 
the Board. 
__________________ 
 32  United Nations publication, Sales No. E.11.XI.7. 
Recommendation 8: Traffickers have not stopped trying to 
divert narcotic drugs or psychotropic substances from 
international trade. The Board reiterates its call for 
Governments to remain vigilant and to monitor 
international trade in the substances subject to the 
control regime laid down in the international drug 
control conventions and the related resolutions. In 
particular, Governments should ensure implementation 
of the system of estimates and assessments, extend the 
import and export authorization requirement to all 
substances in Schedules III and IV of the  
1971 Convention and verify the authenticity of all 
import orders that they consider to be suspicious with 
the competent authorities of the importing countries, or 
with the Board.  
Recommendation 9: Many internationally controlled 
substances have been found to be diverted from domestic 
distribution channels. The Board therefore requests 
Governments to thoroughly investigate the sources of 
the diverted substances and to inform the Board of the 
results of their investigations.  
Recommendation 10: Some Governments have 
experienced problems in addressing non-compliance by 
national stakeholders with some of the control measures 
aimed at preventing diversion from domestic distribution 
channels. The penalties that are applicable to individuals 
or companies found to be negligent or unethical were in 
some cases inadequate to prevent persons from 
cooperating with traffickers. The Board encourages all 
Governments to examine whether the penalties foreseen 
under their national drug control legislation are 
sufficient to deter such problems and, if not, to revise 
their laws accordingly.  
Recommendation 11: One growing problem is the 
diversion of preparations containing buprenorphine from 
domestic distribution channels, to be subsequently 
abused in the countries of diversion or smuggled into 
other countries where there is illicit demand for them. 
The Board urges Governments of all countries in which 
buprenorphine is used for licit purposes to remain 
vigilant and to adopt appropriate control measures, 
while making the substance available for use in medical 
treatment. The Board also encourages Governments of 
those countries into which buprenorphine continues to 
be smuggled to take action against such smuggling and 
to closely cooperate with the other countries concerned 
in order to prevent trafficking in buprenorphine.  
 
 (b) Precursors  
 
Recommendation 12: The pre-notification of export of 
precursors is an important tool in the international 
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precursor control system. Some countries, however, do 
not have in place domestic systems that would allow them 
to provide, prior to exporting precursor chemicals, 
notifications to the countries importing the chemicals. 
The Board urges all Governments to make sure that they 
are informed of any proposed export of precursors and 
to provide pre-export notifications, particularly to 
importing countries that have officially requested such 
notifications. Exporting countries are encouraged to 
systematically use the PEN Online system for all 
transactions, as the system is capable of sending  
pre-export notifications to all countries, including 
countries not yet registered with the system, via an 
integrated fax or e-mail option.  
Recommendation 13: Exporting countries are urged to 
ensure that their exports do not violate the applicable 
laws and regulations of the importing countries.  
Recommendation 14: In cases where there are grounds to 
believe that a shipment is suspicious, the Government of 
the exporting country should release the shipment only 
after receiving confirmation from the competent 
authority of the importing country. 
Recommendation 15: Governments of importing 
countries that have not yet done so should invoke  
article 12, paragraph 10 (a), of the 1988 Convention, 
which requires exporting countries to notify them prior 
to exporting precursors to their territory. 
Recommendation 16: Some Governments of importing 
countries are not reviewing and responding to pre-export 
notifications where necessary. In addition, significant 
amounts of precursors are intended for re-export but not 
all subsequent transactions appear to be traceable 
through the PEN Online system. Importing countries are 
reminded to provide timely feedback to exporting 
countries, if requested to do so, by using the reply 
function of the PEN Online system.  
Recommendation 17: Multilateral international 
cooperation is essential to identifying and responding to 
emerging trends in trafficking in precursors, illicit 
manufacture of drugs and new methods of diversion. In 
the framework of Project Cohesion and Project Prism, 
such cooperation and the dissemination of related 
information have provided tangible results, as evidenced 
most recently by Operation PAAD. Criminal trafficking 
organizations are becoming more and more resourceful, 
organized and adept at circumventing the growing 
number of control measures that have been introduced. 
The Board therefore urges Governments to actively 
contribute to the multilateral operations and activities 
under Project Cohesion and Project Prism, including by 
sharing strategic intelligence and offer information on 
suspicious orders, stopped shipments and seized 
precursors in real time. 
Recommendation 18: As the controlled precursors that 
have traditionally been used have become more costly to 
source, drug trafficking organizations have rapidly 
adapted to the situation by obtaining intermediates,  
“pre-precursors”, made-to-order chemicals or 
pharmaceutical preparations and natural products 
containing the controlled precursors. In March 2011, the 
Commission on Narcotic Drugs adopted resolution 54/8, 
in which it outlined measures to address the issue of 
pharmaceutical preparations containing ephedrine and 
pseudoephedrine. The Board welcomes the increased 
focus on shipments of ephedrine and pseudoephedrine 
in the form of pharmaceutical preparations and 
encourages Governments to implement the measures 
outlined in Commission on Narcotic Drugs resolution 
54/8. In addition, Governments, in cooperation with 
industry, are encouraged to apply more flexible 
approaches to identifying suspicious orders and 
preventing the diversion of new precursor chemicals. 
Where necessary, legislation should be introduced to 
allow for the investigation and prosecution of cases 
where such new chemicals are used in the illicit 
manufacture of drugs.  
Recommendation 19: Each year, the Board prepares its 
report on the implementation of article 12 of  
the 1988 Convention, and that report contains 
recommendations to Governments on the control of 
precursors. The Board calls on Governments to 
implement the recommendations contained in the 2011 
report of the Board on the implementation of article 12 
of the 1988 Convention.33  
 
 3. Prevention of illicit drug production, 
manufacture, trafficking and abuse 
 
813. Parties to the international drug control treaties 
have an obligation to limit to legitimate purposes the 
production, manufacture, export, import and distribution 
of, trade in and use of internationally controlled 
substances and to prevent their diversion and abuse. 
Recommendation 20: The Board notes with concern that 
the total area under illicit opium poppy cultivation in 
Afghanistan increased by 7 per cent in 2011 and that half 
of the country’s 34 provinces were involved in such 
cultivation. Potential illicit opium production also 
increased significantly, by 61 per cent, between 2010 and 
__________________ 
 33  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics Control 
Board for 2011 ... 
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2011. Progress in reducing illicit opium poppy cultivation 
in Afghanistan appears to be slow. The Board urges the 
Government of Afghanistan to take adequate measures 
to implement the National Drug Control Strategy and to 
ensure that illicit poppy cultivation in the country is 
reduced and effectively prevented, particularly through 
awareness and eradication campaigns, while providing 
alternative livelihoods for the farming community. 
Efforts should be made to sustain the progress already 
achieved. 
Recommendation 21: East and South-East Asia continues 
to be one of the main regions in which methamphetamine 
is illicitly manufactured. There are indications that 
methamphetamine has been illicitly manufactured on a 
large scale in the so-called Golden Triangle, as the 
amount of methamphetamine seized in the region 
increased in 2010. Furthermore, there is significant 
smuggling of methamphetamine within the region and 
from North America, West Africa and West Asia. The 
abuse of methamphetamine in East and South-East Asia 
has been increasing, particularly among young drug 
abusers. The Board urges Governments of countries in 
the region to devise appropriate and effective strategies 
to address the threats posed by trafficking in and abuse 
of methamphetamine and to strengthen regional 
cooperation in that regard.  
Recommendation 22: The abuse of prescription drugs 
(pharmaceutical preparations containing controlled 
substances) has become one of the fastest growing drug 
problems in several regions. The Board urges all 
Governments to enact comprehensive measures aimed at 
stemming the abuse of prescription drugs, in particular 
through the establishment of awareness-raising 
initiatives targeting the general public and health-care 
providers; the introduction of prescription monitoring 
programmes; the establishment of proper disposal 
mechanisms; and the enforcement of laws and 
regulations on prescribing drugs. 
Recommendation 23: Countries in Central America and 
the Caribbean have reported significant drug abuse. 
Organized criminal groups continue to use Central 
America and the Caribbean as a major trans-shipment 
area for illicit drug consignments. The Board hopes that 
the Governments of countries in Central America and 
the Caribbean will consider allocating additional 
resources to drug abuse prevention and the 
implementation of public health and drug abuse 
prevention programmes, focusing on campaigns for 
educating youth about the dangers of drug abuse and 
providing appropriate treatment for drug abusers. In 
addition, the Board encourages the Governments of 
countries in the region, with the assistance of 
international organizations, to consider concerted action 
in the area of crime prevention and criminal justice 
reform, as well as regional strategies to reduce drug 
trafficking.  
Recommendation 24: Authorities of countries in South 
America have detected illicitly manufactured 
amphetamine-type stimulants, including MDMA 
(“ecstasy”) and methamphetamine. The Board calls on 
Governments of countries throughout the region to be 
aware of the risk that their countries might be used for 
the illicit manufacture of amphetamine-type stimulants 
and to take appropriate measures to prevent such illicit 
activity from taking place in their countries. 
Recommendation 25: In recent years, the main cocaine-
manufacturing countries, in particular the Plurinational 
State of Bolivia, have also reported increasing seizures of 
cannabis. In 2009 and 2010, a total of about 3,000 tons of 
cannabis plant and herb were seized in the Plurinational 
State of Bolivia. In the past few years, increased seizures 
of cannabis herb were reported by Colombia and Peru. 
The Board calls on the Governments of those countries 
to determine, in cooperation with UNODC, the 
magnitude of and current trends in the illicit cultivation 
of cannabis plant on their territory and to further 
strengthen their efforts to combat such cultivation. 
Recommendation 26: The Board remains concerned about 
the increasing illicit cultivation of cannabis plant, in 
particular indoors, that continues to be reported by a 
number of countries in Europe. The Board calls on 
Governments to take effective measures to address that 
problem.  
Recommendation 27: Smuggling of drugs through Africa 
has become a serious threat to the development, stability 
and security of African countries. Cocaine from South 
America is trafficked through countries in West Africa, 
while heroin enters Africa through airports and seaports 
in East Africa. As a result, the abuse of those drugs is 
increasing in the African countries affected by such 
trafficking. The Board calls on the Governments of the 
African countries concerned to take effective measures 
to combat the smuggling of cocaine and heroin through 
their territory and to strengthen regional and 
interregional cooperation in that regard. Furthermore, 
the Board encourages the Governments of African 
countries to take appropriate measures to support the 
prevention of drug abuse and the treatment and 
rehabilitation of drug abusers. 
Recommendation 28: The Board has taken note with 
concern of recent reports indicating that the illicit 
manufacture of amphetamine-type stimulants might take 
hold in West African countries, including Nigeria. The 
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Board calls on the Governments of countries in West 
Africa to be aware of that risk and take the measures 
necessary to address the problem.  
Recommendation 29: The smuggling of pharmaceutical 
preparations containing precursors continues in countries 
in South Asia and East Asia. The Board urges the 
Governments of countries in Asia to cooperate on a 
regional basis and to remain vigilant in order to prevent 
the diversion of such pharmaceutical preparations. 
Those Governments should also make sure that their 
regulatory capacity keeps pace with developments in 
industry.  
Recommendation 30: Many Governments have reported 
that they have fully or almost fully implemented the 
Board’s Guidelines for Governments on Preventing the 
Illegal Sale of Internationally Controlled Substances 
through the Internet.34 However, there has been relatively 
slow progress in responding to requests from other States 
for cooperation and in elaborating standards of 
investigation and reporting. The Board urges all 
Governments to put in place comprehensive measures to 
prevent the operation of illegal Internet pharmacies 
from their territory. In particular, Governments should 
continue to implement the Guidelines, improve 
international cooperation in that regard and provide 
technical assistance to countries requiring such 
assistance. 
Recommendation 31: In some countries, companies in the 
private sector, including Internet registrars, providers of 
hosting space, credit companies and search engine 
providers, have decided to share information relating to 
activities of illegal Internet pharmacies, in order to enable 
companies to take steps to prevent the misuse of their 
services by illegal Internet pharmacies. The Board 
recommends that Governments encourage companies to 
deny illegal Internet pharmacies access to the legitimate 
business services required to carry out those activities. 
Recommendation 32: The import, export and transit of 
opium poppy seeds are prohibited in many countries 
adjacent to countries where opium poppy is illicitly 
cultivated. The Board recalls Economic and Social 
Council resolution 1999/32 and Commission on 
Narcotic Drugs resolutions 51/15 and 53/12 and requests 
the Governments of countries in which opium poppy is 
illicitly cultivated to cooperate closely with the 
Governments of their neighbouring countries, in order 
to prevent the smuggling of opium poppy seeds. The 
Board invites all Governments to inform it of any 
suspicious transactions involving opium poppy seeds.  
__________________ 
 34  United Nations publication, Sales No. E.09.XI.6. 
Recommendation 33: The Political Declaration of the 
High-level Meeting of the General Assembly on the 
Prevention and Control of Non-communicable Diseases 
(General Assembly resolution 66/2, annex) calls for, inter 
alia, the strengthening of country-level surveillance and 
monitoring systems. The Board encourages 
Governments to include substance use disorders in their 
strategies for addressing non-communicable diseases, 
including in their national health surveillance and 
monitoring systems.  
 
 
 B. Recommendations to the United 
Nations Office on Drugs and Crime 
and to the World Health Organization 
 
 
814. UNODC is the primary United Nations entity 
responsible for providing technical assistance and 
coordination in drug control matters for Governments 
and other organizations. The treaty-based function of 
WHO is to provide recommendations, based on medical 
and scientific assessments, regarding changes in the scope 
of control of narcotic drugs under the 1961 Convention 
and psychotropic substances under the 1971 Convention.  
Recommendation 34: Limited capacity in many low-
income countries prevents them from meeting their 
obligations under the international drug control treaties 
and communication with those Governments remains 
problematic. The Board therefore urges UNODC and 
other relevant international entitites to provide 
assistance in the form of training and capacity-building 
for the competent authorities of countries that require 
such assistance, in order to enable them to fully 
participate in the international monitoring and control 
of narcotic drugs, psychotropic substances and precursor 
chemicals.  
Recommendation 35: The Board notes that there is a 
growing variety of “emerging drugs of abuse” throughout 
the world, in particular in Europe. The Board urges 
WHO and UNODC to review that development and 
undertake specific measures to address the problem.  
Recommendation 36: The Board calls upon WHO, 
UNODC and other relevant international organizations 
to support Governments in their efforts to include 
substance use disorders and access to internationally 
controlled medicines in their national strategies for 
addressing non-communicable diseases (see also 
recommendation 33 above). 
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 C. Recommendations to other relevant 
international organizations 
 
 
815. International organizations also assist in 
international drug control efforts. In cases where States 
require additional operational support in specific areas 
such as drug law enforcement, the Board addresses 
relevant recommendations pertaining to the specific 
spheres of competence of the relevant international and 
regional organizations, such as INTERPOL and the World 
Customs Organization. 
Recommendation 37: The Board notes with concern that 
limited capacity in many low-income countries prevents 
them from meeting their obligations under the  
1988 Convention. The Board therefore invites all 
relevant international organizations, including 
INTERPOL and the World Customs Organization, to 
provide assistance in the form of training and capacity-
building for competent authorities of low-income 
countries to enable them to fully participate in the 
international precursor control mechanism, including by 
monitoring and determining the legitimacy of relevant 
transactions, thus preventing those countries from being 
targeted for the diversion of precursors. 
Recommendation 38: In West Asia, there continues to be 
significant illicit demand for acetic anhydride, which is 
used in heroin manufacture. However, only small 
amounts of acetic anhydride are reported to have been 
seized each year in the region. The seized acetic 
anhydride is often burned on site, thus losing the 
opportunity to collect forensic details and other 
information that would have been useful in backtracking 
investigations and identifying those responsible for the 
diversion of that precursor. The Board calls on regional 
and international organizations, such as CARICC, to 
assist the Government of Afghanistan and the other 
Governments concerned so that such information can be 
shared with the Board via the established Project 
Cohesion mechanisms, with a view to facilitating 
international efforts to counter precursor trafficking. 
Recommendation 39: Progress in enhancing security, 
improving governance and stepping up reconstruction 
and development is essential to helping the Government 
of Afghanistan to improve the drug control situation in 
that country. The Board calls on the international 
community, in particular United Nations entities, to 
continue its efforts to support the Government-led 
counter-narcotics activities in Afghanistan, including in 
the areas of agricultural development, interdiction, 
demand reduction, eradication and public information, 
as well as the effective implementation of Security 
Council resolution 1817 (2008) on precursor control. 
 
(Signed) 
Hamid Ghodse 
President 
(Signed) 
Sri Suryawati 
Rapporteur 
(Signed) 
Pavel Pachta 
Acting Secretary 
Vienna, 11 November 2011 
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Annex I 
 Regional and subregional groupings used in the report of the International 
Narcotics Control Board for 2011 
 The regional and subregional groupings used in the report of the International Narcotics Control Board  
for 2011, together with the States in each of those groupings, are listed below. 
 
Africa 
 
Algeria 
Angola 
Benin 
Botswana 
Burkina Faso 
Burundi 
Cameroon 
Cape Verde 
Central African Republic 
Chad 
Comoros 
Congo 
Côte d’Ivoire 
Democratic Republic of the Congo 
Djibouti 
Egypt 
Equatorial Guinea 
Eritrea 
Ethiopia 
Gabon 
Gambia 
Ghana 
Guinea 
Guinea-Bissau 
Kenya 
Lesotho 
Liberia 
 
Libyaa 
Madagascar 
Malawi 
Mali 
Mauritania 
Mauritius 
Morocco 
Mozambique 
Namibia 
Niger 
Nigeria 
Rwanda 
Sao Tome and Principe 
Senegal 
Seychelles 
Sierra Leone 
Somalia 
South Africa 
South Sudanb 
Sudan 
Swaziland 
Togo 
Tunisia 
Uganda 
United Republic of Tanzania 
Zambia 
Zimbabwe 
 
 
 
__________________ 
 a Since 16 September 2011, “Libya” has replaced “Libyan Arab Jamahiriya” as the short name used in the United Nations. 
 b By its resolution 65/308 of 14 July 2011, the General Assembly decided to admit South Sudan to membership in the  
United Nations. 
REPORT OF THE INTERNATIONAL NARCOTICS CONTROL BOARD  
 
114 
Central America and the Caribbean 
 
Antigua and Barbuda 
Bahamas 
Barbados 
Belize 
Costa Rica 
Cuba 
Dominica 
Dominican Republic 
El Salvador 
Grenada 
 
Guatemala 
Haiti 
Honduras 
Jamaica 
Nicaragua 
Panama 
Saint Kitts and Nevis 
Saint Lucia 
Saint Vincent and the Grenadines 
Trinidad and Tobago 
 
 
North America 
 
Canada 
Mexico 
 
United States of America 
 
 
 
South America 
 
Argentina 
Bolivia (Plurinational State of ) 
Brazil 
Chile 
Colombia 
Ecuador 
 
Guyana 
Paraguay 
Peru 
Suriname 
Uruguay 
Venezuela (Bolivarian Republic of) 
 
 
East and South-East Asia 
 
Brunei Darussalam 
Cambodia 
China 
Democratic People’s Republic of  
    Korea 
Indonesia 
Japan 
Lao People’s Democratic Republic 
Malaysia 
 
Mongolia 
Myanmar 
Philippines 
Republic of Korea 
Singapore 
Thailand 
Timor-Leste 
Viet Nam 
 
 
South Asia 
 
Bangladesh 
Bhutan 
India 
Maldives 
Nepal 
Sri Lanka 
 
West Asia 
 
Afghanistan 
Armenia 
Lebanon 
Oman 
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Azerbaijan 
Bahrain 
Georgia 
Iran (Islamic Republic of) 
Iraq 
Israel 
Jordan 
Kazakhstan 
Kuwait 
Kyrgyzstan 
Pakistan 
Qatar 
Saudi Arabia 
Syrian Arab Republic 
Tajikistan 
Turkey 
Turkmenistan 
United Arab Emirates 
Uzbekistan 
Yemen 
 
Europe 
 
Eastern Europe 
Belarus 
Republic of Moldova 
Russian Federation 
Ukraine 
South-Eastern Europe 
Albania 
Bosnia and Herzegovina 
Bulgaria 
Croatia 
 
The former Yugoslav Republic of 
    Macedonia 
Montenegro 
Romania 
Serbia  
 
Western and Central Europe 
Andorra 
Austria 
Belgium 
Cyprus 
Czech Republic 
Denmark 
Estonia 
Finland 
France 
Germany 
Greece 
Holy See 
Hungary 
Iceland 
Ireland 
Italy 
Latvia 
Liechtenstein 
Lithuania 
Luxembourg 
Malta 
Monaco 
Netherlands 
Norway 
Poland 
Portugal 
San Marino 
Slovakia 
Slovenia 
Spain 
Sweden 
Switzerland 
United Kingdom of Great Britain 
    and Northern Ireland 
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Oceania 
 
Australia 
Cook Islands 
Fiji 
Kiribati 
Marshall Islands 
Micronesia (Federated States of) 
Nauru 
New Zealand 
 
Niue 
Palau 
Papua New Guinea 
Samoa 
Solomon Islands 
Tonga 
Tuvalu 
Vanuatu 
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Annex II 
 
 
  Current membership of the International Narcotics Control Board 
 
 
  Hamid Ghodse 
 
 
 Born in 1938. National of the Islamic Republic of 
Iran. Professor of Psychiatry and of International Drug 
Policy, University of London (since 1987). Director, 
International Centre for Drug Policy, St. George’s 
University of London (since 2003); President, European 
Collaborating Centres for Addiction Studies (since 1992); 
Non-Executive Director, National Patient Safety Agency, 
United Kingdom (since 2001); Chairman, Honours 
Committee, Royal College of Psychiatrists, United 
Kingdom (since 2006). 
 Recipient of the following degrees, qualifications and 
awards: Doctor of Medicine (M.D.), Islamic Republic of 
Iran (1965); Diploma Psychological Medicine (D.P.M.), 
United Kingdom (1974); Doctor of Philosophy (Ph.D.), 
University of London (1976); and Doctor of Science 
(D.Sc.), University of London (2002). Fellow of the Royal 
College of Psychiatrists (F.R.C.Psych.), United Kingdom 
(1985); Fellow of the Royal College of Physicians (F.R.C.P.), 
London (1992); Fellow of the Royal College of Physicians of 
Edinburgh (F.R.C.P.E.), Edinburgh (1997); Fellow of the 
Faculty of Public Health Medicine (F.F.P.H.), United 
Kingdom (1997); Fellow of the Higher Education Academy 
(F.H.E.A.), United Kingdom (2005); International Fellow, 
American Psychiatric Association (APA) (2009). Honorary 
Fellow, Royal College of Psychiatrists (R.C.Psych.) (2006); 
Honorary Fellow, World Psychiatric Association (2008). 
Member of the World Health Organization (WHO) Expert 
Advisory Panel on Alcohol and Drug Dependence (since 
1979); Adviser, Joint Formulary Committee, British 
National Formulary (since 1984); Honorary Consultant 
Psychiatrist, St. George’s and Springfield University 
Hospitals, London (since 1978); Honorary Consultant 
Public Health, Wandsworth Primary Care Trust, London 
(since 1997). Consultant Psychiatrist, St. Thomas’s 
Teaching Hospital and Medical School, London  
(1978-1987); member, rapporteur, chairman and convener 
of various WHO and European Community expert 
committees, review groups and other working groups on 
drug and alcohol dependence; M. S. McLeod Visiting 
Professor, Southern Australia (1990); Honorary Professor, 
Peking University (since 1997). 
 Author or editor of over 350 scientific books and 
papers on drug-related issues and addictions, including the 
following books: The Misuse of Psychotropic Drugs, London 
(1981); Psychoactive Drugs and Health Problems, Helsinki 
(1987); Psychoactive Drugs: Improving Prescribing Practices, 
Geneva (1988); Substance Abuse and Dependence, 
Guildford (1990); Drug Misuse and Dependence: The British 
and Dutch Response, Lancashire, United Kingdom (1990); 
Misuse of Drugs (3rd ed.), London (1997); Young People and 
Substance Misuse, London (2004); Addiction at Workplace, 
Aldershot (2005); International Drug Control into the  
21st Century, Aldershot (2008); Ghodse’s Drugs and 
Addictive Behaviour: A Guide to Treatment (4th ed.), 
Cambridge (2010); International Perspectives on Mental 
Health, London (2011); Substance Abuse Disorders: 
Evidence and Experience, Chichester, United Kingdom 
(2011); Editor-in-Chief, International Psychiatry; Honorary 
Editor-in-Chief, Chinese Journal of Drug Dependence; 
member of the Editorial Board, International Journal of 
Social Psychiatry; member of the Editorial Board, Asian 
Journal of Psychiatry. Convener of WHO expert groups on 
medical education (1986), pharmacy education (1987), 
nurse education (1989) and rational prescribing of 
psychoactive drugs. Chairman, Association of Professors of 
Psychiatry of the British Isles (since 1991); Chairman, 
Association of European Professors of Psychiatry; Director, 
National Programme on Substance Abuse Deaths (since 
1997); member of the International Association of 
Epidemiology (since 1998).  
 Member of the International Narcotics Control Board 
(since 1992). Member of the Standing Committee on 
Estimates (1992). President of the Board (1993, 1994, 1997, 
1998, 2000, 2001, 2004, 2005, 2008, 2010 and 2011). 
 
 
  Galina Korchagina 
 
 
 Born in 1953. National of the Russian Federation. 
Deputy Director of Research at the National Centre for 
Research on Drug Addiction, Ministry of Health and Social 
Development, Russian Federation (since 2010).  
 Leningrad Paediatrics Institute, Russian Federation 
(1976); Doctor of Medicine (2001). Doctor, boarding 
school, Gatchina, Leningrad region, (1976-1979). Head  
of the Organizational and Policy Division, Leningrad 
Regional Drug Clinic (1981-1989); Lecturer, Leningrad 
Regional Medical Academy (1981-1989); Head Doctor,  
City Drug Clinic, St. Petersburg (1989-1994); Assistant 
Lecturer (1991-1996) and Professor (2000-2001), 
Department of Social Technologies, State Institute  
for Services and Economics; Assistant Lecturer  
(1994-2000), Associate Professor (2001-2002) and 
Professor (2002-2008), Department for Research on Drug 
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Addiction, St. Petersburg Medical Academy of 
Postgraduate Studies; Chief Professor and Head of the 
Department for Medical Research and Healthy Lifestyles, 
Herzen State Pedagogical University of Russia (2000-2008); 
Professor, Department for Conflict Studies, Faculty of 
Philosophy, St. Petersburg State University (2004-2008); 
member of numerous associations and societies, including: 
Association of Psychiatrists and Drug Addiction Specialists 
of Russia and St. Petersburg; Kettil Bruun Society for Social 
and Epidemiological Research on Alcohol; International 
Council on Alcohol and Addictions; International Society 
of Addiction Medicine: head of the sociology of science 
aspects of medical and biological research section of the 
Research Council on the Sociology of Science and the 
Organization of Scientific Research, St. Petersburg 
Scientific Centre of the Russian Academy of Sciences 
(2002-2008). Author of more than 100 publications, 
including more than 70 works published in the Russian 
Federation, chapters in monographs and several practical 
guides. Award for excellence in health protection, awarded 
by the Ministry of Health of the Union of Soviet Socialist 
Republics (1987). Consultant, Global Business Coalition on 
HIV/AIDS, Tuberculosis and Malaria (since 2006);  
co-trainer, WHO programme “Skills for change” (since 
1995); participant in meetings of the Commission on 
Narcotic Drugs (2002-2008); expert on the epidemiology of 
drug addiction, Pompidou Group of the Council of  
Europe (1994-2003); temporary representative, WHO 
(1992-2008). 
 Member of the International Narcotics Control Board 
(since 2010). Vice-Chair of the Standing Committee on 
Estimates (2011). 
 
 
  Carola Lander 
 
 
 Born in 1941. National of Germany. Pharmacist, 
doctoral degree in natural science; Certified Specialist in 
Public Health (Chamber of Pharmacists).  
 Research assistant and assistant professor, University 
of Berlin (1970-1979); person in charge of pharmaceutical 
quality control of herbal drugs, Federal Institute for Drugs 
and Medical Devices, Berlin (1979-1990); head of the 
division for the control of manufacturers of narcotic drugs, 
Federal Opium Agency of Germany (1990-1992). Head of 
the Federal Opium Agency, the German authority with 
competence under article 17 of the Single Convention on 
Narcotic Drugs of 1961 and article 6 of the Convention on 
Psychotropic Substances of 1971, and Chairperson of the 
federal expert group for narcotic drugs (1992-2006). 
Member of the German delegation to the Commission on 
Narcotic Drugs (1990-2006). Lecturer on drug regulatory 
affairs, University of Bonn (2003-2005). Recipient of a 
certificate of appreciation for outstanding contributions in 
the field of drug law enforcement awarded by the Drug 
Enforcement Administration of the United States and 
recipient of a certificate of appreciation awarded by the 
former Yugoslav Republic of Macedonia. 
 Member of the International Narcotics Control Board 
(since 2007). Member (2007 and 2011), Vice-Chair (2008) 
and Chair (2009) of the Standing Committee on Estimates. 
Second Vice-President (2009) and First Vice-President 
(2010) of the Board.  
 
 
  Melvyn Levitsky 
 
 
 Born in 1938. National of the United States. Retired 
Ambassador in the United States Foreign Service. Professor 
of International Policy and Practice and Senior Fellow, 
International Policy Center, Gerald R. Ford School of 
Public Policy, University of Michigan (since 2006). Faculty 
Associate, Center for Russian and East European Studies, 
Faculty, Advisor, Weiser Center for Emerging Democracies, 
University of Michigan. Member of the Operating 
Committee, Substance Abuse Research Center, University 
of Michigan. 
 United States diplomat for 35 years, serving as,  
inter alia, Ambassador of the United States to Brazil  
(1994-1998); Assistant Secretary of State for International 
Narcotics Matters (1989-1993); Executive Secretary and 
Special Assistant to the Secretary of the United States 
Department of State (1987-1989); Ambassador of the 
United States to Bulgaria (1984-1987); Deputy Director, 
Voice of America (1983-1984); Deputy Assistant Secretary 
of State for Human Rights and Humanitarian Affairs 
(1982-1983); Director, Office of United Nations Political 
Affairs, Bureau of International Relations (1980-1982); 
Officer-in-Charge for Bilateral Relations, Office of Soviet 
Union Affairs (1975-1978); Political Officer, United States 
Embassy in Moscow (1973-1975); Consul, United States 
consulates in Frankfurt, Germany (1963-1965), and Belem, 
Brazil (1965-1967). Professor of International Relations and 
Public Administration, Maxwell School of Citizenship and 
Public Affairs, Syracuse University (1998-2006). Recipient 
of several United States Department of State Meritorious 
and Superior Honor Awards, Presidential Meritorious 
Service Awards and the United States Secretary of State’s 
Distinguished Service Award. Member of the Washington 
Institute of Foreign Affairs, the American Academy  
of Diplomacy and the American Foreign Service 
Association. Member of the Advisory Board, Drug Free 
America Foundation. Member of the Institute on Global 
Drug Policy. Member of the Board, Global Panel of the 
Prague Society. Member of the Public-Private Working 
Group on Sale of Controlled Substances via the Internet  
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(Harvard University Law School). Distinguished Fellow, 
Daniel Patrick Moynihan Institute of Global Affairs, 
Maxwell School of Citizenship and Public Affairs, 
Syracuse University. Member of the University of 
Michigan Substance Abuse Research Center. Listed in 
Who’s Who in American Politics, Who’s Who in American 
Government and Who’s Who in American Education. 
 Member of the International Narcotics Control 
Board (since 2003). Chairman of the Committee on 
Finance and Administration (2004). Chairman of the 
Working Group on Strategy and Priorities (2005). 
 
 
  Marc Moinard 
 
 
 Born in 1942. National of France. Retired law 
officer. School of Political Sciences, Paris; Paris Law 
Faculty; Faculty of Arts, Poitiers. Public Prosecutor, 
Beuvais (1982-1983); Public Prosecutor, Pontoise (1990); 
Public Prosecutor, Lyon (1990-1991); Public Prosecutor, 
Bobigny (1992-1995); Public Prosecutor in the Court of 
Appeal, Bordeaux (1999-2005), introducing major 
reforms into the legal system involving: the creation of 
centres for legal advice and mediation; the provision of 
legal advice in deprived areas; the establishment of a new 
system of cooperation between the courts and the police 
services allowing for the immediate handling of criminal 
offences; and the creation of a new category of judicial 
personnel — assistant prosecutors. 
 Senior administrative posts in the Ministry of 
Justice: Director of Record Offices (1983-1986); President 
of the teaching board, National School of Clerks to the 
Court; Director of Legal Services; member of the Board of 
Directors, French National School for the Judiciary; 
Representative of the Minister of Justice in the Supreme 
Council of Justice (1995-1996); Director, Criminal 
Matters and Pardons (1996-1998); President, French 
Monitoring Centre for Drugs and Drug Addiction; 
Secretary-General, Ministry of Justice (2005-2008); 
President, Law and Justice Mission, responsible for the 
reform of the judicial map; President, Commission on 
Information Technology and Communication; Head of 
the International Affairs Service, Ministry of Justice. 
Lecturer, Paris Institute of Criminology (1995-2005); 
President, Fondation d’Aguesseau, a welfare body. 
Recipient of the following awards: Commander of the 
National Order of Merit; Commander of the Legion of 
Honour.  
 Member of the International Narcotics Control 
Board (since 2010). Member of the Committee on 
Finance and Administration (2011). Member of the 
Standing Committee on Estimates (2011). 
  Jorge Montaño 
 
 
 Born in 1948. National of Mexico. Professor of 
International Organizations and Mexican Foreign Policy, 
Instituto Tecnológico Autónomo de México, private 
consultant on the enforcement of the North American 
Free Trade Agreement (NAFTA). 
 Law and Political Science, Universidad Nacional 
Autónoma de México; Master of Arts and Doctor of 
Philosophy in International Affairs, London School of 
Economics. Director General de Educación Superior — 
Secretaría de Educación Pública (1976-1979); Member  
of the Mexican Foreign Service (1979-2008); Director  
of International Agencies (1979-1982); Assistant  
Secretary of Multilateral Affairs (1982-1988); Permanent 
Representative of Mexico to the United Nations 
organizations (1989-1992); Chairman of the Group of 
Experts to enhance the efficiency of the United Nations 
structure for drug abuse control (1990); Ambassador of 
Mexico to the United States (1993-1995); member of the 
Multilateral Evaluation Mechanism on Drugs (2001-
2003) of the Inter-American Drug Abuse Control 
Commission (CICAD). Member of the Special Advisory 
Board, World Bank (2010-2012). Author of the following 
publications: Partidos y política en América Latina; 
Implicaciones legales de la presencia de Estados Unidos en 
Viet Nam; Análisis del Sistema de Naciones Unidas; 
ACNUR en América Latina; Negociaciones del Tratado de 
Libre Comercio de America del Norte; Cooperación 
México-Estados Unidos en materia de narcotráfico; 
Debilidades de la certificación del Congreso de Estados 
Unidos; Retos de la frontera norte de México; Tráfico de 
armas en las fronteras mexicanas. Author of 50 articles 
published in specialized journals. Weekly contributor to 
the editorial pages of La Jornada, Reforma and  
El Universal. President and founding member of Foreign 
Affairs Latinoamérica (formerly Foreign Affairs en 
Español). Founding President, Asesoría y Análisis, S.C., 
Mexican Council on Foreign Relations (COMEXI). 
Recipient of awards from the Governments of Chile,  
El Salvador, Greece and Guatemala. Participant in many 
meetings of organizations in the United Nations system, 
the Organization of American States and the Movement 
of Non-Aligned Countries.  
 Member of the International Narcotics Control 
Board (since 2009). Member of the Committee on 
Finance and Administration (2010).  
 
 
  Lochan Naidoo 
 
 
 Born in 1961. National of South Africa. Family 
Practitioner, Durban, South Africa (since 1985).  
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 Bachelor of Medicine and Bachelor of Surgery 
(MBChB), University of Natal, South Africa (1983). 
Professional in Residence Programme: Hanley Hazelden 
(1995); Member of the South African Medical Association 
(since 1995); Member and Vice-Chairman of the Bayport 
Independent Practitioners Association (1995-2000). 
Certified Chemical Dependency Counsellor, National 
Board of Addiction Examiners (NBAE) (1996); Member of 
the American Society of Addiction Medicine (1996-1999). 
Diploma in Business Management, South African Institute 
of Management (1997). Founding member, International 
Society of Addiction Medicine (1999); Programme 
Designer and Principal Addictions Therapist of the Jullo 
Programme, a multi-disciplinary treatment model for 
primary, secondary and tertiary prevention of addiction 
disorders and dual diagnoses (since 1994); Clinical 
Director, Serenity Addiction Treatment Unit, Merebank, 
Durban, South Africa (since 1995). Member of the 
KwaZulu-Natal Managed Care Coalition (since 1995); 
Member of the Durban South Doctors’ Guild (since 2000); 
Honorary Lecturer, Nelson R. Mandela School of Medicine, 
University of KwaZulu-Natal, South Africa (since 2005). 
Curriculum Committee undergraduate Lifestyle Medicine, 
University of KwaZulu-Natal (since 2005). Drafter of the 
National Detoxification Policy and Procedure for the 
Department of Health of South Africa (2006); designer of 
the Roots connect software program, an Internet-driven 
emotional and addiction psychoeducation delivery system 
(2007); Member of the Opiate Advisory Board of South 
Africa (2006-2008); Member of the Board, Central Drug 
Authority of South Africa (2006-2010); Member of the 
Governance Committee, Central Drug Authority of South 
Africa (2006-2010). Member of the Expert Committee on 
Opiate Treatment (2007-2008); Central Drug Authority 
representative to the Western Cape Province, South Africa 
(2007-2010); established “Roots HelpPoints” for early 
intervention and primary prevention among high-risk 
individuals (2008). Co-author of “Guidelines for opiate 
treatment in South Africa”, South African Medical Journal 
(2008). Member of the Suboxone Advisory Board (2009). 
Co-author of “Suboxone update”, South African Medical 
Journal (2010); Designer of “RehabFlow” cloud computing 
software for addiction and co-morbidity management 
(2010); Management Committee Member of eThekweni 
District Mental Heath and Substance Abuse Forum (2010). 
Rehabilitation and addictions trainer for health-care 
practitioners. Medical educator for undergraduate and 
postgraduate medical practitioners (since 1995); Patron of 
Andra Maha Sabha of South Africa; founder, Merebank 
West Community Coalition (1995). Trustee, Merebank 
Community Trust (2000-2005).  
 Member of the International Narcotics Control Board 
(since 2010). Member of the Standing Committee on 
Estimates (2011). Member of the Committee on Finance 
and Administration (2011). 
 
 
  Rajat Ray 
 
 
 Born in 1948. National of India. Professor and Head 
of the Department of Psychiatry and Chief, National Drug 
Dependence Treatment Centre (NDDTC), All India 
Institute of Medical Sciences (AIIMS), New Delhi. 
 Graduate of Medicine (MBBS), Medical College in 
Calcutta (1971). M.D. (Psychiatry), AIIMS (1977). Member 
of the faculty, Department of Psychiatry, National Institute 
of Mental Health and Neuro Sciences in Bangalore  
(1979-1988). Author of several technical reports and 
articles in peer reviewed national and international 
journals. Assistant Editor, Addiction Biology. Member of 
the International Advisory Board, Mental Health and 
Substance Use: Dual Diagnosis. Recipient of research 
support from various bodies at the national level (such as 
the Ministry of Health and Family Welfare and the Indian 
Council of Medical Research) and the international level 
(such as the United Nations Office on Drugs and Crime 
(UNODC) and WHO). Member of a study on HIV/AIDS, a 
collaborative project of NDDTC, AIIMS and the Center for 
Interdisciplinary Research in Immunology and Disease, 
University of California, Los Angeles (UCLA), United 
States of America. Member of the WHO Expert Advisory 
Panel on Drug Dependence and Alcohol Problems. 
Member of the expert group to discuss mental health and 
substance use disorder at the primary care level, an activity 
of the WHO Regional Office for South-East Asia. Member 
of the WHO expert group on regional technical 
consultation to reduce harmful use of alcohol. Coordinator 
of various activities in India on substance use disorder, 
sponsored by WHO (since 2004). Member of the National 
Drug Abuse Control Programme, India, and the Technical 
Guidelines Development Group on Pharmacotherapy of 
Opioid Dependence, a joint project of UNODC and WHO. 
Member and Chairperson of the Technical Resource Group 
on Injecting Drug Use, a project of the National AIDS 
Control Organization. Member of the project advisory 
committee on the prevention of transmission of HIV 
among drug users in South Asian Association for Regional 
Cooperation (SAARC) member States, a project of the 
UNODC Regional Office for South Asia. Member of the 
Subcommittee on Postgraduate Medical Education, 
Medical Council of India. Chairperson, Working Group on 
Classification of Substance — Related and Addictive 
Disorder, International Advisory Group for the Revision of 
ICD-10 Mental and Behavioural Disorders (2011); 
Principal investigator, WHO Project “Web-Based 
Intervention (Portal) for Alcohol and Health”, Geneva 
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(since 2010); principal investigator, NDDTC, Global Fund 
to Fight AIDS, Tuberculosis and Malaria Round 9 and 
Nodal Regional Resource and Training Centre; Principal 
Coordinator, National Policy and Twelfth Five-Year Plan of 
India, covering the period 2012-2017, areas relating to 
control of alcohol and drug problems, Ministry of Social 
Justice and Empowerment, Government of India; Principal 
Investigator, opioid substitution therapy in India: issues 
and lessons learned, a joint project of NDDTC, AIIMS, the 
National AIDS Control Organisation, the government of 
Punjab and the Department for International Development 
(UK aid) — Technical Assistance Support Team, targeted 
intervention (since 2010); member of the Expert 
Committee on Psychotropics and New Drugs, Drug 
Controller General of India (2011). Reviewer and 
contributor, Indian Journal of Medical Research, official 
publication of the Indian Council of Medical Research 
(since 2010). 
 Member of the International Narcotics Control Board 
(since 2010). Member (2010) and Chair (2011) of the 
Standing Committee on Estimates. Second Vice-President 
of the Board (2011). 
 
 
  Viroj Sumyai 
 
 
 Born in 1953. National of Thailand. Retired Assistant 
Secretary-General of the Food and Drug Administration, 
Ministry of Public Health of Thailand, and clinical 
pharmacologist specializing in drug epidemiology. 
Professor, Mahidol University (since 2001). 
 Bachelor of Science degree in Chemistry (1976), 
Chiang Mai University. Bachelor’s degree in Pharmacy 
(1979), Manila Central University. Master’s degree in 
Clinical Pharmacology (1983), Chulalongkorn University. 
He then took apprenticeship in narcotic drugs 
epidemiology at St. George’s University of London in 
England in 1989. Doctor of Philosophy, Health Policy  
and Administration (2009), National Institute of 
Administration. Member of the Pharmaceutical 
Association of Thailand. Member of the Pharmacological 
and Therapeutic Society of Thailand. Member of the Thai 
Society of Toxicology. Author of nine books in the field of 
drug prevention and control, including Drugging Drinks: 
Handbook for Predatory Drugs Prevention and Déjà vu:  
A Complete Handbook for Clandestine Chemistry, 
Pharmacology and Epidemiology of LSD. Columnist, Food 
and Drug Administration Journal. Recipient of the Prime 
Minister Award for Drug Education and Prevention (2005).  
 Member of the International Narcotics Control Board 
(since 2010). Member of the Standing Committee on 
Estimates (since 2010). Chair of the Committee on Finance 
and Administration (2011). 
 
 
  Sri Suryawati 
 
 
 Born in 1955. National of Indonesia. Coordinator, 
Master Degree Program for Medicine Policy and 
Management, Gadjah Mada University. Senior Lecturer  
in Pharmacology/Clinical Pharmacology (since 1980); 
supervisor for more than 120 master’s and doctoral  
theses on medicine policy, the rational use of medicines, 
clinical pharmacokinetics, pharmacoeconomics and 
pharmaceutical management. 
 Pharmacist (1979). Specialist in pharmacology 
(1985); doctoral degree in clinical pharmacokinetics 
(1994). Former Director of the Centre for Clinical 
Pharmacology and Medicine Policy Studies, Gadjah Mada 
University (2002-2010). Former Head of Clinical 
Pharmacology, Faculty of Medicine, Gadjah Mada 
University, Indonesia (1999-2006 and 2008-2009). Member 
of the WHO Expert Advisory Panel for Medicine Policy 
and Management. Member of the Executive Board of the 
International Network for the Rational Use of Drugs 
(INRUD). Member of the WHO Expert Committee on  
the Selection and Use of Essential Medicines (2002, 2003, 
2005 and 2007). Member of the WHO Expert Committee 
on Drug Dependence (2002 and 2006). Member of the 
United Nations Millennium Project Task Force on 
HIV/AIDS, Malaria and Tuberculosis and Access to 
Essential Medicines (Task Force 5) (2001-2005). Consultant 
in essential medicine programmes and promoting rational 
use of medicines in Bangladesh (2006-2007), Cambodia  
(2001-2008), China (2006-2008), Fiji (2009), the Lao 
People’s Democratic Republic (2001-2003), Mongolia 
(2006-2008) and the Philippines (2006-2007). Consultant 
in medicine policy and drug evaluation in Cambodia 
(2003, 2005 and 2007), China (2003), Indonesia  
(2005-2006) and Viet Nam (2003). Facilitator in various 
international training courses in medicine policy and 
promoting the rational use of medicines, including WHO 
and INRUD courses on promoting the rational use of 
medicines (1994-2007), training courses on hospital drugs 
and therapeutics committees (2001-2007) and international 
courses on medicine policy (2002-2003). 
 Member of the International Narcotics Control Board 
(since 2007). Member (2008 and 2011), Vice-Chair (2009) 
and Chair (2010) of the Standing Committee on Estimates. 
Second Vice-President of the Board (2010). Rapporteur 
(2011). 
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  Camilo Uribe Granja 
 
 
 Born in 1963. National of Colombia. Medical 
Director, Maldonado Editorial Foundation, ILADIBA, 
Bogota; Director Toxicology Unit, Clínica de Marly, Bogota 
(since 1990); Toxicologist, Clínica Palermo, Bogota  
(since 1994); Scientific Director, Unidad de Toxicología 
Integral (UNITOX), Hospital Infantil Universitario de San 
José (since 2008); Chief Coordinator, Clinic Toxicology, 
Hospital Infantil Universitario de San José, Bogota. 
 Medical doctor, Surgery, Faculty of Medicine, 
University of Our Lady of the Rosary (1989); specialization 
in clinical toxicology, Faculty of Medicine, University of 
Buenos Aires (1990); specialization in occupational 
toxicology (1997), University Teacher’s Certificate (1998), 
diplomas in hospital management (1998) and high-level 
social security administration (1999), High-Level Public 
Administration School (ESAP). Diploma in toxicological 
emergencies, University of Our Lady of the Rosary, 
FUNDASALUD (1998); diploma in higher education 
tuition, University of Our Lady of the Rosary. Forensic 
medical doctor, toxicologist, technical coordinator and 
manager in several hospitals and institutions. Medical 
Director, Hospital of San Martín, Meta, Colombia (1988); 
Head of Medical Attention, Caja de Previsión Social de 
Comunicaciones (CAPRECOM), Meta and national 
territories (until 1990); Regional Director, CAPRECOM, 
Bogota (until Dec. 1992); Scientific Director, Toxicology 
Clinic, toxicology advisory centre, “Guillermo Uribe 
Cualla” (1991-2005); Director, Clinical Toxicology, Clínica 
Fray Bartolomé de las Casas (until Jan. 1991); Toxicology 
Doctor, Clínica San Pedro Claver (1990-1991); President, 
Tropical Medicine Institute Corporation “Luis Patiño 
Camargo” (until 1992); Medical Coordinator and  
(since 1993) Director, National Emergency Network; 
Director, Toxicology Department, Hospital de Occidente 
Kennedy, Bogota (1993-1998); Director, Toxicology, Health 
Department, District of Bogota (1993-1999); Director, 
Health Services Management Programme, ESAP  
(until 2001); Member of the Steering Committee of Drugs 
and Food Control Administration, National Institute  
of Food and Drug Monitoring (INVIMA) (1994-2001); 
Director-General, INVIMA (2001-2002); Secretary, 
Colombian Medical Association, Cundinamarca and 
Bogota sections (until 2002); Director-General, Nueva 
Clínica Fray Bartolomé de las Casas, Bogota (2002-2003); 
Adviser to the toxicology office, United States Department 
of State (until 2005); Adviser in Toxicology, National 
Narcotics Directorate (DNE) of Colombia (until 2005). 
President, Colombian Association of Toxicology and  
Drug Abuse (ACOTOFA) (since 1992); Vice-President  
(1988-1990 and 1995-1998) and President (2003-2009), 
Latin American Toxicology Association (ALATOX);  
Vice-President, International Union of Toxicology 
(IUTOX) (2005-2007 and 2007-2009). Author of numerous 
works, including: the chapter on benzodiazepines in 
Therapeutic Compendium of the Colombian Internal 
Medicine Association (1992); Criminal Intoxication with 
Scopolamine-Like Substances; Handbook on Toxicological 
Emergency Management; and Manual on the Treatment of 
Intoxication by Plaguicides (1995). Recipient of numerous 
awards, including: award for academic records and 
qualifications, Iberoamerican Congress of Toxicology 
(Bicongretox), Spanish Association of Toxicolgy (AETOX) 
(1993); and honourable mention for services to Colombian 
society in the field of toxicology, First International 
Congress of Toxicology, University of Antioquia (1996). 
Full member, National Medicine Academy, Member of the 
Public Health Committee, Member of the Mental Health 
Committee. Participant in numerous professional 
conferences and seminars, including: XVIII International 
Congress of Internal Medicine, Bogota (1986);  
35th Annual Meeting, Society of Toxicology, Anaheim, 
California (1996); Pan-American Congress of 
Neuropsychopharmacology and International Seminar on 
Addictive Diseases, Bogota (1998). National Congress on 
Heroin: A Challenge for Mental and Public Health, 
Medellin (2008); and International Congress on Synthetic 
Drugs (2009). Head of the Law Faculty, Pontificia 
Universidad Javeriana (1990-2006); Industrial Toxicology 
Professor, Colombian Security Council (until 1993); 
Postgraduate Professor, Fundación Universitaria Luis 
Amigó; and Instructor of Toxicology, Faculty of Medicine, 
National University of Colombia.  
 Member of the International Narcotics Control Board 
(since 2005). Member (since 2009), Vice-Chair (2006 and 
2007) and Chair (2008) of the Standing Committee on 
Estimates. Member (since 2007) and Chair (2010) of the 
Committee on Finance and Administration. 
 
 
  Raymond Yans 
 
 
 Born in 1948. National of Belgium. Graduate in 
Germanic philology and in philosophy (1972).  
 Belgian Foreign Service: Attaché, Jakarta  
(1978-1981); Deputy-Mayor of Liège (1982-1989); Consul, 
Tokyo (1989-1994); Consul, Chargé d’affaires, Luxembourg 
(1999-2003); Head of the Drug Unit, Ministry of Foreign 
Affairs (1995-1999 and 2003-2007); Chairman of the 
Dublin Group (2002-2006); Chairman of the European 
Union Drug Policy Cooperation Working Group during 
the Belgian Presidency of the European Union; charged 
with the national coordination of the ratification and 
implementation process of the Convention on Psychotropic 
Substances of 1971 and the United Nations Convention 
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against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances of 1988 (1995-1998); liaison between the 
Ministry of Foreign Affairs and the National Police for 
drug liaison officers in Belgian embassies (2003-2005); 
participation in the launching by the European Union Joint 
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drugs (1999); active in the creation of the Cooperation 
Mechanism on Drugs between the European Union, Latin 
America and the Caribbean (1997-1999). Author of 
numerous articles and speeches including: “The future of 
the Dublin Group” (2004) and “Is there anything such as a 
European Union Common Drug Policy” (2005). Member 
of the Belgian delegation to the Commission on Narcotic 
Drugs (1995-2007); all the preparatory sessions (on 
amphetamine-type stimulants, precursors, judicial 
cooperation, money-laundering, drug demand reduction 
and alternative development) for the twentieth special 
session of the General Assembly; European Union Seminar 
on Best Practices in Drug Enforcement by Law 
Enforcement Authorities, Helsinki (1999); Joint European 
Union/Southern African Development Community 
Conferences on Drug Control Cooperation, Mmabatho, 
South Africa (1995) and Gabarone (1998); United Nations 
Office on Drugs and Crime/Paris Pact round tables, 
Brussels (2003), Tehran and Istanbul (2005); meetings of 
the High-level Dialogue on Drugs between the Andean 
Community and the European Union, Lima (2005) and 
Vienna (2006). 
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on Estimates (2007-2010). Member of the Committee  
on Finance and Administration (2007-2010). Rapporteur 
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 Born in 1965. National of China. Clinical Professor of 
Psychiatry, Institute of Mental Health, Peking University 
(since 2004). Licensed Psychiatrist, China Medical 
Association (since 1988). Founding President, Chinese 
Psychiatrist Association (2005-2008); Chairperson, 
Credential Committee for Psychiatrists, Ministry of Health 
of China; President-elect, Chinese Society of Psychiatry 
(since 2006); Vice-President, Management Association for 
Psychiatric Hospitals (2009); Vice-Chairman, Alzheimer’s 
Disease, China (since 2002). 
 Bachelor of Medicine, Beijing Medical University 
(1988); Fellow in Psychiatry, University of Melbourne, 
Australia (1996-1997); Fellow in Substance Abuse, Johns 
Hopkins University (1998-1999); Doctor of Medicine 
(M.D.), Peking University (2000); Senior Fellow in Social 
Medicine, Harvard University (2003). Residency in 
psychiatry (1988-1993) and Psychiatrist (1993-1998), 
Institute of Mental Health, Beijing Medical University; 
Head, Associate Professor of Psychiatry, Geriatric 
Psychiatrist, Department of Geriatric Psychiatry, Institute 
of Mental Health, Peking University (1999-2001); Assistant 
Director (2000-2001) and Executive Director (2001-2004), 
Institute of Mental Health, Peking University. Author and 
co-author of numerous works on various topics in 
psychiatry, such as psychopharmacology, early intervention 
of schizophrenia, mental health and HIV/AIDS and drug 
use, mental health outcome of harmful alcohol use, 
neuropsychology of mental disorders, neuroimaging of late 
life depression, late onset psychosis, and assessment, 
treatment and care for dementia. Editor of several 
textbooks, including Geriatric Psychiatry, Textbook of 
Psychiatry for Asia and Psychiatry for Medical Students. 
Recipient of the Outstanding Clinician Award, Beijing 
Medical University, and the Innovation and Creation 
Award, Beijing Medical Professional Union (2004). 
Member of the expert group for the section on analgesics 
and sedatives of the State Food and Drug Administration 
(since 2000). Evaluator of the effectiveness of methadone 
clinics. Leader of a project to follow up the neurocognitive 
and mental functioning of patients infected with 
HIV/AIDS as a result of intravenous drug abuse. Chief 
Psychiatrist, National Community Mental Health Service 
Programme. Senior consultant, Chinese Association on 
Tobacco Control. Senior consultant, Chronic Pain 
Treatment Programme.  
 Member of the International Narcotics Control Board 
(since 2007). Chairman of the Committee on Finance  
and Administration (2009). Member (since 2007) and  
Vice-Chair (2010) of the Standing Committee on 
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 About the International Narcotics Control Board 
 
 
The International Narcotics Control Board (INCB) is an independent and quasi-judicial control organ, established by 
treaty, for monitoring the implementation of the international drug control treaties. It had predecessors under the former 
drug control treaties as far back as the time of the League of Nations. 
 
 
Composition 
 
 
 INCB consists of 13 members who are elected by the Economic and Social Council and who serve in their personal 
capacity, not as Government representatives. Three members with medical, pharmacological or pharmaceutical 
experience are elected from a list of persons nominated by the World Health Organization (WHO) and 10 members are 
elected from a list of persons nominated by Governments. Members of the Board are persons who, by their competence, 
impartiality and disinterestedness, command general confidence. The Council, in consultation with INCB, makes all 
arrangements necessary to ensure the full technical independence of the Board in carrying out its functions. INCB has a 
secretariat that assists it in the exercise of its treaty-related functions. The INCB secretariat is an administrative entity of 
the United Nations Office on Drugs and Crime, but it reports solely to the Board on matters of substance. INCB closely 
collaborates with the Office in the framework of arrangements approved by the Council in its resolution 1991/48. INCB 
also cooperates with other international bodies concerned with drug control, including not only the Council and its 
Commission on Narcotic Drugs, but also the relevant specialized agencies of the United Nations, particularly WHO. It 
also cooperates with bodies outside the United Nations system, especially the International Criminal Police Organization 
(INTERPOL) and the World Customs Organization. 
 
 
Functions 
 
 
 The functions of INCB are laid down in the following treaties: the Single Convention on Narcotic Drugs of 1961 as 
amended by the 1972 Protocol; the Convention on Psychotropic Substances of 1971; and the United Nations Convention 
against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988. Broadly speaking, INCB deals with the 
following: 
 (a) As regards the licit manufacture of, trade in and use of drugs, INCB endeavours, in cooperation with 
Governments, to ensure that adequate supplies of drugs are available for medical and scientific uses and that the diversion 
of drugs from licit sources to illicit channels does not occur. INCB also monitors Governments’ control over chemicals 
used in the illicit manufacture of drugs and assists them in preventing the diversion of those chemicals into the illicit 
traffic; 
 (b) As regards the illicit manufacture of, trafficking in and use of drugs, INCB identifies weaknesses in national 
and international control systems and contributes to correcting such situations. INCB is also responsible for assessing 
chemicals used in the illicit manufacture of drugs, in order to determine whether they should be placed under 
international control. 
 In the discharge of its responsibilities, INCB: 
 (a) Administers a system of estimates for narcotic drugs and a voluntary assessment system for psychotropic 
substances and monitors licit activities involving drugs through a statistical returns system, with a view to assisting 
Governments in achieving, inter alia, a balance between supply and demand; 
 (b) Monitors and promotes measures taken by Governments to prevent the diversion of substances frequently 
used in the illicit manufacture of narcotic drugs and psychotropic substances and assesses such substances to determine 
whether there is a need for changes in the scope of control of Tables I and II of the 1988 Convention; 
 (c) Analyses information provided by Governments, United Nations bodies, specialized agencies or other 
competent international organizations, with a view to ensuring that the provisions of the international drug control 
treaties are adequately carried out by Governments, and recommends remedial measures; 
  
 
 
 (d) Maintains a permanent dialogue with Governments to assist them in complying with their obligations under 
the international drug control treaties and, to that end, recommends, where appropriate, technical or financial assistance 
to be provided. 
 INCB is called upon to ask for explanations in the event of apparent violations of the treaties, to propose appropriate 
remedial measures to Governments that are not fully applying the provisions of the treaties or are encountering 
difficulties in applying them and, where necessary, to assist Governments in overcoming such difficulties. If, however, 
INCB notes that the measures necessary to remedy a serious situation have not been taken, it may call the matter to the 
attention of the parties concerned, the Commission on Narcotic Drugs and the Economic and Social Council. As a last 
resort, the treaties empower INCB to recommend to parties that they stop importing drugs from a defaulting country, 
exporting drugs to it or both. In all cases, INCB acts in close cooperation with Governments. 
 INCB assists national administrations in meeting their obligations under the conventions. To that end, it proposes 
and participates in regional training seminars and programmes for drug control administrators. 
 
 
Reports 
 
 
 The international drug control treaties require INCB to prepare an annual report on its work. The annual report 
contains an analysis of the drug control situation worldwide so that Governments are kept aware of existing and potential 
situations that may endanger the objectives of the international drug control treaties. INCB draws the attention of 
Governments to gaps and weaknesses in national control and in treaty compliance; it also makes suggestions and 
recommendations for improvements at both the national and international levels. The annual report is based on 
information provided by Governments to INCB, United Nations entities and other organizations. It also uses information 
provided through other international organizations, such as INTERPOL and the World Customs Organization, as well as 
regional organizations. 
 The annual report of INCB is supplemented by detailed technical reports. They contain data on the licit movement 
of narcotic drugs and psychotropic substances required for medical and scientific purposes, together with an analysis of 
those data by INCB. Those data are required for the proper functioning of the system of control over the licit movement 
of narcotic drugs and psychotropic substances, including preventing their diversion to illicit channels. Moreover, under 
the provisions of article 12 of the 1988 Convention, INCB reports annually to the Commission on Narcotic Drugs on the 
implementation of that article. That report, which gives an account of the results of the monitoring of precursors and of 
the chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, is also published as 
a supplement to the annual report. 
 Since 1992, the first chapter of the annual report has been devoted to a specific drug control issue on which INCB 
presents its conclusions and recommendations in order to contribute to policy-related discussions and decisions in 
national, regional and international drug control. The following topics were covered in past annual reports: 
 1992:  Legalization of the non-medical use of drugs 
 1993:  The importance of demand reduction 
 1994:  Evaluation of the effectiveness of the international drug control treaties 
 1995:  Giving more priority to combating money-laundering 
 1996:  Drug abuse and the criminal justice system 
 1997:  Preventing drug abuse in an environment of illicit drug promotion 
 1998:  International control of drugs: past, present and future 
 1999:  Freedom from pain and suffering 
 2000:  Overconsumption of internationally controlled drugs 
 2001: Globalization and new technologies: challenges to drug law enforcement in the twenty-first century 
 2002:  Illicit drugs and economic development 
 
 
 
 2003:  Drugs, crime and violence: the microlevel impact 
 2004:  Integration of supply and demand reduction strategies: moving beyond a balanced approach 
 2005: Alternative development and legitimate livelihoods 
 2006: Internationally controlled drugs and the unregulated market 
 2007: The principle of proportionality and drug-related offences 
 2008: The international drug control conventions: history, achievements and challenges 
 2009: Primary prevention of drug abuse 
 2010: Drugs and corruption 
 Chapter I of the report of the International Narcotics Control Board for 2011 is entitled “Social cohesion, social 
disorganization and illegal drugs”. 
 Chapter II presents an analysis of the operation of the international drug control system based primarily on 
information that Governments are required to submit directly to INCB in accordance with the international drug control 
treaties. Its focus is on the worldwide control of all licit activities related to narcotic drugs and psychotropic substances, as 
well as chemicals used in the illicit manufacture of such drugs. 
 Chapter III presents some of the major developments in drug abuse and trafficking and measures by Governments 
to implement the international drug control treaties by addressing those problems. 
 Chapter IV presents the main recommendations addressed by INCB to Governments, the United Nations Office on 
Drugs and Crime, WHO and other relevant international and regional organizations. 
 
 
 
 
 
United Nations system and drug control organs and their secretariat 
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Narcotic Drugs 
 
INCB 
 
UNODCa/INCB secretariatb 
Key: 
 
General Assembly 
aUnited Nations Office on Drugs and Crime. 
bThe INCB secretariat reports on substantive matters to INCB only. 
 
Reports published by the International Narcotics Control Board in 2011 
 
   The Report of the International Narcotics Control Board for 2011 (E/INCB/2011/1) is 
supplemented by the following reports: 
   
   Narcotic Drugs: Estimated World Requirements for 2012 — Statistics for 2010 
(E/INCB/2011/2) 
 
   Psychotropic Substances: Statistics for 2010 — Assessments of Annual Medical and Scientific 
Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic 
Substances of 1971 (E/INCB/2011/3) 
 
   Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and 
Psychotropic Substances: Report of the International Narcotics Control Board for 2011 on the 
Implementation of Article 12 of the United Nations Convention against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2011/4) 
 
   The updated lists of substances under international control, comprising narcotic drugs, 
psychotropic substances and substances frequently used in the illicit manufacture of narcotic 
drugs and psychotropic substances, are contained in the latest editions of the annexes to the 
statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. 
 
Contacting the International Narcotics Control Board 
 
   The secretariat of the Board may be reached at the following address: 
    Vienna International Centre 
    Room E-1339 
    P.O. Box 500 
    1400 Vienna 
    Austria 
 
   In addition, the following may be used to contact the secretariat: 
    Telephone:  (+43-1) 26060 
    Fax:    (+43-1) 26060-5867 or 26060-5868 
    E-mail:   secretariat@incb.org 
   The text of the present report is also available on the website of the Board (www.incb.org). 
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